Advanced Search
MyIDEAS: Login to follow this JEL code

Research classified by Journal of Economic Literature (JEL) codes


Top JEL
/ I: Health, Education, and Welfare
/ / I0: General
/ / I1: Health
/ / I2: Education
/ / I3: Welfare, Well-Being, and Poverty

This topic is covered by the following reading lists:
  1. SOEP based publications

Most recent items first, undated at the end.
  • 2014 Does the Letter Matter (and for Everyone)? - Quasi-experimental Evidence on the Eff ects of Home Invitation on Mammography Uptake
    by Vincenzo Carrieri & Ansgar Wuebker
  • 2014 CHIPRA Quality Demonstration States Help School-Based Health Centers Strengthen Their Medical Home Features
    by Mynti Hossain & Rebecca Coughlin & Joseph Zickafoose
  • 2014 Costs of Early Childhood Home Visiting: An Analysis of Programs Implemented in the Supporting Evidence-Based Home Visiting to Prevent Child Maltreatment Initiative
    by Andrew Burwick & Heather Zaveri & Lisa Shang & Kimberly Boller & Deborah Daro & Debra A. Strong
  • 2014 Making Replication Work: Building Infrastructure to Implement, Scale-up, and Sustain Evidence-Based Early Childhood Home Visiting Programs with Fidelity
    by Kimberly Boller & Deborah Daro & Patricia Del Grosso & Russell Cole & Diane Paulsell & Bonnie Hart & Brandon Coffee-Borden & Debra Strong & Heather Zaveri & Margaret Hargreaves
  • 2014 Making Replication Work: Building Infrastructure to Implement, Scale-up, and Sustain Evidence-Based Early Childhood Home Visiting Programs with Fidelity
    by Kimberly Boller & Deborah Daro & Patricia Del Grosso & Russell Cole & Diane Paulsell & Bonnie Hart & Brandon Coffee-Borden & Debra Strong & Heather Zaveri & Margaret Hargreaves
  • 2014 Regional Partnership Grant Program Cross-Site Evaluation Design Report: Executive Summary
    by Debra A. Strong & Diane Paulsell & Russell Cole & Sarah A. Avellar & Angela V. D'Angelo & Juliette Henke & Rosalind E. Keith
  • 2014 Regional Partnership Grant Program Cross-Site Evaluation Design Report
    by Debra A. Strong & Diane Paulsell & Russell Cole & Sarah A. Avellar & Angela V. D'Angelo & Juliette Henke & Rosalind E. Keith
  • 2014 Small Businesses' Decisions to Offer Health Insurance to Employees
    by Catherine McLaughlin & Adam Swinburn
  • 2014 Risk Factors Associated with Disability Following Work-Related Injuries
    by Nan L. Maxwell & Nathan Wozny
  • 2014 Observed Quality and Psychometric Properties of the CLASS-T in the Early Head Start Family and Child Experiences Survey
    by Eileen Bandel & Nikki Aikens & Cheri A. Vogel & Kimberly Boller & Lauren Murphy
  • 2014 Preliminary Findings from the Literature Review Presented at the Technical Work Group Meeting for the Study of Early Head Start-Child Care Partnerships
    by Patricia Del Grosso & Lauren Akers & rea Mraz Esposito & Diane Paulsell
  • 2014 Theory of Change for the Study of EHS-Child Care Partnerships
    by Various authors
  • 2014 Impacts of an Enhanced Family Health and Sexuality Module of the HealthTeacher Middle School Curriculum
    by Brian Goesling & Silvie Colman & Mindy Scott & Elizabeth Cook
  • 2014 Impacts of Waiting Periods for Home- and Community-Based Services on Consumers and Medicaid Long-Term Care Costs in Iowa
    by Greg Peterson & Randy Brown & Allison Barrett & Beny Wu & Christal Stone Valenzano
  • 2014 Descriptive Study of Three Disability Competent Managed Care Plans for Medicaid Enrollees
    by Vanessa Oddo & Angela Gerolamo & David R. Mann & Catherine DesRoches
  • 2014 Integrating Physical Health Care in Behavioral Health Agencies in Rural Pennsylvania
    by Angela M. Gerolamo & Jung Y. Kim & Jonathan Brown
  • 2014 Limited Father Involvement: Which Families Are Most at Risk?
    by Robert G. Wood & Reginald Covington
  • 2014 The Influence of Curriculum Material Design on Opportunities for Student Learning
    by Janine T. Remillard & Barbara Harris & Roberto Agodini
  • 2014 Snapshot of KIPP Leadership Practices through 2010-2011
    by Joshua Furgeson & Virginia Knechtel & Margaret Sullivan & Christina Clark Tuttle & Lauren Akers & Mary Anne Anderson & Michael Barna & Ira Nichols-Barrer
  • 2014 KIPP Leadership Practices through 2010-2011
    by Joshua Furgeson & Virginia Knechtel & Margaret Sullivan & Christina Clark Tuttle & Lauren Akers & Mary Anne Anderson & Michael Barna & Ira Nichols-Barrer
  • 2014 Developing a Coherent Plan for Effectively Using Data
    by Various authors
  • 2014 A Conceptual Framework for Data-Driven Decision Making
    by Brian Gill & Brandon Coffee-Borden & Kristin Hallgren
  • 2014 Making the Most of Opportunities to Learn What Works: A School District's Guide
    by Lauren Akers & Alexandra Resch & Jillian Berk
  • 2014 Evaluating Housing Programs for Youth Who Age Out of Foster Care
    by Robin Dion & Amy Dworsky
  • 2014 Housing for Youth Aging Out of Foster Care
    by Robin Dion & Amy Dworsky & Jackie Kauff & Rebecca Kleinman
  • 2014 The Family Unification Program: A Housing Resource for Youth Aging Out of Foster Care
    by M. Robin Dion & Rebecca Kleinman & Jackie Kauff & Amy Dworsky
  • 2014 Case Studies of Schools Receiving School Improvement Grants: Findings After the First Year of Implementation
    by Kerstin Carlson Le Floch & Beatrice Birman & Jennifer O'Day & Steven Hurlburt & Diana Mercado-Garcia & Rose Goff & Karen Manship & Seth Brown & Susan Bowles Therriault & Linda Rosenberg & Megan Hague Angus & Lara Hulsey
  • 2014 Value-Added Models for the Pittsburgh Public Schools, 2012-13 School Year
    by Dana Rotz & Matthew Johnson & Brian Gill
  • 2014 Impacts of New Leaders on Student Achievement in Oakland
    by Kevin Booker & Jaime Thomas
  • 2014 Do In-Person Interviews Reduce Bias in a Mixed-Mode Survey of Persons with Disabilities?
    by Eric Grau
  • 2014 National Surveys of Military Personnel, Nursing Students, and the Public: Drivers of Military Nursing
    by Karen Donelan & Carol Romano & Catherine DesRoches & Sandra Applebaum & Johanna R.M. Ward & Bruce A. Schoneboom & Ada Sue Hinshaw
  • 2014 Developing Competency-Based Program Models in Three Community Colleges
    by Ann E. Person & Lisbeth Goble & Julie Bruch
  • 2014 Bridging the Gap: A Comparative Assessment of Vocational Rehabilitation Agency Practices with Transition-Age Youth
    by Todd Honeycutt & Maura Bardos & Stephanie McLeod
  • 2014 Understanding Variation in Treatment Effects in Education Impact Evaluations: An Overview of Quantitative Methods
    by Peter Z. Schochet & Mike Puma & John Deke
  • 2014 Recognizing and Conducting Opportunistic Experiments in Education: A Guide for Policymakers and Researchers
    by Alexandra Resch & Jillian Berk & Lauren Akers
  • 2014 Supplying Disadvantaged Schools with Effective Teachers: Experimental Evidence on Secondary Math Teachers from Teach For America
    by Hanley S. Chiang & Melissa A. Clark & Sheena McConnell
  • 2014 Using Multiple Child Assessments to Inform Practice in Early Childhood Programs: Lessons from Milpitas Unified School District
    by Celina Kamler & Emily Moiduddin & Lizabeth Malone
  • 2014 Requirements for State Teacher Evaluation Policies Promoted by Race to the Top
    by Kirstin Hallgren & Susanne James-Burdumy & Irma Perez-Johnson
  • 2014 State Requirements for Teacher Evaluation Policies Promoted by Race to the Top
    by Kristin Hallgren & Susanne James-Burdumy & Irma Perez-Johnson
  • 2014 Medicare Advantage 2014 Spotlight: Enrollment Market Update
    by Marsha Gold & Gretchen Jacobson & Anthony Damico & Tricia Neuman
  • 2014 Alternative Student Growth Measures for Teacher Evaluation: Profiles of Early-Adopting Districts
    by Brian Gill & Brittany English & Joshua Furgeson & Moira McCullough
  • 2014 Alternative Student Growth Measures for Teacher Evaluation: Profiles of Early-Adopting Districts
    by Brian Gill & Brittany English & Joshua Furgeson & Moira McCullough
  • 2014 Family Voices: Piloting a New Qualitative Measure of Family Engagement for Head Start and Early Head Start Staff and Families
    by Nikki Aikens & Eileen Bandel & Lauren Akers & Julia Lyskawa & Judith Jerald
  • 2014 Strategies for Using Vital Records to Measure Quality of Care in Medicaid and CHIP Programs
    by Keith Kranker & So O’Neil & Vanessa Oddo & Miriam Drapkin & Margo Rosenbach
  • 2014 Effectiveness of Supplemental Educational Services
    by John Deke & Brian Gill & Lisa Dragoset & Karen Bogen
  • 2014 Initial Impacts of the Ticket to Work Program: Estimates Based on Exogenous Variation in Ticket Mail Months
    by David Stapleton & Arif Mamun & Jeremy Page
  • 2014 Explaining Differentials in Employment and Wages Between Young Adults with and Without Disabilities
    by David R. Mann & David C. Wittenburg
  • 2014 How States are Implementing Evidence-Based Teen Pregnancy Prevention Programs Through the Personal Responsibility Education Program
    by Susan Zief & Rachel Shapiro & Debra Strong
  • 2014 What Kinds of Health Insurance Do Small Businesses Offer? Results from a Survey of Five States
    by Catherine McLaughlin & Adam Swinburn
  • 2014 Small Businesses and Health Reform: Results from a Survey of Five States
    by Catherine McLaughlin & Adam Swinburn
  • 2014 A Focused Look at Schools Receiving School Improvement Grants That Have Percetages of English Language Learner Students
    by Laura Golden & Barbara Harris & Diana Mercado-Garcia & rea Boyle & Kerstin Carlson Le Floch & Jennifer O'Day
  • 2014 Moving Markets: Lessons from New Hampshire's Health Care Price Transparency Experiment
    by Ha Tu & Rebecca Gourevitch
  • 2014 PROMISE Recruitment, Enrollment, and Random Assignment Procedures Manual
    by AnnaMaria McCutcheon & Rebekah Selekman & Thomas Fraker
  • 2014 Milpitas Early Learning Transitions Model: Using Assessment Data to Inform Teacher Practice
    by Emily Moiduddin & Celina Kamler & Lizabeth Malone & Kathryn Gonzalez
  • 2014 Tribal Home Visiting Programs: Review of the Evidence
    by Various authors
  • 2014 Home Visiting Programs: Reviewing Evidence of Effectiveness
    by Various authors
  • 2014 Analysis of Integrated HIV Housing and Care Services
    by Margaret Hargreaves & Vanessa Oddo & Lindsey Stillman & Jonathan Sherwood & Steven Sullivan
  • 2014 Making Replication Work: Building Infrastructure to Implement, Scale Up, and Sustain Evidence-Based Early Childhood Home Visiting Programs
    by Kimberly Boller & Deborah Daro & Heather Zaveri
  • 2014 Home Visiting: The Potential for Cost Savings from Home Visiting Due to Reductions in Child Maltreatment
    by Heather Zaveri & rew Burwick & Erin Maher
  • 2014 Making Replication Work: Building Intrastructure to Implement, Scale-Up, and Sustain Evidence-Based Early Childhood Home Visiting Programs with Fidelity
    by Kimberly Boller & Deborah Daro & Patricia Del Grosso & Russell Cole & Diane Paulsell & Bonnie Hart & Brandon Coffee-Borden & Debra Strong & Heather Zaveri & Margaret Hargreaves
  • 2014 Costs of Early Childhood Home Visiting: An Analysis of Programs Implemented in the Supporting Evidence-Based Home Visiting to Prevent Child Maltreatment Initiative
    by Andrew Burwick & Heather Zaveri & Lisa Shang & Kimberly Boller & Deborah Daro & Debra A. Strong
  • 2014 International Efforts to Serve Youth with Disabilities: Lessons for the U.S. Disability Support System
    by Todd Honeycutt & Jennifer A. Lyons & Lorenzo Moreno
  • 2014 A Focused Look at Rural Schools Receiving School Improvement Grants
    by Linda Rosenberg & Megan Davis Christianson & Megan Hague Angus & Emily Rosenthal
  • 2014 Employment Services and Supports Available to Veterans with Disabilities Through the U.S. Department of Veterans Affairs and Other Federal Agencies
    by Michael West & John Kregel
  • 2014 Structuring Payment to Medical Homes After the Affordable Care Act
    by Samuel T. Edwards & Melinda K. Abrams & Richard J. Baron & Robert A. Berenson & Eugene C. Rich & Gary E. Rosenthal & Meredith B. Rosenthal & Bruce E. Landon
  • 2014 Taking a Teen Pregnancy Prevention Program to the Home: The AIM 4 Teen Moms Experience
    by Subuhi Asheer & Ellen Kisker
  • 2014 Case Study of Louisiana's Express Lane Eligibility
    by Stan Dorn & Margaret Wilkinson & Sara Benatar
  • 2014 A Roadmap to a 21st-Century Disability Policy for People with Brain Injury and Other Disabilities
    by David R. Mann & David C. Stapleton & Bonnie L. O'Day
  • 2014 Medicare 101 and 201: Key Issues for State Programs for Medicare-Medicaid Enrollees
    by Julie Klebonis & Michelle Herman Soper & Jim Verdier
  • 2014 Staffing Patterns of Primary Care Practices in the Comprehensive Primary Care Initiative
    by Deborah N. Peikes & Robert J. Reid & Timothy J. Day & Derekh D. F. Cornwell & Stacy B. Dale & Richard J. Baron & Randall S. Brown & Rachel J. Shapiro
  • 2014 Immigrants and Retirement Resources
    by Purvi Sevak & Lucie Schmidt
  • 2014 Reducing Health Care Disparities: Where Are We Now?
    by Marsha Gold
  • 2014 Impact of Playworks on Play, Physical Activity, and Recess: Findings from a Randomized Controlled Trial
    by Susanne James-Burdumy
  • 2014 Kauffman School Evaluation Long-Term Outcomes Report: Year 2
    by Matthew Johnson & Eric Lundquist & Cleo Jacobs Johnson & Claudia Gentile
  • 2014 The Long-Term Effects of Building Strong Families: A Program for Unmarried Parents
    by Robert G. Wood & Quinn Moore & rew Clarkwest & Alexandra Killewald
  • 2014 Does Location Determine Medical Practice Patterns?
    by James Reschovsky
  • 2014 Programs to Reduce Teen Pregnancy, Sexually Transmitted Infections, and Associated Sexual Risk Behaviors: A Systematic Review
    by Brian Goesling & Silvie Colman & Christopher Trenholm & Mary Terzian & Kristin Moore
  • 2014 Integrating Care for Adult Medicaid Beneficiaries with Serious Mental Illnesses
    by Various authors
  • 2014 How are CHIPRA Quality Demonstration States Designing and Implementing Caregiver Peer Support Programs?
    by Grace A. Ferry & Henry Ireys & Dana Petersen & Joseph Zickafoose
  • 2014 How are CHIPRA Quality Demonstration States Working Together to Improve the Quality of Health Care for Children?
    by Dana Petersen & Henry Ireys & Grace Ferry & Leslie Foster
  • 2014 Inpatient Hospital Prices Drive Spending Variation for Episodes of Care for Privately Insured Patients
    by Chapin White & James D. Reschovsky & Amelia M. Bond
  • 2014 Implementing Coordinated Care for Dual Eligibles: Conflicts and Opportunities
    by James M. Verdier
  • 2014 Financial Considerations: Rate Setting for Medicaid Managed Long Term Services and Supports (MLTSS) in Integrated Care Programs
    by Jenna Libersky & James Verdier
  • 2014 Advancing Geriatrics Research, Education, and Practice: Policy Challenges After the Great Recession
    by Judy T. Zerzan & Eugene C. Rich
  • 2014 Optimizing Health for Complex Adults in Primary Care: Current Challenges and a Way Forward
    by Hollis Day & Elizabeth Eckstrom & Sei Lee & Heidi Wald & Steven Counsell & Eugene Rich
  • 2014 Engaging Pregnant and Parenting Teens: Early Challenges and Lessons Learned from the Evaluation of Adolescent Pregnancy Prevention Approaches
    by Subuhi Asheer & Amanda Berger & Alicia Meckstroth & Ellen Kisker & Betsy Keating
  • 2014 Identifying and Serving LGBTQ Youth: Case Studies of Runaway and Homeless Youth Program Grantees
    by Andrew Burwick & Vanessa Oddo & Laura Durso & Daniel Friend & Gary Gates
  • 2014 Experiences of Germany and the Netherlands in Serving Transition-Age Youth
    by Todd Honeycutt & Lorenzo Moreno
  • 2014 Sampling Plan and 18-Month Follow-Up Survey Plan for the National Evaluation of PROMISE Demonstration Programs
    by Karen CyBulski & Thomas Fraker & Eric Grau & Holly Matulewicz
  • 2014 Promoting Readiness of Minors in SSI (PROMISE) National Evaluation Data Collection Plan
    by Thomas Fraker & Gina Livermore & Jacqueline Kauff & Todd Honeycutt
  • 2014 Understanding Differences Between High- and Low-Price Hospitals: Implications for Efforts to Rein in Costs
    by Chapin White & James D. Reschovsky & Amelia M. Bond
  • 2014 Background on Programs that Serve and Collect Data on Homeless Youth and Young Adults
    by Christine Ross & Rebekah Selekman & Wendy Henderson & Milissa Ford Shah & Cathy Connelly & Jennifer Uldricks
  • 2014 Data Analysis for Homeless Youth and Young Adults with Child Welfare Involvement
    by Christine Ross & Rebekah Selekman & Wendy Henderson & Melissa Ford Shah & Cathy Connelly & Jennifer Uldricks
  • 2014 Charter High Schools' Effects on Long-Term Attainment and Earnings
    by Kevin Booker & Brian Gill & Tim Sass & Ron Zimmer
  • 2014 Charter High Schools' Effects on Educational Attainment and Earnings
    by Kevin Booker & Brian Gill & Tim Sass & Ron Zimmer
  • 2014 Charter School Authorizers and Student Achievement
    by Ron Zimmer & Brian Gill & Jonathon Attridge & Kaitlin Obenauf
  • 2014 Do KIPP Schools Boost Student Achievement?
    by Philip M. Gleason & Christina Clark Tuttle & Brian Gill & Ira Nichols-Barrer & Bing-ru Teh
  • 2014 Do Disadvantaged Students Get Less Effective Teaching? Key Findings from Recent Institute of Education Sciences Studies
    by Jeffrey Max & Steven Glazerman
  • 2014 Do Disadvantaged Students Get Less Effective Teaching? Key Findings from Recent Institute of Education Sciences Studies
    by Jeffrey Max & Steven Glazerman
  • 2014 State and Demographic Variation in Use of Depot Antipsychotics by Medicaid Beneficiaries with Schizophrenia
    by Jonathan D. Brown & Allison Barrett & Emily Caffery & Kerianne Hourihan & Henry T. Ireys
  • 2014 Programs Serving Transition-Age Youth: A Comparative Analysis of the U.S. and 10 Other Countries in the Organisation for Economic Co-Operation and Development (OECD)
    by Lorenzo Moreno & Todd Honeycutt & Stephanie McLeod & Claire Gill
  • 2014 Business As Usual: New Jersey Employers’ Experiences with Family Leave Insurance
    by Sharon Lerner & Eileen Appelbaum
  • 2014 Documenting the Need for a National Paid Family and Medical Leave Program: Evidence from the 2012 FMLA Survey
    by Helene Jorgensen & Eileen Appelbaum
  • 2014 A College Degree is No Guarantee
    by Janelle Jones & John Schmitt
  • 2014 Expanding Family and Medical Leave to Small Firms
    by Helene Jorgensen & Eileen Appelbaum
  • 2014 Expanding Federal Family and Medical Leave Coverage: Who Benefits from Changes in Eligibility Requirements?
    by Helene Jorgensen & Eileen Appelbaum
  • 2014 Household Debt and Consumption Inequality: The Spanish Case
    by Gonzalo Paz Pardo & José Manuel Sánchez Santos
  • 2014 Union Bargaining in an Oligopoly Market with Cournot-Bertrand Competition: Welfare and Policy Implications
    by Elizabeth Schroeder & Victor J. Tremblay
  • 2014 Access to Media and HIV Knowledge in India
    by Smriti Agarwal & Pedro de Araujo
  • 2014 The Formation of New Monetary Policies: Decisions of Central Banks on the Great Recession
    by Ana Esther Castro & José Francisco Teixeira
  • 2014 Internet Education and Economic Growth: Evidence from Cross-Country Regressions
    by Lawrence Jin & Jang C. Jin
  • 2014 Measuring Voting Power in Convex Policy Spaces
    by Sascha Kurz
  • 2014 A Game-Theoretic History of the Cuban Missile Crisis
    by Frank C. Zagare
  • 2014 School feeding programs, intrahousehold allocation and the nutrition of siblings: Evidence from a randomized trial in rural Burkina Faso
    by Kazianga, Harounan & de Walque, Damien & Alderman, Harold
  • 2013 Chronicles from the Field: The Townsend Thai Project
    by Townsend, Robert M. & Sakunthasathien, Sombat & Jordan, Rob
  • 2013 Critical Issues in Taxation and Development
    by
  • 2013 Supporting Effective Data Use
    by Various authors
  • 2013 Developing and Enhancing Data Systems
    by Various authors
  • 2013 Report to Congress on the Evaluation of the Medicaid Emergency Psychiatric Demonstration
    by Crystal Blyler & Priyanka Anand & Melissa Azur & Emily Caffery & Grace Ferry & Benjamin Fischer & Angela Gerolamo & Rosalind Keith & Jung Kim & Brenda Natzke & Bonnie O'Day & Allison Siegwarth
  • 2013 Supporting Statement for the Promoting Readiness of Minors in SSI (PROMISE) Evaluation
    by Gina Livermore & Holly Matulewicz & Jacqueline Kauff
  • 2013 Making Replication Work: Building Intrastructure to Implement, Scale-Up, and Sustain Evidence-Based Early Childhood Home Visiting Programs with Fidelity
    by Kimberly Boller & Deborah Daro & Patricia Del Grosso & Russell Cole & Diane Paulsell & Bonnie Hart & Brandon Coffee-Borden & Debra Strong & Heather Zaveri & Margaret Hargreaves
  • 2013 Case Study of Massachusetts' Express Lane Eligibility Processes
    by Jennifer Edwards & Diana Rodin
  • 2013 Case Study of South Carolina's Express Lane Eligibility
    by Jennifer Edwards & Rebecca Kellenberg
  • 2013 KIPP Middle Schools Produce Significant Achievement Gains in Reading, Math, Science, and Social Studies
    by Various authors
  • 2013 New Data Highlight Children's Progress During Head Start
    by Various authors
  • 2013 After Two Years, Three Elementary Math Curricula Outperform a Fourth
    by Roberto Agodini & Barbara Harris & Neil Seftor & Janine Remillard & Melissa Thomas
  • 2013 Evaluation of Expeditionary Learning Middle Schools
    by Various authors
  • 2013 Developing a Health Care Information Portal for California Children's Services Providers: Functions, Models, and Issues
    by Deborah J. Chollet
  • 2013 Using Multifactorial Experiments for Comparative Effectiveness Research in Physician Practices with Electronic Health Record
    by Jelena Zurovac & Lorenzo Moreno & Jesse Crosson & Randall Brown & Robert Schmitz
  • 2013 The Structure and Operations of Social Enterprises in REDF's Social Innovation Fund Portfolio: Interim Report
    by Nan Maxwell & Dana Rotz & Adam Dunn & Linda Rosenberg & Jacqueline Berman
  • 2013 Advancing the Self-Sufficiency and Wellbeing of At-Risk Youth: A Conceptual Framework
    by M. Robin Dion
  • 2013 Promoting Integrated Employment: Lessons Learned from States' Efforts to Transform Their Employment Service Systems for People with Intellectual/Developmental Disabilities
    by Noelle Denny-Brown & Leah Guanga & Daniella Sehgal
  • 2013 CHIPRA Mandated Evaluation of Express Lane Eligibility: Final Findings
    by Sheila Hoag & Adam Swinburn & Sean Orzol & Michael Barna & Maggie Colby & Brenda Natzke & Christopher Trenholm & Fredric Blavin & Genevieve M. Kenney & Michale Huntress & Others
  • 2013 Money Follows the Person Demonstration: Overview of State Grantee Progress, January to June 2013
    by Bailey G. Orshan & Noelle Denny-Brown & Eric Morris & Victoria Peebles & Matthew Kehn & Susan R. Williams & Sarah Schoenfeldt
  • 2013 Employment, Earnings, and Primary Impairments Among Beneficiaries of Social Security Disability Programs
    by David R. Mann & Arif Mamun & Jeffrey Hemmeter
  • 2013 Data Collection Instruments for the Evidence-Based Home Visiting to Prevent Child Maltreatment Cross-Site Evaluation
    by Kimberly Boller & Deborah Daro & Debra Strong & Heather Zaveri & Diane Paulsell & Margaret Hargreaves & Russell Cole & Patricia Del Grosso & Cheri Vogel & rew Burwick & Cassandra Meagher & Kirsten Barrett & Brandon Coffee-Borden
  • 2013 Operational Authority, Support, and Monitoring of School Turnaround
    by Rebecca Herman & Cheryl Graczewski & Susanne James-Burdumy & Matthew Murray & Irma Perez-Johnson & Courtney Tanenbaum
  • 2013 Staffing a Low-Performing School: Behavioral Responses to Selective Teacher Transfer Incentives
    by Ali Protik & Steven Glazerman & Julie Bruch & Bing-ru Teh
  • 2013 Does Health Information Exchange Reduce Redundant Imaging? Evidence From Emergency Departments
    by Eric J. Lammers & Julia Adler-Milstein & Keith E. Kocher
  • 2013 The Effect of Hospital-Physician Integration on Health Information Technology Adoption
    by Eric Lammers
  • 2013 Using Medicare Data to Assess Nurse Practitioner-Provided Care
    by Catherine M. DesRoches & Jennifer Gaudet & Jennifer Perloff & Karen Donelan & Lisa I. Iezzoni & Peter Buerhaus
  • 2013 Migration Patterns for Medicaid Enrollees 2005-2007
    by David K. Baugh & Shinu Verghese
  • 2013 Return-to-Work Outcomes Among Social Security Disability Insurance Program Beneficiaries
    by Yonatan Ben-Shalom & Arif A. Mamun
  • 2013 Dual Eligibles: Opportunities and Challenges
    by James M. Verdier
  • 2013 Testimony for Hearing on Medicare Advantage
    by Marsha R. Gold
  • 2013 Universal Mental Health Screening in Pediatric Primary Care: A Systematic Review
    by Lawrence S. Wissow & Jonathan Brown & Kate E. Fothergill & Anne Gadomski & Karen Hacker & Peter Salmon & Rachel Zelkowitz
  • 2013 Employing Health Information Technology in the Real World to Transform Delivery
    by Marsha Gold
  • 2013 Misdiagnosis: An Emerging Priority for Comparative Effectiveness Research
    by Eugene C. Rich
  • 2013 How Early Head Start Programs Help Meet the Child Care Needs of Low-Income Families
    by Cheri Vogel & Kimberly Boller & Yange Xue & Lauren Murphy
  • 2013 Leveraging Medicaid in a Multi-Payer Medical Home Program: Spotlight on Rhode Island's Chronic Care Sustainability Initiative
    by Julia Paradise & Marsha Gold & Winnie Wang
  • 2013 Medicare Advantage 2014 Spotlight: Plan Availability and Premiums
    by Marsha Gold & Gretchen Jacobson & Anthony Damico & Tricia Neuman
  • 2013 The Earnings Consequences of the Americans with Disabilities Act on People with Disabilities
    by Allison V. Thompkins
  • 2013 Retention of and Access to Effective Teachers in DC Public Schools
    by Elias Walsh
  • 2013 FFY 2013 Adult Core Set Reporting in CARTS
    by Karen Llanos & Jason Williams & Katie Adamek & Bailey Orshan
  • 2013 New Unmarried Dads and Father Involvement: Evidence from the Building Strong Families Evaluaiton
    by Robert G. Wood & Reginald Covington
  • 2013 State of the States: Serving Welfare Recipients in a Post-Recessionary Fiscal and Political Environment
    by Elizabeth Laird & Michelle Derr & Julia Lyskawa
  • 2013 Positive Impacts of Playworks on Students' Healthy Behaviors: Findings from a Randomized Controlled Trial
    by Jane Fortson
  • 2013 Return-to-Work Outcomes Among Social Security Disability Insurance Program Beneficiaries
    by Yonatan Ben-Shalom & Arif Mamun
  • 2013 The Effectiveness of Secondary Math Teachers from Teach For America and the Teaching Fellows Programs
    by Melissa Clark & Hanley chiang & Sheena McConnell & Tim Silva & Kathy Sonnenfeld & Anastasia Erbe & Mike Puma
  • 2013 International Efforts to Serve Youth with Disabilities
    by Todd Honeycutt & Lorenzo Moreno
  • 2013 Trends in Access to Health Care for Workers with Disabilities, 1997-2011
    by Jody Schimmel & Gina Livermore
  • 2013 Transfer Incentives for High-Performing Teachers: Results from a Multisite Randomized Experiment
    by Steven Glazerman & Ali Protik & Bing-ru Teh & Julie Bruch & Jeffrey Max
  • 2013 Case Study of Oregon's Express Lane Eligibility Process
    by Maggie Colby & Sloane Frost
  • 2013 Case Study of Oklahoma's SoonerCare Online Enrollment System
    by Sheila Hoag & Adam Swinburn
  • 2013 Case Study of New Jersey's Express Lane Eligibility Processess
    by Sheila Hoag & Adam Swinburn
  • 2013 Case Study of Maryland's Express Lane Eligibility
    by Brigette Courtot & Margaret Wilkinson
  • 2013 Case Study of Iowa's Express Lane Eligibility Processes
    by Ian Hill & Sarah Benatar & Margaret Wilkinson
  • 2013 Risk Adjustment: What Is the Current State of the Art and How Can it Be Improved?
    by Eric Schone & Randy Brown
  • 2013 Standardized Testing: Mend It, Don't End It
    by Steven Glazerman
  • 2013 How Does a Value-Added Model Compare to the Colorado Growth Model?
    by Elias Walsh & Eric Isenberg
  • 2013 Accounting for Co-Teaching: A Guide for Policymakers and Developers of Value-Added Models
    by Eric Isenberg & Elias Walsh
  • 2013 Companion Document for the Strategic Data Project and Education Pioneers Year 1 Report: Laying the Groundwork for Data-Driven Decision Making
    by Kristin Hallgren & Cassie Pickens Jewell & Celina Kamler & Jacob Hartog & Andrew Gothro
  • 2013 Strategic Data Project and Education Pioneers Year 1 Report: Laying the Groundwork for Data-Driven Decision Making
    by Kristin Hallgren & Cassie Pickens Jewell & Celina Kamler & Jacob Hartog & Andrew Gothro
  • 2013 Access to Effective Teaching for Disadvantaged Students
    by Eric Isenberg & Jeffrey Max & Philip Gleason & Liz Potamites & Robert Santillano & Heinrich Hock & Michael Hansen
  • 2013 Access to Effective Teaching for Disadvantaged Students
    by Eric Isenberg & Jeffrey Max & Philip Gleason & Liz Potamites & Robert Santillano & Heinrich Hock & Michael Hansen
  • 2013 Sensitivity of Teacher Value-Added Estimates to Student and Peer Control Variables
    by Matthew Johnson & Stephen Lipscomb & Brian Gill
  • 2013 FFY 2013 Child Core Set Reporting in CARTS
    by Megan Thomas & Jason Williams & Michaela Vine
  • 2013 Transfer Incentives for High-Performing Teachers: Final Results from a Multisite Randomized Experiment
    by Steven Glazerman & Al Protik & Bing-ru Teh & Julie Bruch & Jeffrey Max
  • 2013 Transfer Incentives for High-Performing Teachers: Final Results from a Multisite Randomized Experiment
    by Steven Glazerman & Ali Protik & Bing-ru Teh & Julie Bruch & Jeffrey Max
  • 2013 Examine Critical Access Hospital Payment Policies Within the Context of Integrated Systems
    by JudyAnn Bigby
  • 2013 Effectiveness of Home Visiting in Inproving Child Health and Reducing Child Maltreatment
    by Sarah A. Avellar & Lauren H. Supplee
  • 2013 Association Between Enhanced Access Services in Pediatric Primary Care and Utilization of Emergency Departments: A National Parent Survey
    by Joseph S. Zickafoose & Lisa R. DeCamp & Lisa A. Prosser
  • 2013 Managing Care Transitions in Medicaid: Spotlight on Community Care of North Carolina
    by Marsha Gold & Winnie Wang & Julia Paradise
  • 2013 Replicating Experimental Impact Estimates with Nonexperimental Methods in the Context of Control Crossover
    by Brian Gill & Joshua Furgeson & Hanley S. Chiang & Bing-Ru Teh & Joshua Haimson & Natalya Verbitsky-Savitz
  • 2013 Money Follows the Person 2012 Annual Evaluation Report
    by Carol V. Irvin & Noelle Denny-Brown & Matthew Kehn & Rebecca Sweetland Lester & Debra Lipson & Wilfredo Lim & Jessica Ross & Alex Bohl & Victoria Peebles & Samuel Simon & Bailey Orshan & Susan R. Williams & Eric Morris & Christal Stone
  • 2013 Money Follows the Person 2012 Annual Evaluation Report
    by Carol V. Irvin & Noelle Denny-Brown & Matthew Kehn & Rebecca Sweetland Lester & Debra Lipson & Wilfredo Lim & Jessica Ross & Alex Bohl & Victoria Peebles & Samuel Simon & Bailey Orshan & Susan R. Williams & Eric Morris & Christal Stone
  • 2013 Findings from HeA PA and Implications for ACA Implementation
    by Leslie Foster & Adam Dunn & Maggie Colby
  • 2013 The Personal Responsibility Education Program (PREP): Launching a Nationwide Adolescent Pregnancy Prevention Effort
    by Susan Zief & Rachel Shapiro & Debra Strong
  • 2013 Recent Developments in State Efforts to Rebalance Long-Term Services and Supports
    by Rebecca Sweetland Lester & Carol V. Irvin & Wilfredo Lim
  • 2013 Disparities in Post-Transition Outcomes by Level of Care Needs Among Former Nursing Home Residents
    by Wilfredo Lim & Carol V. Irvin
  • 2013 Home- and Community-Based Service Use Among Medicare-Medicaid Enrollees with Functional Limitations, 2007-2008
    by Allison Hedley Dodd & Rosalie Malsberger
  • 2013 Rapid Evaluation Approaches for Complex Initiatives
    by Margaret B. Hargreaves
  • 2013 Measuring Teacher Value Added in DC, 2012-2013 School Year
    by Eric Isenberg & Elias Walsh
  • 2013 Risk Adjustment: What is the Current State of the Art and How Can it Be Improved?
    by Eric Schone & Randall Brown & Sarah Goodell
  • 2013 Risk Adjustment: What is the Current State of the Art, and How Can it Be Improved?
    by Eric Schone & Randall S. Brown
  • 2013 Data Analytics in Medicaid: Spotlight on Colorado's Accountable Care Collaborative
    by Julia Paradise & Marsha Gold & Winnie Wang
  • 2013 Do Financial Incentives Increase the Use of Electronic Health Records? Findings from an Experiment
    by Lorenzo Moreno & Suzanne Felt-Lisk & Stacy Dale
  • 2013 Instructional Practices and Student Achievement: Correlations from a Study of Math Curricula
    by Douglas H. Clements & Roberto Agodini & Barbara Harris
  • 2013 Instructional Practices and Student Math Achievement: Correlations from a Study of Math Curricula
    by Douglas H. Clements & Roberto Agodini & Barbara Harris
  • 2013 After Two Years, Three Elementary Math Curricula Outperform a Fourth
    by Roberto Agodini & Barbara Harris & Neil Seftor & Janine Remillard & Melissa Thomas
  • 2013 After Two Years, Three Elementary Math Curricula Outperform a Fourth
    by Roberto Agodini & Barbara Harris & Neil Seftor & Janine Remillard & Melissa Thomas
  • 2013 Examining the Effect of EVS Spending on HCAHPS Scores: A Value Optimization Matrix for Expense Management
    by Deirdre McCaughey & Samantha Stalley & Eric Williams
  • 2013 Measurement Error Properties in an Accelerometer Sample of U.S. Elementary School Children
    by Nicholas Beyler & Susanne James-Burdumy & Martha Bleeker & Jane Fortson & Max Benjamin
  • 2013 Utilization of Dental Services Among Medicaid-Enrolled Children
    by Ellen Bouchery
  • 2013 Using Alternative Student Growth Measures for Evaluating Teacher Performance: What the Lterature Says
    by Brian Gill & Julie Bruch & Kevin Booker
  • 2013 Using Alternative Student Growth Measures for Evaluating Teacher Performance: What the Literature Says
    by Brian Gill & Julie Bruch & Kevin Booker
  • 2013 Early Interventions to Prevent Disability for Workers with Mental Health Conditions: Impacts from the DMIE
    by Gilbert Gimm & Denise Hoffman & Henry T. Ireys
  • 2013 Addressing Teacher Shortages in Disadvantaged Schools: Alternative Routes to Teacher Certification and Student Achievement
    by Elizabeth Warner & Jill Constantine & Melissa Clark & Vicki Bernstein & Russ Whitehurst
  • 2013 Striking While the Iron is Hot: The Effect of Vocational Rehabilitation Service Wait Times on Employment Outcomes for Applicants Receiving Social Security Disability Benefits
    by Todd Honeycutt & David Stapleton
  • 2013 Medicare Basics: An Overview for States Seeking to Integrate Care for Medicare-Medicaid Enrollees
    by Jenna Libersky & James Verdier
  • 2013 Borrowing Constraints, College Enrollment, and Delayed Entry
    by Matthew T. Johnson
  • 2013 The Effectiveness of Secondary Math Teachers from Teach For America and the Teaching Fellows Programs
    by Melissa A. Clark & Hanley S. Chiang & Tim Silva & Sheena McConnell & Kathy Sonnenfeld & Anastasia Erbe & Michael Puma
  • 2013 Teach For America/Teaching Fellows and Effective Teaching in Secondary Math
    by Mathematica Policy Research
  • 2013 Addressing Teacher Shortages in Disadvantaged Schools: Lessons from Two Institute of Education Sciences Studies
    by Melissa Clark & Sheena McConnell & Jill Constantine & Hanley Chiang
  • 2013 The HCBS Taxonomy: A New Language for Classifying Home- and Community-Based Services
    by Victoria Peebles & Alex Bohl
  • 2013 Balancing Fidelity and Flexibility: Implementing the Gen.M Program in Texas
    by Rachel Shapiro
  • 2013 Money Follows the Person Demonstration: Overview of State Grantee Progress, July to December 2012
    by Susan R. Williams & Eric Morris & Bailey Orshan & Noelle Denny-Brown & Matthew Kehn & Jessica Ross & Christal Stone
  • 2013 Regulatory Changes and the Recession: How Did They Affect Ticket to Work Participants' Employment Efforts?
    by Jody Schimmel
  • 2013 New Evidence on the Role of Provider Business Model in the Economic Viability of Employment Networks Under Ticket to Work
    by Jody Schimmel
  • 2013 Participant and Provider Outcomes Since the Inception of Ticket to Work and the Effects of the 2008 Regulatory Changes
    by Jody Schimmel & David Stapleton & David R. Mann & Dawn Phelps
  • 2013 Initial Impacts of the Ticket to Work Program for Young New Social Security Disability Awardees: Estimates Based on Randomly Assigned Mail Months
    by David Stapleton & Arif Mamun & Jeremy Page
  • 2013 Improving Post-High School Outcomes for Transition-Age Students with Disabilities: An Evidence Review
    by R. Brian Cobb & Stephen Lipscomb & Jennifer Wolgemuth & Theresa Schulte & Abigail Veliquette & Morgen Alwell & Keriu Batchelder & Robert Bernard & Paul Hernandez & Helen Holmquist-Johnson & Rebecca Orsi & Laura Sample McMeeking & Jun Wang & Andrea Welnberg
  • 2013 Improving Post-High School Outcomes for Transition-Age Students with Disabilities: An Evidence Review
    by R. Brian Cobb & Stephen Lipscomb & Jennifer Wolgemuth & Theresa Schulte & Abigail Veliquette & Morgen Alwell & Keriu Batchelder & Robert Bernard & Paul Hernandez & Helen Holmquist-Johnson & Rebecca Orsi & Laura Sample McMeeking & Jun Wang & Andrea Welnberg
  • 2013 Overview of State Projects and the National Evaluation
    by Henry T. Ireys
  • 2013 Medicaid Analytic Extract Provider Characteristics (MAXPC) Evaluation Report, 2010
    by Deo Bencio
  • 2013 Statistical Power for School-Based RCTs with Binary Outcomes
    by Peter Z. Schochet
  • 2013 State Differences in the Vocational Rehabilitation Experiences of Transition-Age Youth with Disabilities
    by Todd Honeycutt & Allison Thompkins & Maura Bardos & Steven Stern
  • 2013 Association Between Outpatient Visits Following Hospital Discharge and Readmissions Among Medicare Beneficiaries with Atrial Fibrillation and Other Chronic Conditions
    by Mai Hubbard & Sloane Frost & Kimberly Siu & Nicole Quon & Dominick Esposito
  • 2013 State Costs of Excessive Alcohol Consumption, 2006
    by Jeffrey J. Sacks & Jim Roeber & Ellen E. Bouchery & Katherine Gonzales & Frank J. Chaloupka & Robert D. Brewer
  • 2013 Medication Discontinuation and Reinitiation Among Medicare Part D Beneficiaries Taking Costly Medications
    by Margaret S. Colby & Dominick Esposito & Seth Goldfarb & Daniel E. Ball & Vivian Herrera & Leslie J. Conwell & Susan B. Garavaglia & Eric S. Meadows & Martin D. Marciniak
  • 2013 Perspectives on HeA PA from Certified Application Assistants
    by Adam Dunn & Dana Petersen & Leslie Foster
  • 2013 Some Hospitals are Falling Behind in Meeting 'Meaningful Use' Criteria and Could be Vulerable to Penalties in 2015
    by Catherine M. DesRoches & Chantal Worzala & Scott Bates
  • 2013 Enrollment, Employment, and Earnings in the Medicaid Buy-In Program, 2010
    by Matthew Kehn & Jody Schimmel
  • 2013 A Typology of Electronic Health Record Workarounds in Small-to-Medium Size Primary Care Practices
    by Asia Friedman & Jesse C. Crosson & Jenna Howard & Elizabeth C. Clark & Maria Pellerano & Ben-Tzion Karsh & Benjamin Crabtree & Carlos Roberto Jaén & Deborah J. Cohen
  • 2013 Findings from an Analysis of Publicly Available Reports on Medicaid and CHIP Performance Measures
    by Brenda Natzke & Maggie Colby & Erin Taylor
  • 2013 Case Studies of Leading Primary Care Practice Facilitation Programs
    by Erin Fries Taylor & Lyndee Knox & Dana Petersen & Kristin Geonnotti & Rachel Machta
  • 2013 Program Snapshot: Vermont Blueprint's EQuIP Program
    by Lyndee Knox & Erin Fries Taylor
  • 2013 Program Snapshot: The Safety Net Medical Home Initiative
    by Dana Petersen & Erin Fries Taylor & Kristin Geonnotti
  • 2013 Program Snapshot: Oklahoma's Practice Enhancement Assistants
    by Rachel M. Machta & Erin Fries Taylor
  • 2013 Program Snapshot: North Carolina's Practice Support Efforts
    by Lyndee Knox & Erin Fries Taylor
  • 2013 Lessons Learned from Leading Models of Practice Facilitation
    by Erin Fries Taylor & Lyndee Knox & Dana Petersen & Kristin Geonnotti & Rachel Machta
  • 2013 Creating Capacity for Improvement in Primary Care: The Case for Developing a Quality Improvement Infrastructure
    by Erin Fries Taylor & Deborah Peikes & Janice Genevro & David Meyers
  • 2013 Building Quality Improvement Capacity in Primary Care: Supports and Resources
    by Erin Fries Taylor & Janice Genevro & Deborah Peikes & Kristin Geonnotti & Winnie Wang & David Meyers
  • 2013 Services and Supports People with Disabilities Need to Stay Employed
    by Noelle Denny-Brown & Bonnie O'Day & Stephanie McLeod
  • 2013 Trends in the Composition and Outcomes of Young Social Security Disability Awardees
    by Yonatan Ben-Shalom & David Stapleton
  • 2013 Evaluation of the DC Public Education Reform Amendment Act (PERAA): School Year 2010-2011
    by Erikson Arcaira & Stephen Coleman & Jacly MacFarlane & rea Palmiter & Brenda Turnbull & Beatirce Birman & Erin Dunlop & Jane Hannaway & Umut Ozek & Steve Glazerman & Elias Walsh & Michael Feurer & Maxine Freund & Taunya Nesin
  • 2013 Subsidized Childcare and Child Development in Columbia: Effects of Hogares Comunitarios de Bienestar as a Function of Timing and Length of Exposure
    by Raquel Bernal & Camila Fernández
  • 2013 Evaluation of the Work Incentives Planning and Assistance (WIPA) Program in 2011: Beneficiaries Served, Services Provided, and Program Costs
    by Jody Schimmel & Sara Prenovitz & Gina Livermore & Alex Bryce
  • 2013 Data Tables for FACES 2009 Report. Getting Ready for Kindergarten: Children's Progress During Head Start
    by Ashley Kopack Klein & Nikki Aikens & Jerry West & Serge Lukashanets & Louisa Tarullo
  • 2013 Getting Ready for Kindergarten: Children's Progress During Head Start. FACES 2009 Report
    by Nikki Aikens & Ashley Kopack Klein & Louisa Tarullo & Jerry West
  • 2013 Adoption of Electronic Health Records Grows Rapidly, But Fewer Than Half of US Hospitals had at Least a Basic System in 2012
    by Catherine M. DesRoches & Dustin Charles & Michael F. Furukawa & Maulik S. Joshi & Peter Kralovec & Farzad Mostashari & Chantal Worzala & Ashish K. Jha
  • 2013 Health Information Technology in the United States: Better Information Systems for Better Care, 2013
    by Catherine M. DesRoches & Michael W. Painter & Ashish K. Jha
  • 2013 Medicaid Analytic Extract Date of Death (MAX DOD) Master File, 2009 Update
    by Julie Sykes & Shinu Verghese
  • 2013 Implications of State Methods for Offering Personal Assistance Services
    by Laura Ruttner & Carol V. Irvin
  • 2013 Impacts of Five Expeditionary Learning Middle Schools on Academic Achievement
    by Ira Nichols-Barrer & Joshua Haimson
  • 2013 Return-to-Work Outcomes Among Social Security Disability Insurance Program Beneficiaries
    by Yonatan Ben-Shalom & Arif Mamun
  • 2013 What Were the Top Outcomes of State Medicaid Infrastructure (MIG) Grants?
    by Kristin Andrews
  • 2013 Classroom Observations from Phase 2 of the Pennsylvania Teacher Evaluation Pilot: Assessing Internal Consistency, Score Variation, and Relationships with Value Added
    by Elias Walsh & Stephen Lipscomb
  • 2013 Is Geriatric Care Associated with Less Emergency Department Use?
    by Laura P. D'Arcy & Sally C. Stearns & Marisa E. Domino & Laura C. Hanson & Morris Weinberger
  • 2013 Patterns of Older Americans' Health Care Utilization Over Time
    by Richard J. Manski & John F. Moeller & Haiyan Chen & Jody Schimmel & Patricia A. St. Clair & John V. Pepper
  • 2013 The Healthy Weight Collaborative: Using Learning Collaboratives to Enhance Community-Based Prevention Initiatives Addressing Childhood Obesity
    by Margaret B. Hargreaves & Todd Honeycutt & Cara Orfield & Michaela Vine & Charlotte Cabili & Michaella Morzuch & Sylvia K. Fisher & Ronette Briefel
  • 2013 Proven Strategies for Missouri Health Care Covergage: Program Outreach and Enrollment
    by Sean Orzol
  • 2013 A Rude Awakening: The Perioperative Sleep Apnea Epidemic
    by Stavros G. Memtsoudis & Melanie C. Besculides & Madhu Mazumdar
  • 2013 Charter School Authorizers and Student Achievement
    by Ron Zimmer & Brian Gill & Jonathon Attridge & Kaitlin Obenauf
  • 2013 How are States and Evaluators Measuring Medical Homeness in the CHIPRA Quality Demonstration Grant Program?
    by Stacey McMorrow & Anna Christensen & Brenda Natzke & Kelly Devers & Rebecca Peters
  • 2013 How are States and Evaluators Measuring Medical Homeness in the CHIPRA Quality Demonstration Grant Program?
    by Stacey McMorrow & Anna Christensen & Brenda Natzke & Kelly Devers & Rebecca Peters
  • 2013 Measuring Implementation of Early Childhood Interventions at Multiple System Levels
    by Diane Paulsell & Ann M. Berghout & Maegan Lokteff
  • 2013 Intervention Dosage in Early Childhood Care and Education: It's Complicated
    by Barbara A. Wasik & Shira Kolnik Mattera & Chrishana M. Lloyd & Kimberly Boller
  • 2013 Using Performance Measures to Promote Evidence-Based Care: A Bayesian Approach
    by Timothy F. Christian & Thomas W. Croghan & Myles Maxfield
  • 2013 Income Eligibility for Assistance Under the ACA: The Question of Monthly vs. Annual Income
    by John L. Czajka
  • 2013 Translating Modified Adjusted Gross Income (MAGI) to Current Monthly Income
    by John L. Czajka
  • 2013 Programs to Reduce Teen Pregnancy, Sexually Transmitted Infections, and Associated Sexual Risk Behaviors: A Systematic Review
    by Brian Goesling & Silvie Colman & Christopher Trenholm & Mary Terzian & Kristin Moore
  • 2013 Medication Continuity Among Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder
    by Jonathan D. Brown & Allison Barrett & Emily Caffery & Kerianne Hourihan & Henry T. Ireys
  • 2013 Meeting Meaningful Use Criteria and Managing Patient Populations: A National Survey of Practicing Physicians
    by Catherine M. DesRoches & Anne-Marie Audet & Michael Painter & Karen Donelan
  • 2013 Medicare Advantage 2013 Spotlight: Enrollment Market Update
    by Marsha Gold & Gretchen Jacobson & Anthony Damico & Tricia Neuman
  • 2013 Characteristics and Service Use of Medicaid Buy-In Participants with Higher Incomes: A Descriptive Analysis
    by Denise Hoffman & Kristin Andrews & Valerie Cheh
  • 2013 Dual Eligible Care in a SNP vs. FFS: Preliminary Findings from a Natural Arizona Experiment
    by Maggie Colby & Jim Verdier
  • 2013 Systematic Reviews as a Tool in Evidence-Based Decision Making: Improving Research and Informing Practice
    by Jill Constantine
  • 2013 Enrollment, Employment, and Earnings in the Medicaid Buy-In Program, 2011
    by Matthew Kehn
  • 2013 The Disability System and Programs to Promote Employment for People with Disabilities
    by David Wittenburg & David R. Mann & Allison Thompkins
  • 2013 Perspectives of Physicians and Nurse Practitioners on Primary Care Practice
    by Karen Donelan & Catherine M. DesRoches & Robert S. Dittus & Peter Buerhaus
  • 2013 Making Sense of the Change in How Medicare Advantage Plans are Paid
    by Marsha Gold
  • 2013 Paying More Wisely: Effects of Payment Reforms on Evidence-Based Clinical Decision-Making
    by Timothy K. Lake & Eugene C. Rich & Christal Stone Valenzano & Myles M. Maxfield
  • 2013 Paying the Doctor: Evidence-Based Decisions at the Point-of-Care and the Role of Fee-for-Service Incentives
    by Eugene C. Rich & Timothy K. Lake & Christal Stone Valenzano & Myles M. Maxfield
  • 2013 Is Timing Everything? Disability Onset of Youth and Their Outcomes as Young Adults
    by David R. Mann & Todd C. Honeycutt
  • 2013 Findings from an Experimental Evaluation of Playworks: Effects on Play, Physical Activity and Recess
    by Nicholas Beyler & Martha Bleeker & Susanne James-Burdumy & Jane Fortson & Rebecca A. London & Lisa Westrich & Katie Stokes-Guinan & Sebastian Castrechini
  • 2013 Playworks Implementation in 17 Schools from 6 U.S. Cities
    by Rebecca A. London & Sebastian Castrechini & Katie Stokes-Guinan & Lisa Westrich & Martha Bleeker & Susanne James-Burdumy
  • 2013 New Medicare-Medicaid Enrollees: The Transition to Medicaid Coverage Among Medicare Beneficiaries
    by Carol V. Irvin & Rosemary Borck & Wilfredo Lim
  • 2013 Searching for Savings and Better Patient Outcomes: An Evaluation of Three Disability Competent Managed Care Plans
    by David R. Mann
  • 2013 Effectiveness of Alternative Ways of Implementing Care Coordination Components in Medicare D-SNPs
    by Jelena Zurovac & Randy Brown & Bob Schmitz
  • 2013 Outreach to Low-Income Families During the First Year of HeA PA
    by Maggie Colby
  • 2013 Relationship Between NCQA Medical Home Recognition and Health Care Utilizaiton Among Children in Medicaid with Disabilities or Special Health Care Needs
    by Kate Stewart & Henry Ireys & Dana Petersen & Joe Zickafoose & Lisa Schottenfeld
  • 2013 Impacts of Waiting Periods for Home and Community Based Servicws on Consumers and Medicaid Costs in Iowa
    by Greg Peterson & Randy Brown & Allison Barrett
  • 2013 Findings from the Evaluation of the Non-Elderly Disabled (NED) Housing Choice Voucher Program
    by Debra Lipson & Denise Hoffman & Matthew Kehn
  • 2013 Evaluating Infrastructure Development in Complex Home Visiting Systems
    by Margaret Hargreaves & Russell Cole & Brandon Coffee-Borden & Diane Paulsell & Kimberly Boller
  • 2013 Lessons from Three Pilots to Integrate Physical and Behavioral Health Care for Medicaid Beneficiaries in Pennsylvania
    by Jung Y. Kim & Angela M. Gerolamo & Jonathan Brown
  • 2013 Identifying Medicare Beneficiaries with Disabilities: Improving on Claims-Based Algorithms
    by Yonatan Ben-Shalom & David Stapleton
  • 2013 Analysis of the Variation in Efficiency of Medicare Advantage Plans
    by Marsha Gold & Maria Cupples Hudson
  • 2013 Ticket to Work Participants: Then and Now
    by Crystal Blyler & Denise Hoffman & Gina Livermore
  • 2013 What Are Error Rates for Classifying Teacher and School Performance Using Value-Added Models?
    by Peter Z. Schochet & Hanley S. Chiang
  • 2013 Using Pragmatic Clinical Trials to Test the Effectiveness of Patient-Centered Medical Home Models in Real-World Settings
    by Deborah Peikes & Kristin Geonnotti & Winnie Wang
  • 2013 The Logic Model: The Foundation to Implement, Study, and Refine Patient-Centered Medical Home Models
    by Dana Petersen & Erin Fries Taylor & Deborah Peikes
  • 2013 Using Implementation Research to Guide Adaptation, Implementation, and Dissemination of Patient-Centered Medical Home Models
    by Laura Damschroder & Deborah Peikes & Dana Petersen
  • 2013 Fuzzy-Set Qualitative Comparative Analysis: A Configurational Comparative Method to Identify Multiple Pathways to Improve Patient-Centered Medical Home Models
    by Marcus Thygeson & Deborah Peikes & Aparajita Zutshi
  • 2013 Formative Evaluation: Fostering Real-Time Adaptations and Refinements to Improve the Effectiveness of Patient-Centered Medical Home Interventions
    by Kristin Geonnotti & Deborah Peikes & Winnie Wang & Jeffrey Smith
  • 2013 Efficient Orthogonal Designs: Testing the Comparative Effectiveness of Alternative Ways of Implementing Patient-Centered Medical Home Components
    by Jelena Zurovac & Deborah Peikes & Aparajita Zutshi & Randy Brown
  • 2013 Expanding the Toolbox: Methods to Study and Refine Patient-Centered Medical Home Models
    by Debbie Peikes & Dana Petersen & Aparajita Zutshi & David Meyers & Janice Genevro
  • 2013 Shrinkage of Value-Added Estimates and Characteristics of Students with Hard-to-Predict Achievement Levels
    by Mariesa Herrmann & Elias Walsh & Eric Isenberg & Alexandra Resch
  • 2013 National and State Trends in Enrollment and Spending for Dual Eligibles Under Age 65 in Medicaid Managed Care
    by Jenna Libersky & Allison Hedley Dodd & Shinu Verghese
  • 2013 Medicare Part D Prescription Drug Coverage for Medicare-Medicaid Enrollees in the Capitated Financial Alignment Demonstration
    by James M. Verdier
  • 2013 Does Tracking of Students Bias Value-Added Estimates for Teachers?
    by Ali Protik & Elias Walsh & Alexandra Resch & Eric Isenberg & Emma Kopa
  • 2013 Trends and Patterns in the Use of Prescription Drugs Among Medicaid Beneficiaries: 1999 to 2009
    by James M. Verdier & Ashley Zlatinov
  • 2013 Advancing the Self-Sufficiency and Well-Being of At-Risk Youth: A Conceptual Framework
    by Robin Dion & M.C. Bradley & rew Gothro & Maura Bardos & Jiffy Lansing & Matthew Stagner & Amy Dworsky
  • 2013 A Framework for Advancing the Well-Being and Self-Sufficiency of At-Risk Youth
    by M. Robin Dion
  • 2013 Program Subgroups: Patterns of Impacts for Home-Based, Center-Based, and Mixed-Approach Programs
    by Rachel Chazan-Cohen & Helen H. Raikes & Cheri Vogel
  • 2013 Family Subgroups and Impacts at Ages 2, 3, and 5: Variability by Race/Ethnicity and Demographic Risk
    by Helen H. Raikes & Cheri Vogel & John M. Love
  • 2013 Impacts of Early Head Start Participation on Child and Parent Outcomes at Ages 2, 3, and 5
    by Cheri Vogel & Jeanne Brooks-Gunn & Anne Martin & Mary M. Klute
  • 2013 Design and Methods in the Early Head Start Study
    by Richard A. Faldowski & Rachel Chazan-Cohen & John M. Love & Cheri Vogel
  • 2013 Assessing the Usability of MAX 2008 Encounter Data for Comprehensive Managed Care
    by Vivian L.H. Byrd & Allison Hedley Dodd
  • 2013 Horseshoes, Hand Grenades, and Treatment Effects? Reassessing Bias in Nonexperimental Estimators
    by Kenneth Fortson & Philip Gleason & Emma Kopa & Natalya Verbitsky-Savitz
  • 2013 Medicare Health Plans and Dually Eligible Beneficiaries: Industry Perspectives on the Current and Future Market
    by Marsha Gold & Winnie Wang & Gretchen Jacobson
  • 2013 Using Technology to Improve Care Transitions: The IMPACT Project
    by Larry Garber & Craig Schneider
  • 2013 Connecting At-Risk Youth to Promising Occupations
    by M.C. Bradley & Jiffy Lansing & Matthew Stagner
  • 2013 Primum Non Nocere: Reconciling Patient-Centered Outcomes with Evidence-Based Care
    by Eugene C. Rich
  • 2013 Helping You Take Care of Yourself Men of Color Prostate Health Workshops
    by Laura Ruttner & Irina Cheban & So O'Neil
  • 2013 The ACA, Health Care Costs, and Disparities in Employer-Sponsored Health Insurance
    by Nan L. Maxwell
  • 2013 KIPP Middle Schools: Impacts on Achievement and Other Outcomes
    by Christina Clark Tuttle & Brian Gill & Philip Gleason & Virginia Knechtel & Ira Nichols-Barrer & Alexandra Resch
  • 2013 KIPP Middle Schools: Impacts on Achievement and Other Outcomes
    by Christina Clark Tuttle & Brian Gill & Philip Gleason & Virginia Knechtel & Ira Nichols-Barrer & Alexandra Resch
  • 2013 Integrating Family Support Services into Schools: Lessons from the Elev8 Initiative
    by Angela Valdovinos D'Angelo & Lauren Rich & Jaclyn Kwiatt
  • 2013 Health-E-App Public Access: A New Online Path to Children's Health Care Coverage in California. Applicant Characteristics and Experiences
    by Adam Dunn & Leslie Foster
  • 2013 Four States' Approaches to Practice-Level Quality Measurement and Reporting
    by Grace A. Ferry & Henry T. Ireys & Leslie Foster & Kelly J. Devers & Lauren Smith
  • 2013 How Are CHIPRA Demonstration States Approaching Practice-Level Quality Measurement and What Are They Learning?
    by Grace A. Ferry & Henry T. Ireys & Leslie Foster & Kelly J. Devers & Lauren Smith
  • 2013 The Effects of Mental Health Parity on Spending and Utilization for Bipolar, Major Depression, and Adjustment Disorders
    by Alisa B. Busch & Frank Yoon & Colleen L. Barry & Vanessa Azzone & Sharon-Lise T. Normand & Howard H. Goldman & Haiden A. Huskamp
  • 2013 Mental Health Communications Skills Training for Medical Assistants in Pediatric Primary Care
    by Jonathan D. Brown & Lawrence S. Wissow & Benjamin L. Cook & Shaina Longway & Emily Caffery & Chris Pefaure
  • 2013 Using the MAX-NHANES Merged Data to Evaluate the Association of Obesity and Medicaid Costs
    by Allison Hedley Dodd & Philip M. Gleason
  • 2013 The Youth Transition Demonstration: Lifting Employment Barriers for Youth with Disabilities
    by Thomas Fraker
  • 2013 Social Security Numbers in Medicaid Records: Reporting and Validity, 2009
    by John L. Czajka & Shinu Verghese
  • 2013 Toward a More Perfect Union: Creating Synergy Between the Money Follows the Person and Managed Long-Term Services and Supports Programs
    by Debra J. Lipson & Christal Stone Valenzano
  • 2013 The Effects of Transitional Care Models on Re-Admissions: A Review of the Current Evidence
    by Deborah Peikes & Rebecca Sweetland Lester & Boyd Gilman & Randall Brown
  • 2013 Medicaid Analytic eXtract 2008 Encounter Data Chartbook Appendix Tables
    by Rosemary Borck & Ashley Zlatinov & Susan Williams
  • 2013 Medicaid Analytic eXtract 2008 Encounter Data Chartbook
    by Rosemary Borck & Ashley Zlatinov & Susan Williams
  • 2013 How to Provide and Pay for Long-Term Care of an Aging Population is an International Concern
    by Marsha Gold
  • 2013 Parents' Preferences for Enhanced Access to the Pediatric Medical Home: A Qualitative Study
    by Joseph S. Zickafoose & Lisa R. DeCamp & Dana J. Sambuco & Lisa A. Prosser
  • 2013 The Economic Well-Being of Lesbian, Gay, and Bisexual Youth Transitioning Out of Foster Care
    by Amy Dworsky
  • 2013 Enhancing the Primary Care Team to Provide Redesigned Care: The Roles of Practice Facilitators and Care Managers
    by Erin Fries Taylor & Rachel M. Machta & David S. Meyers & Janice Genevro & Deborah N. Peikes
  • 2013 Matching Study Designs to Disability-Related Comparative Effectiveness Research Questions
    by Jeffrey Ballou & Eugene Rich & Matthew Kehn
  • 2013 Can Administrative Records Be Used to Reduce Nonresponse Bias?
    by John L. Czajka
  • 2013 Stochastic Dominance and Demographic Policy Evaluation: A Critique
    by Cordoba, Juan Carlos & Liu, Xiying
  • 2013 Beyond Expected Utility in the Economics of Health and Longevity
    by Cordoba, Juan Carlos & Ripoll, Marla
  • 2013 What explains schooling differences across countries?
    by Cordoba, Juan Carlos & Ripoll, Marla
  • 2013 Maisons et pôles de santé : places et impacts dans les dynamiques territoriales d'offre de soins en France
    by Guillaume Chevillard & Julien Mousquès & Véronique Lucas-Gabrielli & Yann Bourgueil & Stéphane Rican & Gérard Salem
  • 2013 School Segregation and the Identification of Tipping Behavior
    by Gregorio Caetano & Vikram Maheshri
  • 2013 Socioeconomic Determinants of Child Health - Empirical Evidence from Indonesia
    by Subha Mani
  • 2013 The Affordable Care Act: A Hidden Jobs Killer?
    by Helene Jorgensen & Dean Baker
  • 2013 Has Education Paid Off for Black Workers?
    by John Schmitt & Janelle Jones
  • 2013 Making Jobs Good
    by John Schmitt & Janelle Jones
  • 2013 State Savings with an Efficient Medicare Prescription Drug Benefit
    by Nicole Woo & Dean Baker
  • 2013 Ecuador’s Economy Since 2007
    by Mark Weisbrot & Jake Johnston & Stephan Lefebvre
  • 2013 Reducing Waste With an Efficient Medicare Prescription Drug Benefit
    by Dean Baker
  • 2013 Misión de Equidad y Movilidad Social
    by Armando Montenegro
  • 2013 Managerial Strategies for Enhancing Universities-Business Environment Partnership
    by Pârvu Iuliana & Mitran Paula Cornelia & Ipate Drago? Mihai
  • 2013 Human Capital: Cause And Effect Of The Economic Growth. An Empirical Analysis
    by NEAGU OLIMPIA & & &
  • 2013 Financial Markets, Banking and the Design of Monetary Policy: A Stable Baseline Scenario
    by Florian Hartmann & Peter Flaschel
  • 2013 The Changing Effectiveness of Monetary Policy
    by Jonathan E. Leightner
  • 2013 Monetary Transfers in the U.S.: How Efficient Are Tax Rebates?
    by Diego E. Vacaflores
  • 2013 Effects of Fiscal Policy and Monetary Policy on the Stock Market in Poland
    by Yu Hsing
  • 2013 Effects of Fiscal and Monetary Policy in the Great Recession
    by Gonzalo Caballero
  • 2013 Forthcoming Issue on Game Theory and Political Economy
    by William D. Ferguson
  • 2013 A Note on Forecasting the Rate of Change of the Price of Oil: Asymmetric Loss and Forecast Rationality
    by Christian Pierdzioch & Jan-Christoph Rülke
  • 2013 Economies : An Open Access Journal for the Field of Development Macroeconomics
    by Ralf Fendel
  • 2013 Economies and Sustainability
    by Shu-Kun Lin
  • 2013 The spillover effects of Medicare managed care: Medicare Advantage and hospital utilization
    by Baicker, Katherine & Chernew, Michael E. & Robbins, Jacob A.
  • 2013 Flows, funds and the complexity of deprivation: Using concepts from ecological economics for the study of poverty
    by Scheidel, Arnim
  • 2013 The Financing of Water Supply and Sewerage Services in Romania
    by Alina Florentina CUCOS & Nicolae Viorel TRIF & Doinita CAZAN
  • 2013 Management Education Principles, Information and Communication Technologies and Sustainable Development in Nigeria
    by Richard INGWE & Peter K. BESSONG & Ikwun ANGIATING
  • 2013 Hacia un nuevo modelo de atención primaria en salud: evaluación del proyecto de salud familiar Ancora U.C
    by Püschel, Klaus & Téllez, Álvaro & Montero, Joaquín & Brunner, Astrid & Peñaloza,Blanca & Rojas, María Paulina & Poblete, Fernando & Pantoja, Tomás
  • 2013 Metropolization and Higher Education as Factors of Community Wellbeing Differentiation: Preliminary Decomposition of Inequalities
    by Wlodzimierz Okrasa & Grzegorz Gudaszewski
  • 2012 Explaining variations in breast cancer screening across European countries
    by Wuebker, A.;
  • 2012 Surveying Romanian Migrants in Italy Before and After the EU Accession: Migration Plans, Labour Market Features and Social Inclusion
    by Isilda Mara
  • 2012 From Kuttabs to Schools: Educational Modernization, Religion, and Human Capital in Twentieth Century Egypt
    by Saleh, Mohamed
  • 2012 From Kuttabs to Schools: Educational Modernization, Religion, and Human Capital in Twentieth Century Egypt
    by Saleh, Mohamed
  • 2012 Homework assignment and student achievement in OECD countries
    by Torberg Falch & Marte Rønning
  • 2012 Have Natural Disasters Become Deadlier?
    by Raghav Gaiha1 & Kenneth Hill & Ganesh Thapa
  • 2012 Supporting Evidence-Based Home Visiting to Prevent Child Maltreatment: Cross-Site Evaluation Cost Study Background and Design Update
    by Andrew Burwick & Debra Strong & Yange Xue & Heather Koball & Brandon Coffee-Borden & Heather Zaveri & Kimberly Boller & Deborah Daro
  • 2012 Measuring School and Teacher Value Added in DC, 2011-2012 School Year
    by Eric Isenberg & Heinrich Hock
  • 2012 Developing Medicare and Medicaid Substance Abuse Treatment Spending Estimates
    by Ellen Bouchery & Rick Harwood & Rosalie Malsberger & Emily Caffery & Jessica Nysenbaum & Kerianne Hourihan
  • 2012 Self-Insurance and Stop Loss for Small Employers
    by Deborah Chollet
  • 2012 Landscape Analysis of Non-Cognitive Measures
    by Sally Atkins-Burnett & Camila Fernandez & Lauren Akers & Jessica Jacobson & Claire Smither-Wulsin
  • 2012 Rising Family Income Inequality: The Importance of Sorting
    by Deborah Reed & Maria Cancian
  • 2012 Health Tracking Household Survey: Methodology Report 2010 (Round Six)
    by Barbara Lepidus Carlson & John Hall & Karen Cybulski & Richard Strouse
  • 2012 The State of Teacher Induction in Urban America
    by Martha Bleeker & Sarah Dolfin & Amy Johnson & Steve Glazerman & Eric Isenberg & Mary Grider
  • 2012 Assessing the Evidence of Effectiveness of Home Visiting Program Models Implemented in Tribal Communities
    by Patricia Del Grosso & Rebecca Kleinman & rea Mraz Esposito & Emily Sama-Miller & Diane Paulsell
  • 2012 A User's Guide to the Database of Publicly Available Medicaid and CHIP Performance Measure Reports
    by Jessica Nysenbaum & Alyssa Crawford & Winnie Wang & Erin Taylor & Maggie Colby & Cheryl Camillo
  • 2012 Health Information Technology in the United States: Driving Toward Delivery System Change, 2012
    by Catherine M. DesRoches & Michael W. Painter & Ashish K. Jha
  • 2012 Health Information Technology in the United States: Driving Toward Delivery System Change, 2012
    by Catherine M. DesRoches & Michael W. Painter & Ashish K. Jha
  • 2012 Potential Impact of the Affordable Care Act on the Ryan White HIV/AIDS Program
    by Margaret Hargreaves & Vanessa Oddo & Ann Bagchi & Boyd Gilman
  • 2012 Implications of Health Homes for NCQA Health Plan Accreditation
    by Center for Health Care Strategies & Mathematica Policy Research
  • 2012 Health Home Considerations for a Medicaid Managed Care Delivery System: Avoiding Duplication of Services and Payment
    by Center for Health Care Strategies & Mathematica Policy Research
  • 2012 Data Analysis Considerations to Inform Medicaid Health Home Program Design
    by Center for Health Care Strategies & Mathematica Policy Research
  • 2012 Income Measurement for the 21st Century: Updating the Current Population Survey
    by John L. Czajka & Gabrielle Denmead
  • 2012 Proven Strategies in Health Care Coverage Program Outreach and Enrollment
    by Sean Orzol & Linda Barterian & Michael Barna
  • 2012 Medicaid Substance Abuse Treatment Spending: Findings Report
    by Ellen Bouchery & Rick Harwood & Rosalie Malsberger & Emily Caffery & Jessica Nysenbaum & Kerianne Hourihan
  • 2012 Catalog of Research: Programs for Low-Income Couples
    by Sarah Avellar & rew Clarkwest & M. Robin Dion & Subuhi Asheer & Kelley Borradaile & Megan Hague Angus & Timothy Novak & Julie Redline & Heather Zaveri & Marykate Zukiewicz
  • 2012 From Comparative Effectiveness Research to Patient-Centered Outcomes Research: Policy History and Future Directions
    by Laura P. D'Arcy & Eugene C. Rich
  • 2012 Chartbook: Medicaid Pharmacy Benefit Use and Reimbursement in 2009
    by Ann D. Bagchi & James Verdier & Dominick Esposito
  • 2012 Chartbook: Medicaid Pharmacy Benefit Use and Reimbursement in 2008
    by Ann D. Bagchi & James Verdier & Dominick Esposito
  • 2012 Informing the Performance-Based Contract Between First 5 LA and LAUP: Child Progress in the 2011-2012 Program Year
    by Yange Xue & Sally Atkins-Burnett & Emily Moiduddin
  • 2012 Sustainability, Partnerships, and Teamwork in Health IT Implementation: Essential Findings from the Transforming Healthcare Quality Through IT Grants
    by Suzanne Felt-Lisk & Grace Ferry & Rebecca Roper & Melanie Au & James Walker & J.B. Jones & Virginia Lerch
  • 2012 Nonfinancial Barriers and Access to Care for US Adults
    by Jeffrey T. Kullgren & Catherine G. McLaughlin & Nandita Mitra and & Katrina Armstrong
  • 2012 Combination Classes and Educational Achievement
    by Jaime L. Thomas
  • 2012 Executive Summary of the Sixth Ticket to Work Evaluation Report
    by Gina Livermore & Bonnie O'Day & Yonatan Ben-Shalom & Sarah Prenovitz & Jody Schimmel & Craig Thornton
  • 2012 CHIPRA Mandated Evaluation of Express Lane Eligibility: First Year Findings
    by Sheila Hoag & Sean Orzol & Margaret Colby & Adam Swinburn & Fredric Blavin & Genevieve M. Kenney & Michael Huntress
  • 2012 Professional Associations and Activities to Promote Breast, Cervical, and Colorectal Cancer Secreening in Massachusetts
    by Margaret Hargreaves & Laura Ruttner & Alena Davidoff-Gore & So O'Neil
  • 2012 Vocational Rehabilitation on the Road to Social Security Disability: Longitudinal Statistics from Matched Administrative Data
    by David C. Stapleton & Frank H. Martin
  • 2012 An Assessment of Consultative Examination (CE) Processes, Content, and Quality: Findings from the CE Review Data
    by David Wittenburg & Gordon Steinagle & Sloane Frost & Ron Fine
  • 2012 Inter-Rater Reliability Analysis of Data to Document the Consultative Examination Process: Volume 2
    by David Wittenburg & Debra Wright & Sloane Frost & Gordon Steinagle & Ron Fine
  • 2012 Inter-Rater Reliability Analysis of Data to Document the Consultative Examination Process: Volume 1
    by David Wittenburg & Debra Wright & Sloane Frost & Gordon Steinagle & Ron Fine
  • 2012 New Evidence on Incentives for Providers to Use Electronic Health Records in Medicare: Findings from a Demonstration
    by Lorenzo Moreno & Suzanne Felt-Lisk & Stacy Dale & Robert Berenson & Mat Kendall
  • 2012 Evaluation of the Electronic Health Records Demonstration: Final Report
    by Suzanne Felt-Lisk & Lorenzo Moreno & Martha Kovac & Randall Blair & Stacy Dale & Amy Overcash & Rachel Shapiro
  • 2012 Using Systematic Reviews to Inform Policy Initiatives: Lessons from the HHS Teen Pregnancy Prevention Evidence Review
    by Brian Goesling
  • 2012 Why We Fight: Understanding Military Participation Over the Life Cycle
    by David R. Mann
  • 2012 The Social Security Administration's Youth Transition Demonstration Projects: Interim Report on West Virginia Youth Works
    by Thomas Fraker & Arif Mamun & Michelle Manno & John Martinez & Debbie Reed & Allison Thompkins & David Wittenburg
  • 2012 The Social Security Administration's Youth Transition Demonstration Projects: Interim Report on Broadened Horizons, Brighter Futures
    by Thomas Fraker & Todd Honeycutt & Arif Mamun & Michelle Manno & John Martinez & Bonnie O'Day & Debbie Reed & Allison Thompkins
  • 2012 The Social Security Administration's Youth Transition Demonstration Projects: Interim Report on the Career Transition Program
    by Thomas Fraker & Peter Baird & Arif Mamun & Michelle Manno & John Martinez & Debbie Reed & Allison Thompkins
  • 2012 Assessing the Usability of Encounter Data for Enrollees in Comprehensive Managed Care Across MAX 2007-2009
    by Vivian L.H. Byrd & Allison Hedley Dodd
  • 2012 MAX and NCHS Survey Linkage, 1999-2009
    by Julie Sykes & Kerianne Hourihan
  • 2012 Medicaid Analytic Extract Provider Characteristics (MAXPC) Evaluation Report, 2009
    by Deo Bencio & Julie Sykes
  • 2012 The Availability and Usability of Behavioral Health Organization Encounter Data in MAX 2009
    by Jessica Nysenbaum & Ellen Bouchery & Rosalie Malsberger
  • 2012 Quality Support Coaching in LAUP: Baseline Findings from the 2011-2012 Program Year
    by Pamela Winston & Sally Atkins-Burnett & Emily Moiduddin & Yange Xue & Lauren Akers & Julia Lyskawa & Susan Sprachman & Nikki Aikens & Rebecca Mason
  • 2012 Quality Support Coaching in LAUP: Findings from the 2011-2012 Program Year
    by Pamela Winston & Sally Atkins-Burnett & Lauren Akers & Yange Xue & Emily Moiduddin & Elisha Smith & Nikki Aikens & Julia Lyskawa & Rebecca Mason & Susan Sprachman
  • 2012 Quality Support Coaching at LAUP
    by Lauren Akers & Sally Atkins-Burnett & Emily Moiduddin & Pam Winston & Artineh Samkian & Sharon Murphy
  • 2012 Evaluation of Adolescent Pregnancy Prevention Approaches: Design of the Impact Study
    by Kimberly Smith & Silvie Colman
  • 2012 Data Tables for Child Outcomes and Classroom Quality in FACES 2009 Report
    by Nikki Aikens & Emily Moiduddin & Yange Xue & Louisa Tarullo & Jerry West
  • 2012 Child Outcomes and Classroom Quality in FACES 2009
    by Emily Moiduddin & Nikki Aikens & Louisa Tarullo & Jerry West & Yange Xue
  • 2012 Are Nurses Ready for Health Care Reform? A Decade of Survey Research
    by Peter I. Buerhaus & Catherine DesRoches & Sandra Applebaum & Robert Hess & Linda D. Norman & Karen Donelan
  • 2012 Replicating Home Visiting Programs with Fidelity: Baseline Data and Preliminary Findings
    by Deborah Daro & Bonnie Hart & Kimberly Boller & M.C. Bradley
  • 2012 Evidence-Based Home Visiting Systems Evaluation Update: Infrastructure-Building Plans and Activities in 2011
    by Diane Paulsell & Margaret Hargreaves & Brandon Coffee-Borden & Kimberly Boller
  • 2012 Instructional Practices That Support ELL Children in Los Angeles Universal Preschool Classrooms
    by Sally Atkins-Burnett & Emily Moiduddin & Nikki Aikens & Yange Xue & Artineh Samkian & Sharon Murphy
  • 2012 Longitudinal Statistics for New Supplemental Security Income Beneficiaries
    by Yonatan Ben-Shalom & David Stapleton & Dawn Phelps & Maura Bardos
  • 2012 Physician Service Use and Participation in Medicaid, 2009
    by David Baugh & Shinu Verghese
  • 2012 Commentary: Teaching Health Centers and the Path to Graduate Medical Education Reform
    by Eugene C. Rich
  • 2012 Medicare Advantage 2013 Spotlight: Plan Availability and Premiums
    by Marsha Gold & Gretchen Jacobson & Anthony Damico & Tricia Neuman
  • 2012 Perceptions of Electronic Health Records and Their Effect on the Quality of Care: Results from a Survey of Patients in Four States
    by Jelena Zurovac & Stacy Dale & Martha Kovac
  • 2012 Is School Value-Added Indicative of Principal Quality?
    by Hanley Chiang & Stephen Lipscomb & Brian Gill
  • 2012 Past as Prologue: How Comparative Effectiveness Research Became Patient-Centered Outcomes Research
    by Eugene C. Rich
  • 2012 Making a Plan and Sticking to It: Implementing an Enhanced Version of HealthTeacher in Chicago
    by Rachel Shapiro & Ellen Kisker
  • 2012 Which Medicaid Buy-In Participants Use SSA Work Supports?
    by Denise Hoffman & Jody Schimmel
  • 2012 The Long-Term Effects of Building Strong Families: A Relationship Skills Education Program for Unmarried Parents
    by Quinn Moore & Robert G. Wood & rew Clarkwest & Alexandra Killewald & Shannon Monahan
  • 2012 The Long-Term Effects of Building Strong Families: A Relationship Skills Education Program for Unmarried Parents
    by Robert G. Wood & Quinn Moore & rew Clarkwest & Alexandra Killewald & Shannon Monahan
  • 2012 The Long-Term Effects of Building Strong Families: A Relationship Skills Education Program for Unmarried Parents
    by Robert G. Wood & Quinn Moore & rew Clarkwest & Alexandra Killewald & Shannon Monahan
  • 2012 The Narrative Communications Project: Takeaway Findings on a Message-Framing Approach
    by Sheila Hoag & Victoria Peebles & Christopher Trenholm & Gene Lewit
  • 2012 New Denial and Disenrollment Coding Strategies to Drive State Enrollment Performance
    by Mary Harrington & Christopher Trenholm & Andrew Snyder
  • 2012 Synthesis of Findings from System Change Grant Programs
    by Carol V. Irvin & Rebecca Sweetland Lester
  • 2012 Best Bets for Reducing Medicare Costs for Dual Eligible Beneficiaries: Assessing the Evidence
    by Randall Brown & David R. Mann
  • 2012 Utilization of Well-Child Care Among Medicaid-Enrolled Children
    by Ellen Bouchery
  • 2012 Utilization of Dental Services Among Medicaid Enrolled Children
    by Ellen Bouchery
  • 2012 Paying Wisely: Reforming Incentives to Promote Evidence-Based Decisions at the Point of Care
    by Eugene C. Rich & Tim Lake & Christal Stone Valenzano
  • 2012 Supporting Policy and Program Decisions: Recommendations for Conducting High Quality Systematic Evidence Reviews
    by Susan Zief & Roberto Agodini
  • 2012 Effectiveness of Four Supplemental Reading Comprehension Interventions
    by Susanne James-Burdumy & John Deke & Russell Gersten & Julieta Lugo-Gil & Rebecca Newman-Gonchar & Joseph Dimino & Kelly Haymond & Albert Yung-Hsu Liu
  • 2012 Dental Usage Under Changing Economic Conditions
    by Richard J. Manski & John F. Moeller & Haiyan Chen & Jody Schimmel & Patricia A. St. Clair & John V. Pepper
  • 2012 Wealth Effect and Dental Care Utilization in the United States
    by Richard J. Manski & John F. Moeller & Haiyan Chen & Patricia A. St. Clair & Jody Schimmel & John V. Pepper
  • 2012 Identifying Transition-Age Youth with Disabilities Using Existing Surveys
    by Todd Honeycutt & David Wittenburg
  • 2012 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for September 2012
    by Winnie Wang & Marsha Gold
  • 2012 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for August 2012
    by Winnie Wang & Marsha Gold
  • 2012 SMI Innovations Project: Southeast Pennsylvania Case Study. The HealthChoices HealthConnections Pilot Program
    by Tricia Collins Higgins & Jung Y. Kim & Dominick Esposito & Angela M. Gerolamo
  • 2012 SMI Innovations Project: Southwest Pennsylvania Case Study. The Connected Care Pilot Program
    by Jung Y. Kim & Dominick Esposito & Tricia Collins Higgins
  • 2012 SMI Innovations Project in Pennsylvania: Final Evaluation Report
    by Jung Y. Kim & Tricia Collins Higgins & Dominick Esposito & Angela M. Gerolamo & Mark Flick
  • 2012 Current and Emerging Issues in Medicaid Risk-Based Managed Care: Insights from an Expert Roundtable
    by Marsha Gold & Julia Paradise
  • 2012 Institutional Level of Care Among Money Follows the Person Participants
    by Jessica Ross & Sam Simon & Carol Irvin & Dean Miller
  • 2012 Reporting Person-Level Separate CHIP Data to MSIS: A Guide for States Programmer's Supplement
    by Cheryl A. Camillo & Matthew Hodges & Stephen Kuncaitis & Paul M. Montebello & Ashley Zlatinov
  • 2012 Evidence for the Role of Home Visiting in Child Maltreatment Prevention
    by Kimberly Boller
  • 2012 Replicating and Scaling Up Evidence-Based Home Visiting Programs: The Role of Implementation Research
    by Diane Paulsell
  • 2012 Should You Use Beta-MAX for Medicaid Research?
    by Rosemary Borck & Rosalie Malsberger & Kristin Andrews
  • 2012 Testimony for Hearing on Medicare Health Plans
    by Marsha R. Gold
  • 2012 Student Selection, Attrition, and Replacement in KIPP Middle Schools
    by Ira Nichols-Barrer & Brian P. Gill & Philip Gleason & Christina Clark Tuttle
  • 2012 Testimony for Hearing on Securing the Future of the Social Security Disability Insurance Program
    by David C. Stapleton
  • 2012 The Effects of Health Care Benefits on Health Care Use and Health: A Randomized Trial for Disability Insurance Beneficiaries
    by Charles Michalopoulos & David Wittenburg & Dina A.R. Israel & Anne Warren
  • 2012 Health and Wealth of a Nation: Employer-Based Health Insurance and the Affordable Care Act
    by Nan L. Maxwell
  • 2012 Assessing the Usability of MAX 2008 Encounter Data for Enrollees in Comprehensive Managed Care
    by Vivian L. H. Byrd & Allison Hedley Dodd & Rosalie Malsberger & Ashley Zlatinov
  • 2012 Medicaid Enrollment Gaps, 2005-2007
    by John L. Czajka
  • 2012 Migration Patterns for Medicaid Enrollees, 2005-2007
    by David Baugh & Shinu Verghese
  • 2012 Migration Patterns for Medicaid Enrollees, 2005-2007
    by David Baugh & Shinu Verghese
  • 2012 The Financial Repercussions of New Work-Limiting Health Conditions for Older Workers
    by Jody Schimmel & David C. Stapleton
  • 2012 Keeping Watch: Building State Capacity to Oversee Medicaid Managed Long-Term Services and Supports
    by Debra J. Lipson & Jenna Libersky & Rachel Machta & Lynda Flowers & Wendy Fox-Grage
  • 2012 Keeping Watch: Building State Capacity to Oversee Medicaid Managed Long Term Supports and Services
    by Debra J. Lipson
  • 2012 Reporting Person-Level Separate CHIP Data to MSIS: A Guide for States
    by Matthew Hodges & Cheryl A. Camillo & Paul M. Montebello & Ashley Zlatinov
  • 2012 Conducting Surveys with Proxies: Evaluating a Standardized Measure to Determine Need
    by Sara Skidmore & Kirsten Barrett & Debra Wright & Jennifer Gardner
  • 2012 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for July 2012
    by Winnie Wang
  • 2012 BOND Stage 1 Early Assessment Report
    by David Wittenburg & David Stapleton & Michelle Derr & Denise W. Hoffman & David R. Mann
  • 2012 Beliefs and Endogenous Cognitive Levels: An Experimental Study
    by Marina Agranov & Elizabeth Potamites & rew Schotter & Chloe Tergiman
  • 2012 Implementing Eligibility Changes Under the Affordable Care Act: Issues Facing State Medicaid and CHIP Programs
    by Cheryl A. Camillo
  • 2012 Medicaid Enrollment Gaps, 2005 to 2007
    by John L. Czajka
  • 2012 Evidence-Based Practices for Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder
    by Jonathan D. Brown & Allison Barrett & Henry Ireys & Emily Caffery & Kerianne Hourihan
  • 2012 Evidence-Based Treatment for Schizophrenia and Bipolar Disorder in State Medicaid Programs
    by Allison Barrett & Jonathan Brown & Emily Caffery & Kerianne Hourihan & Henry Ireys
  • 2012 Approaches to Developing State-Level Rates for Children's Health Care Quality Measures Based on Data from Multiple Sources
    by Michaela Vine & Margo Rosenbach
  • 2012 Improving Access to Oral Health Services in Medicaid and CHIP: How States Can Report the Dental Measures in the Initial Core Set of Children's Health Care Quality Measures
    by Michaela Vine & Margo Rosenbach
  • 2012 Statistical Power for Regression Discontinuity Designs in Education: Empirical Estimates of Design Effects Relative to Randomized Controlled Trials
    by John Deke & Lisa Dragoset
  • 2012 Back to Work: Recent SSA Employment Demonstrations for People with Disabilities
    by David R. Mann & David Wittenburg
  • 2012 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for June 2012
    by Winnie Wang & Marsha Gold
  • 2012 Rewarding Physicians for Their Patients' Health Outcomes: What Can Medicare Learn from Education's Value-Added Models?
    by Greg Peterson & Eric Schone
  • 2012 Methods for Accounting for Co-Teaching in Value-Added Models
    by Heinrich Hock & Eric Isenberg
  • 2012 Mini-MAX User's Guide
    by Ellen Bouchery & David Baugh & John Czajka & Rosemary Borck & Rosalie Malsberger & Allison Dodd & Sheng Wang & Carol Irvin & Julie Sykes
  • 2012 Seclusion and Restraint Practices in Residential Treatment Facilities for Children and Youth
    by Jonathan D. Brown & Kirsten Barrett & Henry T. Ireys & Kamala Allen & Sheila A. Pires & Gary Blau & Melissa Azur
  • 2012 Care Management for Medicare-Medicaid Enrollees
    by James M. Verdier
  • 2012 Medicare Advantage 2012 Data Spotlight: Enrollment Market Update
    by Marsha Gold & Gretchen Jacobson & Anthony Damico & Tricia Neuman
  • 2012 Value for the Money Spent? Exploring the Relationship Between Expenditures, Insurance Adequacy, and Access to Care for Publicly Insured Children
    by Margaret S. Colby & Debra J. Lipson & Sarah R. Turchin
  • 2012 How Changes in Washington University's Medicare Coordinated Care Demonstration Pilot Ultimately Achieved Savings
    by Deborah Peikes & Greg Peterson & Randall S. Brown & Sandy Graff & John P. Lynch
  • 2012 There is Little Experience and Limited Data to Support Policy Making on Integrated Care for Dual Eligibles
    by Marsha R. Gold & Gretchen A. Jacobson & Rachel L. Garfield
  • 2012 Six Features of Medicare Coordinated Care Demonstration Programs that Cut Hospital Admissions of High-Risk Patients
    by Randall S. Brown & Deborah Peikes & Greg Peterson & Jennifer Schore & Carol M. Razafindrakoto
  • 2012 Work Incentive Simplification Pilot (WISP): Recommendations of the Technical Advisory Panel Regarding the Evaluation Design
    by David Wittenburg & David R. Mann & David C. Stapleton
  • 2012 Emerging Medicaid Accountable Care Organizations: The Role of Managed Care
    by Marsha Gold & Jessica Nysenbaum & Sonya Streeter
  • 2012 MAX and MCBS Survey Linkage, 2007-2008
    by Rosalie Malsberger
  • 2012 Assessing the Usability of the MAX 2007 Inpatient and Prescription Encounter Data for Enrollees in Comprehensive Managed Care
    by Allison Hedley Dodd & Jessica Nysenbaum & Ashley Zlatinov
  • 2012 Movement of Children Between Medicaid and CHIP, 2005-2007
    by John L. Czajka
  • 2012 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for May 2012
    by Rachel Machta & Marsha Gold
  • 2012 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for April 2012
    by Rachel Machta & Marsha Gold
  • 2012 Children's Progress During the 2010-2011 LAUP Year
    by Yange Xue & Sally Atkins-Burnett & Emily Moiduddin & Sharon Murphy & Artineh Samkian
  • 2012 Replicating Experimental Impact Estimates Using a Regression Discontinuity Approach
    by Philip M. Gleason & Alexandra M. Resch & Jillian A. Berk
  • 2012 How Will the ACA Affect Community Rehabilitation Programs?
    by Deborah Chollet & Jill Bernstein
  • 2012 Durable Medical Equipment and Home Health Among the Largest Contributors to Area Variations in Use of Medicare Services
    by James D. Reschovsky & Arkadipta Ghosh & Kate A. Stewart & Deborah J. Chollet
  • 2012 Durable Medical Equipment and Home Health Among the Largest Contributors to Area Variations in Use of Medicare Services
    by James D. Reschovsky & Arkadipta Ghosh & Kate A. Stewart & Deborah J. Chollet
  • 2012 Value-Added Estimates for Phase 1 of the Pennsylvania Teacher and Principal Evaluation Pilot
    by Stephen Lipscomb & Hanley Chiang & Brian Gill
  • 2012 Value-Added Estimates for Phase 1 of the Pennsylvania Teacher and Principal Evaluation Pilot
    by Stephen Lipscomb & Hanley Chiang & Brian Gill
  • 2012 Impacts of Title I Supplemental Educational Services on Student Achievement
    by John Deke & Lisa Dragoset & Karen Bogen & Brian Gill
  • 2012 Impacts of Title I Supplemental Educational Services on Student Achievement
    by John Deke & Lisa Dragoset & Karen Bogen & Brian Gill
  • 2012 The Dynamics of Women Disconnected from Employment and Welfare
    by Quinn Moore & Robert G. Wood & Anu Rangarajan
  • 2012 Early Head Start Home Visitation: The Role of Implementation in Bolstering Program Benefits
    by Brenda Jones Harden & Rachel Chazan-Cohen & Helen Raikes & Cheri Vogel
  • 2012 Housing for Youth Aging Out of Foster Care: A Review of the Literature and Program Typology
    by Amy Dworsky & Keri-Nicole Dillman & M. Robin Dion & Brandon Coffee-Borden & Miriam Rosenau
  • 2012 Value-Added Estimates for Phase 1 of the Pennsylvania Teacher and Principal Evaluation Pilot
    by Stephen Lipscomb & Hanley Chiang & Brian Gill
  • 2012 Small, Nonteaching, and Rural Hospitals Continue to be Slow in Adopting Electronic Health Record Systems
    by Catherine M. DesRoches & Chantal Worzala & Maulik S. Joshi & Peter D. Kralovec & Ashish K. Jha
  • 2012 Using an Experimental Evaluation of Charter Schools to Test Whether Nonexperimental Comparison Group Methods Can Replicate Experimental Impact Estimates
    by Kenneth Fortson & Natalya Verbitsky-Savitz & Emma Kopa & Philip Gleason
  • 2012 Using Social Network Analysis to Predict Early Collaboration Within Health Advocacy Coalitions
    by Todd C. Honeycutt & Debra A. Strong
  • 2012 Can the Ticket to Work Program Be Self-Financing?
    by Craig Thornton
  • 2012 Defining, Building, and Measuring Capacity: Findings from an Advocacy Evaluation
    by Debra A. Strong & Jung Y. Kim
  • 2012 Value-Added Models for the Pittsburgh Public Schools
    by Matthew Johnson & Stephen Lipscomb & Brian Gill & Kevin Booker & Julie Bruch
  • 2012 Applying Advocacy Skills in Tumultuous Times: Adaptive Capacity of Insuring America's Children Grantees
    by Jung Y. Kim & Victoria Peebles & Christopher A. Trenholm
  • 2012 Findings from a Randomized Experiment of Playworks: Selected Results from Cohort 1
    by Martha Bleeker & Susanne James-Burdumy & Nicholas Beyler & Allison Hedley Dodd & Rebecca A. London & Lisa Westrich & Katie Stokes-Guinan & Sebastian Castrechini
  • 2012 Orthogonal Design: A Powerful Method for Comparative Effectiveness Research with Multiple Interventions
    by Jelena Zurovac & Randy Brown
  • 2012 Coordinating Care for Adults with Complex Care Needs in the Patient-Centered Medical Home: Challenges and Solutions
    by Eugene Rich & Debra Lipson & Jenna Libersky & Michael Parchman
  • 2012 Linkages to Care for Newly Diagnosed Individuals Who Test HIV Positive in Nonprimary Care Settings
    by Boyd Gilman & Julia Hidalgo & Cicely Thomas & Melanie Au & Margaret Hargreaves
  • 2012 Quality Rating and Improvement Systems: Frameworks for Early Care and Education Systems Change
    by Diane Schaak & Kate Tarrant & Kimberly Boller & Kathryn Tout
  • 2012 Random Assignment Within Schools: Lessons Learned from the Teach For America Experiment
    by Steven Glazerman
  • 2012 Moving High-Performing Teachers: Implementation of Transfer Incentives in Seven Districts
    by Steven Glazerman & Ali Protik & Bing-ru Teh & Julie Bruch & Neil Seftor
  • 2012 Moving High-Performing Teachers: Implementation of Transfer Incentives in Seven Districts
    by Steven Glazerman & Ali Protik & Bing-ru Teh & Julie Bruch & Neil Seftor
  • 2012 Predictors of Maternal and Child Double Burden of Malnutrition in Rural Indonesia and Bangladesh
    by Vanessa M. Oddo & Jee H. Rah & Richard D. Semba & Kai Sun & Nasima Akhter & Mayang Sari & Saskia de Pee & Regina Moench-Pfanner & Martin Bloem & Klaus Kraemer
  • 2012 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for March 2012
    by Rachel Machta & Marsha Gold
  • 2012 Learning from Charter School Management Organizations: Strategies for Student Behavior and Teacher Coaching
    by Robin Lake & Melissa Bowen & Allison Demeritt & Moira McCullough & Joshua Haimson & Brian Gill
  • 2012 Paying More for Primary Care: Can It Help Bend the Medicare Cost Curve?
    by James D. Reschovsky & Arkadipta Ghosh & Kate Stewart & Deborah Chollet
  • 2012 Paying More for Primary Care: Can It Help Bend the Medicare Cost Curve?
    by James D. Reschovsky & Arkadipta Ghosh & Kate Stewart & Deborah Chollet
  • 2012 How Are the Costs of Care for Medical Falls Distributed? The Costs of Medical Falls by Component of Cost, Timing, and Injury Severity
    by Alex A. Bohl & Elizabeth A. Phelan & Paul. A. Fishman & Jeffrey R. Harris
  • 2012 Adult Employment Assistance Services for Persons with Autism Spectrum Disorders: Effects on Employment Outcomes
    by John D. Westbrook & Chad Nye & Carlton J. Fong & Judith T. Wan & Tara Cortopassi & Frank H. Martin
  • 2012 Selection in Massachusetts' Commonwealth Care Program: Lessons for State Basic Health Plans
    by Deborah Chollet & Allison Barrett & Amy Lischko
  • 2012 Type of Health Insurance and the Substance Abuse Treatment Gap
    by Ellen Englert Bouchery & Henrick J. Harwood & Joan Dilonardo & Rita Vandivort-Warren
  • 2012 An Evaluation of the Chicago Teacher Advancement Program (Chicago TAP) After Four Years
    by Steven Glazerman & Allison Seifullah
  • 2012 Obtaining Providers' 'Buy-In' and Establishing Effective Means of Information Exchange Will be Critical to HITECH's Success
    by Marsha R. Gold & Catherine G. McLaughlin & Kelly J. Devers & Robert A. Berenson & Randall R. Bovbjerg
  • 2012 Health-e-App Public Access: A New Online Path to Children's Health Care Coverage in California. An Overview of the First Year
    by Leslie Foster
  • 2012 Promoting Readiness of Minors in Supplemental Security Income (PROMISE): Recommendations of the Technical Advisory Panel Regarding the Use of Incentive Payments and the Evaluation Design
    by Thomas Fraker & Todd Honeycutt
  • 2012 Promoting Readiness of Minors in Supplemental Security Income (PROMISE): Recommendations of the Technical Advisory Panel Regarding the Use of Incentive Payments and the Evaluation Design
    by Thomas Fraker & Todd Honeycutt
  • 2012 Early Evaluations of the Medical Home: Building on a Promising Start
    by Deborah Peikes & Aparajita Zutshi & Janice L. Genevro & Michael L. Parchman & David S. Meyers
  • 2012 Examining Charter Student Achievement Effects Across Seven States
    by Ron Zimmer & Brian Gill & Kevin Booker & Stéphane Lavertu & John Wittle
  • 2012 Movement of Children Between Medicaid and CHIP, 2005 to 2007
    by John L. Czajka
  • 2012 The Medicaid Analytic eXtract 2008 Chartbook
    by Rosemary Borck & Allison Hedley Dodd & Ashley Zlatinov & Shinu Verghese & Rosalie Malsberger & Cara Petroski
  • 2012 Integrating Care for Dual Eligibles: The Role of Medicare Special Needs Plans
    by James M. Verdier
  • 2012 Comparison Friction: Experimental Evidence from Medicare Drug Plans
    by Jeffrey R. Kling & Sendhil Mullainathan & Eldar Shafir & Lee C. Vermeulen & Marian V. Wrobel
  • 2012 Developing Quality Measures for Medicaid Beneficiaries with Schozophrenia
    by Sam Simon & Thomas Croghan & Robert C. Saunders & Sarah Hudson Scholle & Milesh M. Patel & Jeremy Gottlich
  • 2012 Medicare Advantage: Lessons for Medicare's Future
    by Marsha Gold
  • 2012 How Many Disability Beneficiaries Forgo Cash Benefits Because of Work? Evidence from a New Measure
    by Jody Schimmel & David Stapleton
  • 2012 The Work Incentives Planning and Assistance Program: Promoting Employment Among Social Security Disability Beneficiaries
    by Jody Schimmel & Bonnie O'Day & Allison Roche
  • 2012 Cross-Site Evaluation Cost Study: Introduction to the Implementing Agency Staff Time Use Survey
    by Andrew Burwick & Heather Zaveri & Debra Strong
  • 2012 Integrating Care for Dual Eligibles in New York: Issues and Options
    by James M. Verdier & Jenna Libersky & Jessica Gillooly
  • 2012 Service Providers' Experiences Under the Revised Ticket to Work Regulations
    by Sarah Prenovitz
  • 2012 Assessing the Rothstein Test: Does It Really Show Teacher Value-Added Models Are Biased?
    by Dan Goldhaber & Duncan Chaplin
  • 2012 Is There a Trade-off Between Quality and Cost? Telephone Versus Face-to-Face Interviewing of Persons with Disabilities
    by Debra Wright & Matt Sloan & Kirsten Barrett
  • 2012 Assessing the 'Rothstein Falsification Test': Does it Really Show Teacher Value-Added Models Are Biased?
    by Dan Goldhaber & Duncan Chaplin
  • 2012 Survey Shows That at Least Some Physicians Are Not Always Open or Honest with Patients
    by Lisa I. Iezzoni & Sowmya R. Rao & Catherine M. DesRoches & Christine Vogeli & Eric G. Campbell
  • 2012 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for February 2012
    by Rachel Machta & Marsha Gold
  • 2012 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for January 2012
    by Rachel Machta & Marsha Gold
  • 2012 The Effects of Building Strong Families: A Healthy Marriage and Relationship Skills Education Program for Unmarried Parents
    by Robert G. Wood & Sheena McConnell & Quinn Moore & rew Clarkwest & JoAnn Hsueh
  • 2012 Advancing Systems Thinking in Evaluation: A Review of Four Publications
    by Margaret B. Hargreaves & Donna Podems
  • 2012 A Roadmap to a 21st-Century Disability Policy
    by David Mann & David Stapleton
  • 2012 Assessing Cultural Perspectives on Healthcare Quality
    by Ann D. Bagchi & Raquel af Ursin & Alicia Leonard
  • 2012 Charter-School Management Organizations: Diverse Strategies and Diverse Student Impacts
    by Joshua Furgeson & Brian Gill & Joshua Haimson & Alexandra Killewald & Moira McCullough & Ira Nichols-Barrer & Bing-ru Teh & Natalya Verbitsky-Savitz & Melissa Bowen & Allison Demeritt & Paul Hill & Robin Lake
  • 2012 Organizing Care for Complex Patients in the Patient-Centered Medical Home
    by Eugene C. Rich & Debra Lipson & Jenna Libersky & Deborah N. Peikes & Michael L. Parchman
  • 2012 Children and the Wealth of Nations
    by Cordoba, Juan Carlos
  • 2012 Women’s employment and marital stability: the role of the context
    by Marta Styrc & Anna Matysiak
  • 2012 Innovating Learning: Key Elements for Developing Creative Classrooms in Europe
    by Stefania Bocconi & Panagiotis Kampylis & Yves Punie
  • 2012 Venezuela's Economic Recovery: Is It Sustainable?
    by Jake Johnston & Mark Weisbrot
  • 2012 Bad Jobs on the Rise
    by John Schmitt & Janelle Jones
  • 2012 Where Have All the Good Jobs Gone?
    by John Schmitt & Janelle Jones
  • 2012 The Mexican Economy and the 2012 Elections
    by Rebecca Ray & Mark Weisbrot
  • 2012 Ecuador’s Economy Since 2007
    by Rebecca Ray & Sara Kozameh
  • 2012 Health-insurance Coverage for Low-wage Workers, 1979-2010 and Beyond
    by John Schmitt
  • 2012 A Pilot Study to Identify Areas for Further Improvements in Patient and Public Involvement in Health Technology Assessments for Medicines
    by Josie Messina & David. L. Grainger
  • 2012 Estimating Preference-Based EQ-5D Health State Utilities or Item Responses from Neuropathic Pain Scores
    by Ning Yan. Gu & Chris Bell & Marc F. Botteman & Xiang Ji & John A. Carter & Ben van Hout
  • 2012 Patients' Perceptions of the Interpersonal Sensitivity of Their Healthcare Providers: The Potential Role of Patient-Provider Racial/Ethnic Concordance
    by Karon L. Phillips & David A. Chiriboga & Yuri Jang
  • 2012 Psychometric Evaluation of an Inpatient Consumer Survey Measuring Satisfaction with Psychiatric Care
    by Glorimar Ortiz & Lucille Schacht
  • 2012 Comparison of Expected Outcomes between Patients and Neurologists Using Kano's Methodology in Symptomatic Migraine Treatment
    by J. Matas-Guiu & M.T. Caloto & G. Nocea
  • 2012 Practicing Patient-Centered Care: The Questions Clinically Excellent Physicians Use to Get to Know their Patients as Individuals
    by Laura A. Hanyok & David B. Hellmann & Cynthia Rand & Roy C. Ziegelstein
  • 2012 Cognitive Testing and Readability of an Item Bank for Measuring the Impact of Headache on Health-Related Quality of Life
    by Diane M. Turner-Bowker & Renee N. Saris-Baglama & Michael A. DeRosa & Christine A. Paulsen
  • 2012 Patient and Public Involvement in Patient-Reported Outcome Measures: Evolution Not Revolution
    by Sophie Staniszewska & Kirstie L. Haywood & Jo Brett & Liz Tutton
  • 2012 Patient and Public Involvement in Developing Patient-Reported Outcome Measures: Indispensable, Desirable, Challenging
    by Oliver Groene
  • 2012 Seeking What Matters: Patients as Research Partners
    by Musa Mayer
  • 2012 Assessing Stakeholder Opinion on Relations between Cancer Patient Groups and Pharmaceutical Companies in Europe
    by Susanna Leto di Priolo & Andras Fehervary & Phil Riggins & Kathy Redmond
  • 2012 Content Validity of Visual Analog Scales to Assess Symptom Severity of Acute Angioedema Attacks in Adults with Hereditary Angioedema: An Interview Study
    by Carolyn Vivienne. McMillan & Jane Speight & Anurag Relan & Luca Bellizzi & Gerald Haase & Marco Cicardi
  • 2012 Designing Family-Centered Male Circumcision Services: A Conjoint Analysis Approach
    by John F.P. Bridges & Sarah C. Searle & Frederic W. Selck & Neil A. Martinson
  • 2012 Burden of a Multiple Sclerosis Relapse: The Patient's Perspective
    by MerriKay Oleen-Burkey & Jane Castelli-Haley & Maureen J. Lage & Kenneth P. Johnson
  • 2012 A Comparison of Analytic Hierarchy Process and Conjoint Analysis Methods in Assessing Treatment Alternatives for Stroke Rehabilitation
    by Maarten J. IJzerman & Janine A. van Til & John F.P. Bridges
  • 2012 Patient Preferences for First-Line Oral Treatment for Mild-to-Moderate Ulcerative Colitis: A Discrete-Choice Experiment
    by Paul Hodgkins & Paul Swinburn & Dory Solomon & Linnette Yen & Sarah Dewilde & Andrew Lloyd
  • 2012 Re-Engineering the Post-Discharge Appointment Process for General Medicine Patients
    by Robert Chang & David Spahlinger & Christopher S. Kim
  • 2012 Test-Retest Reliability of an Interactive Voice Response Version of the EQ-5D in a Sample of Cancer Survivors
    by J. Jason. Lundy & Stephen Joel. Coons
  • 2012 Patients' Perceptions of Sharing in Decisions: A Systematic Review of Interventions to Enhance Shared Decision Making in Routine Clinical Practice
    by France Lgar & Stphane Turcotte & Dawn Stacey & Stphane Ratt & Jennifer Kryworuchko & Ian D. Graham
  • 2012 The Authors' Reply
    by Hareth Al-Janabi & Terry N. Flynn & Joanna Coast
  • 2012 Caregivers' Quality of Life and Economic Evaluations
    by Afschin Gandjour
  • 2012 Dabigatran Etexilate: A Pharmacoeconomic Review of its Use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
    by Kate McKeage
  • 2012 A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease
    by Petra Menn & Reiner Leidl & Rolf Holle
  • 2012 Costs Associated with Febrile Neutropenia in the US
    by Shannon L. Michels & Rich L. Barron & Matthew W. Reynolds & Karen Smoyer Tomic & Jingbo Yu & Gary H. Lyman
  • 2012 Lost Productivity in Four European Countries among Patients with Rheumatic Disorders: Are Absenteeism and Presenteeism Transferable?
    by Saskia Knies & Math J.J.M. Candel & Annelies Boonen & Silvia M.A.A. Evers & Andre J.H.A. Ament & Johan L. Severens
  • 2012 Reimbursement Decisions of the All Wales Medicines Strategy Group: Influence of Policy and Clinical and Economic Factors
    by Warren G. Linley & Dyfrig A. Hughes
  • 2012 Cost of Illness of Cystic Fibrosis in Germany: Results from a Large Cystic Fibrosis Centre
    by Mareike Heimeshoff & Helge Hollmeyer & Jonas Schreygg & Oliver Tiemann & Doris Staab
  • 2012 Assessing the Quality of Pharmacoeconomic Studies in India: A Systematic Review
    by Pooja R. Desai & Hitesh S. Chandwani & Karen L. Rascati
  • 2012 Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity Disorder in Children and Adolescents
    by Vanja Sikirica & M. Haim Erder & Jipan Xie & Dendy Macaulay & Melissa Diener & Paul Hodgkins & Eric Q. Wu
  • 2012 Valuation of the Child Health Utility 9D Index
    by Katherine Stevens
  • 2012 Developing Adolescent-Specific Health State Values for Economic Evaluation: An Application of Profile Case Best-Worst Scaling to the Child Health Utility 9D
    by Julie Ratcliffe & Terry Flynn & Frances Terlich & Katherine Stevens & John Brazier & Michael Sawyer
  • 2012 A Parent-Child Dyad Approach to the Assessment of Health Status and Health-Related Quality of Life in Children with Asthma
    by Wendy J. Ungar & Katherine Boydell & Sharon Dell & Brian M. Feldman & Deborah Marshall & Andrew Willan & James G. Wright
  • 2012 The Impact of Rotavirus Vaccination on Discounted Net Tax Revenue in Egypt: A Government Perspective Analysis
    by Mark P. Connolly & Oleksandr Topachevskyi & Baudouin Standaert & Omayra Ortega & Maarten Postma
  • 2012 Preference-Based Health-Related Quality-of-Life Outcomes in Children with Autism Spectrum Disorders: A Comparison of Generic Instruments
    by J. Mick. Tilford & Nalin Payakachat & Erica Kovacs & Jeffrey M. Pyne & Werner Brouwer & Todd G. Nick & Jayne Bellando & Karen A. Kuhlthau
  • 2012 Economic Evaluations of Childhood Influenza Vaccination: A Critical Review
    by Anthony T. Newall & Mark Jit & Philippe Beutels
  • 2012 Comparative Effectiveness and Child Health
    by Lisa A. Prosser
  • 2012 Valuing Children's Health: Whose Quality of Life Matters?
    by Eve Wittenberg
  • 2012 Quetiapine: A Pharmacoeconomic Review of its Use in Bipolar Disorder
    by Greg L. Plosker
  • 2012 Duloxetine Use in Chronic Low Back Pain: Treatment Patterns and Costs
    by Jasmina I. Ivanova & Howard G. Birnbaum & Evan Kantor & Matt Schiller & Ralph W. Swindle
  • 2012 Cost Utility of Tumour Necrosis Factor-α Inhibitors for Rheumatoid Arthritis: An Application of Bayesian Methods for Evidence Synthesis in a Markov Model
    by Christine M. Nguyen & Mark Bounthavong & Margaret A.S. Mendes & Melissa L.D. Christopher & Josephine N. Tran & Rashid Kazerooni & Anthony P. Morreale
  • 2012 Hospital Reimbursement Price Cap for Cancer Drugs: The French Experience in Controlling Hospital Drug Expenditures
    by A. Degrassat-Thas & M. Bensadon & C. Rieu & M. Angalakuditi & C. Le Pen & P. Paubel
  • 2012 Economic Evaluation of Smoking-Cessation Therapies: A Critical and Systematic Review of Simulation Models
    by Kristian Bolin
  • 2012 Cost Effectiveness of Rituximab for Non-Hodgkin's Lymphoma: A Systematic Review
    by Philipp W.P. Auweiler & Dirk Mller & Stephanie Stock & Andreas Gerber
  • 2012 Corrigendum
    by Adis International Limited
  • 2012 The Authors' Reply
    by A. George. Awad & Lakshmi N.P. Voruganti
  • 2012 The Lack of Impact of Quality-of-Life Measures in Schizophrenia: A Shared Responsibility?
    by Laurent Boyer & Pascal Auquier
  • 2012 Cost Effectiveness of Quetiapine in Patients with Acute Bipolar Depression and in Maintenance Treatment after an Acute Depressive Episode
    by Mattias Ekman & Peter Lindgren & Carolin Miltenburger & Genevieve Meier & Julie C. Locklear & Mary Lou. Chatterton
  • 2012 Pharmacoeconomics of the Myeloid Growth Factors: A Critical and Systematic Review
    by Bradford R. Hirsch & Gary H. Lyman
  • 2012 Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal
    by Dwayne Boyers & Xueli Jia & David Jenkinson & Graham Mowatt
  • 2012 A Critical Review of Model-Based Economic Studies of Depression: Modelling Techniques, Model Structure and Data Sources
    by Hossein Haji Ali Afzali & Jonathan Karnon & Jodi Gray
  • 2012 Value of Information and Pricing New Healthcare Interventions
    by Andrew R. Willan & Simon Eckermann
  • 2012 The Authors' Reply
    by Livio Garattini & Katelijne van de Vooren & Alessandro Curto
  • 2012 Human Papillomavirus Vaccination Is Not Exclusively a Matter of Price
    by Alessandro Capone & Giampiero Favato
  • 2012 The Impact of Co-Morbidity Burden on Preference-Based Health-Related Quality of Life in the United States
    by Patrick W. Sullivan & Vahram H. Ghushchyan & Elizabeth A. Bayliss
  • 2012 Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma
    by Joshua Pink & Steven Lane & Dyfrig A. Hughes
  • 2012 Anti-Inflammatory Medication Adherence, Healthcare Utilization and Expenditures among Medicaid and Children's Health Insurance Program Enrollees with Asthma
    by Jill Boylston. Herndon & Soeren Mattke & Alison Evans Cuellar & Seo Yeon. Hong & Elizabeth A. Shenkman
  • 2012 Changes in Antipsychotic Medication Use after Implementation of a Medicaid Mental Health Carve-Out in the US
    by John Robst
  • 2012 Pharmacoeconomics of Bisphosphonates for Skeletal-Related Event Prevention in Metastatic Non-Breast Solid Tumours
    by John A. Carter & Avani D. Joshi & Satyin Kaura & Marc F. Botteman
  • 2012 Issues in the Economic Evaluation of Influenza Vaccination by Injection of Healthy Working Adults in the US: A Review and Decision Analysis of Ten Published Studies
    by Thomas J. Hogan
  • 2012 Selecting a Mix of Prevention Strategies against Cervical Cancer for Maximum Efficiency with an Optimization Program
    by Nadia Demarteau & Thomas Breuer & Baudouin Standaert
  • 2012 Changes in Utilization and Costs for Patients with Rheumatoid Arthritis, 1997 to 2006
    by Howard G. Birnbaum & Crystal Pike & Ritesh Banerjee & Tracy Waldman & Mary Cifaldi
  • 2012 Cost Effectiveness of Anticoagulation in Acute Coronary Syndromes
    by Jaime Latour-Prez & Eva de-Miguel-Balsa
  • 2012 Cost Effectiveness of Pharmacological Maintenance Treatment for Chronic Obstructive Pulmonary Disease: A Review of the Evidence and Methodological Issues
    by Maureen P.M.H. Rutten-van Mlken & Lucas M.A. Goossens
  • 2012 Golimumab for the Treatment of Psoriatic Arthritis: A NICE Single Technology Appraisal
    by Huiqin Yang & Dawn Craig & David Epstein & Laura Bojke & Kate Light & Ian N. Bruce & Mark Sculpher & Nerys Woolacott
  • 2012 Rufinamide: A Pharmacoeconomic Profile of its Use as Adjunctive Therapy in Lennox-Gastaut Syndrome
    by Paul L. McCormack
  • 2012 Common Drug Review Recommendations: An Evidence Base for Expectations?
    by Angela Rocchi & Elizabeth Miller & Robert B. Hopkins & Ron Goeree
  • 2012 Methodological Quality of Economic Evaluations of New Pharmaceuticals in the Netherlands
    by Ties Hoomans & Johan L. Severens & Nicole van der Roer & Gepke O. Delwel
  • 2012 Pricing Human Papillomavirus Vaccines: Lessons from Italy
    by Livio Garattini & Katelijne van de Vooren & Alessandro Curto
  • 2012 Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001-7
    by Frank R. Lichtenberg
  • 2012 Measuring Quality of Life in Patients with Schizophrenia: An Update
    by A. George. Awad & Lakshmi N.P. Voruganti
  • 2012 Population- versus Cohort-Based Modelling Approaches
    by Olivier Ethgen & Baudouin Standaert
  • 2012 Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payer's Perspective
    by Aurea Duran & Nishan Sengupta & Alexander Diamantopoulos & Fiona Forster & Louis Kwong & Michael Lees
  • 2012 Health Utility Elicitation: Is There Still a Role for Direct Methods?
    by Lisa A. Prosser & Scott D. Grosse & Eve Wittenberg
  • 2012 Osteoporotic Fractures: A Systematic Review of US Healthcare Costs and Resource Utilization
    by Sangeeta Budhia & Yeshi Mikyas & Michael Tang & Enkhe Badamgarav
  • 2012 Dabigatran Etexilate for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip or Knee Surgery: A NICE Single Technology Appraisal
    by Michael Holmes & Christopher Carroll & Diana Papaioannou
  • 2012 Real Economics Needs to Reflect Real Decisions: A Response to Johnson
    by Mark Sculpher & Karl Claxton
  • 2012 Why Not Real Economics?
    by F. Reed. Johnson
  • 2012 Incorporating Calibrated Model Parameters into Sensitivity Analyses: Deterministic and Probabilistic Approaches
    by Douglas C.A. Taylor & Vivek Pawar & Denise T. Kruzikas & Kristen E. Gilmore & Myrlene Sanon & Milton C. Weinstein
  • 2012 Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer
    by Robert I. Griffiths & Richard L. Barron & Michelle L. Gleeson & Mark D. Danese & Anthony OHagan & Victoria M. Chia & Jason C. Legg & Gary H. Lyman
  • 2012 Erratum
    by Adis International Limited
  • 2012 A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis
    by Christopher Fitzpatrick & Katherine Floyd
  • 2012 Does the EQ-5D Reflect Lost Earnings?
    by Carl Tilling & Marieke Krol & Aki Tsuchiya & John Brazier & Job van Exel & Werner Brouwer
  • 2012 Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal
    by Claire McKenna & Emma Maund & Muhammad Sarowar & David Fox & Matt Stevenson & Chris Pepper & Nerys Woolacott & Stephen Palmer
  • 2012 Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic Review
    by Mathilda L. Bongers & Veerle M.H. Coup & Elise P. Jansma & Egbert F. Smit & Carin A. Uyl-de Groot
  • 2012 Economic and Humanistic Burden of External Genital Warts
    by Adam J.N. Raymakers & Mohsen Sadatsafavi & Fawziah Marra & Carlo A. Marra
  • 2012 Impact of Transformation of Negative Values and Regression Models on Differences Between the UK and US EQ-5D Time Trade-Off Value Sets
    by Liv Ariane Augestad & Kim Rand-Hendriksen & Ivar Snb Kristiansen & Knut Stavem
  • 2012 What's Good and Bad About Contraceptive Products?: A Best-Worst Attribute Experiment Comparing the Values of Women Consumers and GPs
    by Stephanie A. Knox & Rosalie C. Viney & Deborah J. Street & Marion R. Haas & Denzil G. Fiebig & Edith Weisberg & Deborah Bateson
  • 2012 Chemotherapy Administration: Modelling the Costs of Alternative Protocols
    by Philip Haywood & Johan de Raad & Kees van Gool & Marion Haas & Gisselle Gallego & Sallie-Anne Pearson & Margaret Faedo & Robyn Ward
  • 2012 Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex) for Spasticity in Multiple Sclerosis
    by Lanting Lu & Hilary Pearce & Chris Roome & James Shearer & Iain A. Lang & Ken Stein
  • 2012 Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis: A Critical and Systematic Review
    by Ccile Gaujoux-Viala & Bruno Fautrel
  • 2012 A Systematic Review and Critical Assessment of Health State Utilities: Weight Change and Type 2 Diabetes Mellitus
    by Scott Doyle & Andrew Lloyd & Lee Moore & Joshua Ray & Alastair Gray
  • 2012 Bevacizumab for Metastatic Colorectal Cancer: A NICE Single Technology Appraisal
    by Sophie Whyte & Abdullah Pandor & Matt Stevenson
  • 2012 Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis
    by Marta O. Soares & Lusa Canto e Castro
  • 2012 Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6-11 Years: A NICE Single Technology Appraisal
    by Jane Burch & Susan Griffin & Claire McKenna & Simon Walker & James Paton & Kath Wright & Nerys Woolacott
  • 2012 Cost-Effectiveness Analysis of Therapies for Chronic Kidney Disease Patients on Dialysis: A Case for Excluding Dialysis Costs
    by Daniel T. Grima & Lisa M. Bernard & Elizabeth S. Dunn & Philip A. McFarlane & David C. Mendelssohn
  • 2012 Erratum
    by Adis International Limited
  • 2012 The General Public's Willingness to Pay for Tax Increases to Support Unrestricted Access to an Alzheimer's Disease Medication
    by Mark Oremus & Jean-Eric Tarride & Parminder Raina & Lehana Thabane & Gary Foster & Charlie H. Goldsmith & Natasha Clayton
  • 2012 The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes: A New Zealand Evaluation
    by Laura Panattoni & Paul M. Brown & Braden Te Ao & Mark Webster & Patrick Gladding
  • 2012 A 3-Dimensional View of Access to Licensed and Subsidized Medicines under Single-Payer Systems in the US, the UK, Australia and New Zealand
    by Rajan Ragupathy & Katri Aaltonen & June Tordoff & Pauline Norris & David Reith
  • 2012 Losing Sight of the Wood for the Trees: Some Issues in Describing and Valuing Health, and Another Possible Approach
    by Paul Dolan & Henry Lee & Tessa Peasgood
  • 2012 Cost Effectiveness of Hepatitis C-Related Interventions Targeting Substance Users and Other High-Risk Groups: A Systematic Review
    by Ava John-Baptiste & Man Wah Yeung & Victoria Leung & Gabrielle van der Velde & Murray Krahn
  • 2012 The Burden of Moderate to Severe Psoriasis: An Overview
    by Giovanna Raho & Daniela Mihajlova Koleva & Livio Garattini & Luigi Naldi
  • 2012 The Authors' Reply
    by Ties Hoomans & Johan L. Severens & Nicole van der Roer & Gepke O. Delwel
  • 2012 Is There a Role for Pharmacoeconomics in Decision Making?
    by Johan C.F. van Luijn
  • 2012 Validity of Cost and Utility Results?
    by Alex Diamantopoulos & Laura Sawyer & Sarika Ogale & Fred Dejonckheere
  • 2012 The Authors' Reply
    by Mark Bounthavong & Christine M. Nguyen & Margaret A.S. Mendes & Melissa L.D. Christopher & Josephine N. Tran & Rashid Kazerooni & Anthony P. Morreale
  • 2012 Patient Preferences for Community Pharmacy Asthma Services: A Discrete Choice Experiment
    by Pradnya Naik-Panvelkar & Carol Armour & John M. Rose & Bandana Saini
  • 2012 Value-of-Information Analysis to Reduce Decision Uncertainty Associated with the Choice of Thromboprophylaxis after Total Hip Replacement in the Irish Healthcare Setting
    by Laura McCullagh & Cathal Walsh & Michael Barry
  • 2012 The State of Health Economic Research in South Africa: A Systematic Review
    by Paul Gavaza & Karen L. Rascati & Abiola O. Oladapo & Star Khoza
  • 2012 The Cost Effectiveness of Newer Epilepsy Treatments: A Review of the Literature on Partial-Onset Seizures
    by Kristian Bolin & Lars Forsgren
  • 2012 Counting the Cost of Not Costing HIV Health Facilities Accurately: Pay Now, or Pay More Later
    by Eduard J. Beck & Carlos Avila & Sofia Gerbase & Guy Harling & Paul De Lay
  • 2012 New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses
    by Douglas W. Mapel & Melissa H. Roberts
  • 2012 Private Manufacturers' Thresholds to Invest in Comparative Effectiveness Trials
    by Anirban Basu & David Meltzer
  • 2012 Do Higher-Priced Generic Medicines Enjoy a Competitive Advantage Under Reference Pricing?
    by Jaume Puig-Junoy
  • 2012 Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain: The ECOBIM Study
    by Tatiana Dilla & Amparo Valladares & Claudia Nicolay & Javier Salvador & Jess Reviriego & Mara Costi
  • 2012 What Explains Willingness to Pay for Smoking-Cessation Treatments - Addiction Level, Quit-Rate Effectiveness or the Opening Bid?
    by Jan Abel. Olsen & Ole J. Rgeberg & Knut Stavem
  • 2012 Insensitivity to Scope in Contingent Valuation Studies: Reason for Dismissal of Valuations?
    by Rikke Sgaard & Jes Lindholt & Dorte Gyrd-Hansen
  • 2012 Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison
    by M. Haim Erder & Jipan Xie & James E. Signorovitch & Kristina S. Chen & Paul Hodgkins & Mei Lu & Eric Q. Wu & Vanja Sikirica
  • 2012 Inclusion of Compliance and Persistence in Economic Models: Past, Present and Future
    by Ananth Kadambi & Robert J. Leipold & Anuraag R. Kansal & Sonja Sorensen & Denis Getsios
  • 2012 Insensitivity to Scope in Contingent Valuation Studies: New Direction for an Old Problem
    by Jennifer A. Whitty
  • 2012 Acknowledgement
    by Adis International Limited
  • 2012 Five-Year Evolution of Drug Prescribing in a University Adult Intensive Care Unit
    by Christine Carron & Pierre Voirol & Philippe Eggimann & Andr Pannatier & Ren Chiolro & Jean-Blaise Wasserfallen
  • 2012 Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis: Results from a 1-Year, Multicentre, Open-Label, Single-Arm Study in a Clinical Setting
    by Ronald Vender & Charles Lynde & Vincent Ho & Dina Chau & Melanie Poulin-Costello
  • 2012 Clopidogrel versus Aspirin in Patients with Atherothrombosis: A CAPRIE-Based Cost-Effectiveness Model for Greece
    by Georgia Kourlaba & Vassilis Fragoulakis & Nikos Maniadakis
  • 2012 Estimating Incremental Costs with Skew: A Cautionary Note
    by Linnea A. Polgreen & John M. Brooks
  • 2012 Lifetime Productivity Losses Associated with Obesity Status in Early Adulthood: A Population-Based Study of Swedish Men
    by Kristian Neovius & Clas Rehnberg & Finn Rasmussen & Martin Neovius
  • 2012 PleurX Peritoneal Catheter Drainage System for Vacuum-Assisted Drainage of Treatment-Resistant, Recurrent Malignant Ascites: A NICE Medical Technology Guidance
    by Judith White & Grace Carolan-Rees
  • 2012 NICE Medical Technologies Guidance: A Novel and Rigorous Methodology to Address a New Health Technology Assessment Challenge
    by Bruce Campbell & Mark Campbell
  • 2012 Is More Expensive Medical Technology Better?: The Use of Analytics in the Evaluation of Clinical Outcomes for Different Material Compositions of Total Knee Implants
    by Jeffrey Voigt & Michael Mosier
  • 2012 Alcohol Reform in Viet Nam: Confronting Rising Consumption, Injury and Harm
    by Nguyen Minh. Tam & Christopher M. Doran & Peter S. Hill & Michael P. Dunne
  • 2012 Cost-Effectiveness Analysis of Treatments for Vertebral Compression Fractures
    by Avram A. Edidin & Kevin L. Ong & Edmund Lau & Jordana K. Schmier & Jason E. Kemner & Steven M. Kurtz
  • 2012 Economic Evaluation of Clopidogrel in Acute Coronary Syndrome Patients without ST-Segment Elevation in Greece: A Cost-Utility Analysis
    by Georgia Kourlaba & Vassilis Fragoulakis & Nikos Maniadakis
  • 2012 Resource Utilization and Outcomes in Patients with Atrial Fibrillation: A Case Control Study
    by Rachael Boggon & Gregory Y.H. Lip & Arlene M. Gallagher & Tjeerd P. van Staa
  • 2012 Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany: Results from Administrative Data Using a Propensity Score-Matching Approach
    by Michael Bumler & Tom Stargardt & Jonas Schreygg & Reinhard Busse
  • 2012 Economic Consequences of the Demography of MRSA Patients and the Impact of Broad-Spectrum Antimicrobials
    by K. Kaier & S. Moog
  • 2012 A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing
    by Ulf Persson & Johanna Svensson & Billie Pettersson
  • 2012 Cost-Effectiveness Analysis of Early versus Non-Early Intervention in Acute Migraine Based on Evidence from the 'Act when Mild' Study
    by John Slof
  • 2012 National Health Insurance Reform in South Africa: Estimating the Implications for Demand for Private Health Insurance
    by Okore Apia Okorafor
  • 2012 Cost Effectiveness of Prostacyclins in Pulmonary Arterial Hypertension
    by Antonio Roman & Joan A. Barber & Pilar Escribano & Maria L. Sala & Laia Febrer & Itziar Oyagez & Eliazar Sabater & Miguel . Casado
  • 2012 Direct Healthcare Costs of Osteoporosis-Related Fractures in Managed Care Patients Receiving Pharmacological Osteoporosis Therapy
    by Hema N. Viswanathan & Jeffrey R. Curtis & Jingbo Yu & Jeffrey White & Bradley S. Stolshek & Claire Merinar & Akhila Balasubramanian & Joel D. Kallich & John L. Adams & Sally W. Wade
  • 2012 Economic Evaluations of Adult Weight Management Interventions: A Systematic Literature Review Focusing on Methods Used for Determining Health Impacts
    by Ulla K. Griffiths & Benedict Anigbogu & Kiran Nanchahal
  • 2012 Understanding Consumer Preferences in the Context of Managed Competition: Evidence from a Choice Experiment in Colombia
    by Antonio J. Trujillo & Fernando Ruiz & John F.P. Bridges & Jeannette L. Amaya & Christine Buttorff & Anglica M. Quiroga
  • 2012 Evaluating the Epidemiology and Morbidity Burden Associated with Human Papillomavirus in Israel: Accounting for CIN1 and Genital Warts in Addition to CIN2/3 and Cervical Cancer
    by Oren Shavit & Raanan Raz & Michal Stein & Gabriel Chodick & Eduardo Schejter & Yehuda Ben-David & Raanan Cohen & Daphna Arbel & Varda Shalev
  • 2012 Using the Economics of Certification to Improve the Safety and Quality of Male Circumcision in Developing Countries: Three Models of Implementation
    by Michael R. Richards
  • 2012 The Need for Measurement of Efficiency in Greek Primary Healthcare: The Case for Rural Southern and Western Greece
    by Nikolaos Oikonomou & Yannis Tountas & John Kyriopoulos
  • 2012 Budget Impact Analysis of Switching to Darunavir/Ritonavir Monotherapy for HIV-Infected People in Spain
    by Juan Pasquau & Joana Gostkorzewicz & Francisco Ledesma & Anne Anceau & Andrew Hill & Christiane Moecklinghoff
  • 2012 A Cost-Utility Analysis of Cinacalcet in Secondary Hyperparathyroidism in Five European Countries
    by Sergio Iannazzo & Michela Carsi & Silvia Chiroli
  • 2012 Insights from Triangulation of Two Purchase Choice Elicitation Methods to Predict Social Decision Making in Healthcare
    by Jennifer A. Whitty & Sharyn R. Rundle-Thiele & Paul A. Scuffham
  • 2012 Alcohol Policy and Taxation in South Africa: An Examination of the Economic Burden of Alcohol Tax
    by John Ele-Ojo. Ataguba
  • 2012 Tackling Alcohol Misuse: Purchasing Patterns Affected by Minimum Pricing for Alcohol
    by Anne Ludbrook & Dennis Petrie & Lynda McKenzie & Shelley Farrar
  • 2012 The Efficiency of a Volumetric Alcohol Tax in Australia
    by Joshua Byrnes & Dennis J. Petrie & Christopher M. Doran & Anthony Shakeshaft
  • 2012 The Role of Health Economics in Alcohol Policy
    by Christopher M. Doran & Joshua Byrnes
  • 2012 Intra-Operative vs Pre-Operative Endoscopic Sphincterotomy in Patients with Gallbladder and Common Bile Duct Stones: Cost-Utility and Value-of-Information Analysis
    by Kurinchi Gurusamy & Edward Wilson & Andrew K. Burroughs & Brian R. Davidson
  • 2012 Triangulating Health Expenditure Estimates from Different Data Sources in Developing Countries: The Case of Pakistan's Private Health Expenditure
    by Christian Lorenz
  • 2012 Economic Implications of Rasburicase Treatment in Adult Patients with Tumour Lysis Syndrome
    by Michael Eaddy & Brian Seal & Krishna Tangirala & Elizabeth Hackney. Davies & Ken ODay
  • 2012 Towards a resource policy—unleashing productivity dynamics and balancing international distortions
    by Raimund Bleischwitz
  • 2012 Return Requirements For Regulated Entities In The Gas Industry
    by Martin EHMER & Lukas D. SCHUCHARDT & Heinz-Werner UFER
  • 2012 Persuasive Communication At The Academic Level And How To Make It More Effective
    by Oana-Matilda SABIE & Armenia ANDRONICEANU
  • 2012 Modern methods of research of non-industrial sphere in the region
    by Morozova Galina Alekseevna
  • 2012 The Role of Maritime University in Specialized Training in Maritime and Port Marketing
    by Iordanoaia Florin
  • 2012 Health Insurance and Implementation of Private System
    by Mangra Mãdãlina Giorgiana
  • 2012 Nutritional Aspects of Romanian Feeding that are Required to be Corrected
    by Constandache Mihaela & Radu Stelu?a
  • 2012 The Family Allowances in Romania During the Period 2004 -2011
    by Urseanu Claudiu Mihãiþã
  • 2012 The Evolution of the Number of the Disabled Persons During the Period 2000-2011
    by Urseanu Claudiu Mihãiþã
  • 2012 Fast Food Paradox: Freedom and Cultural Imperialism
    by Lelia Voinea
  • 2012 Education Management Decision-Makers In European Pre University Education
    by TUSA ANA & VOINIA CLAUDIU SORIN & DUMITRASCU DANUT DUMITRU &
  • 2012 The Market Value Of Human Capital: An Empirical Analysis
    by NEAGU OLIMPIA
  • 2012 Nutrigenomics – Impact on Health
    by Emilia Pascu & Oana-Maria Milea & Petronela-Sonia Nedea
  • 2012 Civic culture and informal media uses: Poles and Greeks discussing „free culture“
    by Yiannis MYLONAS
  • 2012 Value added of teachers in high-poverty schools and lower poverty schools
    by Sass, Tim R. & Hannaway, Jane & Xu, Zeyu & Figlio, David N. & Feng, Li
  • 2012 Weight and earnings among childbearing women in Metropolitan Cebu, Philippines (1983–2002)
    by Colchero, M. Arantxa & Bishai, David
  • 2012 Are there peer effects associated with having English Language Learner (ELL) classmates? Evidence from the Early Childhood Longitudinal Study Kindergarten Cohort (ECLS-K)
    by Cho, Rosa Minhyo
  • 2012 Grain inflation: Identifying agent discretion in response to a conditional school nutrition program
    by Linden, Leigh L. & Shastry, Gauri Kartini
  • 2012 Economic growth and child poverty reduction in Bangladesh and China
    by Begum, Syeda Shahanara & Deng, Quheng & Gustafsson, Björn
  • 2011 Tracking the Historical Evolution of States' Compliance with their Economics and Social Rights Obligations of Result: Insights from the Historical SERF Index
    by Susan Randolph & Patrick Guyer
  • 2011 Planning Evaluations Designed to Meet Scientific Standards: Communicating Key Components of the Plan for a Rigorous and Useful Evaluation of a Teenage Pregnancy Prevention Program
    by Susan Zief & Juliette Henke & Jean Knab & Heather Zaveri
  • 2011 Baby FACES: Ext Interview Spring/Fall 2011 Data Collection Documentation with Variable Names
    by Mathematica Policy Research
  • 2011 Baby FACES: Spanish Parent Questionnaire for Parents of 3-Year-Old Children, Spring 2011
    by Mathematica Policy Research
  • 2011 Baby FACES: Spanish Parent Questionnaire for Parents of 2-Year-Old Children, Spring 2011-2012
    by Mathematica Policy Research
  • 2011 Alabama's Current Insurance Market
    by Deborah Chollet & Kate Stewart & Suzie Witmer
  • 2011 Current and Future Sources of Health Insurance Coverage for Alabama Residents
    by Deborah Chollet & Allison Barrett & Thomas Bell
  • 2011 Five Key Considerations for Exploring the Medicaid Health Homes Opportunity
    by Center for Health Care Strategies & Mathematica Policy Research
  • 2011 Informing the Performance-Based Contract Between First 5 LA and LAUP: Child Progress in the 2010-2011 Program Year
    by Emily Moiduddin & Yange Xue & Sally Atkins-Burnett
  • 2011 Why Have Divorce Rates Fallen? The Role of Women's Age at Marriage
    by Dana Rotz
  • 2011 Combination Classes and Educational Achievement
    by Jaime Thomas
  • 2011 Baby FACES Parent Questionnaire for Parents of 3-Year-Old Children
    by Mathematica Policy Research staff
  • 2011 Baby FACES 2011 Program Director Interview
    by Mathematica Policy Research staff
  • 2011 Baby FACES Teacher/Home Visitor Child Rating for Teachers and Home Visitors of 3-Year-Old Children
    by Mathematica Policy Research staff
  • 2011 Evaluation of the Helping You Take Care of Yourself Curriculum 2009-2010
    by Mindy Lipson & Melanie Besculides & Ebo Dawson-Andoh & Nicholas Redel
  • 2011 Modified Adjusted Gross Income: Implications for Medicaid Eligibility Systems Under the ACA
    by Carrie Au-Yeung & John Czajka
  • 2011 BOND Implementation and Evaluation: Evaluation Analysis Plan
    by Stephen Bell & Daniel Gubits & David Stapleton & David Wittenburg & Michelle Derr & Arkadipta Ghosh & Sara Ansell & David Greenberg
  • 2011 Continued Development of the Medicaid Analytic Extract Enrollee Master (MAXEM) File
    by John L. Czajka & Shinu Verghese
  • 2011 Youth and Family Participation in the Governance of Residential Treatment Facilities
    by Jonathan D. Brown & Henry T. Ireys & Kamala Allen & Tara Krissik & Kirsten Barrett & Sheila A. Pires & Gary Blau
  • 2011 Collecting, Using, and Reporting Medicaid Encounter Data: A Primer for States
    by Vivian L. H. Byrd & James Verdier
  • 2011 Background Review Framework for Study 5: Identifying Existing Literature on Coaching Models
    by Nikki Aikens & Sally Atkins-Burnett & Yange Xue
  • 2011 Development of Parent Engagement Items and Targets fro the Performance-Based Contract, Including Sampling Plan Recommendations
    by Elisha Smith & Cay Bradley & Sameena Salvucci
  • 2011 Developing Child Progress Targets for the Performance-Based Contract, Revised Memo
    by Yange Xue & Sally Atkins-Burnett & Emily Moiduddin
  • 2011 Background Review of Existing Literature on Coaching
    by Nikki Aikens & Lauren Akers
  • 2011 A Pilot Study of Quality Support Coaching in LAUP: Findings from the 2010-2011 Program Year
    by Sally Atkins-Burnett & Pamela Winston & Yange Xue & Emily Moiduddin & Elisha Smith & Susan Sprachman & Nikki Aikens
  • 2011 Design for a Study of Los Angeles Universal Preschool's Quality Support Coaching Model
    by Emily Moiduddin & Nikki Aikens & Susan Sprachman & Sally Atkins-Burnett & Pamela Winston & Elisha Smith
  • 2011 Quality Support Coaching in LAUP: Pilot Study Findings
    by Mathematica Policy Research
  • 2011 Impacts of Performance Pay Under the Teacher Incentive Fund: Study Design Report
    by Steven Glazerman & Hanley Chiang & Alison Wellington & Jill Constantine & Dan Player
  • 2011 Designing an Exchange: A Toolkit for State Policymakers
    by Lee Goldberg & Deborah Chollet & Renée M. Landers
  • 2011 Designing an Exchange: A Toolkit for State Policymakers
    by Report from the study panel on Health Insurance Exchanges created under the Patient Protection & Affordable Care Act of which Deborah Chollet is a member
  • 2011 The Affordable Care Act (ACA): What Are the Implications for the Employment of People with Disabilities?
    by David Stapleton
  • 2011 Data Tables for FACES 2009 Head Start Children, Families, and Programs: Present and Past Data from FACES Report
    by Nikki Aikens & Lara Kristin Hulsey & Emily Moiduddin & Ashley Kopack & Amy Takyi-Laryea & Louisa Tarullo & Jerry West
  • 2011 Head Start Children, Families, and Programs: Present and Past Data from FACES
    by Lara Kristin Hulsey & Nikki Aikens & Ashley Kopack & Jerry West & Emily Moiduddin & Louisa Tarullo
  • 2011 Efforts to Diversify the STEM Workforce
    by Clemencia Cosentino
  • 2011 Cross-Site Evaluation Update: Cost Analysis
    by Andrew Burwick
  • 2011 Building, Evaluating and Using an Evidence Base to Inform the HHS Teenage Pregnancy Prevention (TPP) Program
    by Brian Goesling
  • 2011 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for December 2011
    by Rachel Machta & Marsha Gold
  • 2011 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for October 2011
    by Rachel Machta & Marsha Gold
  • 2011 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for September 2011
    by Rachel Machta & Marsha Gold
  • 2011 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for August 2011
    by Rachel Machta & Marsha Gold
  • 2011 Fourth Report to Congress on the Evaluation of the Medicare Coordinated Care Demonstration
    by Jennifer Schore & Deborah Peikes & Greg Peterson & Angela Gerolamo & Randall Brown
  • 2011 Links Between Young Children's Behavior and Achievement: The Role of Social Class and Classroom Composition
    by Annie Georges & Jeanne Brooks-Gunn & Lizabeth M. Malone
  • 2011 Developing and Running a Primary Care Practice Facilitation Program: A How-To Guide
    by Lyndee Knox & Erin Fries Taylor & Kristin Geonnotti & Rachel Machta & Jung Kim & Jessica Nysenbaum & Michael Parchman
  • 2011 The Early Head Start for Family Child Care Project: Profiles of the Partnership Teams
    by Natalie Pregibon & Lauren Akers & Luke Heinkel & Patricia Del Grosso
  • 2011 Building Partnerships Between Early Head Start Grantees and Family Child Care Providers: Lessons from the Early Head Start for Family Child Care Project
    by Patricia Del Grosso & Lauren Akers & Luke Heinkel
  • 2011 Projected Health Care Spending in Minnesota: 2009-2019
    by David Jones & Michaela Vine & Deborah Chollet
  • 2011 Variability in Pretest-Posttest Correlation Coefficients by Student Achievement Level
    by Russell Cole & Joshua Haimson & Irma Perez-Johnson & Henry May
  • 2011 Reporting Period and Reliability of AHRQ, CMS 30-Day and HAC Quality Measures
    by Eric Schone & Mai Hubbard & David Jones
  • 2011 Money Follows the Person Demonstration: Overview of State Grantee Progress, January to June 2011
    by Noelle Denny-Brown & Debra Lipson & Matthew Kehn & Bailey Orshan & Christal Stone Valenzano
  • 2011 Medicare Contractor Provider Satisfaction Survey (MCPSS) Public Report
    by Bob Schmitz & Karen Bogen
  • 2011 Children's Health Insurance Program: An Evaluation (1997-2010)
    by Sheila Hoag & Mary Harrington & Cara Orfield & Victoria Peebles & Kimberly Smith & Adam Swinburn & Matthew Hodges & Kenneth Finegold & Sean Orzol & Wilma Robinson
  • 2011 Independent Evaluation of the Ninth Scope of Work, QIO Program. Volume I: Findings
    by Arnold Chen & rew Clarkwest & Sarah Croake & Suzanne Felt-Lisk & Myles Maxfield & Lauren Smith & Suzanne Witmer & Jelena Zurovac & Jennifer Lucado & Lauren McGivern & Kathy Paez & Claudia Schur
  • 2011 Progress Toward Meaningful Use: Hospitals' Adoption of Electronic Health Records
    by Ashish K. Jha & Matthew F. Burke & Catherine DesRoches & Maulik S. Joshi & Peter D. Kralovec & Eric G. Campbell & Melinda B. Buntin
  • 2011 Successful Care Coordination and the ACA
    by Randy Brown
  • 2011 How Will Insurance Markets Look?
    by Deborah Chollet
  • 2011 Assessing the Need for a National Disability Survey: Final Report
    by Gina Livermore & Denise Whalen & David C. Stapleton
  • 2011 Outlier Adjustments and Reporting Thresholds
    by Eric Schone
  • 2011 Determinants of Students' Success: The Role of Advanced Placement and Dual Enrollment Programs
    by Cecilia Speroni
  • 2011 High School Dual Enrollment Programs: Are We Fast-Tracking Students Too Fast?
    by Cecilia Speroni
  • 2011 Measuring Medical Care Economic Risk: An Assessment of Data Sources
    by John L. Czajka
  • 2011 Health Information Exchange Among US Hospitals
    by Julia Adler-Milstein & Catherine M. DesRoches & Ashish K. Jha
  • 2011 Finding Credible Program Impacts
    by John Deke
  • 2011 Implementing Expanded Medicaid Eligibility and MAGI Under ACA: State Perspectives
    by Cheryl Camillo
  • 2011 Regulating Abortion: Impact on Patients and Providers in Texas
    by Silvie Colman & Ted Joyce
  • 2011 Out of Sight, Out of Mind: Including Group Quarters Residents with Household Residents Can Change What We Know About Working-Age People with Disabilities
    by David Stapleton & Todd Honeycutt & Bruce Schechter
  • 2011 Evaluation of UNICEF's Early Childhood Development Programme with Focus on Government of Netherlands Funding (2008-2010)
    by Kimberly Boller
  • 2011 Evaluation of UNICEF's Early Childhood Development Programme with Focus on Government of Netherlands Funding (2008-2010): Global Synthesis Report
    by Kimberly Boller & Kathy Buek & rew Burwick & Minki Chatterji & Diane Paulsell & Samia Amin & Evan Borkum & Larissa Campuzano & Jessica Jacobson & Samina Sattar
  • 2011 Do Charter Schools Improve Student Achievement? Evidence from a National Randomized Study
    by Melissa A. Clark & Philip Gleason & Christina Clark Tuttle & Marsha K. Silverberg
  • 2011 Evaluating Collaborative Initiatives: Supporting EBHV Grantees Cross-Site Evaluation Methods and Findings
    by Margaret Hargreaves
  • 2011 Impacts of the 9th SOW QIO Program Care Transitions Theme on Condition-Specific Readmission Rates
    by Jelena Zurovac & Arnold Chen & Sue Felt-Lisk & Myles Maxfield
  • 2011 Money Follows the Person 2010 Annual Evaluation Report
    by Carol Irvin & Debra Lipson & Audra Wenzlow & Samuel Simon & Alex Bohl & Matthew Hodges & John Schurrer
  • 2011 Identifying, Monitoring, and Assessing Promising Innovation: Using Evaluation to Support Rapid Cycle Change
    by Marsha Gold
  • 2011 Using Data to Drive State Improvement in Enrollment and Retention Performance
    by Christopher Trenholm & Mary Harrington & rew Snyder & Alice M. Weiss
  • 2011 Medicare Advantage 2012 Spotlight: Plan Availability and Premiums
    by Marsha Gold & Gretchen Jacobson & Anthony Damico & Tricia Neuman
  • 2011 Long-Term Care Utilization and Expenditures Among American Indian/Alaska Native Medicaid Recipients
    by Laura Ruttner & Carol Irvin
  • 2011 Reviewing Systematic Reviews: Meta-Analysis of What Works Clearinghouse Computer-Assisted Interventions
    by Andrei Streke & Tsze Chan
  • 2011 Building the Evidence Base for the Medical Home: What Sample and Sample Size Do Studies Need?
    by Deborah Peikes & Stacy Dale & Eric Lundquist & Janice Genevro & David Meyers
  • 2011 State Options for Integrating Physical and Behavioral Health Care
    by Allison Hamblin & James Verdier & Melanie Au
  • 2011 Measuring Quality and Using It to Improve Practice and Policy in Early Childhood Development
    by Pia Rebello Britto & Hirokazu Yoshikawa & Kimberly Boller
  • 2011 Fiscal Austerity and the Transition to Twenty-First Century Disability Policy: A Road Map
    by David R. Mann & David C. Stapleton
  • 2011 Correlates of Unintended Birth Among Low-Income Hispanic Immigrants at High Risk for Depression
    by Anna L. Christensen & Deborah F. Perry & Huynh-Nhu Le & Saifuddin Ahmed
  • 2011 Unintended Pregnancy and Perinatal Depression Trajectories in Low-Income, High-Risk Hispanic Immigrants
    by Anna L. Christensen & Elizabeth A. Stuart & Deborah F. Perry & Huynh-Nhu Le
  • 2011 Rethinking the Mental Health Treatment Skills of Primary Care Staff: A Framework for Training and Research
    by Jonathan D. Brown & Lawrence S. Wissow
  • 2011 Charter-School Management Organizations: Diverse Strategies and Diverse Student Impacts
    by Joshua Furgeson & Brian Gill & Joshua Haimson & Alexandra Killewald & Moira McCullough & Ira Nichols-Barrer & Bing-ru Teh & Natalya Verbitsky-Savitz & Melissa Bowen & Allison Demeritt & Paul Hill & Robin Lake
  • 2011 How Common is 'Parking' Among Social Security Disability Insurance Beneficiaries? Evidence from the 1999 Change in the Earnings Level of Substantial Gainful Activity
    by Jody Schimmel & David C. Stapleton & Jae Song
  • 2011 Improving Evaluations of the Medical Home
    by David Meyers & Deborah Peikes & Stacy Dale & Eric Lundquist & Janice Genevro
  • 2011 Evaluation of the Recent Experience of the Work Incentives Planning and Assistance (WIPA) Program: Beneficiaries Served, Services Provided, and Program Costs
    by Jody Schimmel & Allison Roche & Gina Livermore
  • 2011 Employment-Related Outcomes of a Recent Cohort of Work Incentives Planning and Assistance (WIPA) Program Enrollees
    by Gina Livermore & Sarah Prenovitz & Jody Schimmel
  • 2011 Provider Experiences Under the Revised Ticket to Work Regulations
    by Norma Altshuler & Sarah Prenovitz & Bonnie O'Day & Gina Livermore
  • 2011 What Determines Progress in State MFP Transition Programs?
    by Debra J. Lipson & Christal Stone Valenzano & Susan R. Williams
  • 2011 Supporting Family Caregivers Through Title III of the OAA
    by Leslie Foster & Rebecca Kleinman
  • 2011 Closing Schools in a Shrinking District: Do Student Outcomes Depend on Which Schools are Closed?
    by John Engberg & Brian Gill & Gema Zamarro & Ron Zimmer
  • 2011 Economic Costs of Excessive Alcohol Consumption in the U.S., 2006
    by Ellen E. Bouchery & Henrick J. Harwood & Jeffrey J. Sacks & Carol J. Simon & Robert D. Brewer
  • 2011 Medicare-Medicaid Dual Eligibles: Characteristics, Care Needs, and Costs
    by James M. Verdier
  • 2011 Massachusetts Health Care Cost Trends: Price Variation in Health Care Services
    by Analytics & research provided by division staff & Mathematica Policy Research & Freedman Associates
  • 2011 Association Health Plans and Community-Rated Small Group Health Insurance in Washington State
    by Deborah Chollet & Jessica Nysenbaum & Allison Barrett & Eric Morris & James Matthisen
  • 2011 Evaluation of UNICEF's Early Childhood Development Programme with Focus on Government of Netherlands Funding (2008-2010): Ghana Country Case Study Report
    by Kimberly Boller & Kathy Buek & rew Burwick & Minki Chatterji & Diane Paulsell & Samia Amin & Evan Borkum & Larissa Campuzano & Jessica Jacobson
  • 2011 Evaluation of UNICEF's Early Childhood Development Programme with Focus on Government of Netherlands Funding (2008-2010): Nepal Country Case Study Report
    by Kimberly Boller & Kathy Buek & rew Burwick & Minki Chatterji & Diane Paulsell & Samia Amin & Evan Borkum & Larissa Campuzano & Jessica Jacobson
  • 2011 Evaluation of UNICEF's Early Childhood Development Programme with Focus on Government of Netherlands Funding (2008-2010): Tanzania Country Case Study Report
    by Kimberly Boller & Kathy Buek & rew Burwick & Minki Chatterji & Diane Paulsell & Samia Amin & Evan Borkum & Larissa Campuzano & Jessica Jacobson
  • 2011 Evaluation of UNICEF's Early Childhood Development Programme with Focus on Government of Netherlands Funding (2008-2010): Cambodia Country Case Study
    by Kimberly Boller & Kathy Buek & rew Burwick & Minki Chatterji & Diane Paulsell & Samia Amin & Evan Borkum & Larissa Campuzano & Jessica Jacobson
  • 2011 The Youth Transition Demonstration: Interim Findings and Lessons for Program Implementation
    by Thomas Fraker
  • 2011 Building Infrastructure to Support Home Visiting to Prevent Child Maltreatment: Two-Year Findings from the Cross-Site Evaluation of the Supporting Evidence-Based Home Visiting Initiative
    by Patricia Del Grosso & Margaret Hargreaves & Diane Paulsell & Cheri Vogel & Debra A. Strong & Heather Zaveri & Megan Hague Angus & Brandon Coffee-Borden & Russell Cole & Kirsten Barrett & Kimberly Boller & Deborah Daro
  • 2011 Web-Based Screeners and Applications: Potential Tools for Improving Benefit Access and Program Efficiency
    by Emily Sama-Miller & Jacqueline Kauff
  • 2011 Reforming SSDI to Address the Declining Work and Welfare of People with Disabilities: Comment
    by David Wittenburg
  • 2011 Which States Have Limited Medicaid Managed Care Enrollment for Long-Term Care Users?
    by Valerie Cheh
  • 2011 Recent Patterns in Children's Medicaid Enrollment: A National View
    by Rosemary Borck & Valerie Cheh & Lucy Lu
  • 2011 Who Will Enroll in Medicaid in 2014? Lessons from Section 1115 Medicaid Waivers
    by Candace Natoli & Valerie Cheh & Shinu Verghese
  • 2011 Health Information Technology in the Workplace: Findings from a 2010 National Survey of Registered Nurses
    by Catherine M. DesRoches & Paola Miralles & Peter Buerhaus & Robert Hess & Karen Donelan
  • 2011 The Quality Rating and Improvement System (QRIS) Evaluation Toolkit
    by Julieta Lugo-Gil & Samina Sattar & Christine Ross & Kimberly Boller & Gretchen Kirby & Kathryn Tout
  • 2011 Measuring Quality Across Three Child Care Quality Rating and Improvement Systems: Findings from Secondary Analyses
    by Lizabeth Malone & Gretchen Kirby & Pia Caronongan & Kimberly Boller & Kathryn Tout
  • 2011 Defining and Measuring Quailty: An In-Depth Study of Five Child Care Quality Rating and Improvement Systems
    by Pia Caronongan & Gretchen Kirby & Lizabeth Malone & Kimberly Boller
  • 2011 Child Care Quality Rating and Improvement Systems: Approaches to Integrating Programs for Young Children in Two States
    by Gretchen Kirby & Kimberly Boller & Heather Zaveri
  • 2011 Resources for Measuring Services and Outcomes in Head Start Programs Serving Infants and Toddlers
    by Ellen Eliason Kisker & Kimberly Boller & Charles Nagatoshi & Christine Sciarrino & Vinita Jethwani & Teresa Zavitsky & Melissa Ford & John M. Love
  • 2011 Consumer and Provider Perspectives on Shared Decision Making: A Systematic Review of the Peer-Reviewed Literature
    by Nyna Williams & Chris Fleming
  • 2011 Child Care in Outpatient Substance Abuse Treatment Facilities for Women: Findings from the 2008 National Survey of Substance Abuse Treatment Services
    by Jonathan David Brown & Sonya Vartivarian & Cathie E. Alderks
  • 2011 Prescription Drug Use and Cost Among Medicaid Beneficiaries with Disabilities and Chronic Illnesses
    by James M. Verdier & Ann D. Bagchi & Dominick Esposito
  • 2011 Foundation's Consumer Advocacy Health Reform Initiative Strengthened Groups' Effectiveness
    by Debra Strong & Debra Lipson & Todd Honeycutt & Jung Kim
  • 2011 Disability Data in National Surveys
    by Gina Livermore & Denise Whalen & Sarah Prenovitz & Raina Aggarwal & Maura Bardos
  • 2011 Reducing Hospital Readmissions in New York State: A Simulation Analysis of Alternative Payment Incentives
    by Deborah Chollet & Allison Barrett & Timothy Lake
  • 2011 Evaluation of Healthy San Francisco
    by Catherine McLaughlin & Margaret Colby & Erin Taylor & Mary Harrington & Tricia Higgins & Vivian Byrd & Laurie Felland
  • 2011 Special Needs Plans: Availability and Enrollment
    by Marsha Gold & Gretchen Jacobson & Anthony Damico & Tricia Neuman
  • 2011 Firm Perspectives on the Medicare Advantage Market
    by Marsha Gold & Gretchen Jacobson & Tricia Neuman
  • 2011 Medicare Advantage Enrollment Market Update
    by Marsha Gold & Gretchen Jacobson & Anthony Damico & Tricia Neuman
  • 2011 State Policy-Makers' Views on the Role of Consumer Advocates in Health Policy Discussions
    by Debra J. Lipson & Marykate Zukiewicz & Sheila Hoag
  • 2011 Health Care Costs Are a Key Driver of Growth in Federal and State Assistance to Working-Age People with Disabilities
    by Gina Livermore & David C. Stapleton & Meghan O'Toole
  • 2011 Costs, Cuts, and Consequences: Charting a New Course for Working-Age People with Disabilities
    by David Stapleton & Gina Livermore
  • 2011 Do Typical RCTs of Education Interventions Have Sufficient Statistical Power for Linking Impacts on Teacher Practice and Student Achievement Outcomes?
    by Peter Z. Schochet
  • 2011 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for July 2011
    by Rachel Machta & Marsha Gold
  • 2011 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for June 2011
    by Rachel Machta & Marsha Gold
  • 2011 Identifying Effective Health Care Services for Adults with Disabilities: Why Study Designs and Outcome Measures Matter
    by Debra Lipson & Matthew Kehn & Jeffrey Ballou
  • 2011 Exploring the Promise of Population Health Management Programs to Improve Health
    by Suzanne Felt-Lisk & Tricia Higgins
  • 2011 A First Look at How MFP Participants Fare After Returning to the Community
    by John Schurrer & Audra Wenzlow
  • 2011 Longitudinal Outcomes of an Early Cohort of Ticket to Work Participants
    by Gina A. Livermore & Allison Roche
  • 2011 Disability Benefits Suspended or Terminated Because of Work
    by Jody Schimmel & David C. Stapleton
  • 2011 Social Security Disability Beneficiaries with Work-Related Goals and Expectations
    by Gina A. Livermore
  • 2011 Longitudinal Statistics on Work Activity and Use of Employment Supports for New Social Security Disability Insurance Beneficiaries
    by Su Liu & David C. Stapleton
  • 2011 Employment Among Social Security Disability Program Beneficiaries, 1996-2007
    by Arif Mamun & Paul O'Leary & David C. Wittenburg & Jesse Gregory
  • 2011 Employment of Individuals in the Social Security Disability Programs
    by Paul O'Leary & Gina A. Livermore & David C. Stapleton
  • 2011 Synthesis of Research and Resources to Support at-Risk Youth
    by Heather Koball & Robin Dion & rew Gothro & Maura Bardos & Amy Dworsky & Jiffy Lansing & Matthew Stagner & Danijela Korom-Djakovic & Carla Herrera & Alice Elizabeth Manning
  • 2011 Estimation and Identification of the Complier Average Causal Effect Parameter in Education RCTs
    by Peter Z. Schochet & Hanley S. Chiang
  • 2011 Early Childhood Development Programs in Global Contexts: Improving Quality
    by Anne Bridgman. Based on "Quality of Early Childhood Development Programs in Global Contexts: Rationale for Investment & Conceptual Framework & Implications for Equity & " by Pia Rebello Britto & Hirokazu Yoshikawa & Kimberly Boller.
  • 2011 Using Lotteries to Evaluate Schools of Choice: Evidence from a National Study of Charter Schools
    by Christina Clark Tuttle & Philip Gleason & Melissa Clark
  • 2011 Do Laws Requiring Parental Involvement to Obtain an Abortion Help Reduce STIs Among Minors?
    by Silvie Colman & Ted Joyce & Thomas Dee
  • 2011 Extending Medicaid Coverage to Low-Income Childless Adults: Opportunities and Cautions for Managed Care Plans
    by James M. Verdier
  • 2011 Improving Care for Dual Eligibles: Opportunities for Medicare Managed Care Plans
    by James M. Verdier
  • 2011 Laws Requiring Parental Involvement to Obtain Abortion and Prevalence of Sexually Transmitted Infections Among Minors
    by Silvie Colman & Ted Joyce & Thomas S. Dee
  • 2011 Multiple Chronic Conditions Among OAA Title III Program Participants
    by Rebecca Kleinman & Leslie Foster
  • 2011 Fostering Health Information Technology in Small Physician Practices: Lessons from Independent Practice Associations
    by Timothy K. Lake & Tricia Collins Higgins & Paul B. Ginsburg
  • 2011 Managed Long Term Care: Options for New York and Examples from Other States
    by James M. Verdier
  • 2011 Choosing Wisely: Selecting Outcomes for Comparative Effectiveness Research on Services for Adults with Disabilities
    by Debra J. Lipson & Matthew Kehn & Eugene Rich
  • 2011 Matching Study Designs to Research Questions in Disability-Related Comparative Effectiveness Research
    by Jeffrey Ballou & Eugene Rich & Matthew Kehn
  • 2011 Comparative Effectiveness of Care Coordination for Adults with Disabilities
    by Melanie Au & Samuel Simon & Arnold Chen & Debra Lipson & Gilbert Gimm & Eugene Rich
  • 2011 FACES 2009 Study Design
    by Jerry West & Louisa Tarullo & Nikki Aikens & Lizabeth Malone & Barbara Lepidus Carlson
  • 2011 Massachsetts Health Care Cost Trends: Trends in Health Expenditures
    by Deborah Chollet
  • 2011 Identifying, Monitoring, and Assessing Promising Innovations: Using Evaluation to Support Rapid-Cycle Change
    by Marsha Gold & David Helms & Stuart Guterman
  • 2011 Demonstration to Maintain Independence and Employment (DMIE)
    by Denise Whalen & Gilbert Gimm & Henry Ireys & Boyd Gilman & Sarah Croake
  • 2011 Lessons Learned from the Home Visiting Evidence of Effectiveness Review
    by Sarah Avellar & Diane Paulsell
  • 2011 Defining the Role of SNPs in 2011 and 2012
    by James M. Verdier
  • 2011 The Language Interaction Snapshot (LISn): A New Observational Measure for Assessing Language Interactions in Linguistically Diverse Early Childhood Programs
    by Sally Atkins-Burnett & Susan Sprachman & Michael Lopez & Margaret Caspe & Katie Fallin
  • 2011 Electronic Health Records Demonstration Evaluation: Implementation Report 2010
    by Suzanne Felt-Lisk & Rachel Shapiro & Christopher Fleming & Brenda Natzke & Allison Barrett & Grace Anglin
  • 2011 Effective Evaluation of Quality Rating and Improvement Systems for Early Care and Education and School-Age Care
    by Gail Zellman & Richard Brandon & Kimberly Boller & J. Lee Kreader
  • 2011 Learning As We Go: A First Snapshot of Early Head Start Programs, Staff, Families, and Children
    by Cheri A. Vogel & Kimberly Boller & Yange Xue & Randall Blair & Nikki Aikens & rew Burwick & Yevgeny Shrago & Barbara Lepidus Carlson & Laura Kalb & Linda Mendenko & Judith Cannon & Sean Harrington & Jillian Stein
  • 2011 Learning As We Go: A First Snapshot of Early Head Start Programs, Staff, Families, and Children
    by Cheri A. Vogel & Kimberly Boller & Yange Xue & Randall Blair & Nikki Aikens & rew Burwick & Yevgeny Shrago & Barbara Lepidus Carlson & Laura Kalb & Linda Mendenko & Judith Cannon & Sean Harrington & Jillian Stein
  • 2011 Catalog of Research: Programs for Low-Income Fathers
    by Sarah Avellar & M. Robin Dion & rew Clarkwest & Heather Zaveri & Subuhi Asheer & Kelley Borradaile & Megan Hague Angus & Timothy Novak & Julie Redline & Marykate Zukiewicz
  • 2011 Managing the Care of Dual Eligible Beneficiaries: A Review of Selected State Programs and Special Needs Plans
    by James M. Verdier & Melanie Au & Jessica Gillooly
  • 2011 Trajectories of the Home Learning Environment Across the First 5 Years: Associations with Children's Vocabulary and Literacy Skills at Prekindergarten
    by Eileen T. Rodriguez & Catherine S. Tamis-LeMonda
  • 2011 BSF's Effects on Couples Who Attended Group Relationship Skills Sessions: A Special Analysis of 15-Month Data
    by Robert G. Wood & Quinn Moore & Andrew Clarkwest
  • 2011 Massachusetts Health Care Cost Trends: Trends in Health Expenditures
    by Analytics & research provided by Mathematica Policy Research
  • 2011 Coordinating Care in the Medical Neighborhood: Critical Components and Available Mechanisms
    by Erin Fries Taylor & Timothy Lake & Jessica Nysenbaum & Greg Peterson & David Meyers
  • 2011 Long-Term Care and Dual Eligibles: Overview and Managed Care Opportunities
    by James M. Verdier
  • 2011 The SSDI Trust Fund: On the Road to Insolvency
    by David C. Stapleton
  • 2011 Federal Expenditures for Working-Age People with Disabilities in Fiscal Year 2008
    by Gina Livermore & Meghan O'Toole & David Stapleton
  • 2011 The Patient-Centered Medical Homes: Strategies to Put Patients at the Center of Primary Care
    by Deborah Peikes & Janice Genevro & Sarah Scholle & Phyllis Torda
  • 2011 Strategies to Ensure HITECH Supports the Patient-Centered Medical Home
    by Lorenzo Moreno & Deborah Peikes & Amy Krilla
  • 2011 Promoting Public Benefits Access Through Web-Based Tools and Outreach: A National Scan of Efforts. Volume II: Detailed Summary Tables of Benefits Access Efforts
    by Jacqueline Kauff & Emily Sama-Miller & Elizabeth Makowsky
  • 2011 Promoting Public Benefits Access Through Web-Based Tools and Outreach: A National Scan of Efforts. Volume I: Background, Efforts in Brief, and Related Initiatives
    by Jacqueline Kauff & Emily Sama-Miller & Elizabeth Makowsky
  • 2011 Design of Value-Added Models for IMPACT and TEAM in DC Public Schools, 2010-2011 School Year
    by Eric Isenberg & Heinrich Hock
  • 2011 The SSDI Trust Fund: New Solutions to an Old Problem
    by David Stapleton & David Wittenburg
  • 2011 Getting the Most Out of State QRIS Data: Secondary Analyses of Quality Ratings from the QRIS Assessment Project
    by Lizabeth Malone & Gretchen Kirby & Pia Caronongan
  • 2011 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for May 2011
    by Stephanie Peterson & Marsha Gold
  • 2011 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for April 2011
    by Stephanie Peterson & Marsha Gold
  • 2011 Out-of-Pocket Drug Costs and Drug Utilizaiton Patterns of Postmenopausal Medicare Beneficiaries with Osteoporosis
    by Leslie Jackson Conwell & Dominick Esposito & Susan Garavaglia & Eric S. Meadows & Margaret Colby & Vivian Herrera & Seth Goldfarb & Daniel Ball & Martin Marciniak
  • 2011 One-Year Findings on the Use of Employment-Focused Services in YTD Projects
    by Arif Mamun
  • 2011 SSA's Youth Transition Demonstration (YTD) Evaluation
    by Thomas Fraker
  • 2011 AB Demonstration: Recruitment, Process, and Impact Findings After One Year
    by David Wittenburg
  • 2011 The Implications of Comparative Effectiveness Research for Academic Medicine
    by Eugene C. Rich & Ann C. Bonham & Darrell G. Kirch
  • 2011 Individual Health Coverage
    by originally written by Karen Pollitz & updated by Deborah Chollet & Allison Barrett & Bill Erwin
  • 2011 Patterns of Interstate Migration in the United States from the Survey of Income and Program Participation
    by Rubén Hernández-Murillo & Lesli S. Ott & Michael T. Owyang & Denise Whalen
  • 2011 An Assessment of the Effectiveness of Anti-Poverty Programs in the United States
    by Yonatan Ben-Shalom & Robert A. Moffitt & John Karl Scholz
  • 2011 Treatment and Outcomes for Congestive Heart Failure by Race/Ethnicity in TRICARE
    by Ann D. Bagchi & Kate Stewart & Catherine McLaughlin & Patricia Higgins & Thomas Croghan
  • 2011 Developing Initiatives for Home-Based Child Care: Current Research and Future Directions
    by Toni Porter & Diane Paulsell
  • 2011 Patient-Centered Medical Home
    by Eugene Rich & Hoangmai Pham & Rachel Machta
  • 2011 Passing Muster: Evaluating Teacher Evaluation Systems
    by Steven Glazerman & Dan Goldhaber & Susanna Loeb & Stephen Raudenbush & Douglas O. Staiger & Grover J. Whitehurst & Michelle Croft
  • 2011 Student Selection, Attrition, and Replacement at KIPP Middle Schools
    by Ira Nichols-Barrer & Christina Clark Tuttle & Brian Gill & Philip Gleason
  • 2011 Funding Special Education by Capitation: Evidence from State Finance Reforms
    by Elizabeth Dhuey & Stephen Lipscomb
  • 2011 Quality of Early Childhood Development Programs in Global Contexts: Rationale for Investment, Conceptual Framework and Implications for Equity
    by Pia Rebello Britto & Hirokazu Yoshikawa & Kimberly Boller
  • 2011 Medicaid Eligibility Determination Under the Affordable Care Act: Challenges for States
    by John L. Czajka
  • 2011 The Social Security Administration's Youth Transition Demonstration Projects: Interim Report on Colorado Youth WINS
    by Thomas Fraker & Peter Baird & Alison Black & Arif Mamun & Michelle Manno & John Martinez & Anu Rangarajan & Debbie Reed
  • 2011 The Social Security Administration's Youth Transition Demonstration Projects: Interim Report on the City University of New York's Project
    by Thomas Fraker & Alison Black & Joseph Broadus & Arif Mamun & Michelle Manno & John Martinez & Reanin McRoberts & Anu Rangarajan & Debbie Reed
  • 2011 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for March 2011
    by Stephanie Peterson & Marsha Gold
  • 2011 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for February 2011
    by Stephanie Peterson & Marsha Gold
  • 2011 Student Selection, Attrition, and Replacement in KIPP Middle Schools
    by Ira Nichols-Barrer & Christina Clark Tuttle & Brian P. Gill & Philip Gleason
  • 2011 Bending the Employment, Income, and Cost Curves for People with Disabilities
    by David C. Stapleton
  • 2011 Do Low-Income Students have Equal Access to the Highest-Performing Teachers?
    by Steven Glazerman & Jeffrey Max
  • 2011 Do Low-Income Students have Equal Access to the Highest-Performing Teachers?
    by Steven Glazerman & Jeffrey Max
  • 2011 Cross-Site Evaluation of the Supporting Evidence-Based Home Visiting Grantees: Early Efforts to Build Infrastructure
    by Patricia Del Grosso & Debra Strong & Margaret Hargreaves & Diane Paulsell & Cheri Vogel & Heather Zaveri & Megan Hague Angus & Brandon Coffee-Borden & Kimberly Boller
  • 2011 Physical Activity in U.S. Adults: Compliance with the Physical Activity Guidelines for Americans
    by Jared M. Tucker & Gregory J. Welk & Nicholas K. Beyler
  • 2011 Could There Be a Role for Home Telemedicine in the U.S. Medicare Program?
    by Lorenzo Moreno & Arnold Chen & Rachel Shapiro & Stacy Dale
  • 2011 Managed Long Term Care: Current and Emerging Options for Dual Eligibles
    by James M. Verdier
  • 2011 Successful Strategies for Educating Hard-to-Reach Populations: Lessons Learned from Massachusetts' Train-the-Trainer Project Using the Helping You Take Care of Yourself Curriculum
    by Melanie Besculides & Lisa Trebino & Heather Nelson
  • 2011 Assessing the Evidence of Effectiveness of Home Visiting Program Models Implemented in Tribal Communities
    by Patricia Del Grosso & Rebecca Kleinman & rea Mraz Esposito & Emily Sama Martin & Diane Paulsell
  • 2011 The Social Security Administration's Youth Transition Demonstration Projects: Interim Report on Transition WORKS
    by Thomas Fraker & Alison Black & Arif Mamun & Michelle Manno & John Martinez & Bonnie O'Day & Meghan O'Toole & Anu Rangarajan & Debbie Reed
  • 2011 The Effects of Charter High Schools on Educational Attainment
    by Kevin Booker & Tim R. Sass & Brian Gill & Ron Zimmer
  • 2011 Participation in Healthy San Francisco: Trends in Enrollment and Retention
    by Margaret Colby & Catherine McLaughlin & Gregory Bee & Tricia Collins Higgins
  • 2011 Mortality Risk and Human Capital Investment: The Impact of HIV/AIDS in Sub-Saharan Africa
    by Jane G. Fortson
  • 2011 Estimating the Return to College Selectivity Over the Career Using Administrative Earning Data
    by Stacy Dale & Alan B. Krueger
  • 2011 Impact of Early Intervention Programs for Working Adults with Potentially Disabling Conditions: Evidence from the National DMIE Evaluation
    by Gilbert Gimm & Henry Ireys & Boyd Gilman & Sarah Croake
  • 2011 The Evaluation of the Demonstration to Maintain Independence and Employment
    by Henry T. Ireys & Paul Wehman
  • 2011 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for January 2011
    by Stephanie Peterson & Marsha Gold
  • 2011 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for December 2010
    by Stephanie Peterson & Marsha Gold
  • 2011 A Review of Prenatal Home-Visiting Effectiveness for Improving Birth Outcomes
    by L. Michele Issel & Sarah G. Forrestal & Jaime Slaughter & Anna Wiencrot & Arden Handler
  • 2011 Use of Out-of-Home Care Among a Statewide Population of Children and Youth Enrolled in Medicaid
    by Jonathan D. Brown & Morris Hamilton & Brenda Natzke & Henry T. Ireys & Matthew Gillingham
  • 2011 Enabling a Survey of Primary Care to Measure the Health Care Experiences of Adults with Disabilities
    by Susan E. Palsbo & Margarita Pl Hurtado & Roger E. Levine & Kirsten A. Barrett & Margaret F. Mastal
  • 2011 Prenatal Case Management of Pregnant Women: What Is the Evidence for Its Contribution to a Reduction of Disparities in Perinatal Outcomes?
    by L. Michele Issel & Jamie C. Slaughter & Sarah G. Forrestal
  • 2011 Lessons from the Field: Making Accountable Care Organizations Real
    by Timothy K. Lake & Kate A. Stewart & Paul B. Ginsburg
  • 2011 Healthy Indiana Plan: Lessons for Health Reform
    by Timothy K. Lake & Vivian L. H. Byrd & Seema Verma
  • 2011 Money Follows the Person Demonstration Program: A Profile of Participants
    by Debra J. Lipson & Susan R. Williams
  • 2011 An Evaluation of Financial Incentive Policies for Organ Donations in the United States
    by Alison J. Wellington & Edward A. Sayre
  • 2011 Effects of a Discharge Planning Program on Medicaid Coverage of State Prisoners with Serious Mental Illness
    by Audra T. Wenzlow & Henry T. Ireys & Bob Mann & Carol Irvin & Judith L. Teich
  • 2011 Mental Disorders Among Non-Elderly Nursing Home Residents
    by Samuel E. Simon & Debra J. Lipson & Christal M. Stone
  • 2011 Teacher Career Paths, Teacher Quality, and Persistence in the Classroom: Are Public Schools Keeping Their Best?
    by Dan Goldhaber & Betheny Gross & Daniel Player
  • 2011 Examining Effectiveness of Medical Interpreters in Emergency Departments for Spanish-Speaking Patients with Limited English Proficiency: Results of a Randomized Controlled Trial
    by Ann D. Bagchi & Stacy Dale & Natalya Verbitsky-Savitz & Sky Andrecheck & Kathleen Zavotsky & Robert Eisenstein
  • 2011 The Argentine Success Story and its Implications
    by Mark Weisbrot & Rebecca Ray & Juan Montecino & Sara Kozameh
  • 2011 Macroeconomic Policy, Growth and Income Distribution in the Brazilian Economy in the 2000s
    by Franklin Serrano & Ricardo Summa
  • 2011 Representative Ryan’s $30 Trillion Medicare Waste Tax
    by David Rosnick & Dean Baker
  • 2011 The Scorecard on Development, 1960-2010: Closing the Gap?
    by Mark Weisbrot & Rebecca Ray
  • 2011 The Ryan Medicare Plan: Winners and Losers
    by Dean Baker & David Rosnick
  • 2011 Can Market Failure Cause Political Failure?
    by Madhav S, Aney & Maitreesh Ghatak & Massimo Morelli
  • 2011 Celtic tiger and celtic cat
    by Alejandro M. Fernández Castro
  • 2011 Can Patients Diagnosed with Schizophrenia Complete Choice-Based Conjoint Analysis Tasks?
    by John F.P. Bridges & Elizabeth T. Kinter & Annette Schmeding & Ina Rudolph & Axel Mhlbacher
  • 2011 Comparison of Scores Derived from the Box Score-11 Scale and the Pain Attribute of the Health Utilities Index-3
    by Michael Iskedjian & Barbara Jaszewski & Olivier Desjardins
  • 2011 Estimation of Utilities in Attention-Deficit Hyperactivity Disorder for Economic Evaluations
    by Andrew Lloyd & Paul Hodgkins & Rahul Sasane & Ron Akehurst & Edmund J.S. Sonuga-Barke & Patrick Fitzgerald & Annabel Nixon & Haim Erder & John Brazier
  • 2011 Offering Results to Participants in a Diabetes Survey: Effects on Survey Response Rates
    by Jeanette Y. Ziegenfuss & Nilay D. Shah & James R. Deming & Holly K. Van Houten & Steven A. Smith & Timothy J. Beebe
  • 2011 Treatment Satisfaction Instruments for Different Purposes during a Product's Lifecycle: Keeping the End in Mind
    by Diana Rofail & Fiona Taylor & Antoine Regnault & Anna Filonenko
  • 2011 Societal Values in the Allocation of Healthcare Resources: Is it All About the Health Gain?
    by Tania Stafinski & Devidas Menon & Deborah Marshall & Timothy Caulfield
  • 2011 Acknowledgment
    by Adis International Limited
  • 2011 Medication Non-Compliance in Zagreb, Croatia
    by Marcel Leppe & Josip Culig & Jelena Boskovic
  • 2011 Impact of Walking Impairment in Multiple Sclerosis: Perspectives of Patients and Care Partners
    by Nicholas G. LaRocca
  • 2011 Establishing the Content Validity of the King's Health Questionnaire in Men and Women with Overactive Bladder in the US
    by Mary Kay. Margolis & Vasudha Vats & Karin S. Coyne & Con Kelleher
  • 2011 Elicitation of Ostomy Pouch Preferences: A Discrete-Choice Experiment
    by Ole Bonnichsen
  • 2011 Integrating Evidence and Individual Preferences Using a Web-Based Multi-Criteria Decision Analytic Tool: An Application to Prostate Cancer Screening
    by Michelle Cunich & Glenn Salkeld & Jack Dowie & Joan Henderson & Clare Bayram & Helena Britt & Kirsten Howard
  • 2011 Exploring Qualitative Research Synthesis: The Role of Patients' Perspectives in Health Policy Design and Decision Making
    by Helle Ploug. Hansen & Eva Draborg & Finn Brlum. Kristensen
  • 2011 Great Expectations: What Do Patients Using Complementary and Alternative Medicine Hope For?
    by E. Ernst & S.K. Hung
  • 2011 Analysis of Health-Related Quality-of-Life Instruments Measuring the Impact of Bariatric Surgery: Systematic Review of the Instruments Used and their Content Validity
    by Raed Tayyem & Abdulmajid Ali & John Atkinson & Colin R. Martin
  • 2011 Patient Advocacy in Research: Merely an Afterthought?
    by Musa Mayer
  • 2011 Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients: A Canadian Population-Based Analysis
    by Michael Iskedjian & David W. Covert & John H. Walker
  • 2011 Eliciting Preferences for Reimbursed Drugs Selection Criteria in C�te d'Ivoire
    by Vakaramoko Diaby & Henri Di Kakou & Jean Lachaine
  • 2011 An Instrument to Assess the Needs of Patients with Type 2 Diabetes Mellitus for Health-Promotion Activities
    by Anneke N. van Dijk-de Vries & Inge G.P. Duimel-Peeters & Hubertus J.M. Vrijhoef
  • 2011 Impact of Gastrointestinal Problems on Adherence to Low-Dose Acetylsalicylic Acid: A Quantitative Study in Patients with Cardiovascular Risk
    by Christina Moberg & Jrgen Naesdal & Lars-Erik Svedberg & Delphine Duchateau & Nicola Harte
  • 2011 A Qualitative Study on Feasibility of a Web-Based Women's Health Portal and Information System
    by Min Yang & Mark Kosinski & Rosemarie Boulanger
  • 2011 Family Burden after Severe Brain Injury: The Italian Experience with Families and Volunteer Associations
    by Paola Mosconi & Mariangela Taricco & Mirna Bergamini & Luisella Bosisio Fazzi & Cinzia Colombo & Valentina Patrucco & Marinella Corti & Dario Giobbe & Massimo Guerreschi & Maria Rita. Magnarella & Giovanni Sallemi
  • 2011 Patient Preferences for Treatment of Achilles Tendon Pain: Results from a Discrete-Choice Experiment
    by Kent R. Sweeting & Jennifer A. Whitty & Paul A. Scuffham & Michael J. Yelland
  • 2011 Development of an Electronic Daily Uterine Fibroid Symptom Diary
    by Linda S. Deal & Valerie S.L. Williams & Sheri E. Fehnel
  • 2011 Understanding and Assessing the Impact of End-Stage Renal Disease on Quality of Life: A Systematic Review of the Content Validity of Self-Administered Instruments Used to Assess Health-Related Quality of Life in End-Stage Renal Disease
    by Cheryl Glover & Pauline Banks & Amanda Carson & Colin R. Martin & Tim Duffy
  • 2011 Patient-Reported Outcomes, Patient-Reported Information: From Randomized Controlled Trials to the Social Web and Beyond
    by Mike Baldwin & Andrew Spong & Lynda Doward & Ari Gnanasakthy
  • 2011 Public and Patient Involvement at the UK National Institute for Health and Clinical Excellence
    by Leela Barham
  • 2011 Cinacalcet: A Pharmacoeconomic Review of its Use in Secondary Hyperparathyroidism in End-Stage Renal Disease
    by Greg L. Plosker
  • 2011 Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand
    by Naiyana Praditsitthikorn & Yot Teerawattananon & Sripen Tantivess & Supon Limwattananon & Arthorn Riewpaiboon & Saibua Chichareon & Nantakan Ieumwananonthachai & Viroj Tangcharoensathien
  • 2011 To Fund or Not to Fund: Development of a Decision-Making Framework for the Coverage of New Health Technologies
    by Tania Stafinski & Devidas Menon & Christopher McCabe & Donald J. Philippon
  • 2011 Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure: A Systematic Review
    by Alexander Goehler & Benjamin P. Geisler & Jennifer M. Manne & Beate Jahn & Annette Conrads-Frank & Petra Schnell-Inderst & G. Scott. Gazelle & Uwe Siebert
  • 2011 Cost Benefit and Cost Effectiveness of Antifungal Prophylaxis in Immunocompromised Patients Treated for Haematological Malignancies: Reviewing the Available Evidence
    by Petros Pechlivanoglou & Robin De. Vries & Simon M.G.J. Daenen & Maarten J. Postma
  • 2011 Value-Based Pricing: Incentive for Innovation or Zero Net Benefit?
    by Dyfrig A. Hughes
  • 2011 Estimating the Relationship between Preference-Based Generic Utility Instruments and Disease-Specific Quality-of-Life Measures in Severe Chronic Constipation: Challenges in Practice
    by Mark Parker & Alan Haycox & Jane Graves
  • 2011 Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis: Focus on Critically Ill Patients
    by Annette C. Reboli & Coleman Rotstein & Daniel H. Kett & Michael Maschio & Shannon Cartier & Richard Chambers & Miriam Tarallo
  • 2011 Cost Estimation of Cardiovascular Disease Events in the US
    by Amy K. OSullivan & Jaime Rubin & Joshua Nyambose & Andreas Kuznik & David J. Cohen & David Thompson
  • 2011 US FDA Modernization Act, Section 114: Uses, Opportunities and Implications for Comparative Effectiveness Research
    by Peter J. Neumann & Pei-Jung Lin & Tom E. Hughes
  • 2011 Using QALYs in Cancer: A Review of the Methodological Limitations
    by Martina Garau & Koonal K. Shah & Anne R. Mason & Qing Wang & Adrian Towse & Michael F. Drummond
  • 2011 Cost-of-Illness Studies: A Guide to Critical Evaluation
    by Allison Larg & John R. Moss
  • 2011 Challenges in Health State Valuation in Paediatric Economic Evaluation: Are QALYs Contraindicated?
    by Wendy J. Ungar
  • 2011 The Case for Less, Not More, US FDA Regulation
    by John A. Vernon & Joseph H. Golec
  • 2011 Medication Costs to Private Insurers of Diversion of Medications for Attention-Deficit Hyperactivity Disorder
    by Arnie P. Aldridge & Larry A. Kroutil & Alexander J. Cowell & Daniel B. Reeves & David L. Van Brunt
  • 2011 Do Productivity Costs Matter?: The Impact of Including Productivity Costs on the Incremental Costs of Interventions Targeted at Depressive Disorders
    by Marieke Krol & Joc Papenburg & Marc Koopmanschap & Werner Brouwer
  • 2011 Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV: A Systematic Review for Low- and Middle-Income Countries
    by Omar Galrraga & Veronika J. Wirtz & Alejandro Figueroa-Lara & Yared Santa-Ana-Tellez & Ibrahima Coulibaly & Kirsi Viisainen & Antonieta Medina-Lara & Eline L. Korenromp
  • 2011 Presenting Evidence and Summary Measures to Best Inform Societal Decisions When Comparing Multiple Strategies
    by Simon Eckermann & Andrew R. Willan
  • 2011 Prioritizing Comparative Effectiveness Research: Are Drug and Implementation Trials Equally Worth Funding?
    by Afschin Gandjour
  • 2011 Reflections on the Changing Face of German Pharmaceutical Policy: How Far is Germany from Value-Based Pricing?
    by Andreas Gerber & Stephanie Stock & Charalabos-Markos Dintsios
  • 2011 PAID 1.0 in Practice: A Brief Clarification Regarding its Possibilities and Limitations
    by Pieter van Baal & Werner Brouwer
  • 2011 Intravenous Esomeprazole: A Pharmacoeconomic Profile of its Use in the Prevention of Recurrent Peptic Ulcer Bleeding
    by Gillian M. Keating
  • 2011 A Value Set for the EQ-5D Based on Experienced Health States: Development and Testing for the German Population
    by Reiner Leidl & Peter Reitmeir
  • 2011 The Direct Medical Costs Associated with Suspected Heparin-Induced Thrombocytopenia
    by Natasha Nanwa & Nicole Mittmann & Sandra Knowles & Claudia Bucci & Rita Selby & Neil Shear & Scott E. Walker & William Geerts
  • 2011 A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data
    by James G. Xenakis & Elizabeth T. Kinter & K. Jack. Ishak & Alexandra J. Ward & Jen P. Marton & Richard J. Willke & Simon Davies & J. Jaime. Caro
  • 2011 Health Technology Funding Decision-Making Processes Around the World: The Same, Yet Different
    by Tania Stafinski & Devidas Menon & Donald J. Philippon & Christopher McCabe
  • 2011 Pharmacoeconomic Considerations in Treating Iron Overload in Patients with β-Thalassaemia, Sickle Cell Disease and Myelodysplastic Syndromes in the US: A Literature Review
    by Bin Zhang & Prina Z. Donga & Mitra Corral & Medha Sasane & Jeffrey D. Miller & Chris L. Pashos
  • 2011 The Appropriate Elicitation of Expert Opinion in Economic Models: Making Expert Data Fit for Purpose
    by William Sullivan & Katherine Payne
  • 2011 Rotavirus Vaccine RIX4414 (Rotarix™): A Pharmacoeconomic Review of its Use in the Prevention of Rotavirus Gastroenteritis in Developed Countries
    by Greg L. Plosker
  • 2011 The Authors' Reply
    by Zaheer-Ud-Din Babar & Shane L. Scahill
  • 2011 Is There a Role for Pharmacoeconomics in Developing Countries?
    by Jonathan R. Harper
  • 2011 Is There a Role for Pharmacoeconomics in Developing Countries?
    by Romn Prez Velasco & Yot Teerawattananon
  • 2011 Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer: A UK Perspective Considering Duration of Benefit, Long-Term Toxicity and Pattern of Recurrence
    by Peter S. Hall & Claire Hulme & Christopher McCabe & Yemi Oluboyede & Jeff Round & David A. Cameron
  • 2011 Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease: Australian, Canadian and Swedish Healthcare Perspectives
    by Nicole Mittmann & Paul Hernandez & Carl Mellstrm & Lance Brannman & Tobias Welte
  • 2011 Cost Effectiveness of Treatments for Inflammatory Bowel Disease
    by Keith Bodger
  • 2011 Modelling the Epidemiology of Infectious Diseases for Decision Analysis: A Primer
    by Mark Jit & Marc Brisson
  • 2011 Health Economic and Infectious Disease Modelling: A Guide to Merging Streams
    by Andrea Anonychuk & Murray Krahn
  • 2011 Adjuvant Trastuzumab for Breast Cancer: Uncertainties in Clinical and Economic Evidence Following Early Stopping of the HERA Trial
    by Tallal Younis & Chris Skedgel
  • 2011 Bivalirudin: A Pharmacoeconomic Profile of its Use in Patients with Acute Coronary Syndromes
    by Katherine A. Lyseng-Williamson
  • 2011 Economic Burden of Renal Cell Carcinoma in the US: Part II - An Updated Analysis
    by Ya-Chen T. Shih & Chun-Ru Chien & Ying Xu & I-Wen Pan & Grace L. Smith & Thomas A. Buchholz
  • 2011 Economic Burden of Renal Cell Carcinoma: Part I - An Updated Review
    by Ya-Chen T. Shih & Chun-Ru Chien & Ying Xu & I-Wen Pan & Grace L. Smith & Thomas A. Buchholz
  • 2011 Sensitivity Analysis in Cost-Effectiveness Studies: From Guidelines to Practice
    by Rahul Jain & Michael Grabner & Eberechukwu Onukwugha
  • 2011 Sample Size and Power for Cost-Effectiveness Analysis (Part 2): The Effect of Maximum Willingness to Pay
    by Henry A. Glick
  • 2011 The Role of Bortezomib, Thalidomide and Lenalidomide in the Management of Multiple Myeloma: An Overview of Clinical and Economic Information
    by Andrea Messori & Dario Maratea & Chiara Nozzoli & Alberto Bosi
  • 2011 Posaconazole: A Pharmacoeconomic Review of its Use in the Prophylaxis of Invasive Fungal Disease in Immunocompromised Hosts
    by Katherine A. Lyseng-Williamson
  • 2011 Comparing Methods of Data Synthesis: Re-Estimating Parameters of an Existing Probabilistic Cost-Effectiveness Model
    by Mark Oppe & Maiwenn Al & Maureen Rutten-van Mlken
  • 2011 Value of Information in the Osteoarthritis Setting: Cost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDs and Proton Pump Inhibitors
    by Nicholas Latimer & Joanne Lord & Robert L. Grant & Rachel OMahony & John Dickson & Philip G. Conaghan
  • 2011 Advances in Cancer Therapeutics and Patient Access to New Drugs
    by George Dranitsaris & Ilse Truter & Martie S. Lubbe & Eitan Amir & William Evans
  • 2011 Cost Effectiveness of Pneumococcal Conjugate Vaccination against Acute Otitis Media in Children: A Review
    by Chantal W.B. Boonacker & Pieter H. Broos & Elisabeth A.M. Sanders & Anne G.M. Schilder & Maroeska M. Rovers
  • 2011 Sample Size and Power for Cost-Effectiveness Analysis (Part 1)
    by Henry A. Glick
  • 2011 Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations
    by Pieter H.M. van Baal & Albert Wong & Laurentius C.J. Slobbe & Johan J. Polder & Werner B.F. Brouwer & G. Ardine. de Wit
  • 2011 Including Indirect Medical Care Costs from Survivor Years of Life in Economic Evaluations
    by John A. Nyman & Hawre J. Jalal
  • 2011 A Model to Transfer Trial-Based Pharmacoeconomic Analyses to Clinical Practice
    by Afschin Gandjour
  • 2011 Consistently Estimating Absolute Risk Difference when Translating Evidence to Jurisdictions of Interest
    by Simon Eckermann & Michael Coory & Andrew R. Willan
  • 2011 Impact of Treatment Success on Health Service Use and Cost in Depression: Longitudinal Database Analysis
    by Sarah Byford & Barbara Barrett & Nicolas Despigel & Alan Wade
  • 2011 A Systematic Review to Assess the Policy-Making Relevance of Dementia Cost-of-Illness Studies in the US and Canada
    by Mark Oremus & S. Carolina. Aguilar
  • 2011 Febuxostat for the Management of Hyperuricaemia in Patients with Gout: A NICE Single Technology Appraisal
    by Matt Stevenson & Abdullah Pandor
  • 2011 Cost Effectiveness of Treatments for Wet Age-Related Macular Degeneration
    by Paul Mitchell & Lieven Annemans & Richard White & Meghan Gallagher & Simu Thomas
  • 2011 The Authors' Reply
    by Zaheer-Ud-Din Babar & Shane Scahill
  • 2011 Is There a Role for Pharmacoeconomics in Developing Countries?
    by Asrul Akmal. Shafie & Mohamed Azmi. Hassali
  • 2011 Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension, Fabry Disease, Hereditary Angioedema and Chronic Myeloid Leukaemia
    by Carl Rudolf. Blankart & Tom Stargardt & Jonas Schreygg
  • 2011 Calibrating Models in Economic Evaluation: A Comparison of Alternative Measures of Goodness of Fit, Parameter Search Strategies and Convergence Criteria
    by Jonathan Karnon & Tazio Vanni
  • 2011 Calibrating Models in Economic Evaluation: A Seven-Step Approach
    by Tazio Vanni & Jonathan Karnon & Jason Madan & Richard G. White & W. John. Edmunds & Anna M. Foss & Rosa Legood
  • 2011 Effects of Reference Pricing in Pharmaceutical Markets: A Review
    by Matteo Maria. Galizzi & Simone Ghislandi & Marisa Miraldo
  • 2011 Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis
    by Martin Hoyle
  • 2011 Cost Effectiveness of Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B from a Canadian Public Payer Perspective
    by Helen Dakin & Morris Sherman & Scott Fung & Carrie Fidler & Anthony Bentley
  • 2011 Cost-Effectiveness Analysis of Prophylactic Lamivudine Use in Preventing Vertical Transmission of Hepatitis B Virus Infection
    by Hui-Fang Hung & Hsiu-Hsi Chen
  • 2011 Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy: A NICE Single Technology Appraisal
    by Rumona Dickson & Adrian Bagust & Angela Boland & Michaela Blundell & Helen Davis & Yenal Dundar & Juliet Hockenhull & Carlos Martin Saborido & James Oyee & Vidhya Sagar. Ramani
  • 2011 Modelling the Cost Effectiveness of Treatments for Parkinson's Disease: A Methodological Review
    by Judith Dams & Bernhard Bornschein & Jens Peter Reese & Annette Conrads-Frank & Wolfgang H. Oertel & Uwe Siebert & Richard Dodel
  • 2011 QALYs and Carers
    by Hareth Al-Janabi & Terry N. Flynn & Joanna Coast
  • 2011 Erratum
    by Adis International Limited
  • 2011 Acknowledgement
    by Adis International Limited
  • 2011 Rotavirus Vaccine RIX4414 (Rotarix™): A Pharmacoeconomic Review of its Use in the Prevention of Rotavirus Gastroenteritis in Developing Countries
    by Greg L. Plosker
  • 2011 Patient Benefit-Risk Preferences for Targeted Agents in the Treatment of Renal Cell Carcinoma
    by Ateesha F. Mohamed & A. Brett. Hauber & Maureen P. Neary
  • 2011 Willingness to Pay for Adverse Drug Event Regulatory Actions
    by Jacoline Bouvy & Just Weemers & Huub Schellekens & Marc Koopmanschap
  • 2011 Denosumab for the Prevention of Osteoporotic Fractures in Post-Menopausal Women: A NICE Single Technology Appraisal
    by Graham Scotland & Norman Waugh & Pamela Royle & Paul McNamee & Rob Henderson & Rosemary Hollick
  • 2011 Sample Size Determination for Cost-Effectiveness Trials
    by Andrew R. Willan
  • 2011 Utility Estimation in Chronic Obstructive Pulmonary Disease: A Preference for Change?
    by Jennifer Petrillo & Floortje van Nooten & Paul Jones & Maureen Rutten-van Mlken
  • 2011 The Importance of the Comparator in Economic Evaluations: Working on the Efficiency Frontier
    by Mattias Neyt & Hans Van Brabandt
  • 2011 Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium
    by Mickal Hiligsmann & Jean-Yves Reginster
  • 2011 Critical Assessment of Belgian Reimbursement Dossiers of Orphan Drugs
    by Alain Denis & Lut Mergaert & Christel Fostier & Irina Cleemput & Frank Hulstaert & Steven Simoens
  • 2011 Does the Market Share of Generic Medicines Influence the Price Level?: A European Analysis
    by Pieter Dylst & Steven Simoens
  • 2011 Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer: A Systematic Review of the Literature
    by Gery P. Guy & Donatus U. Ekwueme
  • 2011 A Review of the Costs and Cost Effectiveness of Interventions in Chronic Kidney Disease: Implications for Policy
    by Joseph Menzin & Lisa M. Lines & Daniel E. Weiner & Peter J. Neumann & Christine Nichols & Lauren Rodriguez & Irene Agodoa & Tracy Mayne
  • 2011 Cautions Regarding the Fitting and Interpretation of Survival Curves: Examples from NICE Single Technology Appraisals of Drugs for Cancer
    by Martin Connock & Chris Hyde & David Moore
  • 2011 Addressing the Challenge for Well Informed and Consistent Reimbursement Decisions: The Case for Reference Models
    by Hossein Haji Ali Afzali & Jonathan Karnon
  • 2011 A Review of the Cost Effectiveness of Bisphosphonates in the Treatment of Post-Menopausal Osteoporosis in Switzerland
    by Kurt Lippuner & Richard F. Pollock & Jayne Smith-Palmer & Thomas Meury & William J. Valentine
  • 2011 An Application of a Proposed Framework for Formulary Listing in Low-Income Countries: The Case of C�te d'Ivoire
    by Vakaramoko Diaby & Jean Lachaine
  • 2011 Excess Costs Associated with Patients with Chronic Thromboembolic Pulmonary Hypertension in a US Privately Insured Population
    by Noam Y. Kirson & Howard G. Birnbaum & Jasmina I. Ivanova & Tracy Waldman & Vijay Joish & Todd Williamson
  • 2011 Early Retirement and Income Loss in Patients with Early and Advanced Parkinson's Disease
    by Scott Johnson & Matthew Davis & Anna Kaltenboeck & Howard Birnbaum & ElizaBeth Grubb & Marcy Tarrants & Andrew Siderowf
  • 2011 Cost Effectiveness of Self-Monitoring of Blood Glucose (SMBG) for Patients with Type 2 Diabetes and Not on Insulin: Impact of Modelling Assumptions on Recent Canadian Findings
    by Sandra L. Tunis
  • 2011 Early Assessment of Medical Technologies to Inform Product Development and Market Access: A Review of Methods and Applications
    by Maarten J. IJzerman & Lotte M.G. Steuten
  • 2011 Assessing Quality of Life among British Older People Using the ICEPOP CAPability (ICECAP-O) Measure
    by Terry N. Flynn & Phil Chan & Joanna Coast & Tim J. Peters
  • 2011 Cost Effectiveness of Chemoprevention for Prostate Cancer with Dutasteride in a High-Risk Population Based on Results from the REDUCE Clinical Trial
    by Michael W. Kattan & Stephanie R. Earnshaw & Cheryl L. McDade & Libby K. Black & Gerald L. Andriole
  • 2011 Excess Costs Associated with Patients with Pulmonary Arterial Hypertension in a US Privately Insured Population
    by Noam Y. Kirson & Howard G. Birnbaum & Jasmina I. Ivanova & Tracy Waldman & Vijay Joish & Todd Williamson
  • 2011 Nutrition Therapy Cost Analysis in the US: Pre-Mixed Multi-Chamber Bag vs Compounded Parenteral Nutrition
    by Robin S. Turpin & Todd Canada & Frank Xiaoqing. Liu & Catherine J. Mercaldi & Alessandro Pontes-Arruda & Paul Wischmeyer
  • 2011 Drugs for Rare Diseases: Influence of Orphan Designation Status on Price
    by Eline Picavet & Marc Dooms & David Cassiman & Steven Simoens
  • 2011 Cost Effectiveness of Secondary vs Tertiary Prevention for Post-Menopausal Osteoporosis
    by Dirk Mueller & Afschin Gandjour
  • 2011 The Use of Decision-Analytic Models in Parkinson's Disease: A Systematic Review and Critical Appraisal
    by James Shearer & Colin Green & Carl E. Counsell & John P. Zajicek
  • 2011 Ordering Errors, Objections and Invariance in Utility Survey Responses: A Framework for Understanding Who, Why and What to Do
    by Eve Wittenberg & Lisa A. Prosser
  • 2011 Cost-Efficacy Analysis of the MONET Trial Using UK Antiretroviral Drug Prices
    by Brian Gazzard & Andrew Hill & Anne Anceau
  • 2011 Design of Patient Access Schemes in the UK: Influence of Health Technology Assessment by the National Institute for Health and Clinical Excellence
    by Szymon Jarosawski & Mondher Toumi
  • 2011 Hospital Costs, Length of Stay and Mortality Associated with Childhood, Adolescent and Young Adult Meningococcal Disease in the US
    by Keith L. Davis & Timothy J. Bell & Jacqueline M. Miller & Derek A. Misurski & Bela Bapat
  • 2011 Cost Effectiveness of Tobacco Control Policies in Vietnam: The Case of Population-Level Interventions
    by Hideki Higashi & Khoa D. Truong & Jan J. Barendregt & Phuong K. Nguyen & Mai L. Vuong & Thuy T. Nguyen & Phuong T. Hoang & Angela L. Wallace & Tien V. Tran & Cuong Q. Le & Christopher M. Doran
  • 2011 Patent Extension Policy for Paediatric Indications: An Evaluation of the Impact within Three Drug Classes in a State Medicaid Programme
    by Richard E. Nelson & Carrie McAdam-Marx & Megan L. Evans & Robert Ward & Benjamin Campbell & Diana Brixner & Joanne Lafleur
  • 2011 Assessing the Performance of a New Generic Measure of Health-Related Quality of Life for Children and Refining it for Use in Health State Valuation
    by Katherine Stevens
  • 2011 Valuing Health at Different Ages: Evidence from a Nationally Representative Survey in the US
    by Daniel Eisenberg & Gary L. Freed & Matthew M. Davis & Dianne Singer & Lisa A. Prosser
  • 2011 The Impact of Inclusion Criteria in Health Economic Assessments
    by Anke Richter & Patricia Thieda & Kylie Thaler & Gerald Gartlehner
  • 2011 The Economics of the NHS Cancer Drugs Fund
    by Alan Maynard & Karen Bloor
  • 2011 Influenza Vaccination in Healthy Working Adults in Russia: Observational Study of Effectiveness and Return on Investment for the Employer
    by O. Yu. Atkov & A.V. Azarov & D.A. Zhukov & N. Nicoloyannis & L. Durand
  • 2011 Citizens' Preferences for Brand Name Drugs for Treating Acute and Chronic Conditions: A Pilot Study
    by Arina Denoth & Christophe Pinget & Jean-Blaise Wasserfallen
  • 2011 Public and Decision Maker Stated Preferences for Pharmaceutical Subsidy Decisions: A Pilot Study
    by Jennifer A. Whitty & Paul A. Scuffham & Sharyn R. Rundle-Thiele
  • 2011 Germany's Decision Rule for Setting Ceiling Prices of Drugs: A Comparative Analysis with Other Decision Rules
    by Afschin Gandjour
  • 2011 Impact of Fibromyalgia Severity on Health Economic Costs: Results from a European Cross-Sectional Study
    by Andreas Winkelmann & Serge Perrot & Caroline Schaefer & Kellie Ryan & Arthi Chandran & Alesia Sadosky & Gergana Zlateva
  • 2011 Current and Future Economic Burden of Osteoporosis in New Zealand
    by Paul Brown & Rob McNeill & William Leung & Eman Radwan & Jane Willingale
  • 2011 Influence of Patient Co-Payments on Atypical Antipsychotic Choice in Poland: Implications Once Generic Atypicals are Available
    by Magda Wladysiuk & Aleksander Araszkiewicz & Brian Godman & Katarzyna Szabert; Prescribing Research Group, University of Liverpool Management School, Liverpool, UK; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden & Corrado Barbui & Alan Haycox
  • 2011 The Impact of CT Colonography for Colorectal Cancer Screening on the UK NHS: Costs, Healthcare Resources and Health Outcomes
    by Alison Sweet & David Lee & Kerry Gairy & Denver Phiri & Timothy Reason & Kevin Lock
  • 2011 Determinants of Out-of-Pocket Health Expenditure in China: Analysis Using China Health and Nutrition Survey Data
    by Xuedan You & Yasuki Kobayashi
  • 2011 Costs to Hospitals of Acquiring and Processing Blood in the US: A Survey of Hospital-Based Blood Banks and Transfusion Services
    by Richard W. Toner & Laura Pizzi & Brian Leas & Samir K. Ballas & Alyson Quigley & Neil I. Goldfarb
  • 2011 Valuing Child Health Utility 9D Health States with a Young Adolescent Sample: A Feasibility Study to Compare Best-Worst Scaling Discrete-Choice Experiment, Standard Gamble and Time Trade-Off Methods
    by Julie Ratcliffe & Leah Couzner & Terry Flynn & Michael Sawyer & Katherine Stevens & John Brazier & Leonie Burgess
  • 2011 The Chinese Healthcare System: Structure, Problems and Challenges
    by Jens Leth. Hougaard & Lars Peter. sterdal & Yi Yu
  • 2011 Unemployment Problem Of Vet Center Graduates In Georgia
    by Nana PIRVELI
  • 2011 The cost of complying with human rights treaties: The convention on the rights of the child and basic immunization
    by Varun Gauri
  • 2011 New Regulation and the New World of Global Banking
    by Stephen G. Cecchetti & Dietrich Domanski & Goetz von Peter
  • 2011 Good Practices for Quality Assurance in Romanian Higher Education
    by Militaru Cezar & Pavel Adina
  • 2011 Features and Tools Implementation of Knowledge Management
    by Crãciun Bucur Matei & Oprea Margareta
  • 2011 Knowledge Management in a Future Acceptance
    by Crãciun Bucur Matei & Oprea Margareta
  • 2011 General Aspects on the Superior Education Sector in Romania and its Potential Contribution to Economic Development
    by Tigãnaºu Radu
  • 2011 Paradoxes in the Diet of Modern Consumer at the Confluence between Food Science and Food Industry
    by Voinea Lelia & Popescu Dorin & Negrea Mihai
  • 2011 The Importance of Building and Developing University Scientific Research Projects for the Achievement of the Proposed Final Results
    by Toma Cristian Marius & Toma Vasilica & Foia Liliana
  • 2011 Assessment Criteria for the University Scientific Research Projects
    by Toma Cristian Marius
  • 2011 Current Economic And Medical Reforms In The Romanian Health Care System
    by Dragoi Mihaela Cristina
  • 2011 Against representative agent methodology
    by Roger Koppl
  • 2011 Growth, volatility and stabilisation policy in a DSGE model with nominal rigidities and learning-by-doing
    by The Pham
  • 2011 Growth, volatility and stabilisation policy in a DSGE model with nominal rigidities and learning-by-doing
    by The Pham
  • 2011 Dark contrasts: The paradox of high rates of suicide in happy places
    by Daly, Mary C. & Oswald, Andrew J. & Wilson, Daniel & Wu, Stephen
  • 2011 Differences by degree: Evidence of the net financial rates of return to undergraduate study for England and Wales
    by Walker, Ian & Zhu, Yu
  • 2011 The Financial Policy In Higher Education In The View Of Principle Of Equity In Turkey: Who Benefits? Who Pays?
    by Filiz Golpek
  • 2010 Baby FACES: Parent Interview 2010-2012 Data Collection, Spanish Version
    by Mathematica Policy Research
  • 2010 Baby FACES: Program Director Self-Administered Questionnaire
    by Mathematica Policy Research
  • 2010 Baby FACES: Program Director Interview
    by Mathematica Policy Research
  • 2010 Baby FACES: Teacher/Home Visitor Interview
    by Mathematica Policy Research
  • 2010 Baby FACES: Teacher/Home Visitor Child Rating
    by Mathematica Policy Research
  • 2010 Assessment of the National Quality Forum's Consensus Development Process
    by Marsha Gold & Leslie Conwell & Kate Stewart & Jessica Nysenbaum & Stephanie Peterson
  • 2010 The Relationship Between Health Plan Performance Measures and Physician Network Overlap: Implications for Measuring Plan Quality
    by Daniel D. Maeng & Dennis P. Scanlon & Michael E. Chernew & Tim Gronniger & Walter P. Wodchis & Catherine G. McLaughlin
  • 2010 Baby FACES Parent Interview 2010-2012 Versions
    by Mathematica Policy Research staff
  • 2010 Baby FACES Parent Questionnaire for Parents of 2-Year-Old Children
    by Mathematica Policy Research staff
  • 2010 Assessment of the Train the Trainer Project Using the Helping You Take Care of Yourself Curriculum
    by Melanie Besculides & Lisa Trebino & Sarah Jones & Jung Kim
  • 2010 Home Health Independence Patients: High Use, But Not Financial Outliers
    by Valerie Cheh & John Schurrer & Morris Hamilton
  • 2010 Estimating Teacher and School Effectiveness in Pittsburgh: Value-Added Modeling and Results
    by Stephen Lipscomb & Brian Gill & Kevin Booker & Matthew Johnson
  • 2010 Dental Care Utilization and Retirement
    by Richard J. Manski & John Moeller & Haiyan Chen & Patricia A. St. Clair & Jody Schimmel & Larry Magder & John V. Pepper
  • 2010 Dental Care Expenditures and Retirement
    by Richard J. Manski & John Moeller & Haiyan Chen & Patricia A. St. Clair & Jody Schimmel & Larry Magder & John V. Pepper
  • 2010 Using Health IT: Eight Quality Improvement Stories
    by Melanie Au & Suzanne Felt-Lisk & Grace Anglin & Andrew Clarkwest
  • 2010 Intermediate Outcomes, Strategies, and Challenges of Eight Healthy Start Projects
    by Andrea Brand & Deborah Klein Walker & Margaret Hargreaves & Margo Rosenbach
  • 2010 Informing the Performance-Based Contract Between First 5 LA and LAUP: Assessing Child Progress
    by Yange Xue & Sally Atkins-Burnett & Pia Caronongan & Emily Moiduddin
  • 2010 Instructional Practices in Los Angeles Universal Preschool
    by Sally Atkins-Burnett & Yange Xue & Ashley Kopack & Marta Induni & Emily Moiduddin
  • 2010 Findings from the Literature: Instructional Practices Supporting ELL Children
    by Mathematica Policy Research
  • 2010 Strengthening Unmarried Parents' Relationships: The Early Impacts of Building Strong Families
    by Robert G. Wood & Sheena McConnell & Quinn Moore & rew Clarkwest & JoAnn Hsueh
  • 2010 Using Data to Assess Quality Improvement Results
    by Debra J. Lipson
  • 2010 Shaping Emerging Findings from the EBHV Cross-Site Evaluation
    by Kim Boller & Patricia Del Grosso & Deborah Daro
  • 2010 Partnerships to Support Evidence-Based Home Visitation (EBHV)
    by Russell Cole
  • 2010 The Evaluation of Charter School Impacts
    by Philip Gleason & Melissa Clark & Christina Clark Tuttle & Emily Dwoyer
  • 2010 Building State-Level Advocacy Networks: CVC After Two Years
    by Debra A. Strong & Sheila Hoag & Subuhi Asheer & Jamila Henderson
  • 2010 Impacts of Comprehensive Teacher Induction: Final Results from a Randomized Controlled Study
    by Steven Glazerman & Eric Isenberg & Sarah Dolfin & Martha Bleeker & Amy Johnson & Mary Grider & Matthew Jacobus
  • 2010 Achievement Effects of Four Early Elementary School Math Curricula: Findings for First and Second Graders
    by Roberto Agodini & Barbara Harris & Melissa Thomas & Robert Murphy & Lawrence Gallagher
  • 2010 Longitudinal Experiences of an Early Cohort of Ticket to Work Participants
    by Gina Livermore & Allison Roche & Sarah Prenovitz
  • 2010 Time That Beneficiaries Spend Off the Rolls Due to Work and the Payments Generated for Employment Networks
    by David Stapleton & Jody Schimmel & Miriam Loewenberg & Sarah Prenovitz
  • 2010 Longitudinal Statistics for New Social Security Disability Insurance Beneficiaries
    by David Stapleton & Su Liu & Dawn Phelps & Sarah Prenovitz
  • 2010 Benefits Planning, Assistance, and Outreach (BPAO) Service User Characteristics and Use of Work Incentives
    by Gina Livermore & Sarah Prenovitz
  • 2010 Highlights of the Fifth Ticket to Work Evaluation Report
    by Gina Livermore & David Stapleton
  • 2010 Measuring School and Teacher Value Added for IMPACT and TEAM in DC Public Schools
    by Eric Isenberg & Heinrich Hock
  • 2010 Findings from a Study of the SSI/SSDI Outreach, Access, and Recovery (SOAR) Initiative
    by Emily Sama Martin
  • 2010 Ensuring Access to Medicaid for Inmates with Mental Illnessess Who Are Re-Entering Their Communities in Oklahoma
    by Henry Ireys
  • 2010 Policy Options for Older Adults Experiencing the Onset of Work-Limiting Medical Conditions
    by Jody Schimmel & David Stapleton
  • 2010 The Performance of US Hospitals as Reflected in Risk-Standardized 30-Day Mortality and Readmission Rates for Medicare Beneficiaries with Pneumonia
    by Peter K. Lindenauer & Susannah M. Bernheim & Jacqueline N. Grady & Zhenqiu Lin & Yun Wang & Yongfei Wang & Angela R. Merrill & Lein F. Han & Michael T. Rapp & Elizabeth E. Drye & Sharon-Lise T. Normand & Harlan M. Krumholz
  • 2010 National Survey of U.S. Health Professionals' Smoking Prevalence, Cessation Practices, and Beliefs
    by Elisa K. Tong & Richard Strouse & John Hall & Martha Kovac & Steven A. Schroeder
  • 2010 Teacher and Principal Value-Added: Research Findings and Implementation Practices
    by Stephen Lipscomb & Bing-ru Teh & Brian Gill & Hanley Chiang & Antoniya Owens
  • 2010 Home Visiting Evidence of Effectiveness Review: Executive Summary
    by Diane Paulsell & Sarah Avellar & Emily Sama Martin & Patricia Del Grosso
  • 2010 Early Head Start Children in Grade 5: Long-Term Followup of the Early Head Start Research and Evaluation Project Study Sample
    by Cheri A. Vogel & Yange Xue & Emily M. Moiduddin & Barbara Lepidus Carlson & Ellen Eliason Kisker
  • 2010 Expanding Access to Medicaid Data for Research: Feasibility of a MAX Sample
    by Audra Wenzlow & Ellen Bouchery & John Czajka
  • 2010 Chartbook: Medicaid Pharmacy Benefit Use and Reimbursement in 2006
    by Ann Bagchi & James Verdier & Dominick Esposito
  • 2010 Quality and Resource Use Reports (QRURs): Frequently Asked Questions
    by Mathematica Policy Research
  • 2010 Quality Dosage, Thresholds, and Features in Early Childhood Settings: Literature Review Tables
    by Martha Zaslow & Rachel Anderson & Zakia Redd & Julia Wessel & Louisa Tarullo & Margaret Burchinal
  • 2010 Quality Dosage, Thresholds, and Features in Early Childhood Settings: A Review of the Literature
    by Martha Zaslow & Rachel Anderson & Zakia Redd & Julia Wessel & Louisa Tarullo & Margaret Burchinal
  • 2010 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for November 2010
    by Stephanie Peterson & Marsha Gold
  • 2010 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for October 2010
    by Stephanie Peterson & Marsha Gold
  • 2010 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for September 2010
    by Stephanie Peterson & Marsha Gold
  • 2010 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for August 2010
    by Stephanie Peterson & Marsha Gold
  • 2010 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for July 2010
    by Stephanie Peterson & Marsha Gold
  • 2010 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for June 2010
    by Stephanie Peterson & Marsha Gold
  • 2010 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for May 2010
    by Stephanie Peterson & Marsha Gold
  • 2010 Data Tables for FACES 2006: A Second Year in Head Start Report
    by Emily Moiduddin & Nikki Aikens & Louisa Tarullo & Jerry West
  • 2010 A Second Year in Head Start: Characteristics and Outcomes of Children Who Entered the Program at Age Three
    by Louisa Tarullo & Nikki Aikens & Emily Moiduddin & Jerry West
  • 2010 Data Tables for FACES 2006: Head Start Children Go to Kindergarten Report
    by Lizabeth Malone & Lara Hulsey & Nikki Aikens & Jerry West & Louisa Tarullo
  • 2010 Head Start Children Go to Kindergarten
    by Jerry West & Lizabeth Malone & Lara Hulsey & Nikki Aikens & Louisa Tarullo
  • 2010 Mental Health and Substance Abuse Services in Medicaid, 2003: Charts and State Tables
    by Henry T. Ireys & Allison Barrett & James M. Verdier & Ann Bagchi & Carol Irvin & Christine Yip & Jeffrey A. Buck & Judith Teich
  • 2010 Replicating Evidence-Based Home Visiting Models: A Framework for Assessing Fidelity
    by Deborah Daro (Chapin Hall at the University of Chicago)
  • 2010 Supporting Home Visitors in Evidence-Based Programs: Experience of EBHV Grantees
    by Brandon Coffee-Borden & Diane Paulsell
  • 2010 A Government Performance and Results (GPRA) Report: The Status of the Medicaid Infrastructure Grants Program as of 12/31/09
    by Matthew Kehn & Sarah Croake & Jody Schimmel
  • 2010 Exploratory Study of Decision-Making in Low-Income Couples
    by M. Robin Dion & Jean Knab & Debra Wright & Renay Cleary Bradley & John M. Gottman
  • 2010 Exploring the Role of Partners and Spouses in the Decisions of Social Service Clients
    by M. Robin Dion
  • 2010 Does the Amount of Participation in Afterschool Programs Relate to Developmental Outcomes?
    by Jodie Roth & Lizabeth M. Malone & Jeanne Brooks-Gunn
  • 2010 BOND Final Design Report
    by David Stapleton & Stephen Bell & David Wittenburg & Brian Sokol & Debi McInnis
  • 2010 Charter School Authorizers and Student Achievement
    by Ron Zimmer & Brian Gill & Kaitlin Obenauf
  • 2010 Identifying Programs that Impact Teen Pregnancy, Sexually Transmitted Infections, and Associated Sexual Risk Behaviors
    by Brian Goesling & Christopher Trenholm
  • 2010 Evaluation of Medicare Part D Late Enrollment Penalty Demonstration for Low-Income Subsidy Applicants and Residents Affected by Hurricane Katrina
    by Boyd Gilman & Candace Natoli
  • 2010 The Roles of Patient-Centered Medical Homes and Accountable Care Organizations in Coordinating Patient Care
    by David Meyers & Debbie Peikes & Janice Genevro & Greg Peterson & Erin Fries Taylor & Tim Lake & Kim Smith & Kevin Grumbach
  • 2010 Using Comparative Effectiveness Research: Information Alone Won't Lead to Successful Health Care Reform
    by Dominick Esposito & Arnold Chen & Margaret Gerteis & Timothy Lake
  • 2010 Northern New Jersey Health Care Market Reflects Urban-Suburban Contrasts
    by Laurie E. Felland & Grace Anglin & Amelia M. Bond & Gary Claxton & Ann S. O'Malley & Caroleen W. Quach
  • 2010 Initial Implementation of a Couples-Focused Employment Program
    by Heather Zaveri & Alan Hershey
  • 2010 Value-Added: It's Not Perfect, But It Makes Sense
    by Steven Glazerman & Dan Goldhaber & Susanna Loeb & Douglas Staiger & Stephen Raudenbush & Grover Whitehurst
  • 2010 Value for the Money Spent? Exploring the Relationship Between Medicaid Costs and Quality
    by Debra Lipson & Margaret Colby & Tim Lake & Su Liu & Sarah Turchin
  • 2010 The Unknown World of Charter High Schools
    by Kevin Booker & Tim R. Sass & Brian Gill & Ron Zimmer
  • 2010 Strengthening Unmarried Parents' Relationships: The Early Impacts of Building Strong Families
    by Robert G. Wood & Sheena McConnell & Quinn Moore & rew Clarkwest & JoAnn Hsueh
  • 2010 The Impacts of Philadelphia's Accelerated Schools on Academic Progress and Graduation
    by Hanley Chiang & Brian Gill
  • 2010 Recruiting and Training Home Visitors for Evidence-Based Home Visiting (EBHV): Experience of EBHV Grantees
    by Brandon Coffee-Borden & Diane Paulsell
  • 2010 Medicare Contractor Provider Satisfaction Survey (MCPSS) Public Report
    by Bob Schmitz & Anne Ciemnecki
  • 2010 Evaluating Teachers: The Important Role of Value-Added
    by Steven Glazerman & Susanna Loeb & Dan Goldhaber & Douglas Staiger & Stephen Raudenbush & Grover Whitehurst
  • 2010 Relationship Skills Education and Child Support: Evidence from a Program Partnership in Texas
    by Robert Santillano & Robert G. Wood
  • 2010 Evaluation Exemplar: The Critical Importance of Stakeholder Relations in a National, Experimental Abstinence Education Evaluation
    by Paul R. Brandon & Nick L. Smith & Christopher Trenholm & Barbara Devaney
  • 2010 Achievement Effects of Four Early Elementary School Math Curricula: Findings for First and Second Graders
    by Roberto Agodini & Barbara Harris & Melissa Thomas & Robert Murphy & Lawrence Gallagher
  • 2010 Precision Gains from Publically Available School Proficiency Measures Compared to Study-Collected Test Scores in Education Cluster-Randomized Trials
    by John Deke & Lisa Dragoset & Ravaris Moore
  • 2010 Data Tables for FACES 2006: A Year in Head Start Report
    by Lara Hulsey & Nikki Aikens & Yange Xue & Louisa Tarullo & Jerry West
  • 2010 A Year in Head Start: Children, Families and Programs
    by Nikki Aikens & Louisa Tarullo & Lara Hulsey & Christine Ross & Jerry West & Yange Xue
  • 2010 Impacts of Comprehensive Teacher Induction: Final Results from a Randomized Controlled Study
    by Steven Glazerman & Eric Isenberg & Sarah Dolfin & Martha Bleeker & Amy Johnson & Mary Grider & Matthew Jacobus
  • 2010 Aspects of Mental Health Communication Skills Training that Predict Parent and Child Outcomes in Pediatric Primary Care
    by Lawrence Wissow Anne Gadomski & Debra Roter & Susan Larson & Barry Lewis & Jonathan Brown
  • 2010 Does Intensive Mentoring Improve Teaching? Results from a Randomized Experiment
    by Steven Glazerman & Eric Isenberg & Sarah Dolfin & Martha Bleeker & Amy Johnson & Mary Grider & Matthew Jacobus
  • 2010 Efficacy of Schoolwide Programs to Promote Social and Character Development and Reduce Problem Behavior in Elementary School Children
    by Allen Ruby & Emily Doolittle (IES) & Karen Needels & John A. Burghardt & Laura M. Kalb & Heather Koball & Peter Z. Schochet & Victor Battistich
  • 2010 Plan Availability and Premiums
    by Marsha Gold & Gretchen Jacobson & Anthony Damico & Tricia Neuman
  • 2010 Use of One-Stops by Social Security Disability Beneficiaries in Four States Implementing Disability Program Navigator Initiatives
    by Gina Livermore & Silvie Colman
  • 2010 Evaluation of the Work Incentives Planning and Assistance (WIPA) Program: Beneficiaries Served, Services Provided, and Program Costs. Appendix
    by Jody Schimmel & Bonnie O'Day & Allison Roche & Gina Livermore & Dominic Harris
  • 2010 Evaluation of the Work Incentives Planning and Assistance (WIPA) Program: Beneficiaries Served, Services Provided, and Program Costs
    by Jody Schimmel & Bonnie O'Day & Allison Roche & Gina Livermore & Dominic Harris
  • 2010 Simplification of Health and Social Services Enrollment and Eligibility: Lessons for California from Interviews in Four States
    by Scott Cody & Debbie Reed & Danna Basson & Jordan Pedraza & Emily Sama Martin & Betsy Santos & Elisha Smith
  • 2010 Development of the Medicaid Analytic Extract Enrollee Master (MAXEM) File, 2005 and 2006
    by John L. Czajka & Audra Wenzlow & Julie Sykes
  • 2010 Development of the Medicaid Analytic Extract Provider Characteristics (MAXPC) File. Final Implementation Report, 2006
    by Deo S. Bencio & Julie Sykes & Mei-ling Mason
  • 2010 Comparative Effectiveness Research and Innovations: Policy Options to Foster Medical Advances
    by Emily Carrier & Hoangmai H. Pham & Eugene Rich
  • 2010 Medical Home Evaluations: Why They Can Fail, How to Structure Them
    by Debbie Peikes
  • 2010 Integrating Care for Dual Eligibles: Capitated Managed Care Options
    by James M. Verdier
  • 2010 Cleveland Hospital Systems Expand Despite Weak Economy
    by Aaron Katz & Amelia M. Bond & Emily R. Carrier & Elizabeth Docteur & Caroleen W. Quach & Tracy Yee
  • 2010 Racial Variation in Vocational Rehabilitation Outcomes: A Structural Equation Modeling Approach
    by Frank H. Martin
  • 2010 Seeds to Success Modified Field Test Evaluation: Impact and Implementation Findings
    by Kimberly Boller & Patricia Del Grosso
  • 2010 Evaluation of the Universal Newborn Hearing Screening and Intervention Program
    by Shanna Shulman & Melanie Besculides & Anna Saltzman & Henry Ireys & Karl R. White & Irene Forsman
  • 2010 The Late Pretest Problem in Randomized Control Trials of Education Interventions
    by Peter Z. Schochet
  • 2010 Strategies for Engaging and Retaining Latinos in HIV Care
    by Margaret Hargreaves & Julia Hidalgo & Vivian Byrd & Ann Bagchi & Jung Kim
  • 2010 The Seeds to Success Modified Field Test: Implementation Lessons
    by Patricia Del Grosso & Kristin Hallgren & Diane Paulsell & Kimberly Boller
  • 2010 The Seeds to Success Modified Field Test: Impact Evaluation Findings
    by Kimberly Boller & Randall Blair & Patricia Del Grosso & Diane Paulsell
  • 2010 Covering Low-Income Childless Adults in Medicaid: Experiences from Selected States
    by Stephen A. Somers & Allison Hamblin & James M. Verdier & Vivian L.H. Byrd
  • 2010 Medicaid Beneficiaries Using Mental Health or Substance Abuse Services in Fee-for-Service Plans in 13 States, 2003
    by Henry T. Ireys & Allison L. Barrett & Jeffrey A. Buck & Thomas W. Croghan & Melanie Au & Judith L. Teich
  • 2010 Where Americans Get Acute Care: Increasingly, It's Not at Their Doctor's Office
    by Stephen R. Pitts & Emily R. Carrier & Eugene C. Rich & Arthur L. Kellermann
  • 2010 Connecting Education Research to Practitioners and Practitioners to Education Research
    by Mark Dynarski
  • 2010 Using Medical Records to Supplement a Claims-Based Comparative Effectiveness Analysis of Antidepressants
    by Thomas W. Croghan & Dominick Esposito & Gregory Daniel & Peter Wahl & Michael A. Stoto
  • 2010 15-Month Impacts of Oklahoma's Family Expectations Program
    by Barbara Devaney & Robin Dion
  • 2010 What Predicts Sex Partners' Age Differences Among African American Youth? A Longitudinal Study from Adolescence to Young Adulthood
    by José A. Bauermeister & Marc A. Zimmerman & Cleopatra H. Caldwell & Yange Xue & Gilbert C. Gee
  • 2010 Detroit: Motor City to Medical Mecca?
    by Jon Christianson & Grace Anglin & Amelia Bond & Peter Cunningham & Gretchen Kishbauch & Hoangmai H. Pham
  • 2010 How Are the Experiences of Individuals with Severe Mental Illness Different from Those of Other Medicaid Buy-In Participants?
    by Su Liu & Sarah Croake
  • 2010 National Patterns of Risk-Standardized Mortality and Readmission for Acute Myocardial Infarction and Heart Failure
    by Susannah Bernheim & Jacqueline Grady & Zhenqiu Lin & Yun Wang & Yongfei Wang & Shantal Savage & Kanchana Bhat & Joseph Ross & Mayur Desai & Angela Merrill & Lein Han & Michael Rapp & Elizabeth Drye & Sharon-Lise Normand & Harlan Krumholz
  • 2010 Supporting Quality in Home-Based Child Care: Initiative Design and Evaluation Options
    by Diane Paulsell & Toni Porter & Gretchen Kirby & Kimberly Boller & Emily Sama Martin & rew Burwick & Christine Ross & Carol Begnoche
  • 2010 A Compilation of Initiatives to Support Home-Based Child Care
    by Toni Porter & Tahra Nichols & Patricia Del Grosso & Carol Begnoche & Rachel Hass & Lee Vuong & Diane Paulsell
  • 2010 A Review of the Literature on Home-Based Child Care: Implications for Future Directions
    by Toni Porter & Diane Paulsell & Patricia Del Grosso & Sarah Avellar & Rachel Hass & Lee Vuong
  • 2010 Supporting Quality in Home-Based Child Care
    by Diane Paulsell & Toni Porter & Gretchen Kirby
  • 2010 Supporting Quality in Home Based Child Care: A Compendium of 23 Initiatives
    by Toni Porter & Diane Paulsell & Tahra Nichols & Carol Begnoche & Patricia Del Grosso
  • 2010 OAA Title III Services Target the Most Vulnerable Elderly in the United States
    by Allison Barrett & Jody Schimmel
  • 2010 Health Care When Workers Need It Most: Before and After Entry into the Social Security Disability Insurance Program
    by Gina A. Livermore & David C. Stapleton & Henry Claypool
  • 2010 Family-Driven Youth-Guided Practices in Residential Treatment: Findings from a National Survey of Residential Treatment Facilities
    by Jonathan D. Brown & Kirsten Barrett & Henry T. Ireys & Kamala Allen & Sheila A. Pires & Gary Blau
  • 2010 Putting Evidence to Work: An Expanded Research Agenda for Academic Medicine in the Era of Health Care Reform
    by Ann C. Bonham & Eugene C. Rich & David A. Davis & David E. Longnecker & Stephen J. Heinig
  • 2010 Disabled or Young? Relative Age and Special Education Diagnoses in Schools
    by Elizabeth Dhuey & Stephen Lipscomb
  • 2010 Differences in Prevalence, Treatment, and Outcomes of Asthma Among a Diverse Population of Children with Equal Access to Care
    by Kate A. Stewart & Patricia C. Higgins & Catherine G. McLaughlin & Thomas V. Williams & Elder Granger & Thomas W. Croghan
  • 2010 Efforts to Meet Children's Physical Activity and Nutritional Needs: Findings from the I Am Moving, I Am Learning Implementation Evaluation
    by Mary Kay Fox & Kristin Hallgren & Kimberly Boller & Alyn Turner & Charlotte Cabili & Elizabeth Condon & Patricia Del Grosso & David Eden & Daniel Finkelstein & Barbara Kennen & rea Mraz Esposito & Renée Nogales
  • 2010 Economic Integration of Latino Immigrants in New and Traditional Rural Destinations in the United States
    by Randy Capps & Heather Koball & William Kandel
  • 2010 Projected Health Care Spending in Minnesota
    by David Jones & Deborah Chollet
  • 2010 Assessing the Need for Evidence-Based Home Visiting (EBHV): Experience of EBHV Grantees
    by Diane Paulsell & Brandon Coffee-Borden
  • 2010 A Continuing Program for Increasing Insurance Coverage Among Low-Income Families
    by Judith Wooldridge & Beth Stevens & Christopher Trenholm & Eileen Ellis & Ian Hill
  • 2010 Error Rates in Measuring Teacher and School Performance Based on Student Test Score Gains
    by Peter Z. Schochet & Hanley S. Chiang
  • 2010 The Evaluation of Charter School Impacts
    by Philip Gleason & Melissa Clark & Christina Clark Tuttle & Emily Dwoyer
  • 2010 Overview and Lessons on the Design and Implementation of Early Intervention Programs for Individuals with Potentially Disabling Mental Health Conditons
    by Henry Ireys & Boyd Gilman & Gilbert Gimm & Sarah Croake & Noelle Denny-Brown
  • 2010 Impact of Early Intervention Programs for Persons with Mental Health Conditions: Evidence from the National DMIE Evaluation
    by Boyd Gilman & Gilbert Gimm & Henry Ireys & Noelle Denny-Brown & Sarah Croake
  • 2010 Paper of the Year: Effects of Care Coordination on Hospitalization, Quality of Care, and Health Care Expenditures Among Medicare Beneficiaries: 15 Randomized Trials (JAMA 2009)
    by Deborah Peikes & Arnold Chen & Jennifer Schore & Randall Brown
  • 2010 Results from a Radical Makeover of a Care Coordination Program Show How Program Design Affects Success in Reducing Hospitalizations and Costs: Evidence from a Randomized Controlled Trial Before and After Key Changes in Program Design
    by D. Peikes & G. Peterson & R. Brown & J. Schore & C. Razafindrakoto & S. Graff & J. Lynch
  • 2010 Assessing Cultural Perspectives on the Quality of Care
    by Ann D. Bagchi & Raquel af Ursin & Alicia Leonard
  • 2010 Engaging Patients and Families in the Medical Home
    by Sarah Hudson Scholle & Phyllis Torda & Deborah Peikes & Esther Han & Janice Genevro
  • 2010 Necessary But Not Sufficient: The HITECH Act and Health Information Technology's Potential to Build Medical Homes
    by Lorenzo Moreno & Deborah Peikes & Amy Krilla
  • 2010 Integrating Mental Health Treatment Into the Patient Centered Medical Home
    by Thomas W. Croghan & Jonathan D. Brown
  • 2010 Medicare and Medicaid Spending on Dual Eligible Beneficiaries
    by Arkadipta Ghosh & James Verdier & Mark Flick & Ellen Singer
  • 2010 Reducing Racial and Ethnic Disparities in Health Care: Partnerships Between Employers and Health Plans
    by Patricia Collins Higgins & Melanie Au & Erin Fries Taylor
  • 2010 Medicare Incentives for Using EHRs: Insights from Site Visits to Small and Mid-Sized Physician Practices
    by Suzanne Felt-Lisk & Lorraine Johnson & Christopher Fleming & Rachel Shapiro & Brenda Natzke
  • 2010 Therapeutic Alliance in Pediatric Primary Care: Preliminary Evidence for a Relationship with Physician Communication Style and Mothers' Satisfaction
    by Lawrence S. Wissow & Jonathan D. Brown & Janice Krupnick
  • 2010 Aging in Place: Do Older Americans Act Title III Services Reach Those Most Likely to Enter Nursing Homes?
    by Norma Altshuler & Jody Schimmel
  • 2010 Costs and Benefits of Providing In-Person Professional Medical Interpreters in the Emergency Department: Results of a Randomized Controlled Study
    by Ann D. Bagchi & Stacy Dale & Natalya Verbitsky-Savitz & Sky Andrecheck & Kathleen Zavotsky & Robert Eisenstein
  • 2010 Identifying the Evaluation Capacity of Community Health Organizations
    by Beth Stevens & Daniel Finkelstein & Jung Kim & Michaella Morzuch & Cicely Thomas & Mindy Lipson
  • 2010 Healthy Indiana Plan: The First Two Years
    by Carol Irvin
  • 2010 Student Achievement in New York City Middle Schools Affiliated with Achievement First and Uncommon Schools
    by Bing-ru Teh & Moria McCullough & Brian P. Gill
  • 2010 Including Medicare-Medicaid Dual Eligibles in Managed Care: Current Status and Future Prospects
    by James M. Verdier
  • 2010 Strategic Engagement of Policymakers Is Key to Advancing a Children's Health Care Coverage Policy Agenda
    by Debra Draper & Laurie Felland & Ian Hill & Sara Hogan
  • 2010 State-Based Advocacy as a Tool for Expanding Children's Coverage: Lessons from Site Visits to Six IAC Grantee States
    by Ian Hill & Sara Hogan & Debra Draper & Allison Liebhaber
  • 2010 Supplemental Analytical Sample Equivalence Tables for Student Characteristics and Achievement in 22 KIPP Middle Schools: A Report from the National Evaluation of KIPP Middle Schools
    by Christina Clark Tuttle & Bing-ru Teh & Ira Nichols-Barrer & Brian P. Gill & Philip Gleason
  • 2010 An Experimental Evaluation of Four Elementary School Math Curricula
    by Roberto Agodini & Barbara Harris
  • 2010 Care Coordination and Disease Management
    by Debra Lipson & Melanie Au
  • 2010 Establishing and Maintaining Medicaid Eligibility Upon Release from Public Institutions
    by Audra Wenzlow & Henry T. Ireys & Carol Irvin & Matthew Hodges
  • 2010 The Effectiveness of Mandatory-Random Student Drug Testing
    by Susanne James-Burdumy & Brian Goesling & John Deke & Eric Einspruch
  • 2010 The Effectiveness of Mandatory-Random Student Drug Testing
    by Susanne James-Burdumy & Brian Goesling & John Deke & Eric Einspruch
  • 2010 The National Study of Charter Management Organization (CMO) Effectiveness. Report on Interim Findings
    by Robin Lake & Brianna Dusseault & Melissa Bowen & Allison Demeritt & Paul Hill
  • 2010 Standards for Regression Discontinuity Designs
    by P. Schochet & T. Cook & J. Deke & G. Imbens & J.R. Lockwood & J. Porter & J. Smith
  • 2010 Using State Tests for Evaluation Purposes
    by Henry May & Irma Perez-Johnson & Josh Haimson & Samina Sattar & Phil Gleason
  • 2010 Politics and Policy of Comparative Effectiveness: Looking Back, Looking Ahead
    by Eugene C. Rich & Elizabeth Docteur
  • 2010 Student Characteristics and Outcomes in Alternative and Neighborhood High Schools in Philadelphia
    by Hanley Chiang & Brian Gill
  • 2010 The Seeds to Success Modified Field Test: Findings from the Impact and Implementation Studies
    by Kimberly Boller & Patricia Del Grosso & Randall Blair & Yumiko Jolly & Ken Fortson & Diane Paulsell & Eric Lundquist & Kristin Hallgren & Martha Kovac
  • 2010 The Evaluation of Charter School Impacts
    by Philip Gleason & Melissa Clark & Christina Clark Tuttle & Emily Dwoyer
  • 2010 Student Characteristics and Achievement in 22 KIPP Middle Schools
    by Christina Clark Tuttle & Bing-ru Teh & Ira Nichols-Barrer & Brian P. Gill & Philip Gleason
  • 2010 Plan Enrollment Patterns and Trends
    by Marsha Gold & Dawn Phelps & Gretchen Jacobson & Tricia Neuman
  • 2010 Better Beginnings: Partnering with Families for Early Learning Home Visit Observations
    by Kristin Hallgren & Kimberly Boller & Diane Paulsell
  • 2010 Better Beginnings: Developing Home-Based Early Learning Systems in East Yakima and White Center
    by Kristin Hallgren & Diane Paulsell & Patricia Del Grosso
  • 2010 How Temporary Insurance for High-Risk Individuals May Play Out Under Health Reform
    by Deborah J. Chollet
  • 2010 Medical Homes: Will They Improve Primary Care?
    by Jill Bernstein & Deborah Chollet & Deborah Peikes & G. Gregory Peterson
  • 2010 Dual Eligibles in Nursing Facilities and Other Long-Term Care Settings
    by James M. Verdier
  • 2010 Closures Are the Tip of the Iceberg: Exploring Variation in Who Receives State Vocational Rehabilitation (VR) Services
    by David Stapleton & Todd Honeycutt & Bruce Schechter
  • 2010 Demonstration to Maintain Independence and Employment (DMIE): Preliminary Findings from the National Evaluation
    by Henry Ireys & Gilbert Gimm & Boyd Gilman & Noelle Denny-Brown & Sarah Croake
  • 2010 Longitudinal Employment and Work Incentive Statistics for Social Security Disability Insurance (SSDI) Beneficiaries
    by David Stapleton
  • 2010 Ticket to Work Participants and Other Beneficiaries Leaving the Disability Rolls Because of Work
    by Jody Schimmel
  • 2010 Longitudinal Employment Outcomes for Social Security Disability Beneficiaries with Work Goals and Expectations
    by Gina Livermore
  • 2010 National Beneficiary Survey: Round 3 Public Use Data File
    by Debra Wright & Shilpa Khambhati & Beatrice Jones
  • 2010 National Beneficiary Survey: Round 3 Public Use File Codebook
    by Debra Wright & Shilpa Khambhati & Beatrice Jones
  • 2010 An Evaluation of the Teacher Advancement Program (TAP) in Chicago: Year Two Impact Report
    by Steven Glazerman & Allison Seifullah
  • 2010 Strengthening Unmarried Parents' Relationships: The Early Impacts of Building Strong Families
    by Robert G. Wood & Sheena McConnell & Quinn Moore & rew Clarkwest & JoAnn Hsueh
  • 2010 Strengthening Unmarried Parents' Relationships: The Early Impacts of Building Strong Families. Technical Supplement
    by Robert G. Wood & Quinn Moore & rew Clarkwest & JoAnn Hsueh & Sheena McConnell
  • 2010 Implementation of Eight Programs to Strengthen Unmarried Parent Families
    by M. Robin Dion & Sarah A. Avellar & Elizabeth Clary
  • 2010 Strengthening Unmarried Parents' Relationships: The Early Impacts of Building Strong Families
    by Robert G. Wood & Sheena McConnell & Quinn Moore & rew Clarkwest & JoAnn Hsueh
  • 2010 QRS Profile: Virginia Star Quality Initiative
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Vermont STep Ahead Recognition System
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Tennessee Star-Quality Child Care Program
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Pennsylvania Keystone STARS
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Palm Beach Quality Counts
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Oregon Child Care Quality Indicators Program
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Oklahoma Reaching for the Stars
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Ohio Step Up to Quality
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: North Carolina Star Rated License System
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: New Mexico Look for the STARS - AIM HIGH
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: New Hampshire Quality Rating System
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Missouri Quality Rating System
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Mississippi Quality Step System
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Minnesota Parent Aware
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Miami-Dade Quality Counts
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Maryland Child Care Tiered Reimbursement System
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Maine Quality for ME
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Louisiana Quality Start Child Care Rating System
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Los Angeles County Steps to Excellence Project
    by Analytics & research provided by Mathematica Policy Research
  • 2010 QRS Profile: Kentucky STARS for KIDS NOW
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Iowa Child Care Quality Rating System
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Indiana Paths to Quality
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Illinois Quality Counts
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: District of Columbia Going for the Gold Tiered Rate Reimbursement System
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Delaware Stars for Early Success
    by Kimberly Boller & Kathryn Tout
  • 2010 QRS Profile: Colorado Qualistar
    by Kimberly Boller & Kathryn Tout
  • 2010 Compendium of Quality Rating Systems and Evaluations
    by Kathryn Tout & Rebecca Starr & Margaret Soli & Shannon Moodie & Gretchen Kirby & Kimberly Boller
  • 2010 Employment Among SSA Disability Program Beneficiaries: 1996-2007
    by Arif Mamun & Paul O'Leary & David Wittenburg & Jesse Gregory
  • 2010 Financial Incentives for Health Care Providers and Consumers
    by Jill Bernstein & Deborah Chollet & Stephanie Peterson
  • 2010 Income and Health Insurance Coverage: Comparing the American Community Survey (ACS) and the Current Population Survey (CPS)
    by John L. Czajka
  • 2010 Disease Management: Does It Work?
    by Jill Bernstein & Deborah Chollet & G. Gregory Peterson
  • 2010 Using Evidence to Inform Policy: Developing a Policy-relevant Research Agenda for the Patient-Centered Medical Home
    by Bruce E. Landon & James M. Gill & Richard C. Antonelli & Eugene C. Rich
  • 2010 U.S. Approaches to Physician Payment: The Deconstruction of Primary Care
    by Robert A. Berenson & Eugene C. Rich
  • 2010 How to Buy a Medical Home? Policy Options and Practical Questions
    by Robert A. Berenson & Eugene C. Rich
  • 2010 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for April 2010
    by Stephanie Peterson & Marsha Gold
  • 2010 Phone or Face-to-Face? Comparing Data from Surveys of People with Disabilities
    by Matt Sloan & Debra Wright & Kirsten Barrett
  • 2010 Extending Medicaid Coverage to Low-Income Childless Adults: Opportunities and Cautions for Managed Care Plans
    by James M. Verdier
  • 2010 Successfully Implementing SOAR: Lessons Learned from Six States
    by Jacqueline Kauff & Jonathan Brown
  • 2010 Basing Health Care on Empirical Evidence
    by Jill Bernstein & Deborah Chollet & Stephanie Peterson
  • 2010 Prospects for Rebuilding Primary Care Using the Patient-Centered Medical Home
    by Bruce E. Landon & James M. Gill & Richard C. Antonelli & Eugene C. Rich
  • 2010 Relationship Education for Unmarried Couples with Children: Parental Responses to the Building Strong Families Project
    by M. Robin Dion & Alan M. Hershey
  • 2010 Mental Disorders and Service Use Among Welfare and Disability Program Participants in Fee-for-Service Medicaid
    by LaDonna Pavetti & Michelle K. Derr & Jacqueline F. Kauff & Allison Barrett
  • 2010 How Many SSDI Beneficiaries Leave the Rolls for Work? More Than You Might Think
    by Su Liu & David Stapleton
  • 2010 Encouraging Appropriate Use of Preventive Health Services
    by Jill Bernstein & Deborah Chollet & G. Gregory Peterson
  • 2010 National Evaluation of Elementary School Math Curricula
    by Barbara Harris
  • 2010 Effectiveness of Selected Supplemental Reading Comprehension Interventions: Findings from Two Student Cohorts
    by Susanne James-Burdumy & John Deke & Julieta Lugo-Gil & Nancy Carey & Alan Hershey & Russell Gersten & Rebecca Newman-Gonchar & Joseph Dimino & Kelly Haymond & Bonnie Faddis
  • 2010 First 5 Contra Costa Report on Parent Involvement
    by Sarah Duffy & Marta Induni & Emily Moiduddin
  • 2010 Meaning in the Method: Pretesting Methods for a Diverse Population
    by Susan Sprachman & Sally Atkins-Burnett & Nikki Aikens & Margaret Caspe
  • 2010 Is Regression Adjustment Supported By the Neyman Model for Causal Inference?
    by Peter Z. Schochet
  • 2010 Racial Disparities in Hospitalizations for Ambulatory Care—Sensitive Conditions
    by Sasigant S. O'Neil & Timothy Lake & Angela Merrill & er Wilson & David A. Mann & Linda M. Bartnyska
  • 2010 How Does Insurance Coverage Improve Health Outcomes?
    by Jill Bernstein & Deborah Chollet & Stephanie Peterson
  • 2010 Compendium of Student, Teacher, and Classroom Measures Used in NCEE Evaluations of Educational Interventions. Volume II: Technical Details, Measure Profiles, and Glossary
    by Lizabeth M. Malone & Charlotte Cabili & Jamila Henderson & rea Mraz Esposito & Kathleen Coolahan & Juliette Henke & Subuhi Asheer & Meghan O'Toole & Sally Atkins-Burnett & Kimberly Boller
  • 2010 Compendium of Student, Teacher, and Classroom Measures Used in NCEE Evaluations of Educational Interventions. Volume I: Measures Selection Approaches and Compendium Development Methods
    by Kimberly Boller & Sally Atkins-Burnett & Elizabeth M. Malone & Gail P. Baxter & Jerry West
  • 2010 Beyond Affordability: The Impact of Nonfinancial Barriers on Access for Uninsured Adults in Three Diverse Communities
    by Jeffrey T. Kullgren & Catherine G. McLaughlin
  • 2010 Providing Health Benefits and Work-Related Services to Social Security Disability Insurance Beneficiaries: Six-Month Results from the Accelerated Benefits Demonstration
    by David Wittenburg & Anne Warren & Deborah Peikes & Stephen Freedman
  • 2010 Reaching Staff, Parents, and Community Partners to Prevent Childhood Obesity in Head Start, 2008
    by Rachel A. Gooze & Cayce C. Hughes & Daniel M. Finkelstein & Robert C. Whitaker
  • 2010 Evaluating System Change: A Planning Guide
    by Margaret B. Hargreaves
  • 2010 Promising Antipoverty Strategies for Families
    by Maria Cancian & Daniel R. Meyer & Deborah Reed
  • 2010 Roads to Success: Estimated Impacts of an Education and Career Planning Program During Middle School
    by Duncan Chaplin & Martha Bleeker & Kevin Booker
  • 2010 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for March 2010
    by Stephanie Peterson & Marsha Gold
  • 2010 System of Care Approaches in Residential Treatment Facilities Serving Children with Serious Behavioral Health Needs
    by Kamala D. Allen & Sheila A. Pires & Jonathan Brown
  • 2010 What Do We Know About the Link Between Marriage and Health?
    by Heather L. Koball & Emily Moiduddin & Jamila Henderson & Brian Goesling & Melanie Besculides
  • 2010 Regulating Abortion: Impact on Patients and Providers in Texas
    by Silvie Colman & Theodore J. Joyce
  • 2010 Study of Rhode Island's Uninsured: Current Costs and Future Opportunities
    by Deborah Chollet & Jeffrey Ballou & Allison Barrett & Thomas Bell
  • 2010 The Business Case for Accurate Data on Quality and Savings in Medical Home Programs
    by Debbie Peikes
  • 2010 Fostering Effective Grassroots Partnerships: Lessons from Faith-Based and Community Initiatives
    by Pam Winston
  • 2010 Provider Payment: Trends and Methods in the Massachusetts Health Care System
    by Allison Barrett & Timothy Lake
  • 2010 America's Teacher Corps
    by Steven Glazerman & Dan Goldhaber & Susanna Loeb & Douglas O. Staiger & Grover J. Whitehurst
  • 2010 Benefits and Cost-Sharing
    by Marsha Gold & Maria Hudson & Gretchen Jacobson & Tricia Neuman
  • 2010 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for February 2010
    by Stephanie Peterson & Marsha Gold
  • 2010 Quality's New Frontier: Reducing Hospitalizations and Improving Transitions in Long-Term Care
    by Debra J. Lipson & Samuel Simon
  • 2010 The Social Security Administration's Youth Transition Demonstration Projects: Implementation Lessons from the Original Projects
    by John Martinez & Thomas Fraker & Michelle Manno & Peter Baird & Arif Mamun & Bonnie O'Day & Anu Rangarajan & David Wittenburg
  • 2010 The New Jersey Medicaid Program: Some Comparisons to Other States
    by James M. Verdier
  • 2010 Coordinating and Improving Care for Dual Eligibles in Nursing Facilities: Current Obstacles and Pathways to Improvement
    by James M. Verdier
  • 2010 Using Professionally Trained Interpreters to Increase Patient/Provider Satisfaction: Does It Work?
    by Ann D. Bagchi & Stacy Dale & Natalya Verbitsky-Savitz & Sky Andrecheck
  • 2010 Closures Are the Tip of the Iceberg: Exploring the Variation in State Vocational Rehabilitation Programs Exits After Service Receipt
    by David Stapleton & Todd Honeycutt & Bruce Schechter
  • 2010 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for January 2010
    by Stephanie Peterson & Marsha Gold
  • 2010 The Impact of Malpractice Liability Claims on Obstetrical Practice Patterns
    by Gilbert W. Gimm
  • 2010 Accountable Care Organizations: Will They Deliver?
    by Marsha Gold
  • 2010 Episode-Based Payments: Charting a Course for Health Care Payment Reform
    by Hoangmai H. Pham & Paul B. Ginsburg & Timothy K. Lake & Myles M. Maxfield
  • 2010 Changes in Capacity Among Local Coordinated Community Response Coalitions (CCRs) Supported by the DELTA Program
    by Pamela J. Cox & Daniel M. Finkelstein & Victoria E. Perez & Margo L. Rosenbach
  • 2010 Twenty Years of Human Development in Six Affluent Countries: Australia, Canada, Japan, New Zealand, the United Kingdom, and the United States
    by Sarah Burd-Sharps & Kristen Lewis & Patrick Guyer & Ted Lechterman
  • 2010 Update on the Venezuelan Economy
    by Mark Weisbrot & Rebecca Ray
  • 2010 A Modern Framework for Measuring Poverty and Basic Economic Security
    by Shawn Fremstad
  • 2010 Health-Insurance Coverage Rates for US Workers, 1979-2008
    by Hye Jin Rho & John Schmitt
  • 2010 Reconciliation and Representation: The Share of the Population Represented by the Democratic Majority
    by Sarika Gupta
  • 2010 The Budget Deficit Scare Story and the Great Recession
    by Dean Baker
  • 2010 Analysis of Patients' Preferences: Direct Assessment and Discrete-Choice Experiment in Therapy of Adults with Attention-Deficit Hyperactivity Disorder
    by Axel C. Mhlbacher & Matthias Nbling
  • 2010 Using Best-Worst Scaling Choice Experiments to Measure Public Perceptions and Preferences for Healthcare Reform in Australia
    by Jordan J. Louviere & Terry N. Flynn
  • 2010 Adaptive Choice-Based Conjoint Analysis: A New Patient-Centered Approach to the Assessment of Health Service Preferences
    by Charles E. Cunningham & Ken Deal & Yvonne Chen
  • 2010 Conjoint Analysis Applications in Health - How are Studies being Designed and Reported?: An Update on Current Practice in the Published Literature between 2005 and 2008
    by Deborah Marshall & John F.P. Bridges & Brett Hauber & Ruthanne Cameron & Lauren Donnalley & Ken Fyie & F. Reed. Johnson
  • 2010 Multi-Criteria Clinical Decision Support: A Primer on the Use of Multiple-Criteria Decision-Making Methods to Promote Evidence-Based, Patient-Centered Healthcare
    by James G. Dolan
  • 2010 Patient Preferences and Linear Scoring Rules for Patient-Reported Outcomes
    by Ateesha F. Mohamed & A. Brett. Hauber & F. Reed. Johnson & Cheryl D. Coon
  • 2010 Feasibility of Using Modified Adaptive Conjoint Analysis Importance Questions
    by Liana Fraenkel
  • 2010 Deborah Marshall, PhD: An Advocate for Patient-Centered Research
    by Rebecca L. Hancock-Howard
  • 2010 Quality of Life in Restless Legs Syndrome: A Systematic Review of Clinical Trials and a Critical Review of Instruments
    by Jane Speight & Ana Howarth
  • 2010 Electronic Patient Diaries and Questionnaires - ePRO Now Delivering on the Promise?
    by Brian Tiplady
  • 2010 Technology, Reform, and Personal Medical Care
    by Norman Makous
  • 2010 Patient Views on Determinants of Compliance with Tuberculosis Treatment in the Eastern Cape, South Africa: An Application of Q-Methodology
    by Jane Murray. Cramm & Job van Exel & Valerie Mller & Harry Finkenflgel
  • 2010 Towards Patient-Centered Care for Depression: Conjoint Methods to Tailor Treatment Based on Preferences
    by Marsha N. Wittink & Mark Cary & Thomas TenHave & Jonathan Baron & Joseph J. Gallo
  • 2010 Patient-Reported Outcomes in Rheumatoid Arthritis: Assessing the Equivalence of Electronic and Paper Data Collection
    by Brian Tiplady & Kirsteen Goodman & Geraldine Cummings & Dawn Lyle & Robert Carrington & Clare Battersby & Stuart H. Ralston
  • 2010 Qualitative Development of the Rhinitis Control Assessment Test (RCAT), an Instrument for Evaluating Rhinitis Symptom Control
    by Robert A. Nathan & Anand A. Dalal & Richard H. Stanford & Eli O. Meltzer & Michael Schatz & Jennifer Derebery & Matthew Mintz & Michelle A. Thompson & Dana B. DiBenedetti
  • 2010 Measuring Preferences for Colorectal Cancer Screening: What are the Implications for Moving Forward?
    by Deborah Marshall & S. Elizabeth McGregor & Gillian Currie
  • 2010 'New' Evidence for Clinical Practice Guidelines: Should we Search for 'Preference Evidence'?
    by Murray Krahn
  • 2010 Explorative Evaluation of the Impact of Premenstrual Disorder on Daily Functioning and Quality of Life
    by Lothar A.J. Heinemann & Thai Do Minh & Anna Filonenko & Kerstin Uhl-Hochgrber
  • 2010 Assessing Drug Treatment Preferences of Patients with Crohn's Disease: A Conjoint Analysis
    by Gary R. Lichtenstein & Heidi C. Waters & Jenna Kelly & Susan S. McDonald & Elaine L. Zanutto & David Hendricks & Mirza I. Rahman
  • 2010 Contemporary Adult Diabetes Mellitus Management Perceptions
    by William Corser & Catherine Lein & Margaret Holmes-Rovner & Ved Gossain
  • 2010 Effects of HIV Medication Complexity and Depression on Adherence to HIV Medication
    by Virender Kumar & William Encinosa
  • 2010 Development and Testing of the Insulin Treatment Experience Questionnaire (ITEQ)
    by Jrn Moock & Franz Hessel & Diana Ziegeler & Thomas Kubiak & Thomas Kohlmann
  • 2010 Pharmacological Rhythm and Rate Control Treatment for Atrial Fibrillation: Patient and Physician Satisfaction
    by Nils Edvardsson & Anders Westlund & Margareta Thimell & Karin Rise & Alexander Todoran & Tanja berg Kurn & John Kindblom & Olle Almgren
  • 2010 Is it Possible to Measure What Truly Matters? The Paradox of Clinical Audit in Developing Continence Service Standards for Older People
    by Patrick Brown & Jenny Billings & Adrian Wagg & Jonathan Potter
  • 2010 Assessing Preferences Regarding Healthcare Interventions that Involve Non-Health Outcomes: An Overview of Clinical Studies
    by Brent C. Opmeer & Corianne A.J.M. de Borgie & Ben W.J. Mol & Patrick M.M. Bossuyt
  • 2010 Cost Effectiveness of Darunavir/Ritonavir in Highly Treatment-Experienced, HIV-1-Infected Adults in the USA
    by Josephine Mauskopf & Anita Brogan & Silas Martin & Erik Smets
  • 2010 Costs to Achieve Undetectable HIV RNA with Darunavir-Containing Highly Active Antiretroviral Therapy in Highly Pretreated Patients: The POWER Experience
    by Andrew M. Hill & Bonaventura Clotet & Margaret Johnson & Matthias Stoll & Nicholas Bellos & Erik Smets
  • 2010 The Cost of Managing HIV Infection in Highly Treatment-Experienced, HIV-Infected Adults in France
    by Xavier Colin & Antoine Lafuma & Dominique Costagliola & Jean-Marie Lang & Pascal Guillon
  • 2010 Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in Sweden
    by Ola Ghatnekar & Catharina Hjortsberg & Magnus Gissln & Stefan Lindbck & Mickael Lthgren
  • 2010 The Impact of Disease Stage on Direct Medical Costs of HIV Management: A Review of the International Literature
    by Adrian Levy & Karissa Johnston & Lieven Annemans & Andrea Tramarin & Julio Montaner
  • 2010 Modelling the Budget Impact of Darunavir in the Treatment of Highly Treatment-Experienced, HIV-Infected Adults in France
    by Xavier Colin & Antoine Lafuma & Dominique Costagliola & Erik Smets & Josephine Mauskopf & Pascal Guillon
  • 2010 Clinical Management of Treatment-Experienced, HIV/AIDS Patients in the Combination Antiretroviral Therapy Era
    by Mark A. Boyd & Andrew M. Hill
  • 2010 Predicting Direct Costs of HIV Care During the First Year of Darunavir-Based Highly Active Antiretroviral Therapy Using CD4 Cell Counts: Evidence from POWER
    by Andrew M. Hill & Kelly Gebo & Lindsay Hemmett & Mickael Lthgren & Gabriele Allegri & Erik Smets
  • 2010 Cost Effectiveness of Darunavir/Ritonavir 600/100 mg bid in Treatment-Experienced, Lopinavir-Naive, Protease Inhibitor-Resistant, HIV-Infected Adults in Belgium, Italy, Sweden and the UK
    by Karen Moeremans & Lindsay Hemmett & Jonas Hjelmgren & Gabriele Allegri & Erik Smets
  • 2010 US Cost Effectiveness of Darunavir/Ritonavir 600/100 mg bid in Treatment-Experienced, HIV-Infected Adults with Evidence of Protease Inhibitor Resistance Included in the TITAN Trial
    by Anita Brogan & Josephine Mauskopf & Sandra E. Talbird & Erik Smets
  • 2010 Cost Effectiveness of Darunavir/Ritonavir 600/100 mg bid in Protease Inhibitor-Experienced, HIV-1-Infected Adults in Belgium, Italy, Sweden and the UK
    by Karen Moeremans & Lieven Annemans & Mickael Lthgren & Gabriele Allegri & Veronique Wyffels & Lindsay Hemmet & Karin Caekelbergh & Erik Smets
  • 2010 A Review of Economic Evaluations of Darunavir Boosted by Low-Dose Ritonavir in Treatment-Experienced Persons Living with HIV Infection
    by Josephine Mauskopf & Lieven Annemans & Andrew M. Hill & Erik Smets
  • 2010 The Authors' Reply
    by Laura McCullagh & Lesley Tilson & Cathal Walsh & Michael Barry
  • 2010 The Authors' Reply
    by Alok Kapoor & Nila Radhakrishnan & Kenneth J. Smith
  • 2010 Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement:: A Systematic Review
    by Jonathan M. Plumb & Andreas Clemens & Brigitta U. Monz
  • 2010 An Economic Evaluation of Colesevelam when Added to Metformin-, Insulin- or Sulfonylurea-Based Therapies in Patients with Uncontrolled Type 2 Diabetes Mellitus
    by W. Robert. Simons & Michael A. Hagan
  • 2010 Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder
    by Tatia Chay. Woodward & Eskinder Tafesse & Peter Quon & Arthur Lazarus
  • 2010 A New Method for Examining the Cost Savings of Reducing COPD Exacerbations
    by Douglas W. Mapel & Michael Schum & Eva Lydick & Jeno P. Marton
  • 2010 Frequency of Treatment-Effect Modification Affecting Indirect Comparisons: A Systematic Review
    by Michael Coory & Susan Jordan
  • 2010 Using Conjoint Analysis and Choice Experiments to Estimate QALY Values: Issues to Consider
    by Terry N. Flynn
  • 2010 The Value of Value of Information: Best Informing Research Design and Prioritization Using Current Methods
    by Simon Eckermann & Jon Karnon & Andrew R. Willan
  • 2010 Fondaparinux: A Pharmacoeconomic Review of its Use in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome
    by Kate McKeage & Katherine A. Lyseng-Williamson
  • 2010 Economic Burden of Epilepsy among the Privately Insured in the US
    by Jasmina I. Ivanova & Howard G. Birnbaum & Yohanne Kidolezi & Ying Qiu & David Mallett & Sue Caleo
  • 2010 Assessing the Relationship between Computational Speed and Precision: A Case Study Comparing an Interpreted versus Compiled Programming Language using a Stochastic Simulation Model in Diabetes Care
    by Phil McEwan & Klas Bergenheim & Yong Yuan & Anthony P. Tetlow & Jason P. Gordon
  • 2010 Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review
    by Jaume Puig-Junoy
  • 2010 Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer: A Critical and Systematic Review
    by Patricia R. Blank & Konstantin J. Dedes & Thomas D. Szucs
  • 2010 Financial Effects of Pharmaceutical Price Regulation on R&D Spending by EU versus US Firms
    by Joseph Golec & John A. Vernon
  • 2010 Time for Cooperation in Health Economics among the Modelling Community
    by Rene J.G. Arnold & Sean Ekins
  • 2010 Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma: A Pragmatic Trial
    by Edward C.F. Wilson & David Price & Stanley D. Musgrave & Erika J. Sims & Lee Shepstone & Jamie Murdoch & H. Miranda. Mugford & Annie Blyth & Elizabeth F. Juniper & Jon G. Ayres & Stephanie Wolfe & Daryl Freeman & Richard F.T. Gilbert & Elizabeth V. Hillyer & Ian Harvey
  • 2010 Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy: A Pragmatic Trial
    by Edward C.F. Wilson & Erika J. Sims & Stanley D. Musgrave & Lee Shepstone & Annie Blyth & Jamie Murdoch & H. Miranda. Mugford & Elizabeth F. Juniper & Jon G. Ayres & Stephanie Wolfe & Daryl Freeman & Richard F.T. Gilbert & Ian Harvey & Elizabeth V. Hillyer & David Price
  • 2010 Q-TWiST Analysis of Patients Receiving Temsirolimus or Interferon Alpha for Treatment of Advanced Renal Cell Carcinoma
    by Arthur S. Zbrozek & Gary Hudes & Donna Levy & Andrew Strahs & Anna Berkenblit & Robert DeMarinis & Shreekant Parasuraman
  • 2010 Impact of Rapid Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Testing on Mortality and Cost Effectiveness in Hospitalized Patients with Bacteraemia: A Decision Model
    by Jack Brown & Joseph A. Paladino
  • 2010 The Cost of Relapse for Patients with a Manic/Mixed Episode of Bipolar Disorder in the EMBLEM Study
    by Jihyung Hong & Catherine Reed & Diego Novick & Josep Maria. Haro & Frank Windmeijer & Martin Knapp
  • 2010 The State of Health Economic Evaluation Research in Nigeria: A Systematic Review
    by Paul Gavaza & Karen L. Rascati & Abiola O. Oladapo & Star Khoza
  • 2010 Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement: A Systematic Review
    by Alok Kapoor & Warren Chuang & Nila Radhakrishnan & Kenneth J. Smith & Dan Berlowitz & Jodi B. Segal & Jeffrey N. Katz & Elena Losina
  • 2010 Does the Inclusion of a Cost Attribute Result in Different Preferences for the Surgical Treatment of Primary Basal Cell Carcinoma?: A Comparison of Two Discrete-Choice Experiments
    by Brigitte A.B. Essers & Debby van Helvoort-Postulart & Martin H. Prins & Martino Neumann & Carmen D. Dirksen
  • 2010 Cost Effectiveness of 5-Alpha Reductase Inhibitors for the Prevention of Prostate Cancer in Multiple Patient Populations
    by Stephanie R. Earnshaw & Cheryl L. McDade & Libby K. Black & Christopher F. Bell & Michael W. Kattan
  • 2010 Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis
    by Roisin Adams & Cathal Walsh & Douglas Veale & Barry Bresnihan & Oliver FitzGerald & Michael Barry
  • 2010 Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?
    by Lesley Chim & Patrick J. Kelly & Glenn Salkeld & Martin R. Stockler
  • 2010 Methodological Concerns with Economic Evaluations of Meningococcal Vaccines
    by Teresa L. Kauf
  • 2010 Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal
    by Adrian Bagust & Janette Greenhalgh & Angela Boland & Nigel Fleeman & Claire McLeod & Rumona Dickson & Yenal Dundar & Christine Proudlove & Richard Shaw
  • 2010 Economic Content in Medical Journal Advertisements for Medical Devices and Prescription Drugs
    by D. Clay. Ackerly & Seth W. Glickman & Kevin A. Schulman
  • 2010 Cost Effectiveness of Donepezil in the Treatment of Mild to Moderate Alzheimer's Disease: A UK Evaluation Using Discrete-Event Simulation
    by Denis Getsios & Steve Blume & K. Jack. Ishak & Grant D.H. Maclaine
  • 2010 Direct and Indirect Costs of Non-Vertebral Fracture Patients with Osteoporosis in the US
    by Crystal Pike & Howard G. Birnbaum & Matt Schiller & Hari Sharma & Russel Burge & Eric T. Edgell
  • 2010 Health Economic Burden of Patients with Restless Legs Syndrome in a German Ambulatory Setting
    by Richard Dodel & Svenja Happe & Ines Peglau & Geert Mayer & Jrgen Wasem & Jens-Peter Reese & Guido Giani & Max Geraedts & Claudia Trenkwalder & Wolfgang H. Oertel & Karin Stiasny-Kolster
  • 2010 Economic Burden of Multiple Sclerosis: A Systematic Review of the Literature
    by Huseyin Naci & Rachael Fleurence & Julie Birt & Amy Duhig
  • 2010 Alitretinoin for Severe Chronic Hand Eczema: A NICE Single Technology Appraisal
    by Mark Rodgers & Susan Griffin & Mike Paulden & Russell Slack & Steven Duffy & John R. Ingram & Nerys Woolacott & Mark Sculpher
  • 2010 Single Technology Appraisal at the UK National Institute for Health and Clinical Excellence: A Source of Evidence and Analysis for Decision Making Internationally
    by Mark Sculpher
  • 2010 Towards More Consistent Use of Generic Quality-of-Life Instruments
    by Mattias Neyt
  • 2010 Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis
    by Jeroen P. Jansen & Sabine Gaugris & Ernest H. Choy & Andrew Ostor & Julian T. Nash & Wiro Stam
  • 2010 Pharmacoeconomic Evaluation in Ireland: A Review of the Process
    by Lesley Tilson & Aisling OLeary & Cara Usher & Michael Barry
  • 2010 Does the Funding Source Influence the Results in Economic Evaluations?: A Case Study in Bisphosphonates for the Treatment of Osteoporosis
    by Rachael L. Fleurence & D. Eldon. Spackman & Christopher Hollenbeak
  • 2010 Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis: A Critical and Systematic Review
    by William A. Prescott & Fred Doloresco & Jack Brown & Joseph A. Paladino
  • 2010 A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment
    by Jean-Eric Tarride & Robert Hopkins & Gord Blackhouse & James M. Bowen & Matthias Bischof & Camilla Von Keyserlingk & Daria OReilly & Feng Xie & Ron Goeree
  • 2010 Varenicline: A Pharmacoeconomic Review of its Use as an Aid to Smoking Cessation
    by Gillian M. Keating & Katherine A. Lyseng-Williamson
  • 2010 Cost Effectiveness of High-Dose Intravenous Esomeprazole for Peptic Ulcer Bleeding
    by Alan N. Barkun & Viviane Adam & Joseph J.Y. Sung & Ernst J. Kuipers & Joachim Mossner & Dennis Jensen & Robert Stuart & James Y. Lau & Emma Naucler & Jan Kilhamn & Helena Granstedt & Bengt Liljas & Tore Lind
  • 2010 Estimation of a Valuation Function for a Diabetes Mellitus-Specific Preference-Based Measure of Health: The Diabetes Utility Index�
    by Murali Sundaram & Michael J. Smith & Dennis A. Revicki & Lesley-Ann Miller & Suresh Madhavan & Gerry Hobbs
  • 2010 The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK
    by Agnes Benedict & Lara Verdian & Grant Maclaine
  • 2010 Healthcare Rationing by Proxy: Cost-Effectiveness Analysis and the Misuse of the $50 000 Threshold in the US
    by John F.P. Bridges & Eberechukwu Onukwugha & C. Daniel. Mullins
  • 2010 Measuring Quality of Life for Certain Events versus Pre-Specified Points in Time
    by Mattias Neyt
  • 2010 Can't Get No Satisfaction? Will Pay for Performance Help?: Toward an Economic Framework for Understanding Performance-Based Risk-Sharing Agreements for Innovative Medical Products
    by Adrian Towse & Louis P. Garrison
  • 2010 Access with Evidence Development in the UK: Past Experience, Current Initiatives and Future Potential
    by Andrew Briggs & Karen Ritchie & Elisabeth Fenwick & Kalipso Chalkidou & Peter Littlejohns
  • 2010 Access with Evidence Development: The US Experience
    by Penny E. Mohr & Sean R. Tunis
  • 2010 Access with Evidence Development Schemes: A Framework for Description and Evaluation
    by Christopher J. McCabe & Tania Stafinski & Richard Edlin & Devidas Menon
  • 2010 Funding the Unfundable: Mechanisms for Managing Uncertainty in Decisions on the Introduction of New and Innovative Technologies into Healthcare Systems
    by Tania Stafinski & Christopher J. McCabe & Devidas Menon
  • 2010 Principles of Design of Access with Evidence Development Approaches: A Consensus Statement from the Banff Summit
    by Devidas Menon & Christopher J. McCabe & Tania Stafinski & Richard Edlin
  • 2010 We Know Accurately Only When We Know Little
    by Stuart MacLeod & Craig Mitton
  • 2010 Erlotinib: A Pharmacoeconomic Review of its Use in Advanced Non-Small Cell Lung Cancer
    by Katherine A. Lyseng-Williamson
  • 2010 Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US
    by Virginia M. Rosen & Douglas C.A. Taylor & Hemangi Parekh & Ankur Pandya & David Thompson & Andreas Kuznik & David D. Waters & Michael Drummond & Milton C. Weinstein
  • 2010 Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma: Long-Term Economic Evaluation
    by Eric Deconinck & Houda Miadi-Fargier & Claude Le. Pen & Pauline Brice
  • 2010 The Cost and Incidence of Prescribing Errors Among Privately Insured HIV Patients
    by Fred J. Hellinger & William E. Encinosa
  • 2010 Adverse Drug Interactions: Moving from Perception to Action
    by Ryan Mayhew & June M. McKoy & Thanh Ha Luu & Isaac Lopez & Melissa Frick & Charles L. Bennett
  • 2010 Should Financial Incentives be Used to Differentially Reward 'Me-Too' and Innovative Drugs?
    by Brita Pekarsky
  • 2010 The Cost Utility of Autologous Chondrocytes Implantation Using ChondroCelect in Symptomatic Knee Cartilage Lesions in Belgium
    by Laetitia Gerlier & Mark Lamotte & Micheline Wille & Peter C. Kreuz & Johan Vanlauwe & Dominique Dubois & Franois M. Meurgey
  • 2010 Measuring the Externality of Antibacterial Use from Promoting Antimicrobial Resistance
    by Klaus Kaier & Uwe Frank
  • 2010 A Review and Critique of Studies Reporting Utility Values for Schizophrenia-Related Health States
    by Ifigeneia Mavranezouli
  • 2010 Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices
    by Lizheng Shi & Jinan Liu & Yordanka Koleva & Vivian Fonseca & Anupama Kalsekar & Manjiri Pawaskar
  • 2010 The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions: A Critical Appraisal of Recent Methodological Developments
    by Andrea Manca & Mark J. Sculpher & Ron Goeree
  • 2010 The Economics of a 'Liberated' NHS
    by Nancy J. Devlin
  • 2010 Is There a Role for Pharmacoeconomics in Developing Countries?
    by Babar Zaheer-Ud-Din & Shane Scahill
  • 2010 Methods of Model Calibration: Observations from a Mathematical Model of Cervical Cancer
    by Douglas C.A. Taylor & Vivek Pawar & Denise Kruzikas & Kristen E. Gilmore & Ankur Pandya & Rowan Iskandar & Milton C. Weinstein
  • 2010 An Analysis of NICE's 'Restricted' (or 'Optimized') Decisions
    by Phill ONeill & Nancy J. Devlin
  • 2010 Evaluation of Benefit-Risk
    by Silvio Garattini
  • 2010 New Prescription for the Spanish Drug Sector: Fighting against Public Deficit without Wasting Ammunition
    by Fernando Antoanzas & Pedro Gmez
  • 2010 Cost Effectiveness of Imiquimod 5% Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses: A Decision Tree Model
    by Edward C.F. Wilson
  • 2010 Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy
    by Mario Eandi & Lorenzo Pradelli & Sergio Iannazzo & Silvia Chiroli & Giuseppe Pontoriero
  • 2010 Economic Efficiency of Genetic Screening to Inform the Use of Abacavir Sulfate in the Treatment of HIV
    by Teresa L. Kauf & Raymond A. Farkouh & Stephanie R. Earnshaw & Maria E. Watson & Penny Maroudas & Mike G. Chambers
  • 2010 Economic Implications of Sleep Disorders
    by Tracy L. Skaer & David A. Sclar
  • 2010 Cost Effectiveness of Pharmacogenomics: A Critical and Systematic Review
    by William B. Wong & Josh J. Carlson & Rahber Thariani & David L. Veenstra
  • 2010 Generating Evidence for Comparative Effectiveness Research Using More Pragmatic Randomized Controlled Trials
    by C. Daniel. Mullins & Danielle Whicher & Emily S. Reese & Sean Tunis
  • 2010 No Head-to-Head Trial? Simulate the Missing Arms
    by J. Jaime. Caro & K. Jack. Ishak
  • 2010 There's a Reason They Call Them Dummy Variables: A Note on the Use of Structural Equation Techniques in Comparative Effectiveness Research
    by William H. Crown
  • 2010 Comparative Effectiveness Without Head-to-Head Trials: A Method for Matching-Adjusted Indirect Comparisons Applied to Psoriasis Treatment with Adalimumab or Etanercept
    by James E. Signorovitch & Eric Q. Wu & Andrew P. Yu & Charles M. Gerrits & Evan Kantor & Yanjun Bao & Shiraz R. Gupta & Parvez M. Mulani
  • 2010 Managed Care Pharmacy Sees Potential of Comparative Effectiveness Research to Improve Patient Care and Lower Costs
    by Judith Cahill & Neal Learner
  • 2010 Comparative Effectiveness, Personalized Medicine and Innovation: The Path Forward
    by Adrian Thomas & Audrey Phillips & Robert Donnelly & Catherine Tak. Piech
  • 2010 Comparative Effectiveness Research: The View from a Pharmaceutical Company
    by Marc L. Berger & David Grainger
  • 2010 Comparative Effectiveness Research and Personalized Medicine: Catalyzing or Colliding?
    by Robert S. Epstein & J. Russell. Teagarden
  • 2010 Comparative Effectiveness Research and the Psychology of Medical Practice: The Vicissitudes of Knowledge Implementation
    by Jerome P. Kassirer & John B. Wong
  • 2010 Perspective and Desire in Comparative Effectiveness Research: The Relative Unimportance of Mere Preferences, the Central Importance of Context
    by Anthony J. Culyer
  • 2010 Comparative Effectiveness Regulations and Pharmaceutical Innovation
    by John A. Vernon & Joseph H. Golec & J. Stedman. Stevens
  • 2010 Cost-Effectiveness Analysis in Markets with High Fixed Costs
    by David M. Cutler & Keith M. Marzilli. Ericson
  • 2010 Regulatory Benefit-Risk Assessment and Comparative Effectiveness Research: Strangers, Bedfellows or Strange Bedfellows?
    by Louis P. Garrison
  • 2010 The Economics of Comparative Effectiveness Studies: Societal and Private Perspectives and their Implications for Prioritizing Public Investments in Comparative Effectiveness Research
    by David Meltzer & Anirban Basu & Rena Conti
  • 2010 Value-Based Approaches to Healthcare Systems and Pharmacoeconomics Requirements in Asia: South Korea, Taiwan, Thailand and Japan
    by Isao Kamae
  • 2010 International Comparison of Comparative Effectiveness Research in Five Jurisdictions: Insights for the US
    by Adrian R. Levy & Craig Mitton & Karissa M. Johnston & Brian Harrigan & Andrew H. Briggs
  • 2010 Using Comparative Effectiveness Research to Inform Policy and Practice in the UK NHS: Past, Present and Future
    by Kalipso Chalkidou & Tom Walley
  • 2010 Perspectives on Comparative Effectiveness Research: Views from Diverse Constituencies
    by Dave Nellesen & Howard G. Birnbaum & Paul E. Greenberg
  • 2010 Introducing Perspectives on Comparative Effectiveness Research
    by Howard G. Birnbaum & Paul E. Greenberg
  • 2010 Cost Effectiveness of Establishing a Neonatal Screening Programme for Phenylketonuria in Libya
    by Erikas Sladkevicius & Rodney J. Pollitt & Ali Mgadmi & Julian F. Guest
  • 2010 Catastrophic Healthcare Payments and Impoverishment in the Occupied Palestinian Territory
    by Awad Mataria & Firas Raad & Mohammad Abu-Zaineh & Cam Donaldson
  • 2010 The Use of Research Abstracts in Formulary Decision Making by the Joint Oncology Drug Review of Canada
    by Adam V. Weizman & Josh Griesman & Chaim M. Bell
  • 2010 Reducing Uncertainty in Value-Based Pricing Using Evidence Development Agreements: The Case of Continuous Intraduodenal Infusion of Levodopa/Carbidopa (Duodopa) in Sweden
    by Michael Willis & Ulf Persson & York Zoellner & Birgit Gradl
  • 2010 Reforming the English NHS: A Continuing Journey
    by Karen Bloor & Alan Maynard
  • 2010 The Missing Technology: An International Comparison of Human Capital Investment in Healthcare
    by Bianca K. Frogner
  • 2010 Critique of an Economic Evaluation Using the Drummond Checklist
    by Christopher M. Doran
  • 2010 Economic Efficiency of Alcohol Policy
    by Christopher M. Doran & Thameemul A. Jainullabudeen
  • 2010 Issues Surrounding Orphan Disease and Orphan Drug Policies in Europe
    by Alain Denis & Lut Mergaert & Christel Fostier & Irina Cleemput & Steven Simoens
  • 2010 Cost Effectiveness of Long-Acting Risperidone in Sweden
    by Marja Hensen & Bart Heeg & Mickael Lthgren & Ben van Hout
  • 2010 Cost of Illness and Drivers of Cost in Atrial Fibrillation in Sweden and Germany
    by Linus Jnsson & sa Eliasson & John Kindblom & Olle Almgren & Nils Edvardsson
  • 2010 Global Spending on Orphan Drugs in France, Germany, the UK, Italy and Spain during 2007
    by Javier Orofino & Javier Soto & Miguel A. Casado & Itziar Oyagez
  • 2010 Burden and Cost of Hospital Admissions for Vaccine-Preventable Paediatric Pneumococcal Disease and Non-Typable Haemophilus influenzae Otitis Media in New Zealand
    by Richard J. Milne & Stephen Vander Hoorn
  • 2010 Cost Effectiveness of Insulin Glargine plus Oral Antidiabetes Drugs Compared with Premixed Insulin Alone in Patients with Type 2 Diabetes Mellitus in Canada
    by Sandra L. Tunis & Luc Sauriol & Michael E. Minshall
  • 2010 Costs and Consequences of Clopidogrel versus Aspirin for Secondary Prevention of Ischaemic Events in (High-Risk) Atherosclerotic Patients in Sweden: A Lifetime Model Based on the CAPRIE Trial and High-Risk CAPRIE Subpopulations
    by J. Floris S. Logman & Bart M.S. Heeg & Johan Herlitz & Ben A. van Hout
  • 2010 Audit of Diabetes-Dependent Quality of Life (ADDQoL) [Chinese Version for Singapore] Questionnaire: Reliability and Validity among Singaporeans with Type 2 Diabetes Mellitus
    by Swee Sung. Soon & Su Yen. Goh & Yong Mong. Bee & Jiat Ling. Poon & Shu Chuen. Li & Julian Thumboo & Hwee Lin. Wee
  • 2010 The Effect of Protest Zeros on Estimates of Willingness to Pay in Healthcare Contingent Valuation Analysis
    by William M. Fonta & H. Eme. Ichoku & Jane Kabubo-Mariara
  • 2010 Oncologist Preferences for Health States Associated with the Treatment of Advanced Ovarian Cancer
    by Lisa M. Hess & Daniel C. Malone & Grant H. Skrepnek & Pamela G. Reed & Edward Armstrong & Stephen Joel. Coons
  • 2010 Gary Buurman, 1944-2010
    by Stuart Birks
  • 2010 A Systematic Data Review of the Cost of Rehydration Therapy
    by Jay Pershad
  • 2010 Cost Effectiveness of Preventive Screening Programmes for Type 2 Diabetes Mellitus in Germany
    by Thilo M. Schaufler & Malte Wolff
  • 2010 Productivity Loss Resulting from Coronary Heart Disease in Australia
    by Henry Zheng & Fred Ehrlich & Janaki Amin
  • 2010 Healthcare Costs of Atypical Antipsychotic Use for Patients with Bipolar Disorder in a Medicaid Programme
    by Ying Qiu & Alex Z. Fu & Gordon G. Liu & Dale B. Christensen
  • 2010 Public Option and Private Profits: What do Markets Expect?
    by Fabio Milani
  • 2010 Cost Effectiveness of CT Colonography for UK NHS Colorectal Cancer Screening of Asymptomatic Adults Aged 60-69 Years
    by David Lee & Dominic Muston & Alison Sweet & Chris Cunningham & Andrew Slater & Kevin Lock
  • 2010 Willingness to Pay for Maternal Health Outcomes: Are Women Willing to Pay More than Men?
    by Laura Ternent & Paul McNamee & David Newlands & Danielle Belemsaga & Adjima Gbangou & Suzanne Cross
  • 2010 Health System Choice: A Pilot Discrete-Choice Experiment Eliciting the Preferences of British and Australian Citizens
    by Paul A. Scuffham & Jennifer A. Whitty & Matthew Taylor & Ruth C. Saxby
  • 2010 Do Reduced Inpatient Costs Associated with Highly Active Antiretroviral Therapy (HAART) Balance the Overall Cost for HIV Treatment?
    by Paul G. Farnham
  • 2010 Cost-Effectiveness Analysis of Treatments for Premenstrual Dysphoric Disorder
    by Regina Rendas-Baum & Min Yang & Joseph Gricar & Gene V. Wallenstein
  • 2010 Organization and Estimated Patient-Borne Costs of Oral Anticoagulation Therapy in Italy: Results from a Survey
    by Lorenzo Pradelli & Sergio Iannazzo & Orietta Zaniolo & Paola Botrugno
  • 2010 Outpatient Medication Costs of Patients with Cystic Fibrosis in Germany
    by Daniela Eidt-Koch & Thomas O.F. Wagner & Thomas Mittendorf & J.-Matthias Graf von der Schulenburg
  • 2010 The Authors' Reply
    by George Dranitsaris & Sanjay Mehta
  • 2010 Ongoing Pharmaceutical Reforms in France: Implications for Key Stakeholder Groups
    by Catherine Sermet & Veronique Andrieu & Brian Godman & Eric Van Ganse & Alan Haycox & Jean-Pierre Reynier
  • 2010 Oral Therapies for the Treatment of Pulmonary Arterial Hypertension: a Population-Based Cost-Minimization Analysis
    by Marie-Claude Lefebvre & Elke Hunsche
  • 2010 Healthcare Costs in Renal Transplant Recipients Using Branded versus Generic Ciclosporin
    by J. Harold. Helderman & Ning Kang & Antonio P. Legorreta & Judy Y. Chen
  • 2010 Inpatient Costs of Endophthalmitis Evaluated for the Whole of France
    by Xavier Colin & Gilles Berdeaux & Antoine Lafuma & Annie Salvanet-Bouchara & Laurent Kodjikian
  • 2010 Analytical Strategies for Characterizing Chemotherapy Diffusion with Patient-Level Population-Based Data
    by Cami S. Sima & Katherine S. Panageas & Glenn Heller & Deborah Schrag
  • 2010 Is the Societal Approach Wide Enough to Include Relatives?: Incorporating Relatives' Costs and Effects in a Cost-Effectiveness Analysis
    by Thomas Davidson & Lars-ke Levin
  • 2010 Considering the Value Associated with Innovation in Health Technology Appraisal Decisions (Deliberations): A NICE Thing to do?
    by Colin Green
  • 2010 Export Performance, Labor Standards and Institutions: Evidence from a Dynamic Panel Data Model
    by Michaël Bonnal
  • 2010 Autocorrelation, return horizons, and momentum in stock returns
    by Ming-Shiun Pan
  • 2010 The Importance of Internal Audit in Primary and Secondary Education
    by Grejdan Gabriela Elena & Joldos Ana Maria & Pintilie Corneliu
  • 2010 Not just guidelines: Pirate codes and the emergence of property rights in The Invisible Hook
    by Charles North
  • 2010 The importance of knowledge on the evaluation criteria in university scientific research projects
    by Cristian Marius Toma
  • 2010 The correlation between the development of human resource in education and the Romanian economy
    by Daniela-Roxana Pintilie & Ciprian-Constantin Pintilie & Andreea-Monica Chelu
  • 2010 Social Responsibility At The Academic Level. Study Case: The University Of Bucharest
    by Paul Marinescu & Sorin-George Toma & Ionut Constantin
  • 2010 Management immunodeficiency from preuniversity educational system
    by Lucica Cristea (Mitican)
  • 2009 The Impact of the Flat Tax Reform on Inequality: The Case of Romania
    by Flaviu Mihaescu & Liviu Voinea
  • 2009 School Feeding Programs and th e Nutrition of Siblings: Evidence from a Randomized Trial in Rural Burkina Faso
    by Harounan Kazianga & Damien de Walque & Harold Alderman
  • 2009 School Evaluation: Current Practices in OECD Countries and a Literature Review
    by Violaine Faubert
  • 2009 Baby FACES: Exit Interview Spring 2009/Fall 2010 Documentation with Variable Names
    by Mathematica Policy Research
  • 2009 Baby FACES: Parent Interview 2009 Data Collection
    by Mathematica Policy Research
  • 2009 The Social Security Administration's Youth Transition Demonstration Projects: Analysis Plan for Interim Reports
    by Anu Rangarajan & Debbie Reed & Arif Mamun & John Martinez & Thomas Fraker
  • 2009 Summary: Pay-For-Performance
    by Mathematica Policy Research staff
  • 2009 Achievement Effects of Four Early Elementary School Math Curricula: Findings from First Graders in 39 Schools
    by Roberto Agodini & Barbara Harris & Sally Atkins-Burnett & Sheila Heaviside & Timothy Novak & Robert Murphy
  • 2009 Baby FACES Parent Interview 2009 Data Collection
    by Mathematica Policy Research staff
  • 2009 Evaluation of Care and Disease Management Under Medicare Advantage: Final Report
    by Lisa Green & Julia Doherty & Judy Goldbert Dey & Elizabeth Pietrafesa & Emily Dwoyer
  • 2009 Part B Drug Payment Reform: Lower Expenditures Without Signs of Adverse Effects
    by Jeffrey Ballou & Arnold Chen & Valerie Cheh & Deo Bencio & Bonnie Hart & Joshua Parks & John Hall
  • 2009 Analysis of Medical Expenditures and Service Use of Medicaid Buy-In Participants, 2002-2005
    by Gilbert Gimm & Kristin L. Andrews & Jody Schimmel & Henry T. Ireys & Su Liu
  • 2009 Do Charter Schools 'Cream Skim' Students and Increase Racial-Ethnic Segregation?
    by Ron Zimmer & Brian Gill & Kevin Booker & Stephane Lavertu & John Witte
  • 2009 Overall Approach for the EBHV Cross-Site Evaluation
    by Kim Boller & Heather Koball
  • 2009 Effectiveness of Reading and Math Software Products: Findings from the National Evaluation
    by Mark Dynarski
  • 2009 The Multiple Comparisons Problem in IES Impact Evaluations: Guidelines and Applications
    by Peter Z. Schochet & John Deke
  • 2009 Comprehensive Teacher Induction: Year 1 Impact Findings from an RCT
    by Steven Glazerman & Sarah Dolfin & Martha Bleeker & Amy Johnson & Eric Isenberg & Julieta Lugo-Gil & Mary Grider & Edward Britton
  • 2009 Effectiveness of Selected Supplemental Reading Comprehension Interventions: Impacts on a First Cohort of Fifth-Grade Students
    by Susanne James-Burdumy
  • 2009 Effects of Software Products: Findings from the National Evaluation
    by Mark Dynarski
  • 2009 Evaluation of Teachers Trained Through Different Routes to Certification
    by Jill Constantine
  • 2009 Achievement Effects of Four Early Elementary School Math Curricula: Findings from First Graders in 39 Schools
    by Roberto Agodini
  • 2009 Home Visit Observation Booklet (HOVRS-A): Baby FACES Spring 2010
    by Kimberly Boller & Cheri Vogel & Rhoda Cohen & Niki Aikens & Kristin Hallgren
  • 2009 Shared Decision-Making in Practice: Lessons from Implementation Efforts
    by Margaret Gerteis & Rosemary Borck
  • 2009 An Exploratory Analysis of the Relationship Between Psychiatric Nurses' Perceptions of Workload and Unit Activity
    by Angela M. Gerolamo
  • 2009 HIV/AIDS and Fertility
    by Jane G. Fortson
  • 2009 TANF Recipients Living with a Disability: Policy Framework, Prevalence, and Service Strategies
    by LaDonna Pavetti
  • 2009 From National Disability Data Disorder to National Disability Data System?
    by David Stapleton
  • 2009 Money Follows the Person (MFP) Demonstration: State Program Goals, Features, and Implementation Progress
    by Debra J. Lipson & Noelle Denny-Brown & Susan R. Williams
  • 2009 Money Follows the Person (MFP): Opportunities for Long-Term Care (LTC) Systems
    by Carol Irvin & Jeffrey Ballou & Audra Wenzlow
  • 2009 Poverty and Hardship Among Working-Age People with Disabilities
    by Gina Livermore
  • 2009 Substitutability Across Institutional Post-Acute Care Settings: 1998-2006
    by Robert Schmitz & Samuel Simon
  • 2009 Review of SoonerCare Behavioral Health Services
    by Melanie Au & James Verdier
  • 2009 A Government Performance and Results Act (GPRA) Report: The Status of the Medicaid Infrastructure Grants Program as of 12/31/08
    by Sarah Croake & Su Liu
  • 2009 National Beneficiary Survey: Round 2 Public Use File Codebook
    by Debra Wright & Shilpa Khambhati & Beatrice Jones
  • 2009 National Beneficiary Survey Round 1: Public Use Data Files
    by Debra Wright & Shilpa Khambhati & Beatrice Jones
  • 2009 National Beneficiary Survey Round 1: Public Use File Codebook
    by Debra Wright & Shilpa Khambhati & Beatrice Jones
  • 2009 An Approach for Addressing the Multiple Testing Problem in Social Policy Impact Evaluations
    by Peter Z. Schochet
  • 2009 College Experiences Survey: Methodological Summary
    by David DesRoches & John Hall & Betsy Santos
  • 2009 Analyzing the Effects of Data Collection Mode Change in the 2003 National Survey of Recent College Graduates (NSRCG)
    by Donsig Jang & Zhanyun Zhao & Kelly H. Kang
  • 2009 Cross-Site Evaluation of the Supporting Evidence-Based Home Visiting Grantees: Summary of the Planning Year
    by Patricia Del Grosso & Deborah Daro
  • 2009 Cross-Site Evaluation of the Supporting Evidence-Based Home Visiting Grantee Cluster: Evaluation Design. Volume 1
    by Heather Koball & Heather Zaveri & Kimberly Boller & Deborah Daro & Jean Knab & Diane Paulsell & Margaret Hargreaves & Debra A. Strong & Lizabeth Malone & Patricia Del Grosso & Yange Xue
  • 2009 Supporting Evidence-Based Home Visiting to Prevent Child Maltreatment: Overview of the Cross-Site Evaluation
    by Heather Koball & Heather Zaveri & Kimberly Boller & Deborah Daro & Jean Knab & Diane Paulsell & Margaret Hargreaves & Debra A. Strong & Lizabeth Malone & Patricia Del Grosso & Yange Xue
  • 2009 Promising Results from the Medicare Chronic Care Practice Research Network Analysis
    by Debbie Peikes & Greg Peterson & Randall Brown
  • 2009 Effective Care Coordination. Coordinating Care for Adults with Multiple Chronic Illnesses: Searching for the Holy Grail
    by Randall Brown
  • 2009 Effective Care Coordination: The Hard Evidence from the Field
    by Randall Brown
  • 2009 The Promise of Care Coordination: Models That Decrease Hospitalizations and Improve Outcomes for Beneficiaries with Chronic Illnesses
    by Randall Brown & Deborah Peikes & Greg Peterson & Jennifer Schore
  • 2009 Analysis of Transition Events in Health Insurance Coverage
    by John L. Czajka & James Mabli
  • 2009 Case Study of North Carolina: Exploring Medicaid and SCHIP Enrollment Trends and Their Links to Policy and Practice
    by Christopher Trenholm & Embry Howell & Brigette Courtot
  • 2009 Promising Models of Care Coordination in Medicare: Lessons for Medicaid Beneficiaries with Chronic Illnesses
    by Deborah Peikes & Randall Brown & Greg Peterson & Jennifer Schore
  • 2009 Lessons from the Medicare Coordinated Care Demonstration and Other Studies on Coordinating Care for People with Disabilities
    by Deborah Peikes & Randall Brown
  • 2009 The Promise of Care Coordination: Models that Decrease Hospitalizations and Improve Outcomes for Medicare Beneficiaries with Chronic Illnesses
    by Deborah Peikes & Randall Brown & Greg Peterson & Jennifer Schore
  • 2009 State Variation in Out-of-Home Medicaid Mental Health Services for Children and Youth: An Examination of Residential Treatment and Inpatient Hospital Services
    by Jonathan Brown & Brenda Natzke & Henry Ireys & Matthew Gillingham & Morris Hamilton
  • 2009 Temporal Trends in Anti-Diabetes Drug Use in TRICARE Following Safety Warnings in 2007 About Rosiglitazone
    by Kate A. Stewart & Brenda M. Natzke & Thomas V. Williams & Elder Granger & S. Ward Casscells & Thomas W. Croghan
  • 2009 Employer-Sponsored Insurance, Health Care Cost Growth, and the Economic Performance of U.S. Industries
    by Neeraj Sood & Arkadipta Ghosh & José J. Escarce
  • 2009 Survey of Outcomes Measurement in Research on Character Education Programs
    by Ann E. Person & Emily Moiduddin & Megan Hague-Angus & Lizabeth M. Malone
  • 2009 Features of Successful Care Coordination Programs
    by Randy Brown & Debbie Peikes & Greg Peterson
  • 2009 Antidepressant Use in a Nationally Representative Sample of Community-Dwelling US Latinos With and Without Depressive and Anxiety Disorders
    by H.M. González & W. Tarraf & B.T. West & T.W. Croghan & M.E. Bowen & Z. Cao & M. Alegria
  • 2009 Understanding Two Categories of TANF Spending: 'Other' and 'Authorized Under Prior Law'
    by Michelle K. Derr & Tara Anderson & LaDonna Pavetti & Elizabeth Scott
  • 2009 Doubling Down: Reforming Retirement and Disability Policy at the Same Time
    by David Stapleton
  • 2009 Understanding Temporary Assistance for Needy Families Caseloads After Passage of the Deficit Reduction Act of 2005
    by LaDonna Pavetti & Linda Rosenberg & Michelle K. Derr
  • 2009 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for November 2009
    by Stephanie Peterson & Marsha Gold
  • 2009 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for October 2009
    by Stephanie Peterson & Marsha Gold
  • 2009 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for September 2009
    by Stephanie Peterson & Marsha Gold
  • 2009 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for August 2009
    by Stephanie Peterson & Marsha Gold
  • 2009 The Demonstration to Maintain Independence and Employment: Implications for National Health Care Reform
    by Noelle Denny-Brown & Boyd Gilman & Gilbert Gimm & Henry Ireys & Sarah Croake
  • 2009 Toward Understanding EHR Use in Small Physician Practices
    by Suzanne Felt-Lisk & Lorraine Johnson & Christopher Fleming & Rachel Shapiro & Brenda Natzke
  • 2009 Practical Lessons for Health Reform from the Military Health System
    by Thomas Croghan & Kristen Purcell & Kate Stewart
  • 2009 Implementation of Mental Health Parity: Lessons from California
    by Margo L. Rosenbach & Timothy K. Lake & Susan R. Williams & Jeffrey A. Buck. Reprinted with permission from Psychiatric Services (Copyright 2009). American Psychiatric Association
  • 2009 Good Things Come in Small Packages: Lessons Learned from the Ohio High School Transformation Initiative
    by Sarah Jones & Monica Martinez & Cindy Cai
  • 2009 Recommendations of the Special Commission on the Health Care Payment System
    by Analytics & research provided by Mathematica Policy Research
  • 2009 Recommendations of the Special Commission on the Health Care Payment System
    by Analytics & research provided by Mathematica Policy Research
  • 2009 Employer Demand for Health Services Researchers in the Year 2020
    by Craig Thornton & Jonathan D. Brown
  • 2009 Early Implementation Experiences of State MFP Programs
    by Noelle Denny-Brown & Debra J. Lipson
  • 2009 Overview of Global Budgets
    by Deborah Chollet
  • 2009 Overview of Global Payment
    by Deborah Chollet
  • 2009 Pay for Performance: Lessons from Experience
    by Suzanne Felt-Lisk
  • 2009 Payment Models and Benefit Design
    by Deborah Chollet
  • 2009 Overview of Payment Models
    by Deborah Chollet
  • 2009 Using State Tests in Education Experiments: A Discussion of the Issues
    by Henry May & Irma Perez-Johnson & Joshua Haimson & Samina Sattar & Phil Gleason
  • 2009 Plan Availability and Premiums
    by Marsha Gold & Dawn Phelps & Tricia Neuman & Gretchen Jacobson
  • 2009 Enhanced Primary Care Case Management Programs in Medicaid: Issues and Options for States
    by James M. Verdier
  • 2009 Pediatric Primary Care as a Component of Systems of Care
    by Jonathan D. Brown
  • 2009 Leadership Team Member Organizations and Coalition Structures: Aggregate Findings from the Leadership Team Network Survey
    by Todd Honeycutt & Jung Kim & Debra A. Strong & Judith Wooldridge
  • 2009 Building Advocacy Capacity: Where Grantees Started
    by Jung Kim & Debra A. Strong & Judith Wooldridge & Margaret Gerteis
  • 2009 Will Health Care Reform Increase the Employment of People with Disabilities?
    by David Stapleton & Su Liu
  • 2009 Is It Time to Establish a National Disability Data System?
    by David C. Stapleton & Craig Thornton
  • 2009 State Policymaker Views on the Role of Consumer Advocacy Groups in Health Coverage Policy Development: Summary of Findings
    by Debra J. Lipson & Subuhi Asheer
  • 2009 Analysis of Medical Expenditures and Service Use of Medicaid Buy-In Participants, 2002-2005
    by Gilbert Gimm & Kristin L. Andrews & Jody Schimmel & Henry T. Ireys & Su Liu
  • 2009 Family Structure, Childbearing, and Parental Employment: Implications for the Level and Trend in Poverty
    by Marla Cancian & Deborah Reed
  • 2009 Measuring School and Teacher Effectiveness in the EPIC Charter School Consortium: Year 2
    by Liz Potamites & Kevin Booker & Duncan Chaplin & Eric Isenberg
  • 2009 Measuring School Effectiveness in Memphis: Year 2
    by Liz Potamites & Duncan Chaplin & Eric Isenberg & Kevin Booker
  • 2009 The Effect of Interview Experience on Follow-Up Response Propensity in a Longitudinal Survey
    by Matt Sloan & Debra Wright
  • 2009 Do Typical RCTs of Education Interventions Have Sufficient Statistical Power for Linking Impacts on Teacher Practice and Student Achievement Outcomes?
    by Peter Z. Schochet
  • 2009 Community Participation in Health Initiatives for Marginalized Populations
    by Celia Larson & David Schlundt & Kushal Patel & Irwin Goldzweig & Margaret Hargreaves
  • 2009 Relationship Between Alcohol Use and Violent Behavior Among Urban African American Youths from Adolescence to Emerging Adulthood: A Longitudinal Study
    by Yange Xue & Marc A. Zimmerman & Rebecca Cunningham
  • 2009 Racial/Ethnic and Socioeconomic Disparities in Access to Care and Quality of Care for U.S. Health Center Patients Compared with Non-Health Center Patients
    by Leiyu Shi & Jenna Tsai & Patricia Collins Higgins & Lydie A. Lebrun
  • 2009 Dental Care Coverage Transitions
    by Richard J. Manski & John F. Moeller & Haiyan Chen & Patricia A. St Clair & Jody Schimmel & Larry S. Magder & John V. Pepper
  • 2009 Tracking Medicare Health and Prescription Drug Plans Monthly Report for July 2009
    by Stephanie Peterson & Marsha Gold
  • 2009 Key Findings and Implications from the Universal Preschool Child Outcomes Study (UPCOS), 2007-2008
    by First 5 LA & Mathematica Policy Research
  • 2009 What Happens to Medicaid Buy-In Participants After They Leave the Program?
    by Su Liu & Silvie Colman
  • 2009 Findings from a Study of the SSI/SSDI Outreach, Access, and Recovery (SOAR) Initiative
    by Jacqueline Kauff & Jonathan Brown & Norma Altshuler & Noelle Denny-Brown & Emily Sama Martin
  • 2009 Evaluating Systems Change Efforts to Support Evidence-Based Home Visiting: Concepts and Methods
    by Margaret Hargreaves & Diane Paulsell
  • 2009 Technical Methods Report: The Estimation of Average Treatment Effects for Clustered RCTs of Education Interventions
    by Peter Z. Schochet
  • 2009 Medicare Governance and Provider Payment Policy
    by Hoangmai H. Pham & Paul B. Ginsburg & James M. Verdier
  • 2009 Enhanced Primary Care Case Management Programs in Medicaid: Issues and Options for States
    by James M. Verdier & Vivian Byrd & Christal Stone
  • 2009 A Review of Recent Evaluation Efforts Associated with Programs and Policies Designed to Promote the Employment of Adults with Disabilities
    by Gina A. Livermore & Nanette Goodman
  • 2009 Impacts of Comprehensive Teacher Induction: Results from the Second Year of a Randomized Controlled Study
    by Eric Isenberg & Steven Glazerman & Martha Bleeker & Amy Johnson & Julieta Lugo-Gil & Mary Grider & Sarah Dolfin & Edward Britton
  • 2009 How Accountability Pressure on Failing Schools Affects Student Achievement
    by Hanley Chiang
  • 2009 Evaluation of Mountain Health Choices: Implementation, Challenges, and Recommendations
    by Michael Hendryx & Carol Irvin & James Mulligan & Sally Richardson & Johnna S. Beane & Margo Rosenbach
  • 2009 ABCTE Teachers in Florida and Their Effect on Student Performance
    by Christina Clark Tuttle & Tara Anderson & Steven Glazerman
  • 2009 An Exploratory Analysis of Adequate Yearly Progress, Identification for Improvement, and Student Achievement in Two States and Three Cities
    by Brian Gill & J.R. Lockwood III & Francisco Martorell & Claude Messan Setodji & Kevin Booker
  • 2009 Does the Missouri Teacher Career Ladder Program Raise Student Achievement?
    by Kevin Booker & Steven Glazerman
  • 2009 Teacher Bonuses for Extra Work: A Profile of Missouri's Career Ladder Program
    by Timothy Silman & Steven Glazerman
  • 2009 Effects of the Missouri Career Ladder Program on Teacher Mobility
    by Kevin Booker & Steven Glazerman
  • 2009 Aspects of Health Reform: Contributions from the Economic Research Initiative on the Uninsured
    by Catherine McLaughlin & Helen Levy & Brian Quinn
  • 2009 TANF Recipients Living with a Disability: Policy Framework, Prevalence, and Service Strategies
    by Donna Pavetti
  • 2009 Reducing Racial and Ethnic Disparities in Health Care: Partnerships Between Employers and Health Plans
    by Patricia Collins Higgins & Melanie Au & Erin Fries Taylor
  • 2009 Sanctions and Time Limits in California's Welfare Program
    by Caroline Danielson & Deborah Reed & Qian Li & Jay Liao
  • 2009 Sanctions and Time Limits in California's Welfare Program
    by Caroline Danielson & Deborah Reed & Qian Li & Jay Liao
  • 2009 The Children of LAUP: Executive Summary of the First 5 LA Universal Preschool Child Outcomes Study
    by John M. Love & Sally Atkins-Burnett & Cheri Vogel
  • 2009 Los Angeles Universal Preschool Programs, Children Served, and Children's Progress in the Preschool Year: Final Report of the First 5 LA Universal Preschool Child Outcomes Study
    by John M. Love & Sally Atkins-Burnett & Cheri Vogel & Nikki Aikens & Yange Xue & Maricar Mabutas & Barbara Lepidus Carlson & Emily Sama Martin & Nora Paxton & Margaret Caspe & Susan Sprachman & Kathy Sonnenfeld
  • 2009 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for June 2009
    by Stephanie Peterson & Marsha Gold
  • 2009 Providing Supports to Youth with Disabilities Transitioning to Adulthood: Case Descriptions from the Youth Transition Demonstration
    by Richard G. Luecking & David Wittenburg
  • 2009 The Social Security Administration's Youth Transition Demonstration Projects
    by Thomas Fraker & Anu Rangarajan
  • 2009 Changing Circumstances: Experiences of Child SSI Recipients Before and After Their Age-18 Redetermination for Adult Benefits
    by Jeffrey Hemmeter & Jacqueline Kauff & David Wittenburg
  • 2009 Unmet Health Care Needs and Medical Out-of-Pocket Expenses of SSI Children
    by Anne DeCesaro & Jeffrey Hemmeter
  • 2009 Family Caregiving and Employment Among Parents of Children with Disabilities on SSI
    by Kalman Rupp & Steve Ressler
  • 2009 A Life-Cycle Perspective on the Transition to Adulthood Among Children Receiving Supplemental Security Income Payments
    by Paul S. Davies & Kalman Rupp & David Wittenburg
  • 2009 Patterns of Hospital Performance in Acute Myocardial Infarction and Heart Failure 30-Day Mortality and Readmission
    by Harlan M. Krumholz & Angela R. Merrill & Eric M. Schone & Geoffrey C. Schreiner & Jersey Chen & Elizabeth H. Bradley & Yun Wang & Yongfei Wang & Zhenqiu Lin & Barry M. Straube & Michael T. Rapp & Sharon-Lise T. Normand & Elizabeth E. Drye
  • 2009 Pathways to the Use of Health Services Research in Policy
    by Marsha Gold
  • 2009 Characteristics, Access, Utilization, Satisfaction, and Outcomes of Healthy Start Participants in Eight Sites
    by Margo Rosenbach & So O'Neil & Benjamin Cook & Lisa Trebino & Deborah Klein Walker
  • 2009 Final Evaluation Report: Best Practices for Enrolling Low-Income Beneficiaries into the Medicare Prescription Drug Benefit Program
    by Mary Laschober & Jung Yee Kim
  • 2009 Racial and Ethnic Health Disparities in TRICARE
    by Ann D. Bagchi & Eric Schone & Patricia Higgins & Elder Granger & S. Ward Casscells & Thomas Croghan
  • 2009 Medicaid Beneficiaries with Congestive Heart Failure: Association of Medication Adherence with Healthcare Use and Costs
    by Dominick Esposito & Ann D. Bagchi & James M. Verdier & Deo S. Bencio & Myoung S. Kim
  • 2009 Maximizing the Value of Philanthropic Efforts Through Planned Partnerships Between the U.S. Government and Private Foundations
    by Ann E. Person & Debra A. Strong & Joshua Furgeson & Jillian A. Berk
  • 2009 Teaching Self-Sufficiency Through Home Visitation and Life Skills Education
    by Alicia Meckstroth & rew Burwick & Quinn Moore & Michael Ponza
  • 2009 Synthesis of 10 Case Studies: Exploring Medicaid and SCHIP Enrollment Trends and Their Links to Policy and Practice
    by Judith Wooldridge & Christopher Trenholm & Angela Gerolamo
  • 2009 Implications of State Program Features for Attaining MFP Transition Goals
    by Debra J. Lipson & Susan R. Williams
  • 2009 Income and Poverty in 2002: The View from Five Surveys
    by John L. Czajka
  • 2009 Racial and Ethnic Disparities in Children's Health Care in the Military Health System
    by Kate Stewart & Patricia Collins Higgins & Catherine McLaughlin & Tom Croghan & Tom Williams & Elder Granger & S. Ward Casscells
  • 2009 What Physicians Think About Resource Use Reports
    by Sunyna S. Williams & Margaret Gerteis & Mary A. Laschober & Myles Maxfield
  • 2009 Looking Behind the Numbers: Patient Experiences in the Military Health System
    by Kristen Purcell & Rhoda Cohen & Eric Zeidman & Thomas Williams
  • 2009 Characteristics of High-Impact Investigator-Initiated Research: Results from Selected Case Studies
    by Tim Lake & Tara Krissik & Kate Stewart & Marsha Gold
  • 2009 Racial and Ethnic Health Disparities in TRICARE
    by Ann D. Bagchi & Eric Schone & Patricia Collins Higgins & Elder Granger & S. Ward Casscells & Thomas Croghan
  • 2009 An Assessment of the Impact of an Educational Pharmacy Management Intervention on Prescribers to Medicaid Beneficiaries
    by Dominick Esposito & James M. Verdier
  • 2009 Investigator-Initiated Health Services Research Funded by AHRQ: Results from a 2008 Survey of Principal Investigators on Goals, Dissemination Strategies, and Impacts
    by Kate Stewart & Tim Lake & Marsha Gold
  • 2009 Emerging Federal and State Activities Related to the Collection of Data to Measure Racial and Ethnic Health Disparities
    by Patricia Collins Higgins & Erin Fries Taylor
  • 2009 A Viable Alternative to Private Managed Care Models in Medicaid: Performance of Oklahoma's Primary Care Case Management Program in Controlling Preventable Hospitalizations
    by Margaret Colby & Sam Simon & James Verdier
  • 2009 Emerging National and State Activities on Language Services in Health Care
    by Melanie Au & Erin Fries Taylor & Marsha Gold
  • 2009 Factors Influencing EHR Use in Small Physician Practices: Case Studies in Four States
    by Sue Felt-Lisk & Christopher Fleming & Rachel Shapiro & Brenda Natzke & Lorraine Johnson
  • 2009 Medicare Advantage (MA) Within a Strengthened Medicare Program
    by Marsha Gold
  • 2009 Pathways to Using Health Services Research (HSR) in Policymaking: Lessons for Getting Beyond the Black Box
    by Marsha Gold
  • 2009 Best Practices in Public Health Systems Research: Resources and Gaps in Administrative Data to Identify Relevant Population Health Outcomes
    by Marsha Gold
  • 2009 Healthy People (HP) 2010 Disparity Elimination Goals: Case Studies of State Efforts
    by Marsha Gold
  • 2009 Medicare Advantage (MA) Benefit Design and Beneficiary Choice
    by Marsha Gold
  • 2009 How Many Nursing Home Residents Live with a Mental Illness?
    by Ann D. Bagchi & James M. Verdier & Samuel E. Simon
  • 2009 Minors' Behavioral Responses to Parental Involvement Laws: Delaying Abortion Until Age 18
    by Silvie Colman & Ted Joyce
  • 2009 Using Payment Incentives to Improve Care for the Chronically Ill in Medicare: First Year Implementation of the Medicare Care Management Performance Demonstration (MCMP)
    by Suzanne Felt-Lisk & Christopher Fleming & Brenda Natzke & Rachel Shapiro
  • 2009 Health Information Exchange: The Role of Safety-Net Providers
    by Suzanne Felt-Lisk & Melanie Au & Patricia Higgins
  • 2009 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for May 2009
    by Stephanie Peterson & Marsha Gold
  • 2009 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for April 2009
    by Stephanie Peterson & Marsha Gold
  • 2009 Considering a Health Insurance Exchange: Lessons from the Rhode Island Experience
    by Deb Faulkner & Amy Lischko & Deborah Chollet
  • 2009 Technical Methods Report: Estimation and Identification of the Complier Average Causal Effect Parameter in Education RCTs
    by Peter Z. Schochet & Hanley Chiang
  • 2009 Chartbook: Medicaid Pharmacy Benefit Use and Reimbursement in 2005
    by Ann Bagchi & James Verdier & Dominick Esposito
  • 2009 Enhancing Medicaid Primary Care Case Management to Improve Care Management and Accountability
    by James M. Verdier
  • 2009 Is It Time to Establish a National Disability Data System?
    by David Stapleton & Craig Thornton
  • 2009 Is It Time to Establish a National Disability Data System?
    by David Stapleton & Craig Thornton
  • 2009 Treatment Approach and HbA1c Control Among US Adults with Type 2 Diabetes: NHANES 1999-2004
    by Allison Hedley Dodd & Margaret S. Colby & Kristina S. Boye & Cheryl Fahlman & Sunny Kim & Ronette R. Briefel
  • 2009 Measuring Racial and Ethnic Disparities in Health Care: Efforts to Improve Data Collection
    by Patricia Collins Higgins & Erin Fries Taylor
  • 2009 Counting Working-Age People with Disabilities: What Current Data Tell Us and Options for Improvement
    by Kalamazoo & MI: W.E. Upjohn Institute & rew J. Houtenville & David C. Stapleton & Robert R. Weathers II & Richard V. Burkhauser & editors
  • 2009 Health Insurance and Health Care Access Before and After SSDI Entry
    by Gina Livermore & David Stapleton & Henry Claypool
  • 2009 Rigorous Evaluation of Roads to Success: Design Report
    by Duncan Chaplin & Martha Bleeker & Claire Smither
  • 2009 The National Health Plan Collaborative: Overview of Its Origins, Accomplishments, and Lessons Learned
    by Erin Fries Taylor & Marsha Gold
  • 2009 Characteristics, Employment, and Sources of Support Among Working-Age SSI and DI Beneficiaries
    by Gina Livermore & David Stapleton & Allison Roche
  • 2009 Process Evaluation of the Work Incentives Planning and Assistance Program
    by Bonnie O'Day & Allison Roche & Norma Altshuler & Liz Clary & Krista Harrison
  • 2009 Experience Corps: Effects on Student Reading
    by Nancy Morrow-Howell & Stacey McCrary & YungSoo Lee & Ed Spitznagel & Melissa Jonson-Reid
  • 2009 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for March 2009
    by Stephanie Peterson & Marsha Gold
  • 2009 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for February 2009
    by Stephanie Peterson & Marsha Gold
  • 2009 Experiences of Child Supplemental Security Income (SSI) Recipients Around Their Age 18 Redetermination
    by David Wittenburg & Jeffrey Hemmeter & Jacqueline Kauff
  • 2009 An Evaluation of the Teacher Advancement Program (TAP) in Chicago: Year One Impact Report
    by Steven Glazerman & Allison McKie & Nancy Carey
  • 2009 Ticket to Work (TTW) at the Crossroads: A Solid Foundation with an Uncertain Future (as of June 2008)
    by David Stapleton & Gina Livermore
  • 2009 Interim Report on the Demonstration to Maintain Independence and Employment
    by Gilbert Gimm & Noelle Denny-Brown & Boyd Gilman & Henry T. Ireys & Tara Anderson
  • 2009 An Illustrative Analysis of Medicare Options Compare: What's There and What's Not?
    by Marsha Gold
  • 2009 Employment Support for the Transition to Retirement: Can a New Program Help Older Workers Work Longer and Protect Those Who Cannot?
    by David Stapleton
  • 2009 Employment Support for the Transition to Retirement: Can a New Program Help Older Workers Continue to Work and Protect Those Who Cannot?
    by David C. Stapleton
  • 2009 Profile of Children Entering Los Angeles Universal Preschool (LAUP), Fall 2007
    by This research brief describes the work done for First 5 LA by Mathematica Policy Research & its subcontractors & Juárez and Associates & American Institutes for Research & to conduct the First 5 LA/LAUP Universal Preschool Child Outcomes study.
  • 2009 Costs to Medicare of the IDEATel Home Telemedicine Demonstration: Findings from an Independent Evaluation
    by Lorenzo Moreno & Stacy B. Dale & Arnold Y. Chen & Carol A. Magee
  • 2009 Evaluation of Experience Corps: Student Reading Outcomes
    by Nancy Morrow-Howell & Melissa Jonson-Reid & Stacey McCrary & YungSoo Lee & Ed Spitznagel & Emily Dwoyer & Kathy Sonnenfeld & Susan Sprachman
  • 2009 Improving Access to Language Services in Health Care: A Look at National and State Efforts
    by Melanie Au & Erin Fries Taylor & Marsha Gold
  • 2009 Marriage and Relationship Skills Education as a Way to Prepare Prisoners for Reintegration
    by M. Robin Dion & Timothy Silman & Debra A. Strong & Betsy Santos
  • 2009 Effectiveness of Selected Supplemental Reading Comprehension Interventions: Impacts on a First Cohort of Fifth-Grade Students
    by Susanne James-Burdumy & Wendy Mansfield & John Deke & Nancy Carey & Julieta Lugo-Gil & Alan Hershey & Aaron Douglas & Russell Gersten & Rebecca Newman-Gonchar & Joseph Dimino & Bonnie Faddis & Janice Dole
  • 2009 2008 Principal/Vice Principal Survey Results for Evaluation of the Effective Practice Incentive Community (EPIC)
    by Duncan Chaplin & Hanley Chiang & Margaret Sullivan & Virginia Knechtel & Dominic Harris & Shinu Verghese & Kathy Sonnenfeld & Barbara Kennen & John Hall
  • 2009 The Effects of State Policy Decisions on the Employment and Earnings of Medicaid Buy-In Participants in 2006
    by Henry T. Ireys & Gilbert Gimm & Su Liu
  • 2009 Costs and Benefits of Eliminating the Medicare Waiting Period for SSDI Beneficiaries
    by Gina Livermore & David Stapleton & Henry Claypool
  • 2009 Transforming Disability Policy for Youth and Young Adults with Disabilities
    by Bonnie O'Day & David Stapleton
  • 2009 Baseline Statistics for Evaluation of the Effective Practice Incentive Community (EPIC)
    by Scott Cody & Alison Wellington & Margaret Sullivan & Virginia Knechtel & Duncan Chaplin
  • 2009 Design of the Evaluation of the Effective Practice Incentive Community (EPIC) Initiative
    by Scott Cody & Alison Wellington & Duncan Chaplin
  • 2009 Charter Schools in Eight States: Effects on Achievement, Attainment, Integration, and Competition
    by Ron Zimmer & Brian Gill & Kevin Booker & Stephane Lavertu & Tim Sass & John Witte
  • 2009 Medicare Advantage Benefit Design: What Does It Provide, What Doesn't It Provide, and Should Standards Apply?
    by Marsha Gold & Maria Cupples Hudson
  • 2009 State Policies to Encourage High-Deductible and Limited-Benefit Health Plans: Costs, Constituents, and Concerns
    by Lynn Quincy
  • 2009 Tracking Medicare Health and Prescription Drug Plans Monthly Report for January 2009
    by Stephanie Peterson & Marsha Gold
  • 2009 Achievement Effects of Four Early Elementary School Math Curricula: Findings from First Graders in 39 Schools
    by Roberto Agodini & Barbara Harris & Sally Atkins-Burnett & Sheila Heaviside & Timothy Novak & Robert Murphy
  • 2009 Transitioning Medicaid Enrollees from Institutions to the Community: Number of People Eligible and Number of Transitions Targeted Under Money Follows the Person (MFP)
    by Audra T. Wenzlow & Debra J. Lipson
  • 2009 Effects of Care Coordination on Hospitalization, Quality of Care, and Health Care Expenditures Among Medicare Beneficiaries: 15 Randomized Trials
    by Deborah Peikes & Arnold Chen & Jennifer Schore & Randall Brown
  • 2009 Using Qualitative and Quantitative Methods to Evaluate Small-Scale Disease Management Pilot Programs
    by Dominick Esposito & Erin Fries Taylor & Marsha Gold
  • 2009 Effectiveness of Reading and Mathematics Software Products: Findings from Two Student Cohorts
    by Larissa Campuzano & Mark Dynarski & Roberto Agodini & Kristina Rall
  • 2009 Long-Term Poverty and Disability Among Working-Age Adults
    by Peiyun She & Gina A. Livermore
  • 2009 Beyond the HIPAA Privacy Rule: Enhancing Privacy, Improving Health Through Research
    by Sharyl J. Nass & Laura A. Levit & Lawrence O. Gostin & editors. Committee on Health Research & the Privacy of Health Information: The HIPAA Privacy Rule; Institute of Medicine & of which Thomas Croghan was a member
  • 2009 An Evaluation of Teachers Trained Through Different Routes to Certification
    by Jill Constantine & Daniel Player & Tim Silva & Kristin Hallgren & Mary Grider & John Deke
  • 2009 An Evaluation of Teachers Trained Through Different Routes to Certification
    by Jill Constantine & Daniel Player & Tim Silva & Kristin Hallgren & Mary Grider & John Deke
  • 2009 Focus on Quality: Communication in the Health Care Encounter
    by Ann Bagchi & Raquel af Ursin & Alicia Leonard
  • 2009 Wrapping Around Medicare: The Role of Medicaid
    by James M. Verdier
  • 2009 The Social Security Administration's Youth Transition Demonstration Projects: Evaluation Design Report
    by Anu Rangarajan & Thomas Fraker & Todd Honeycutt & Arif Mamun & John Martinez & Bonnie O'Day & David Wittenburg
  • 2009 Analytic Support for Washington Citizens' Work Group on Health Care: Evaluation of Health Care Reform Proposals
    by Deborah Chollet & Jeffrey Ballou & Alison Wellington & Thomas Bell & Allison Barrett & Gregory Peterson & Stephanie Peterson
  • 2009 SCHIP Children: How Long Do They Stay and Where Do They Go?
    by Christopher Trenholm & James Mabli & Ander Wilson
  • 2009 State and Local Implementation of the No Child Left Behind Act, Volume VII: Title I School Choice and Supplemental Educational Services
    by Georges Vernex & Scott Naftel & Karen Ross & Kerstin Carlson Le Floch & Christopher Beighley & Brian Gill
  • 2009 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for December 2008
    by Stephanie Peterson & Marsha Gold
  • 2009 SoonerCare Managed Care History and Performance: 1115 Waiver Evaluation
    by James Verdier & Margaret Colby
  • 2009 Results from the Administration on Aging's 2005/2006 Survey of Area Agencies on Aging (AAAs)
    by Jody Schimmel & Kristin Andrews
  • 2009 The Role of State Faith Community Liaisons in Charitable Choice Implementation: Practice Models from the States
    by Pamela Winston & Ann E. Person
  • 2009 SoonerCare 1115 Waiver Evaluation
    by James Verdier & Margaret Colby & Debra Lipson & Samuel Simon & Christal Stone & Thomas Bell & Vivian Byrd & Mindy Lipson & Victoria Pérez
  • 2009 SoonerCare 1115 Waiver Evaluation: Chart Book
    by James Verdier & Margaret Colby & Debra Lipson & Samuel Simon & Christal Stone & Thomas Bell & Vivian Byrd & Mindy Lipson & Victoria Pérez
  • 2009 Evaluation of Care and Disease Management Under Medicare Advantage: Interim Report
    by Lisa Green & Judy Goldberg Dey & Julia Doherty & Christopher Moore & Elizabeth Pietrafesa & Emily Dwoyer
  • 2009 Discussion of Sensitive Health Topics with Youth During Primary Care Visits: Relationship to Youth Perceptions of Care
    by Jonathan D. Brown & Lawrence S. Wissow
  • 2009 Both Sides Now: The Story of School Desegregation's Graduates
    by Amy Stuart Wells & Jennifer Jellison Holme & Anita Tijerina Revilla & Awo Korantemaa Atanda
  • 2009 Baby FACES Program Director Self-Administered Questionnaire
    by Jillian Stein & Linda Mendenko
  • 2009 Baby FACES Program Director Interview
    by Jillian Stein & Linda Mendenko
  • 2009 Merit-Aid and the Distribution of Entering Students Across Ontario Universities
    by Martin D. Dooley & A. Abigail Payne & A. Leslie Robb
  • 2009 The Impact of ESL Funding Restrictions on Student Academic Achievement
    by Martin Dooley & Cesar Furtado
  • 2009 Free Ride: The Senate Health Bill’s Approach to “Employer Responsibility” Means Some Large Employers Get to Take It Easy
    by Shawn Fremstad
  • 2009 Taming the Deficit: Saving Our Children from Themselves
    by Dean Baker & David Rosnick
  • 2009 Bolivia: The Economy During the Morales Administration
    by Mark Weisbrot & Rebecca Ray & Jake Johnston
  • 2009 Honduras: Recent Economic Performance
    by Jose Antonio Cordero
  • 2009 Inequality as Policy: The United States Since 1979
    by John Schmitt
  • 2009 Job Sharing: Tax Credits to Prevent Layoffs and Stimulate Employment
    by Dean Baker
  • 2009 Free Trade in Health Care: The Gains from Globalized Medicare and Medicaid
    by Dean Baker & Hye-Jin Rho
  • 2009 Reimbursement Roulette: The Baucus Bill’s Too Playful Approach to “Play-or-Pay” in Health Care Reform
    by Shawn Fremstad
  • 2009 More Budget Belt-Tightening Means More Job Losses for States
    by Matt Sherman
  • 2009 Employer Responsibility in Health Care Reform: Potential Effects on Low- and Moderate-Income Workers
    by Shawn Fremstad
  • 2009 Cut Loose: State and Local Layoffs of Public Employees in the Current Recession
    by Matt Sherman & Nathan Lane
  • 2009 Half in Ten: Why Taking Disability into Account is Essential to Reducing Income Poverty and Expanding Economic Inclusion
    by Shawn Fremstad
  • 2009 Update on the Ecuadorian Economy
    by Mark Weisbrot & Luis Sandoval
  • 2009 Paid Sick Days Don’t Cause Unemployment
    by John Schmitt & Hye Jin Rho & Alison Earle & Jody Heymann
  • 2009 Contagion Nation: A Comparison of Paid Sick Day Policies in 22 Countries
    by Jody Heymann & Hye Jin Rho & John Schmitt & Alison Earle
  • 2009 The State and Local Drag on the Stimulus
    by Dean Baker & Rivka Deutsch
  • 2009 Pay for Play? Tax Credits for Paid Time Off
    by Dean Baker
  • 2009 The Chávez Administration at 10 Years: The Economy and Social Indicators
    by Mark Weisbrot & Rebecca Ray & Luis Sandoval
  • 2009 Leave No Child Behind: A Quick Take on How Congress Should Restructure the Child Tax Credit to More Fairly Value Families and Reduce Inequality
    by Shawn Fremstad
  • 2009 The Determinants of the Attractiveness of National Higher Education System
    by Hayrapetyan Grigor & Hayrapetyan Viktoriya
  • 2009 Price Recall, Bertrand Paradox and Price Dispersion With Elastic Demand
    by Carvalho, M.
  • 2009 University and Business Relations: Connecting the Knowledge Economy
    by J. Stanley Metcalfe
  • 2009 Public and Private Hospitals
    by Productivity Commission
  • 2009 Annual Review of Regulatory Burdens on Business: Social and Economic Infrastructure Services
    by Productivity Commission
  • 2009 Using Qualitative Research to Inform the Development of a Comprehensive Outcomes Assessment for Asthma
    by Diane M. Turner-Bowker & Renee N. Saris-Baglama & Michael A. DeRosa & Christine A. Paulsen & Christopher P. Bransfield
  • 2009 How do People with Different Levels of Activation Self-Manage their Chronic Conditions?
    by Anna Dixon & Judith Hibbard & Martin Tusler
  • 2009 Patients' Preferences for Generic and Branded Over-the-Counter Medicines: An Adaptive Conjoint Analysis Approach
    by Merja Halme & Kari Linden & Kimmo Kri
  • 2009 Using the Pediatric Asthma Therapy Assessment Questionnaire to Measure Asthma Control and Healthcare Utilization in Children
    by Gregory B. Diette & Shiva G. Sajjan & Elizabeth A. Skinner & Thomas W. Weiss & Albert W. Wu & Leona E. Markson
  • 2009 First Things First: Difficulty with Current Medications is Associated with Patient Willingness to Add New Ones
    by Brian J. Zikmund-Fisher & Timothy P. Hofer & Mandi L. Klamerus & Eve A. Kerr
  • 2009 Using Self-Regulation Theory to Examine Patient Goals, Barriers, and Facilitators for Taking Medication
    by Suzan N. Kucukarslan & Sheena Thomas & Abraham Bazzi & Deborah Virant-Young
  • 2009 Gender Differences in the Selection of an Action Plan for Patients with Type 2 Diabetes Mellitus
    by Jim Nuovo & Thomas Balsbaugh & Bridget Levich
  • 2009 Behind Closed Doors: What Happens when Patients and Providers Talk about Prostate-Specific Antigen Screening?: Survey of the Effects of a Community-Based Intervention
    by Lauren McCormack & Pamela Williams-Piehota & Carla Bann
  • 2009 Public Involvement in Setting a National Research Agenda: A Mixed Methods Evaluation
    by Sandy Oliver & David G. Armes & Gill Gyte
  • 2009 Development and Validation of a Functional Health Literacy Test
    by Xu-Hao Zhang & Julian Thumboo & Kok-Yong Fong & Shu-Chuen Li
  • 2009 Using the Health Utilities Index in Routine Clinical Care: Process, Feasibility, and Acceptability: A Randomized Controlled Trial
    by Maria-Jose Santana & David H. Feeny
  • 2009 Use of, Satisfaction with, and Willingness to Switch Prescription and Over-The-Counter Treatments for Chronic Urticaria: An Online Survey
    by Donald E. Stull & Sonia Gavriel
  • 2009 A Model of Patient Choice with Mid-Therapy Information
    by William C. Grant & Teresa L. Kauf
  • 2009 Paying for Enhanced Service: Comparing Patients' Experiences in a Concierge and General Medicine Practice
    by Justin M. Ko & David G. Fairchild & Dana G. Safran
  • 2009 Upper Gastrointestinal Symptoms Experienced by Users of Low-Dose Aspirin (Acetylsalicylic Acid) [75-325 mg/day] for Primary and Secondary Coronary Artery Disease Prevention: Perspectives from Patient Focus Groups
    by Mary Kay. Margolis & Elisabeth Srstadius & J�rgen N�sdal & Stephanie Manson & Karin Coyne
  • 2009 The Impact on Patient Health Outcomes of Interventions Targeting the Patient-Physician Relationship
    by Stephen M. Auerbach
  • 2009 Jordan Louviere, PhD: Honoring a Pioneer in the Study of Patient and Citizen Choice
    by Terry Flynn
  • 2009 Personal Health Budgets for the UK NHS: A Revolution for the Patient?
    by Peter Beresford
  • 2009 The Effect of Item Screeners on the Quality of Patient Survey Data: A Randomized Experiment of Ambulatory Care Experience Measures
    by Hector P. Rodriguez & Ted von. Glahn & Angela Li & William H. Rogers & Dana Gelb. Safran
  • 2009 Health-Related Quality of Life and Quality of Life in Type 2 Diabetes: Relationships in a Cross-Sectional Study
    by Murali Sundaram & Jan Kavookjian & Julie Hicks. Patrick
  • 2009 Healthcare Experiences of Limited English-Proficient Asian American Patients: A Cross-Sectional Mail Survey
    by Quyen Ngo-Metzger & Dara H. Sorkin & Russell S. Phillips
  • 2009 Impact of Natalizumab on Patient-Reported Outcomes in a Clinical Practice Setting: A Cross-Sectional Survey
    by Siddhesh A. Kamat & Krithika Rajagopalan & Judith J. Stephenson & Sonalee Agarwal
  • 2009 Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans
    by Ronald R. White & Greg Lenhart & Puneet K. Singhal & Ralph P. Insinga & Robbin F. Itzler & James M. Pellissier & Arthur W. Segraves
  • 2009 Utilities of the EQ-5D: Transferable or Not?
    by Saskia Knies & Silvia M.A.A. Evers & Math J.J.M. Candel & Johan L. Severens & Andr J.H.A. Ament
  • 2009 The Importance of Clinical Variables in Comparative Analyses Using Propensity-Score Matching: The Case of ESA Costs for the Treatment of Chemotherapy-Induced Anaemia
    by Daniel Polsky & Daria Eremina & Gregory Hess & Jerrold Hill & Scott Hulnick & Adam Roumm & Joanna L. Whyte & Joel Kallich
  • 2009 Comparing Three Software Tools for Implementing Markov Models for Health Economic Evaluations
    by Petra Menn & Rolf Holle
  • 2009 A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US
    by Sandra L. Tunis
  • 2009 Methods for Measuring Temporary Health States for Cost-Utility Analyses
    by Davene R. Wright & Eve Wittenberg & J. Shannon. Swan & Rebecca A. Miksad & Lisa A. Prosser
  • 2009 The Role of Patient Preferences in Cost-Effectiveness Analysis: A Conflict of Values?
    by John E. Brazier & Simon Dixon & Julie Ratcliffe
  • 2009 Determinants of Willingness to Pay for a New Therapy in a Sample of Menopausal-Aged Women
    by Andrej Rasch & Jan-Marc Hodek & Claus Runge & Wolfgang Greiner
  • 2009 The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US
    by Jasmina I. Ivanova & Howard G. Birnbaum & Seth Samuels & Matthew Davis & Amy L. Phillips & Dennis Meletiche
  • 2009 Economic Burden of Follicular Non-Hodgkin's Lymphoma
    by Talia Foster & Jeffrey D. Miller & Mark E. Boye & Mason W. Russell
  • 2009 A Decision-Theoretic Framework for the Application of Cost-Effectiveness Analysis in Regulatory Processes
    by Gianluca Baio & Pierluigi Russo
  • 2009 Estimating Drug Costs in Economic Evaluations in Ireland and the UK: An Analysis of Practice and Research Recommendations
    by Dyfrig A. Hughes & Lesley Tilson & Michael Drummond
  • 2009 Case-Control Studies in Pharmacoeconomic Research: An Overview
    by J. Jaime. Caro & Krista F. Huybrechts
  • 2009 Legal and Economic Perspectives Concerning US Government Investigations of Alleged Off-Label Promotion by Drug Manufacturers
    by Paul E. Kalb & Paul E. Greenberg
  • 2009 Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohn's Disease
    by Andrew P. Yu & Scott Johnson & Si-Tien Wang & Pavel Atanasov & Jackson Tang & Eric Wu & Jingdong Chao & Parvez M. Mulani
  • 2009 Cost-Effectiveness Analysis of Capecitabine Compared with Bolus 5-Fluorouracil/l-Leucovorin for the Adjuvant Treatment of Colon Cancer in Japan
    by Takeru Shiroiwa & Takashi Fukuda & Kojiro Shimozuma & Yasuo Ohashi & Kiichiro Tsutani
  • 2009 Cost Effectiveness of Fondaparinux in Non-ST-Elevation Acute Coronary Syndrome
    by Jaime Latour-Perez & Eva de-Miguel-Balsa
  • 2009 Costs of Illness in a Russian Cohort of Patients with Parkinson's Disease
    by Yaroslav Winter & Sonja von Campenhausen & Georgy Popov & Jens P. Reese & Jens Klotsche & Kai Btzel & Eugene Gusev & Wolfgang H. Oertel & Richard Dodel & Alla Guekht
  • 2009 Economic Evaluations in the EURONHEED: A Comparative Analysis
    by Florencia Hutter & Fernando Antoanzas
  • 2009 Societal and Patient Burden of Fibromyalgia Syndrome
    by Lieven Annemans & Katell Le Lay & Charles Taeb
  • 2009 Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines
    by Natasha K. Stout & Amy B. Knudsen & Chung Yin. Kong & Pamela M. McMahon & G. Scott. Gazelle
  • 2009 Is it Time for Reporting Guidelines for Calibration Methods?
    by Scott B. Cantor
  • 2009 How to Deal with Cost Differences at Baseline
    by Antoinette D.I. van Asselt & Ghislaine A.P.G. van Mastrigt & Carmen D. Dirksen & Arnoud Arntz & Johan L. Severens & Alfons G.H. Kessels
  • 2009 Determinants of Direct Cost Differences among US Employees with Major Depressive Disorders Using Antidepressants
    by Howard G. Birnbaum & Rym Ben-Hamadi & Paul E. Greenberg & Matthew Hsieh & Jackson Tang & Camille Reygrobellet
  • 2009 Converting the SF-12 into the EQ-5D: An Empirical Comparison of Methodologies
    by Ling-Hsiang Chuang & Paul Kind
  • 2009 Economic Outcomes Associated with Microvascular Complications of Type 2 Diabetes Mellitus: Results from a US Claims Data Analysis
    by Elise M. Pelletier & Boyung Shim & Rami Ben-Joseph & J. Jaime. Caro
  • 2009 Holistic Preferences for 1-Year Health Profiles Describing Fluctuations in Health: The Case of Chronic Obstructive Pulmonary Disease
    by Maureen P.M.H. Rutten-van Mlken & Martine Hoogendoorn & Leida M. Lamers
  • 2009 Pharmacoeconomic Considerations in Treating Actinic Keratosis
    by Marjorie V. Neidecker & Mary Lynn. Davis-Ajami & Rajesh Balkrishnan & Steven R. Feldman
  • 2009 Cost Effectiveness of Influenza Vaccination in Older Adults: A Critical Review of Economic Evaluations for the 50- to 64-Year Age Group
    by Anthony T. Newall & Heath Kelly & Stuart Harsley & Paul A. Scuffham
  • 2009 Update of Recent Reforms in Germany to Enhance the Quality and Efficiency of Prescribing of Proton Pump Inhibitors and Lipid-Lowering Drugs
    by Brian Godman & Ulrich Schwabe & Gisbert Selke & Bjrn Wettermark
  • 2009 Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium
    by Irina Cleemput & Nancy Thiry
  • 2009 The Author's Reply
    by Lieven Annemans, on behalf of the authors
  • 2009 Pharmaceutical Risk-Sharing Agreements
    by Afschin Gandjour
  • 2009 Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections
    by Kamal M.F. Itani & Kasem S. Akhras & Robert Stellhorn & Alvaro Quintana & David Budd & Sanjay Merchant
  • 2009 Utility Assessment in Patients with Mental Disorders: Validity and Discriminative Ability of the Time Trade-Off Method
    by Hans-Helmut Knig & Oliver H. Gnther & Matthias C. Angermeyer & Christiane Roick
  • 2009 The Cost of Dementia in Europe: A Review of the Evidence, and Methodological Considerations
    by Linus Jnsson & Anders Wimo
  • 2009 Costing Infectious Disease Outbreaks for Economic Evaluation: A Review for Hepatitis A
    by Jeroen Luyten & Philippe Beutels
  • 2009 The Cost and Impact of Health Conditions on Presenteeism to Employers: A Review of the Literature
    by Alyssa B. Schultz & Chin-Yu Chen & Dee W. Edington
  • 2009 The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics
    by Joseph Cook & Graeme Hunter & John A. Vernon
  • 2009 Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response: A Decision Analysis Based on German Guidelines
    by Uwe Siebert & Gaby Sroczynski & Pamela Aidelsburger & Siegbert Rossol & Jurgen Wasem & Michael P. Manns & John G. McHutchison & John B. Wong
  • 2009 Impact of Transdermal Oxybutynin on Work Productivity in Patients with Overactive Bladder: Results from the MATRIX Study
    by Laura T. Pizzi & Amy Talati & Eric Gemmen & Naomi V. Dahl & Thomas J. Bunz & Peter K. Sand
  • 2009 Cost Effectiveness of Drug-Eluting Stents In Belgian Practice: Healthcare Payer Perspective
    by Mattias Neyt & Chris De Laet & Annemieke De Ridder & Hans Van Brabandt
  • 2009 Willingness to Pay for Cancer Prevention
    by Timothy L. Hunt & Bryan R. Luce & Matthew J. Page & Robin Pokrzywinski
  • 2009 Reviewing the Cost Effectiveness of Rotavirus Vaccination: The Importance of Uncertainty in the Choice of Data Sources
    by Joke Bilcke & Philippe Beutels
  • 2009 Economic and Human Costs of Restless Legs Syndrome
    by Thomas Reinhold & Falk Mller-Riemenschneider & Stefan N. Willich & Bernd Brggenjrgen
  • 2009 Cost Effectiveness of Herpes Zoster Vaccine in Canada
    by Mehdi Najafzadeh & Carlo A. Marra & Eleni Galanis & David M. Patrick & David M. Patrick
  • 2009 Weighting Must Wait: Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected
    by Allan Wailoo & Aki Tsuchiya & Christopher McCabe
  • 2009 Swimming Upstream: Comparative Effectiveness Research in the US
    by Jeremy A. Greene
  • 2009 Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK
    by Jeroen P. Jansen & Ritesh Kumar & Yehuda Carmeli
  • 2009 Healthcare Costs and Obesity Prevention: Drug Costs and Other Sector-Specific Consequences
    by David R. Rappange & Werner B.F. Brouwer & Rudolf T. Hoogenveen & Pieter H.M. Van Baal
  • 2009 Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials
    by Aline Gauthier & Andrea Manca & Susan Anton
  • 2009 Willingness to Pay for a QALY Based on Community Member and Patient Preferences for Temporary Health States Associated with Herpes Zoster
    by Tracy A. Lieu & G. Thomas. Ray & Ismael R. Ortega-Sanchez & Ken Kleinman & Donna Rusinak & Lisa A. Prosser
  • 2009 Cost Effectiveness of Facility-Based Care, Home-Based Care and Mobile Clinics for Provision of Antiretroviral Therapy in Uganda
    by Joseph B. Babigumira & Ajay K. Sethi & Kathleen A. Smyth & Mendel E. Singer
  • 2009 Information Technology Facilitates Cost-Effectiveness Analysis in Developing Countries: An Observational Study of Breast Cancer Chemotherapy in Taiwan
    by Ya-Chen Tina. Shih & I-Wen Pan & Yi-Wen Tsai
  • 2009 Strengthening Cost-Effectiveness Analysis in Thailand through the Establishment of the Health Intervention and Technology Assessment Program
    by Sripen Tantivess & Yot Teerawattananon & Anne Mills
  • 2009 Barriers to Generalizability of Health Economic Evaluations in Latin America and the Caribbean Region
    by Federico Augustovski & Cynthia Iglesias & Andrea Manca & Michael Drummond & Adolfo Rubinstein & Sebastin Garca. Mart
  • 2009 Cost Effectiveness in Low- and Middle-Income Countries: A Review of the Debates Surrounding Decision Rules
    by Samuel D. Shillcutt & Damian G. Walker & Catherine A. Goodman & Anne J. Mills
  • 2009 The Future of Health Technology Assessment in Healthcare Decision Making in Asia
    by Bong-Min Yang
  • 2009 Developing Nations Special Issue
    by Mendel E. Singer
  • 2009 Cost-Effectiveness Analysis of Adjuvant Therapy for Operable Breast Cancer from a Chinese Perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus Cyclophosphamide
    by Peng Liubao & Wan Xiaomin & Tan Chongqing & Jon Karnon & Chen Gannong & Li Jianhe & Cui Wei & Luo Xia & Cao Junhua
  • 2009 30 Years of Pharmaceutical Cost-Utility Analyses: Growth, Diversity and Methodological Improvement
    by Peter J. Neumann & Chi-Hui Fang & Joshua T. Cohen
  • 2009 A Cost-Effectiveness Model Comparing Rivaroxaban and Dabigatran Etexilate with Enoxaparin Sodium as Thromboprophylaxis after Total Hip and Total Knee Replacement in the Irish Healthcare Setting
    by Laura McCullagh & Lesley Tilson & Cathal Walsh & Michael Barry
  • 2009 Budget-Impact Analyses: A Critical Review of Published Studies
    by Ewa Orlewska & Laszlo Gulcsi
  • 2009 Economic Evaluation and Cost-Effectiveness Thresholds: Signals to Firms and Implications for R&D Investment and Innovation
    by John A. Vernon & Robert Goldberg & Joseph Golec
  • 2009 New Anticoagulants for the Prevention of Deep Venous Thrombosis: Time to Consider Cost Effectiveness?
    by Stavros Apostolakis & Eduard Shantsila & Gregory Y.H. Lip
  • 2009 Demand for Outpatient Healthcare: Empirical Findings from Rural India
    by Sisira Sarma
  • 2009 Cost Savings Associated with Filling a 3-Month Supply of Prescription Medicines
    by Atonu Rabbani & G. Caleb. Alexander
  • 2009 A Comparison of Costs among Patients with Type 2 Diabetes Mellitus Who Initiated Therapy with Exenatide or Insulin Glargine
    by Derek Misurski & Maureen J. Lage & Rosalind Fabunmi & Kristina S. Boye
  • 2009 The Cost Effectiveness of Home-Based Provision of Antiretroviral Therapy in Rural Uganda
    by Elliot Marseille & James G. Kahn & Christian Pitter & Rebecca Bunnell & William Epalatai & Emmanuel Jawe & Willy Were & Jonathan Mermin
  • 2009 Cost Effectiveness of Antiretrovirals - Long Term or Short Term?
    by Steffen Flessa
  • 2009 Assessing Comparative Effectiveness Research in the US
    by Joshua P. Cohen & John F.P. Bridges
  • 2009 Which Barriers Prevent the Efficient Use of Resources in Medical Device Sectors?
    by Steven Simoens
  • 2009 The Economic Value of Primary Prophylaxis Using Pegfilgrastim Compared with Filgrastim in Patients with Breast Cancer in the UK
    by Zhimei Liu & Quan V. Doan & Jennifer Malin & Robert Leonard
  • 2009 Economic Evaluation of Sinfrontal in the Treatment of Acute Maxillary Sinusitis in Adults
    by Kyra C. Kneis & Afschin Gandjour
  • 2009 Short-Term Cost and Health Consequences of Duodenal Levodopa Infusion in Advanced Parkinson's Disease in Sweden: An Exploratory Study
    by Ivar Snb. Kristiansen & Dag Nyholm & Dag Isacson
  • 2009 Financial Risk of the Biotech Industry versus the Pharmaceutical Industry
    by Joseph Golec
  • 2009 Value-Based Insurance Design in Medicare
    by William E. Encinosa
  • 2009 Soft Regulations in Pharmaceutical Policy Making: An Overview of Current Approaches and their Consequences
    by Bjrn Wettermark & Brian Godman & Bengt Jacobsson & Flora M. Haaijer-Ruskamp
  • 2009 Cost Effectiveness of Glatiramer Acetate and Natalizumab in Relapsing-Remitting Multiple Sclerosis
    by Stephanie R. Earnshaw & Jonathan Graham & MerriKay Oleen-Burkey & Jane Castelli-Haley & Kenneth Johnson
  • 2009 Implementing Differential Pricing for Essential Medicines via Country-Specific Bilateral Negotiated Discounts
    by Ebenezer Kwabena. Tetteh
  • 2009 Aversion to Geographic Inequality and Geographic Variation in Preferences in the Context of Healthcare
    by Carlota Quintal
  • 2009 Comparative Utility of Aripiprazole and Haloperidol in Schizophrenia: Post Hoc Analysis of Two 52-Week, Randomized, Controlled Trials
    by John M. Kane & Edward Kim & Hong J. Kan & Zhenchao Guo & John A. Bates & Richard Whitehead & Andrei Pikalov
  • 2009 Development of a Budget-Impact Model to Quantify Potential Cost Savings from Prescription Opioids Designed to Deter Abuse or Ease of Extraction
    by Alan G. White & Howard G. Birnbaum & Dov B. Rothman & Nathaniel Katz
  • 2009 Oral Therapies for the Treatment of Pulmonary Arterial Hypertension: A Population-Based Cost-Minimization Analysis
    by George Dranitsaris & Sanjay Mehta
  • 2009 Direct Economic Burden of High-Risk and Metastatic Melanoma in the Elderly: Evidence from the SEER-Medicare Linked Database
    by Keith L. Davis & Debanjali Mitra & Srividya Kotapati & Ramy Ibrahim & Jedd D. Wolchok
  • 2009 Cost Effectiveness of Sirolimus-Eluting Stents Compared with Bare Metal Stents in Acute Myocardial Infarction: Insights from the TYPHOON Trial
    by Florence Canoui-Poitrine & Grgoire Jeanblanc & Corinne Alberti & Priscilla Armoogum & Ana Cebrian & Didier Carri & Patrick Henry & Emmanuel Teiger & Michel Slama & Christian Spaulding & Isabelle Durand-Zaleski
  • 2009 Health-Promoting Schools: Evidence for a Holistic Approach to Promoting Health and Improving Health Literacy
    by Albert Lee
  • 2009 Informing Disinvestment through Cost-Effectiveness Modelling: Is Lack of Data a Surmountable Barrier?
    by Jonathan Karnon & Jill Carlton & Carolyn Czoski-Murray & Kevin Smith
  • 2009 Handicap e integrazione scolastica
    by Carlo Buratti
  • 2009 Opportunity Cost Of Educational Human Capital Investment. Application For The Position Of Beneficiary-Investor
    by Florea Voiculescu
  • 2008 Trends in Aged Care Services: some implications
    by Productivity Commission
  • 2008 Effect of Television on Child Cognitive Outcome
    by Samrat Bhattacharya & Abdul Munasib
  • 2008 Assessment of the Initial Phase of the Train the Trainer Project Using the Helping You Take Care of Yourself Curriculum
    by Lisa Trebino & Kerianne Hourihan & Melanie Besculides
  • 2008 Findings from the Healthy Start National Evaluation: Phase II
    by Deborah Klein Walker & Margo Rosenbach
  • 2008 Reliability and Validity of Child Outcome Measures with Culturally and Lingusitically Diverse Preschoolers: The First 5 LA Universal Preschool Child Outcomes Study Spring 2007 Pilot Study
    by Cheri Vogel & Nikki Aikens & Sally Atkins-Burnett & Emily Sama Martin & Margaret Caspe & Susan Sprachman & John M. Love
  • 2008 The Transition to Permanent PACE
    by Valerie Cheh & Leslie Foster
  • 2008 Outreach and Communication with Practitioners about Measures and Research: Development and Use of a Compendium and Consumer's Guide
    by Patricia Lozano & Christine Ong & Sandra Barrueco & Michael L. López & Katie Fallin
  • 2008 A Vision for Research on Universal Preschool: Background, Purpose, and Goals of the Los Angeles Universal Preschool Program and Its Evaluation
    by Katie Fallin & Michael L. López & Patricia Lozano & Christine Ong & Jessica Brauner
  • 2008 Medicaid Value Program: Evaluation Findings
    by Marsha Gold & Dominick Esposito & Erin Taylor & Kristin Andrews
  • 2008 Evaluation of Medicare Advantage Special Needs Plans
    by Robert Schmitz & Angela Merrill & Jennifer Schore & Rachel Shapiro & Jim Verdier
  • 2008 Health Insurance Partnership Board Studies: Enrollment, Cost, and Implementation of a Preliminary Expanded Partnership
    by Deborah Chollet & Jeffrey Ballou & Thomas Bell & James Matthisen & Amy Lischko & Vicki Wilson & Karen Pollitz & Kevin Lucia
  • 2008 Advocacy Capacity Assessment Instrument
    by Margaret Gerteis & Julia Coffman & Jung Kim & Krisztina Marton
  • 2008 The Medicaid Analytic eXtract 2004 Chartbook
    by Victoria Perez & Bob Schmitz & Audra T. Wenzlow & Kathy Shepperson & David Baugh & Susan Radke
  • 2008 Impacts of Comprehensive Teacher Induction: Results from the First Year of a Randomized Controlled Study
    by Steven Glazerman & Sarah Dolfin & Martha Bleeker & Amy Johnson & Eirc Isenberg & Julieta Lugo-Gil & Mary Grider & Edward Britton
  • 2008 Analysis of Minnesota Affordability Proposal
    by Deborah Chollet & Kate Stewart & Allison Barrett
  • 2008 Girls Shape the Future Study: Findings and Lessons Learned from an Effort to Assess the Effectiveness of the Girls Incorporated® Will Power/Won't Power® Program
    by Susan Goerlich Zief & Anu Rangarajan & Caterina Pisciotta
  • 2008 Early Predictors of Girls' Adolescent Sexual Activity: Longitudinal Findings from the Girls Shape the Future Study
    by Brian Goesling & Anu Rangarajan
  • 2008 Tools for Developing, Implementing, and Evaluating State Policy
    by Bernadette Ford Lattimore & So O'Neil & Melanie Besculides
  • 2008 The National Children's Study Research Plan: A Review
    by National Research Council & Institute of Medicine. Panel to review the National Children's Study Research Plan & of which Daniel Kasprzyk was a member. Committee on National Statistics & Division of Behavioral & Social Sciences & Education
  • 2008 Assessing Accomplished Teaching: Advanced-Level Certification Programs
    by Milton D. Hakel & Judith Anderson Koenig & Stuart W. Elliott & editors. Committee on Evaluation of Teacher Certification by the National Board for Professional Teaching Standards & of which Mark Dynarski was a member
  • 2008 Health Care Survey of DoD Beneficiaries 2008 Annual Report
    by Kristin Andrews & Katherine Bencio & Jonathan Brown & Leslie Conwell & Cheryl Fahlman & Eric Schone
  • 2008 Differences in Hospitalizations for Ambulatory Care Sensitive Conditions Among Maryland Medicare Beneficiaries, 2006
    by So O'Neil & Angela Merrill & er Wilson & Tim Lake
  • 2008 Assessment of Disparities in Potentially Avoidable Hospitalizations of Maryland Medicare Patients
    by So O'Neil & Angela Merrill & er Wilson & Tim Lake
  • 2008 Summary of Focus Group Sessions at the 2008 Annual Grantee Meeting
    by Jung Kim & Julia Coffman
  • 2008 Study Design and Data Tables for FACES 2006 Baseline Report
    by Jerry West & Louisa Tarullo & Nikki Aikens & Lara Hulsey
  • 2008 Technical Methods Report: Statistical Power for Regression Discontinuity Designs in Education Evaluations
    by Peter Z. Schochet
  • 2008 Report to HRSA: Opportunities to Advance Clinical Pharmacy Services in Safety-Net Settings
    by Suzanne Felt-Lisk & Todd Sorensen & Zandra Glenn & Margaret Colby & Christopher Fleming
  • 2008 The Effect of the Program of All-Inclusive Care for the Elderly (PACE) on Quality
    by Jody Beauchamp & Valerie Cheh & Robert Schmitz & Peter Kemper & John Hall
  • 2008 Easing the Part D Transition: An Evaluation of Federal and State Efforts to Ensure Dual Eligibles and Other Low-Income Beneficiaries Maintain Prescription Drug Coverage
    by Ann Bagchi & Matthew Hodges & Christine Yip & Sandra Nelson
  • 2008 Evaluation of Effectiveness of AHRQ's Grant-Supported Research on Healthcare Costs, Productivity, Organization, and Market Forces
    by Marsha Gold & Timothy Lake & Kate Stewart & Tara Krissik & Kirsten Barrett
  • 2008 Effects of Employment on Marriage: Evidence from a Randomized Study of the Job Corps Program
    by Arif A. Mamun
  • 2008 Case Study of Illinois: Exploring Links Between Policy, Practice and the Trends in New Medicaid/SCHIP Enrollments
    by Kathy Gifford & Gaylee Morgan & Donna Marks & Chris Trenholm
  • 2008 Survey and Research Instruments that Address the Health Effects of Caregiving
    by Robert Weathers & Allison Hedley Dodd & Krista Harrison
  • 2008 Looking at Medicare Advantage: What Has Happened Since the Launch? What Will Happen in the Future?
    by Marsha Gold & Erin Fries Taylor & Christopher Fleming & Dawn Phelps & Maria Cupples Hudson & Miriam Loewenberg
  • 2008 Beginning Head Start: Children, Families and Programs in Fall 2006
    by Louisa Tarullo & Jerry West & Nikki Aikens & Lara Hulsey
  • 2008 Final Report to Congress on the Informatics for Diabetes Education and Telemedicine (IDEATel) Demonstration, Phases I and II
    by Lorenzo Moreno & Rachel Shapiro & Stacy B. Dale & Leslie Foster & Arnold Chen
  • 2008 Strategies for Increasing TANF Work Participation Rates: Summary Report
    by LaDonna Pavetti & Jacqueline Kauff & Michelle K. Derr & Jeffrey Max & Ann Person & Gretchen Kirby
  • 2008 Achieving Higher TANF Work Participation Rates: Case Studies from Maryland and Utah
    by Jacqueline Kauff & Michelle K. Derr
  • 2008 Providing Unpaid Work Experience Opportunities for TANF Recipients: Examples from Erie County, New York; Montana; and Hamilton County, Ohio
    by Michelle K. Derr
  • 2008 Using Data to Monitor and Improve the Work Participation of TANF Recipients: Examples from New York City and Utah
    by Jeffrey Max & Gretchen Kirby
  • 2008 Providing Paid Employment Opportunities for TANF Participants Engaged in Vocational Education Programs: Examples from Denver, Colorado; Kentucky; and California
    by Ann Person & LaDonna Pavetti & Jeffrey Max
  • 2008 Predictors of Nursing Home Hospitalization: A Review of the Literature
    by David C. Grabowski & Kate A. Stewart & Suzanne M. Broderick & Laura A. Coots
  • 2008 A Study of States' TANF Diversion Programs
    by Linda Rosenberg & Michelle Derr & LaDonna Pavetti & Subahi Asheer & Megan Hague Angus & Samina Sattar & Jeffrey Max
  • 2008 Implementation of the Head Start National Reporting System: Spring 2007
    by Louisa B. Tarullo & Cheri A. Vogel & Nikki Aikens & Emily Sama Martin & Renée Nogales & Patricia Del Grosso
  • 2008 Implementation of the Head Start National Reporting System: Spring 2007
    by Louisa B. Tarullo & Cheri A. Vogel & Nikki Aikens & Emily Sama Martin & Renée Nogales & Patricia Del Grosso
  • 2008 Designing Subsidized Health Coverage Programs to Attract Enrollment: A Review of the Literature and a Synthesis of Stakeholder Views
    by Lynn Quincy & Patricia Collins & Kristin Andrews & Christal Stone
  • 2008 The Chicago Program Evaluation Project: A Picture of Early Childhood Programs, Teachers, and Preschool-Age Children in Chicago
    by Christine Ross & Emily Moiduddin & Cassandra Meagher & Barbara Carlson
  • 2008 Ticket to Work at the Crossroads: A Solid Foundation with an Uncertain Future
    by David Stapleton & Gina Livermore & Criag Thornton & Bonnie O'Day & Robert Weathers & Krista Harrison & So O'Neil & Emily Sama Martin & David Wittenburg & Debra Wright
  • 2008 The Social Security Administration's Youth Transition Demonstration Projects: Profiles of the Random Assignment Projects
    by John Martinez & Michelle S. Manno & Peter Baird & Thomas Fraker & Todd Honeycutt & Arif Mamun & Bonnie O'Day & Anu Rangarajan
  • 2008 The Role of State Faith Community Liaisons in Charitable Choice Implementation
    by Pamela Winston & Ann E. Person & Elizabeth Clary
  • 2008 Ticket to Work at the Crossroads: A Solid Foundation with an Uncertain Future
    by David Stapleton & Gina Livermore & Craig Thornton & Bonnie O'Day & Robert Weathers & Krista Harrison & So O'Neil & Emily Sama Martin & David Wittenburg & Debra Wright
  • 2008 Databases Strengthen Long-Term Care Partnerships
    by Ann Bagchi & Jung Kim
  • 2008 Medicare's Private Plans: A Report Card on Medicare Advantage (MA)
    by Marsha Gold
  • 2008 Improving Public Coverage for Children: Lessons from CKF in Washington
    by Sheila Hoag & Chioma Uzoigwe
  • 2008 Learning About Preschool Curricula: PCER and Beyond
    by John M. Love
  • 2008 What Do We Know, and Not Know, About Women with Disabilities in the Workforce?
    by Bonnie O'Day & Susan Foley
  • 2008 The Promise and Challenge of Using Volunteers to Provide Community-Based Marriage Education
    by Robin Dion & Sarah Avellar
  • 2008 The Oklahoma Marriage Initiative: A Process Evaluation
    by M. Robin Dion & Sarah A. Avellar & Heather H. Zaveri & Debra A. Strong & Alan M. Hershey & Timothy J. Silman & Betsy Santos
  • 2008 The Oklahoma Marriage Initiative: A Process Evaluation
    by M. Robin Dion & Sarah A. Avellar & Heather H. Zaveri & Debra A. Strong & Alan M. Hershey & Timothy J. Silman & Betsy Santos
  • 2008 Discussion of Maternal Stress During Pediatric Primary Care Visits
    by Jonathan D. Brown & Lawrence S. Wissow
  • 2008 Disagreement in Parent and Primary Care Provider Reports of Mental Health Counseling
    by Jonathan D. Brown & Lawrence S. Wissow
  • 2008 Donations and the Pursuit of Mission in Higher Education
    by Burton Weisbrod & Jeffrey Ballou & Evelyn Asch
  • 2008 Paying for Medical Homes: A Calculated Risk
    by Hoangmai H. Pham & Deborah Peikes & Paul B. Ginsburg
  • 2008 Medical Homes: The Information Exchange Challenge
    by Myles Maxfield & Hoangmai H. Pham & Deborah Peikes
  • 2008 Qualifying a Physician Practice as a Medical Home
    by Ann S. O'Malley & Deborah Peikes & Paul B. Ginsburg
  • 2008 Cash and Counseling: An Innovative Model for Consumer Choice
    by Randall S. Brown
  • 2008 Analysis of Reform Models for Extending Health Care Coverage in New Mexico
    by Deborah Chollet & Lee Reynis
  • 2008 Bring Them Back, Move Them Forward: Case Studies of Programs Preparing Out-of-School Youths for Further Education and Careers
    by Rob Buschmann & Joshua Haimson
  • 2008 The Late Pretest Problem in Randomized Control Trials of Education Interventions
    by Peter Z. Schochet
  • 2008 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for October 2008
    by Stephanie Peterson & Marsha Gold
  • 2008 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for November 2008
    by Stephanie Peterson & Marsha Gold
  • 2008 I Am Moving, I Am Learning: Early Findings from the Implementation of an Obesity Prevention Enhancement in Head Start Region III
    by Daniel Finkelstein & Robert Whitaker & Elaine Hill & Mary Kay Fox & Linda Mendenko & Kimberly Boller
  • 2008 Testing Case Management in a Rural Context: An Impact Analysis of the Illinois Future Steps Program
    by Alicia Meckstroth & Ann Person & Quinn Moore & rew Burwick & rew McGuirk & Michael Ponza & Shawn Marsh & Tim Novak & Zhanyun Zhao & Justin Wheeler
  • 2008 Teaching Self-Sufficiency: An Impact and Benefit-Cost Analysis of a Home Visitation and Life Skills Education Program
    by Alicia Meckstroth & rew Burwick & Quinn Moore & Michael Ponza & Shawn Marsh & rew McGuirk & Tim Novak & Zhanyun Zhao
  • 2008 Using Physician Payment Reform to Enhance Health System Performance
    by Marsha Gold & Suzanne Felt-Lisk
  • 2008 Surveying Persons with Disabilities: A Source Guide, Version II
    by Jason Markesich
  • 2008 Using Medicaid Analytic eXtract (MAX) Data on Rx Drug Use and Costs to Analyze Current Medicaid and Medicare Policy Issues
    by James M. Verdier
  • 2008 A Guide to Emerging Strategies for Promoting Prevention and Improving Oral Health Care Delivery in Head Start: Lessons from the Oral Health Initiative Evaluation
    by Patricia Del Grosso & Amy Brown & Sandra Silva & Jamila Henderson & Naomi Tein & Diane Paulsell
  • 2008 Strategies for Promoting Prevention and Improving Oral Health Care Delivery in Head Start: Findings from the Oral Health Initiative Evaluation
    by Patricia Del Grosso & Amy Brown & Sandra Silva & Jamila Henderson & Naomi Tein & Diane Paulsell
  • 2008 Chartbook: Medicaid Pharmacy Benefit Use and Reimbursement in 2004
    by Ann Bagchi & Jim Verdier & Dominick Esposito
  • 2008 Infusing Academics into Career and Technical Education
    by Joshua Haimson & James R. Stone & III & Donna Pearson
  • 2008 Social and Economic Integration of Latino Immigrants in New Rural Destinations
    by Heather Koball & Randy Capps & William Kandel & Jamila Henderson & Everett Henderson
  • 2008 Integrating Latino Immigrants in New Rural Destinations
    by Heather Koball & Randy Capps & William Kandel & Jamila Henderson & Everett Henderson
  • 2008 Medicare's Private Plans: A Report Card on Medicare Advantage
    by Marsha Gold
  • 2008 Implementing a Large-Scale Test of Marriage and Relationship Skills Education: Building Strong Families
    by Alan M. Hershey & M. Robin Dion
  • 2008 Design for the Evaluation of Early Elementary School Mathematics Curricula
    by Roberto Agodini & John Deke & Sally Atkins-Burnett & Barbara Harris & Robert Murphy
  • 2008 Results from the Administration on Aging's Third National Survey of Older Americans Act Program Participants
    by Jody Beauchamp & Lisa Trebino
  • 2008 Employment and Work Expectations of Social Security Disability Beneficiaries
    by Gina Livermore
  • 2008 Measuring Employment of People with Disabilities
    by David Wittenburg
  • 2008 The Integration of Latino Immigrants in the Rural United States
    by Heather Koball & William Kandel & Randolph Capps & Rosa Maria Castañeda
  • 2008 Availability of Data to Measure Disparities in Leading Health Indicators at the State and Local Levels
    by Marsha Gold & Allison Hedley Dodd & Melissa Neuman
  • 2008 Pathways to Adulthood and Marriage: Teenagers' Attitudes, Expectations, and Relationship Patterns
    by Robert G. Wood & Sarah Avellar & Brian Goesling
  • 2008 Sample Loss and Survey Bias in Estimates of Social Security Beneficiaries: A Tale of Two Surveys
    by John L. Czajka & James Mabli & Scott Cody
  • 2008 Evaluation of Medicare Disease Management Programs: LifeMasters Final Report of Findings
    by Dominick Esposito & Kate A. Stewart & Randall Brown
  • 2008 Evaluation of Medicare Disease Management Programs: LifeMasters Final Report of Findings
    by Dominick Esposito & Kate A. Stewart & Randall Brown
  • 2008 Understanding the Variation in Costs Among HIV Primary Care Providers
    by Boyd H. Gilman & Jeremy C. Green
  • 2008 Impacts of a Disease Management Program for Dually Eligible Beneficiaries
    by Dominick Esposito & Randall Brown & Arnold Chen & Jennifer Schore & Rachel Shapiro
  • 2008 Evaluation of a Medicaid Psychotropic Drug Management Program in Utah
    by Dominick Esposito & James M. Verdier
  • 2008 15-Site Randomized Trial of Coordinated Care in Medicare Fee-for-Service
    by Randall Brown & Deborah Peikes & Arnold Chen & Jennifer Schore
  • 2008 Improving Public Coverage for Children: Lessons from CKF in New Jersey
    by Chioma Uzoigwe & Sheila Hoag & Judith Wooldridge
  • 2008 How Do Employment Outcomes of Medicaid Buy-In Participants Vary Based on Prior Medicaid Coverage? An Example from Massachusetts
    by Marsha Langer Ellison & Mihail Samnaliev & Alexis D. Henry & Jody Schimmel Beauchamp & Annette Shea & Jay Himmelstein
  • 2008 Mission and Money: Understanding the University
    by Burton A. Weisbrod & Jeffrey P. Ballou & Evelyn D. Asch
  • 2008 State Efforts to Address the Healthy People 2010 Goal to Eliminate Health Disparities: Two Case Studies
    by Leslie Jackson Conwell & Melissa Neuman & Marsha Gold
  • 2008 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for September 2008
    by Stephanie Peterson & Marsha Gold
  • 2008 Research Design Report for the Evaluation of the Money Follows the Person (MFP) Grant Program
    by Randall Brown & Carol Irvin & Debra Lipson & Sam Simon & Audra Wenzlow
  • 2008 How Medicaid Agencies Administer Mental Health Services: Results from a 50-State Survey
    by James Verdier & Allison Barrett
  • 2008 Antidepressant Use in Black and White Populations in the United States
    by Hector M González & Thomas Croghan & Brady West & David Williams & Randolph Nesse & Wassim Tarraf & Robert Taylor & Ladson Hinton & Harold Neighbors & James Jackson
  • 2008 Using Section 125 Premium-Only Plans to Expand Health Coverage
    by Lynn Quincy
  • 2008 Private Health Insurance: High Risk Pools, GAP Plans, and Options for Reform
    by Deborah Chollet
  • 2008 Using Research to Guide the Development of an Evolving Statewide Initiative
    by Heather Zaveri & Nikki Aikens
  • 2008 Pathways to Adulthood and Marriage: Teenagers' Attitudes, Expectations, and Relationship Patterns
    by Robert G. Wood & Sarah Avellar & Brian Goesling
  • 2008 Health Benefits for the Uninsured: Design and Early Implementation of the Accelerated Benefits Demonstration
    by David Wittenburg & Peter Baird & Lisa Schwartz & David Butler
  • 2008 Mejores Inicios: El Estado del Aprendizaje Temprano y Preparación para el Kindergarten en East Yakima
    by Diane Paulsell & Kimberly Boller & Nikki Aikens & Martha Kovac & Patricia Del Grosso
  • 2008 Mejores Inicios: El Estado del Aprendizaje Temprano y Preparación para el Kindergarten en East Yakima y White Center
    by Diane Paulsell & Kimberly Boller & Nikki Aikens & Martha Kovac & Patricia Del Grosso
  • 2008 Mejores Inicios: El Estado del Aprendizaje Temprano y Preparación para el Kindergarten en White Center
    by Diane Paulsell & Kimberly Boller & Nikki Aikens & Martha Kovac & Patricia Del Grosso
  • 2008 Marriage and Health Care Coverage Among Families with Children
    by Brian Goesling & Heather Koball
  • 2008 Where Do I Send Thee? Does Physician-Ownership Affect Referral Patterns to Ambulatory Surgery Centers?
    by Jon R. Gabel & Cheryl Fahlman & Ray Kang & Gregory Woznlak & Phil Kletke & Joel W. Hay
  • 2008 The United Kingdom Pathways to Work Program: A Path to Employment?
    by Bonnie O'Day & David Stapleton
  • 2008 Earnings and Work Expectations of Social Security Disability Beneficiaries
    by Gina A. Livermore
  • 2008 Going Beyond Test Scores: Evaluating Charter School Impact on Educational Attainment in Chicago and Florida
    by Kevin Booker & Tim R. Sass & Brian Gill & Ron Zimmer
  • 2008 Recent Changes in State Medicaid Policies: Implications for PLWHA and Ryan White Grantees
    by Debra J. Lipson & Boyd Gilman
  • 2008 Effect of Medicaid Policy Reforms on Ryan White Grantees and Clients: Results from Six State Case Studies
    by Boyd Gilman & Debra J. Lipson
  • 2008 Modernization of Public Assistance in Florida: A Case Study
    by Scott Cody & Emily Sama Martin & Renée Nogales
  • 2008 Three Independent Evaluations of Healthy Kids Programs Find Substantial Gains in Children's Dental Health Care
    by Dana Hughes & Embry Howell & Christopher Trenholm & Ian Hill & Lisa Dubay
  • 2008 The Marriage Measures Guide of State-Level Statistics
    by Brian Goesling & Robert G. Wood & Carol Razafindrakoto & Jamila Henderson
  • 2008 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for August 2008
    by Stephanie Peterson & Marsha Gold
  • 2008 Review of International Evidence on the Cost of Disability
    by David Stapleton & Ali Protik & Christal Stone
  • 2008 Monitoring and Assessing the Use of External Quality Review Organizations to Improve Services for Young Children: A Toolkit for State Medicaid Agencies
    by Tara Krissik & Henry T. Ireys & Anne Markus & Sara Rosenbaum
  • 2008 Participants in the Medicaid Buy-In Program, 2000-2004: Characteristics, Earnings, and Medical Expenditures
    by Su Liu & Henry T. Ireys & Craig Thornton
  • 2008 The Effects of Complications and Comorbidities on the Quality of Preventive Diabetes Care: A Literature Review
    by Leslie Jackson Conwell & Chad Boult
  • 2008 Medicaid Prescription Drug Use by Dual Eligibles: Issues for Medicare Part D
    by James Verdier & Ann Bagchi & Dominick Esposito
  • 2008 Better Beginnings: The State of Early Learning and Kindergarten Readiness in White Center
    by Diane Paulsell & Kimberly Boller & Nikki Aikens & Martha Kovac & Patricia Del Grosso
  • 2008 Better Beginnings: The State of Early Learning and Kindergarten Readiness in East Yakima and White Center
    by Diane Paulsell & Kimberly Boller & Nikki Aikens & Martha Kovac & Patricia Del Grosso
  • 2008 Better Beginnings: The State of Early Learning and Kindergarten Readiness in East Yakima
    by Diane Paulsell & Kimberly Boller & Nikki Aikens & Martha Kovac & Patricia Del Grosso
  • 2008 How Oklahoma Laid the Foundation for Its Marriage Initiative
    by Debra A. Strong
  • 2008 Prevalence of Unclaimed Prescriptions at Military Pharmacies
    by Dominick Esposito & Eric Schone & Thomas Williams & Su Liu & Karen CyBulski & Rita Stapulonis & Nancy Clusen
  • 2008 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for July 2008
    by Stephanie Peterson & Marsha Gold
  • 2008 Preschool Curriculum Evaluation Research Consortium (2008). Effects of Preschool Curriculum Programs on School Readiness (NCER 2008-2009)
    by the following Mathematica staff participated in the PCER Consortium: John Love & Sarah Avellar & Steve Glazerman & Susan Sprachman
  • 2008 Associations of Parent Ratings of Children's Behavior with Child Development in an Ethnically and Linguistically Diverse Sample of Preschool Children
    by Julieta Lugo-Gil & Yange Xue & Cheri Vogel & Elaine Hill & John M. Love & Deanna Gomby & Deborah Parrish
  • 2008 Development of "The Respect for Difference Scale" (RDS): A New Parent Report Measure
    by Susan Sprachman & Margaret Caspe & Sally Atkins-Burnett
  • 2008 What Do Parents Mean When They Rate Their Children's Behavior?
    by Nikki Aikens & Sally Atkins-Burnett & Susan Sprachman & Annalee Kelly & Christine Ong & Rita Rico & Jatzin Alvarado & Deanna Gomby
  • 2008 Measurement Equivalence of Teacher Rating Scales of Social-Emotional Development with a Culturally and Linguistically Diverse Sample of Preschool Children
    by Aaron Douglas & Sally Atkins-Burnett
  • 2008 Use of Conceptual Scoring to Increase Reliability and Validity of Direct Child Assessments with Linguistically Diverse Preschoolers
    by Sally Atkins-Burnett & Nikki Aikens
  • 2008 Development of a Language Routing Protocol to Determine Bilingual Spanish Speaking Children's Language of Assessment
    by Kathy Sonnenfeld & Margaret Caspe & Nikki Aikens & Susan Sprachman & Sally Atkins-Burnett & Michael López
  • 2008 Implementation of the Head Start National Reporting System: Spring 2006
    by Cheri A. Vogel & Renée Nogales & Nikki Aikens & Louisa Tarullo
  • 2008 Implementation of the Head Start National Reporting System: Spring 2006
    by Cheri A. Vogel & Renée Nogales & Nikki Aikens & Louisa Tarullo
  • 2008 Starting Early: How the Oklahoma Marriage Initiative Helps Schools Prepare Young People for Healthy Marriages
    by Robin Dion & Timothy Silman
  • 2008 Passport to Teaching: Career Choices and Experiences of American Board Certified Teachers
    by Steven Glazerman & Elizabeth Seif & Gail Baxter
  • 2008 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for June 2008
    by Stephanie Peterson & Marsha Gold
  • 2008 The Role of SNPs in Medicare Managed Care: What Value Can They Add?
    by James M. Verdier
  • 2008 Report to Congress on the Evaluation of Medicare Disease Management Programs
    by Arnold Chen & Randall Brown & Dominick Esposito & Jennifer Schore & Rachel Shapiro
  • 2008 Development of "The Respect for Differences Scale" (RDS): A New Parent Report Measure
    by Margaret Caspe & Susan Sprachman & Sally Atkins-Burnett & Nikki Aikens
  • 2008 Third Report to Congress on the Evaluation of the Medicare Coordinated Care Demonstration
    by Deborah Peikes & Randall Brown & Arnold Chen & Jennifer Schore
  • 2008 Integrating Medicare and Medicaid
    by James M. Verdier
  • 2008 Guidelines for Multiple Testing in Impact Evaluations of Educational Interventions
    by Peter Z. Schochet
  • 2008 Demand for Health Services Researchers in 2020. The Health Services Research of 2020: Summit on the Future of the Health Services Research Workforce
    by Craig Thornton & Jonathan Brown
  • 2008 Mental Health and Medicaid
    by Jim Verdier
  • 2008 Using Medical Records to Supplement a Claims-Based Comparative Effectiveness Analysis of Antidepressant Treatment
    by Thomas W. Croghan & Dominick Esposito & Gregory Daniel & Peter Wahl & Michael A. Stoto & M. Haim Erder
  • 2008 Coverage Advocacy Can Be Sustained After the Funding Ends
    by Beth Stevens & Sheila Hoag
  • 2008 Covering Kids and Families Influence on Enrollment and Retention in Public Coverage
    by Christopher Trenholm
  • 2008 Lessons from Covering Kids & Families for State Comprehensive Coverage Initiatives
    by Judith Wooldridge
  • 2008 High School Reform in Boston Public Schools: The Effect of Focus on High Schools on Student Academic Outcomes
    by Susanne James-Burdumy & Irma Perez-Johnson & Sonya Vartivarian
  • 2008 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for May 2008
    by Stephanie Peterson & Marsha Gold
  • 2008 Medicare Advantage In 2008
    by Marsha Gold
  • 2008 Measuring Teacher Effectiveness in Memphis
    by Eric Isenberg
  • 2008 Changing Circumstances: Experiences of Child SSI Recipients Before and After Their Age-18 Redetermination for Adult Benefits
    by Jeffrey Hemmeter & Jacqueline Kauff & David Wittenburg
  • 2008 A Profile of Kindergarten Readiness in East Yakima: Fall 2007
    by Kimberly Boller & Diane Paulsell & Nikki Aikens & Liz Potamites & Barbara Carlson & Martha Kovac
  • 2008 A Profile of Kindergarten Readiness in White Center: Fall 2007
    by Kimberly Boller & Diane Paulsell & Nikki Aikens & Liz Potamites & Barbara Carlson & Martha Kovac
  • 2008 Building a Community-Wide Early Learning System: East Yakima at Baseline
    by Patricia Del Grosso & Nikki Aikens & Diane Paulsell & Kimberly Boller & Todd Honeycutt & Subuhi Asheer
  • 2008 Building a Community-Wide Early Learning System: White Center at Baseline
    by Diane Paulsell & Kimberly Boller & Patricia Del Grosso & Nikki Aikens & Todd Honeycutt & Subuhi Asheer
  • 2008 SNPs and States: Overcoming the Challenges in Integrating Medicare and Medicaid Benefits
    by James M. Verdier
  • 2008 Special Needs Plans: Assessing the Value and Proper Role of SNPs
    by James M. Verdier
  • 2008 Health Insurance Exchange Study
    by Deborah Chollet & Su Liu & Kate Stewart & Alison Wellington & Allison Barrett & Mila Kofman & Amy M. Lischko
  • 2008 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for April 2008
    by Stephanie Peterson & Marsha Gold
  • 2008 Findings from Phase I of the Evaluation 2006
    by Mathematica Policy Research & contributor
  • 2008 Health Care Access and Use Among Low-Income Children on Subsidized Insurance Programs in California
    by Christopher Trenholm & Anna Saltzman & Shanna Shulman & Michael Cousineau & Dana Hughes
  • 2008 Achievement and Attainment in Chicago Charter Schools
    by Kevin Booker & Brian Gill & Ron Zimmer & Tim R. Sass
  • 2008 Measuring Charter School Effectiveness Across States
    by Kevin Booker & Duncan Chaplin & Eric Isenberg
  • 2008 Initiating Treatment on Generic Antidepressants May Not Save Health Care Costs
    by Dominick Esposito & Peter Wahl & Gregory Daniel & Michael A. Stoto & M. Haim Erder & Thomas W. Croghan
  • 2008 Measuring School Effectiveness in Memphis
    by Kevin Booker & Eric Isenberg
  • 2008 The Three E's: Enrollment, Employment, and Earnings in the Medicaid Buy-In Program, 2006
    by Gilbert Gimm & Sarah R. Davis & Kristin L. Andrews & Henry T. Ireys & Su Liu
  • 2008 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for March 2008
    by Stephanie Peterson & Marsha Gold
  • 2008 Title I School Choice and Supplemental Educational Services
    by Brian Gill & Jennifer Sloan McCombs & Scott Naftel & Karen Ross & Mengli Song & Jennifer Harmon & Georges Vernez
  • 2008 Chartbook: Medicaid Pharmacy Benefit Use and Reimbursement in 2003
    by Jim Verdier & Ann Bagchi & Dominick Esposito
  • 2008 Confounding and Process-Model Fit in Research on Income Inequality and Population Health: A Rejoinder to Zimmerman and Glymour
    by Andrew Clarkwest
  • 2008 Neo-Materialist Theory and the Temporal Relationship Between Income Inequality and Longevity Change
    by Andrew Clarkwest
  • 2008 Evaluating the Performance of Philadelphia's Charter Schools
    by Ron Zimmer & Suzanne Blanc & Brian Gill & Jolley Christman
  • 2008 Impacts of Abstinence Education on Teen Sexual Activity, Risk of Pregnancy, and Risk of Sexually Transmitted Diseases
    by Christopher Trenholm & Barbara Devaney & Kenneth Fortson & Melissa Clark & Lisa Quay & Justin Wheeler
  • 2008 The Truncation-by-Death Problem: What to Do in an Experimental Evaluation When the Outcome Is Not Always Defined
    by Sheena McConnell & Elizabeth A. Stuart & Barbara Devaney
  • 2008 Changing the Paradigm from Treatment to Prevention: A Diabetes Case Model Context
    by Marsha Gold
  • 2008 Engaging Consumers: What Can Be Learned from Public Health Consumer Education Programs?
    by Margaret Gerteis & Matthew Hodges & James Mulligan
  • 2008 State Comprehensive Access Initiatives
    by Deborah Chollet
  • 2008 Implementation of the Building Strong Families Program
    by M. Robin Dion & Alan M. Hershey & Heather H. Zaveri & Sarah A. Avellar & Debra A. Strong & Timothy Silman & Ravaris Moore
  • 2008 Statistical Power for Random Assignment Evaluations of Education Programs
    by Peter Z. Schochet
  • 2008 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for February 2008
    by Stephanie Peterson & Marsha Gold
  • 2008 A Profile of Medicaid Institutional and Community-Based Long-Term Care Service Use and Expenditures Among the Aged and Disabled Using MAX 2002
    by Audra T. Wenzlow & Robert Schmitz & Kathy Shepperson
  • 2008 Medicaid-Financed Nursing Home Services: Characteristics of People Served and Their Patterns of Care, 2001-2002
    by Audra T. Wenzlow & Robert Schmitz & Jill Gurvey
  • 2008 Two Steps Forward, One Step Back: The Uneven Economic Progress of TANF Recipients
    by Robert G. Wood & Quinn Moore & Anu Rangarajan
  • 2008 Providing Specialized Personal and Work Support
    by Michelle K. Derr
  • 2008 Creating TANF and Vocational Rehabilitation Agency Partnerships
    by Emily Sama Martin & LaDonna Pavetti & Jacqueline Kauff
  • 2008 Creating Work Opportunities
    by Michelle K. Derr & LaDonna Pavetti
  • 2008 Conducting In-Depth Assessments
    by LaDonna Pavetti & Michelle Derr & Emily Sama Martin
  • 2008 Assisting TANF Recipients Living with Disabilities to Obtain and Maintain Employment
    by Jacqueline Kauff
  • 2008 Missouri's Teacher Career Ladder Program
    by Kevin Booker & Steven Glazerman
  • 2008 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for January 2008
    by Stephanie Peterson & Marsha Gold
  • 2008 Improving Child and Parent Mental Health in Primary Care: A Cluster-Randomized Trial of Communication Skills Training
    by Lawrence Sagin Wissow & Anne Gadomski & Debra Roter & Susan Larson & Jonathan Brown & Ciara Zachary & Edward Bartlett & Ivor Horn & Xianghua Luo & Mei-Cheng Wang
  • 2008 Do We Know If Medicare Advantage Special Needs Plans Are Special?
    by James Verdier & Marsha Gold & Sarah Davis
  • 2008 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for December 2007
    by Stephanie Peterson & Marsha Gold
  • 2008 Impacts of Comprehensive Teacher Induction: Results from the First Year of a Randomized Controlled Study
    by Steven Glazerman & Sarah Dolfin & Martha Bleeker & Amy Johnson & Eric Isenberg & Julieta Lugo-Gil & Mary Grider & Edward Britton
  • 2008 Federal Policy Efforts to Improve Outcomes Among Disadvantaged Families by Supporting Marriage and Family Stability
    by M. Robin Dion & Alan J. Hawkins
  • 2008 Impact of Multitiered Copayments on the Use and Cost of Prescription Drugs Among Medicare Beneficiaries
    by Boyd H. Gilman & John Kautter
  • 2008 Training Without Certification : An Experimental Study
    by Nadège Marchand & Claude Montmarquette
  • 2008 Measuring Poverty and Economic Inclusion: The Current Poverty Measure, the NAS Alternative, and the Case for a Truly New Approach
    by Shawn Fremstad
  • 2008 The Impact of the Medicare Drug Benefit on Health Care Spending by Older Households
    by Dean Baker & Ben Zipperer
  • 2008 "Illiteracy" Revisited: What Ortega and Rodríguez Read in the Household Survey
    by David Rosnick & Mark Weisbrot
  • 2008 Working Families and Economic Insecurity in the States: The Role of Job Quality and Work Supports
    by Shawn Fremstad & Rebecca Ray & Hye Jin Rho
  • 2008 How Not to Attack an Economist (and an Economy): Getting the Numbers Right
    by Mark Weisbrot
  • 2008 An Empty Research Agenda: The Creation of Myths About Contemporary Venezuela
    by Mark Weisbrot
  • 2008 The Benefits and Savings of Publicly-Funded Clinical Trials of Prescription Drugs
    by Dean Baker
  • 2008 The Venezuelan Economy in the Chávez Years
    by Mark Weisbrot & Luis Sandoval
  • 2008 Annual Review of Regulatory Burdens on Business: Manufacturing and Distributive Trades
    by Productivity Commission
  • 2008 Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain: A Randomized, Open-Label, Parallel-Group, Multicenter Study
    by Kavita Gajria & Mark Kosinski & Jeff Schein & Shane Kavanagh & Dominique Dubois
  • 2008 How Much Time Do Patients Spend on Outpatient Visits?: The American Time Use Survey
    by Louise B. Russell & Yoko Ibuka & Deborah Carr
  • 2008 The Burden of Restless Legs Syndrome: An Assessment of Work Productivity, Sleep, Psychological Distress, and Health Status Among Diagnosed and Undiagnosed Individuals in an Internet-Based Panel
    by Sheri Fehnel & Laurie Zografos & Tammy Curtice & Hemal Shah & Lori McLeod
  • 2008 Association of Pre-Existing Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients
    by Steven B. Zeliadt & Scott D. Ramsey & Arnold L. Potosky & Neeraj K. Arora & David K. Blough & Ingrid Oakley-Girvan & Ann S. Hamilton & Stephen K. Van Den Eeden & David F. Penson
  • 2008 Preferences of Patients with Advanced Colorectal Cancer for Treatment with Oral or Intravenous Chemotherapy
    by Candida M. Mastroianni & Caterina Viscomi & Silvia Ceniti & Rosanna De Simone & Aldo Filice & Gennaro Gadaleta Caldarola & Stefania Infusino & Caterina Manfredi & Antonio Rea & Claudia Sandomenico & Salvatore Turano & Francesco Serrano & Giovanni Condemi & Carla Cortese & Tullia Prantera & Salvatore Palazzo
  • 2008 Hormonal Contraceptive Users' Self-Reported Benefits, Adverse Reactions, and Fears in 2001 and 2007
    by Miia Tiihonen & Hanna-Mari Leppanen & Anna-Mari Heikkinen & Riitta Ahonen
  • 2008 Obesity and Symptom Burden in Family Medicine Patients
    by James E. Rohrer & Norman H. Rasmussen & Margaret S. Houston & Kurt B. Angstman
  • 2008 Understanding and Assessing the Impact of Alcoholism on Quality of Life: A Systematic Review of the Content Validity of Instruments Used to Assess Health-Related Quality of Life in Alcoholism
    by Matthew D. Reaney & Colin Martin & Jane Speight
  • 2008 Erik Rifkin, PhD: Writer, Researcher, Patient, and Citizen Advocate
    by Jennifer Chang
  • 2008 Association Between Measures of Fatigue and Health-Related Quality of Life in Rheumatoid Arthritis and Osteoarthritis
    by Marita Cross & Helen Lapsley & Annica Barcenilla & Peter Brooks & Lyn March
  • 2008 The Relationship Between Physician Friendliness and Caring, and Patient Satisfaction: Findings from an Internet-Based Survey
    by Adam A. Uhas & Fabian T. Camacho & Steven R. Feldman & Rajesh Balkrishnan
  • 2008 Does Behavioral Bootstrapping Boost Weight Control Confidence?: A Pilot Study
    by James E. Rohrer & Kristin S. Vickers-Douglas & Robert J. Stroebel
  • 2008 Making Patient-Centered Care More Visible: Planetree's Vision
    by Carrie Brady
  • 2008 Honoring the Life of a Pioneer in Patient-Centered Care: Harvey Picker, PhD (1915-2008)
    by Susan B. Frampton & Sara Guastello
  • 2008 Translation and Validation of the Chinese Diabetic Foot Ulcer Scale - Short Form
    by Lan Fong Hui & Daniel Yee-Tak Fong & Michael Yam & Wing Yuk Ip
  • 2008 The Use of Multi-Criteria Decision Analysis Weight Elicitation Techniques in Patients with Mild Cognitive Impairment: A Pilot Study
    by Janine A. van Til & James G. Dolan & Anne M. Stiggelbout & Karin C.G.M. Groothuis & Maarten J. IJzerman
  • 2008 Psychometric Performance of the National Eye Institute 25-Item Visual Function Questionnaire: In Turkish Diabetic Retinopathy Patients
    by Akinci Fevzi & Yildirim Aysegul
  • 2008 A Randomized Study of Electronic Diary versus Paper and Pencil Collection of Patient-Reported Outcomes in Patients with Non-Small Cell Lung Cancer
    by Alistair E. Ring & Kerry A. Cheong & Claire L. Watkins & David Meddis & David Cella & Peter G. Harper
  • 2008 Lillie Shockney: Breast Cancer Survivor, Advocate, and Researcher
    by John F.P. Bridges
  • 2008 When Time is Not on Your Side: Patient Experiences with Waiting for Home Care and Admission to a Nursing or Residential Home
    by N. Job A. van Exel & Marion de Ruiter & Werner B.F. Brouwer
  • 2008 Honoring Pioneers in Patient-Centered Outcomes Research
    by John F.P. Bridges & Christopher I. Carswell
  • 2008 Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study
    by Maribel Salas & Catarina I. Kiefe & Pamela J. Schreiner & Yongin Kim & Lucia Juarez & Sharina D. Person & O. Dale Williams
  • 2008 Age and Choice in Health Insurance: Evidence from a Discrete Choice Experiment
    by Karolin Becker & Peter Zweifel
  • 2008 If You Want Patients with Knee Osteoarthritis to Exercise, Tell Them about NSAIDs
    by Liana Fraenkel & Terri Fried
  • 2008 Concordance of Couples' Prostate Cancer Screening Recommendations from a Decision Analysis
    by Scott B. Cantor & Robert J. Volk & Murray D. Krahn & Alvah R. Cass & Jawaria Gilani & Susan C. Weller & Stephen J. Spann
  • 2008 The Role of The Patient in Promoting Patient-Centered Outcomes Research
    by Michael J. Klag & Ellen J. MacKenzie & Christopher I. Carswell & John F.P. Bridges
  • 2008 Subgroups and Heterogeneity in Cost-Effectiveness Analysis
    by Mark Sculpher
  • 2008 Exploring Uncertainty in Cost-Effectiveness Analysis
    by Karl Claxton
  • 2008 Valuing Health States for Use in Cost-Effectiveness Analysis
    by John Brazier
  • 2008 Use of Indirect and Mixed Treatment Comparisons for Technology Assessment
    by Alex Sutton & A.E. Ades & Nicola Cooper & Keith Abrams
  • 2008 Estimating `Costs' for Cost-Effectiveness Analysis
    by Alec Miners
  • 2008 The NICE Cost-Effectiveness Threshold: What it is and What that Means
    by Christopher McCabe & Karl Claxton & Anthony J. Culyer
  • 2008 NICE Methodology for Technology Appraisals: Cutting Edge or Tried and Trusted?
    by Louise Longworth & Carole Longson
  • 2008 NICE Guide to the Methods of Technology Appraisal: Pharmaceutical Industry Perspective
    by Julia Earnshaw & Gavin Lewis
  • 2008 NICE's 2008 Methods Guide: Sensible Consolidation or Opportunities Missed?
    by Mark Sculpher
  • 2008 Trastuzumab: A Pharmacoeconomic Review of its Use in Early Breast Cancer
    by Kate McKeage & Katherine A. Lyseng-Williamson
  • 2008 Demand Forecasting for Preventive AIDS Vaccines: Economic and Policy Dimensions
    by Robert Hecht & Gian Gandhi
  • 2008 Conducting Discrete Choice Experiments to Inform Healthcare Decision Making: A User's Guide
    by Emily Lancsar & Jordan Louviere
  • 2008 Assessing the Impact of Global Price Interdependencies
    by Anke Richter
  • 2008 Modelling Approaches: The Case of Schizophrenia
    by Bart M.S. Heeg & Joep Damen & Erik Buskens & Sue Caleo & Frank de Charro & Ben A. van Hout
  • 2008 Waiting for Reimbursement of New Medicines in Canada: It's Time for a Rethink
    by Brett J. Skinner
  • 2008 Cost-Effectiveness Analyses of Natalizumab (Tysabri(R)) Compared with Other Disease-Modifying Therapies for People with Highly Active Relapsing-Remitting Multiple Sclerosis in the UK
    by Ray Gani & Gavin Giovannoni & David Bates & Belinda Kemball & Steve Hughes & John Kerrigan
  • 2008 Generic Entry, Reformulations and Promotion of SSRIs in the US
    by Haiden A. Huskamp & Julie M. Donohue & Catherine Koss & Ernst R. Berndt & Richard G. Frank
  • 2008 Future Drug Prices and Cost-Effectiveness Analyses
    by Martin Hoyle
  • 2008 Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes: A Systematic Review on Content and Adherence to Guidelines
    by Stefan Vegter & Cornelis Boersma & Mark Rozenbaum & Bob Wilffert & GerJan Navis & Maarten J. Postma
  • 2008 The Author's Reply
    by Adam E. Block
  • 2008 Does Direct-to-Consumer Advertising of Antidepressants Lead to a Net Social Benefit?
    by Jon Jureidini & Barbara Mintzes & Melissa Raven
  • 2008 Pharmaceutical Risk-Sharing Agreements
    by Joseph P. Cook & John A. Vernon & Richard Manning
  • 2008 Recent National and Regional Drug Reforms in Sweden: Implications for Pharmaceutical Companies in Europe
    by Bjorn Wettermark & Brian Godman & Karolina Andersson & Lars L. Gustafsson & Alan Haycox & Vittorio Bertele'
  • 2008 Cost Effectiveness of the German Screen-and-Treat Strategy for Postmenopausal Osteoporosis
    by Dirk Mueller & Eva Weyler & Afschin Gandjour
  • 2008 Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model: Application to a Population of US Adult Smokers
    by Paul Howard & Christopher Knight & Annabel Boler & Christine Baker
  • 2008 Guidelines for Conducting Pharmaceutical Budget Impact Analyses for Submission to Public Drug Plans in Canada
    by Deborah A. Marshall & Patrick R. Douglas & Michael F. Drummond & George W. Torrance & Stuart MacLeod & Orlando Manti & Lokanadha Cheruvu & Ron Corvari
  • 2008 Cost of Epilepsy: A Systematic Review
    by Adam Strzelczyk & Jens Peter Reese & Richard Dodel & Hajo M. Hamer
  • 2008 Economic Burden of Heart Failure in the Elderly
    by Lawrence Liao & Larry A. Allen & David J. Whellan
  • 2008 Updated Estimates of Survival and Cost Effectiveness for Imatinib versus Interferon-alpha Plus Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukaemia
    by Shelby D. Reed & Kevin J. Anstrom & Yanhong Li & Kevin A. Schulman
  • 2008 A Multicentre, Prospective Study to Evaluate Costs of Septic Patients in Brazilian Intensive Care Units
    by Ana M.C. Sogayar & Flavia R. Machado & Alvaro Rea-Neto & Amselmo Dornas & Cintia M.C. Grion & Suzana M.A. Lobo & Bernardo R. Tura & Carla L.O. Silva & Ruy G.R. Cal & Idal Beer & Vilto Michels & Jorge Safi & Marcia Kayath & Eliezer Silva
  • 2008 Methodological Issues in Evaluating Cost Effectiveness of Adjuvant Aromatase Inhibitors in Early Breast Cancer: A Need for Improved Modelling to Aid Decision Making
    by Lieven Annemans
  • 2008 Economic Evaluations in Rheumatoid Arthritis: A Critical Review of Measures Used to Define Health States
    by Nick Bansback & Roberta Ara & Jonathan Karnon & Aslam Anis
  • 2008 Economic Evaluation of Interventions to Treat Opiate Dependence: A Review of the Evidence
    by Christopher M. Doran
  • 2008 Perspectives on Patient-Reported Outcomes: Content Validity and Qualitative Research in a Changing Clinical Trial Environment
    by Nancy Kline Leidy & Margaret Vernon
  • 2008 Cost-Effectiveness Analysis: Developing Nations Left Behind
    by Mendel E. Singer
  • 2008 Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study
    by Martin Knapp & Frank Windmeijer & Jacqueline Brown & Stathis Kontodimas & Spyridon Tzivelekis & Josep Maria Haro & Mark Ratcliffe & Jihyung Hong & Diego Novick
  • 2008 An Economic Evaluation of Atorvastatin for Primary Prevention of Cardiovascular Events in Type 2 Diabetes
    by Scott D. Ramsey & Lauren D. Clarke & Craig S. Roberts & Sean D. Sullivan & Scott J. Johnson & Larry Z. Liu
  • 2008 Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis: Cost-Utility Analysis Using a Markov Model
    by Simon Kreck & Jochen Klaus & Reiner Leidl & Christian von Tirpitz & Alexander Konnopka & Herbert Matschinger & Hans-Helmut Konig
  • 2008 The Use of QALY Weights for QALY Calculations: A Review of Industry Submissions Requesting Listing on the Australian Pharmaceutical Benefits Scheme 2002-4
    by Paul A. Scuffham & Jennifer A. Whitty & Andrew Mitchell & Rosalie Viney
  • 2008 Making a Case for Employing a Societal Perspective in the Evaluation of Medicaid Prescription Drug Interventions
    by Sanjoy Roy & S. Suresh Madhavan
  • 2008 An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare
    by Marc A. Koopmanschap & N. Job A. van Exel & Bernard van den Berg & Werner B.F. Brouwer
  • 2008 Zoledronic Acid: A Pharmacoeconomic Review of its Use in the Management of Bone Metastases
    by Kate McKeage & Greg L. Plosker
  • 2008 Community and Patient Values for Preventing Herpes Zoster
    by Tracy A. Lieu & Ismael Ortega-Sanchez & G. Thomas Ray & Donna Rusinak & W. Katherine Yih & Peter W. Choo & Irene Shui & Ken Kleinman & Rafael Harpaz & Lisa A. Prosser
  • 2008 Preferences of Patients with Diabetes Mellitus for Inhaled versus Injectable Insulin Regimens
    by Jeremy Chancellor & Samuel Aballea & Alison Lawrence & Rob Sheldon & Sandrine Cure & Juliette Plun-Favreau & Nick Marchant
  • 2008 Cost-Effectiveness Analyses of Vaccination Programmes: A Focused Review of Modelling Approaches
    by Sun-Young Kim & Sue J. Goldie
  • 2008 Projecting Vaccine Efficacy: Accounting for Geographic Strain Variations
    by Johnie Rose & Mendel E. Singer
  • 2008 Transparency of Economic Evaluations of Health Technologies
    by Joan Rovira
  • 2008 Meandering Down the Road to Transparency
    by Christopher I. Carswell & Joseph A. Paladino
  • 2008 Management of Anaemia: A Critical and Systematic Review of the Cost Effectiveness of Erythropoiesis-Stimulating Agents
    by Mei Sheng Duh & Jennifer R. Weiner & Leigh Ann White & Patrick Lefebvre & Paul E. Greenberg
  • 2008 Having Your Cake and Eating It: Office of Fair Trading Proposal for Funding New Drugs to Benefit Patients and Innovative Companies
    by Brian Godman & Alan Haycox & Ulrich Schwabe & Roberta Joppi & Silvio Garattini
  • 2008 Non-Traditional Settings for Influenza Vaccination of Adults: Costs and Cost Effectiveness
    by Lisa A. Prosser & Megan A. O'Brien & Noelle-Angelique M. Molinari & Katherine H. Hohman & Kristin L. Nichol & Mark L. Messonnier & Tracy A. Lieu
  • 2008 The Burden of Schizophrenia on Caregivers: A Review
    by A. George Awad & Lakshmi N.P. Voruganti
  • 2008 Modelling Methods for Pharmacoeconomics and Health Technology Assessment: An Overview and Guide
    by James E. Stahl
  • 2008 Economic Burden of Psoriatic Arthritis
    by Christoph Ackermann & Arthur Kavanaugh
  • 2008 Cost Effectiveness of Itraconazole in the Prophylaxis of Invasive Fungal Infections
    by Robin de Vries & Simon Daenen & Keith Tolley & Axel Glasmacher & Archie Prentice & Sarah Howells & Hariette Christopherson & Lolkje T.W. de Jong-van den Berg & Maarten J. Postma
  • 2008 Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration: Multi-Country Observational Study
    by Alan F. Cruess & Gergana Zlateva & Xiao Xu & Gisele Soubrane & Daniel Pauleikhoff & Andrew Lotery & Jordi Mones & Ronald Buggage & Caroline Schaefer & Tyler Knight & Thomas F. Goss
  • 2008 The Last Decade of Italian Pharmaceutical Policy: Instability or Consolidation?
    by Giovanni Fattore & Claudio Jommi
  • 2008 Dynamic Modelling of Infectious Diseases: An Application to the Economic Evaluation of Influenza Vaccination
    by Roberto Pradas-Velasco & Fernando Antonanzas-Villar & Maria Puy Martinez-Zarate
  • 2008 Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis
    by Gabriel Rogers & Ruth Garside & Stuart Mealing & Martin Pitt & Rob Anderson & Matthew Dyer & Ken Stein & Margaret Somerville
  • 2008 Cost-Effectiveness Analyses of Hepatitis A Vaccine: A Systematic Review to Explore the Effect of Methodological Quality on the Economic Attractiveness of Vaccination Strategies
    by Andrea M. Anonychuk & Andrea C. Tricco & Chris T. Bauch & Ba' Pham & Vladimir Gilca & Bernard Duval & Ava John-Baptiste & Gloria Woo & Murray Krahn
  • 2008 The New Myth: The Social Value of the QALY
    by Werner Brouwer & Job van Exel & Rachel Baker & Cam Donaldson
  • 2008 Modelling Downstream Effects in the Presence of Technological Change
    by Duncan Mortimer
  • 2008 Does `NICE blight' exist, and if so, why?
    by Alan Haycox
  • 2008 Acknowledgement
    by Adis International Limited
  • 2008 Book Review
    by Adis International Limited
  • 2008 A Cost-Utility Comparison of Four First-Line Medications in Painful Diabetic Neuropathy
    by Alec B. O'Connor & Katia Noyes & Robert G. Holloway
  • 2008 Single Technology Appraisals by NICE: Are They Delivering Faster Guidance to the NHS?
    by Leela Barham
  • 2008 Management and Prevention of Diabetic Foot Ulcers and Infections: A Health Economic Review
    by Ivy Chow & Elkin V. Lemos & Thomas R. Einarson
  • 2008 Measuring US Pharmaceutical Industry R&D Spending
    by Joseph Golec & John Vernon
  • 2008 Escitalopram and Duloxetine in Major Depressive Disorder: A Pharmacoeconomic Comparison Using UK Cost Data
    by Alan G. Wade & Jose-Luis Fernandez & Clement Francois & Karina Hansen & Natalya Danchenko & Nicolas Despiegel
  • 2008 Economic Impact and Long-Term Graft Outcomes of Mycophenolate Mofetil Dosage Modifications Following Gastrointestinal Complications in Renal Transplant Recipients
    by Gerardo Machnicki & Jean-Francois Ricci & Daniel C. Brennan & Mark A. Schnitzler
  • 2008 A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B
    by D. Eldon Spackman & David L. Veenstra
  • 2008 A Review of Health-Utility Data for Osteoarthritis: Implications for Clinical Trial-Based Evaluation
    by Hirsch S. Ruchlin & Ralph P. Insinga
  • 2008 The Impact of Influenza on Working Days Lost: A Review of the Literature
    by Martin Keech & Paul Beardsworth
  • 2008 Methods for the Meta-Analysis of Willingness-to-Pay Data: An Overview
    by George Van Houtven
  • 2008 Loss Aversion and Cost Effectiveness of Healthcare Programmes: Whose Aversion Counts Anyway?
    by Johan L. Severens
  • 2008 Loss Aversion and Cost Effectiveness of Healthcare Programmes
    by Afschin Gandjour
  • 2008 The Authors
    by Oren Shavit & Moshe Leshno & Assaf Goldberger & Amir Shmueli & Amnon Hoffman
  • 2008 Assessing the Value of a Future Study
    by Afschin Gandjour
  • 2008 Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure: An Individual Patient-Based Simulation Model
    by Guiqing Yao & Nick Freemantle & Marcus Flather & Puvan Tharmanathan & Andrew Coats & Philip A. Poole-Wilson
  • 2008 Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland: An Analysis of the EUROPA Study Including 1251 Polish Patients
    by W. Ken Redekop & Ewa Orlewska & Pawel Maciejewski & Frans F.H. Rutten & Louis W. Niessen
  • 2008 Multiple Sclerosis in the UK: Service Use, Costs, Quality of Life and Disability
    by Paul McCrone & Margaret Heslin & Martin Knapp & Paul Bull & Alan Thompson
  • 2008 Quality-of-Life Assessment in Rheumatoid Arthritis
    by Anthony S. Russell
  • 2008 Unrelated Medical Costs in Life-Years Gained: Should They be Included in Economic Evaluations of Healthcare Interventions?
    by David R. Rappange & Pieter H.M. van Baal & N. Job A. van Exel & Talitha L. Feenstra & Frans F.H. Rutten & Werner B.F. Brouwer
  • 2008 Funding a Clinical Trial: The Perspective of a Medicines Funder
    by Peter Alsop & Scott Metcalfe & Jackie Evans
  • 2008 Trastuzumab in Early-Stage Breast Cancer: The Question of Treatment Timing
    by Steven Simoens
  • 2008 Effectiveness of a Structured Intensive Weight Loss Program Using Health Educators
    by James E. Rohrer & Harvey D. Cassidy & Diane Dressel & Barbara Cramer
  • 2008 Relationship between the Change in Mental Health and Indicators of Medical Costs in the Prevention of Lifestyle-Related Disease
    by Reiko Ishihara & Chihoko Kame & Akira Babazono
  • 2008 An Economic Evaluation of Quantitative Ultrasonometry as Pre-Screening Test for the Identification of Patients with Osteoporosis
    by Mickael Hiligsmann & Olivier Ethgen & Olivier Bruyere & Jean-Yves Reginster
  • 2008 Assessing the Barriers to Engaging Challenging Populations in Disease Management Programs: The Medicaid Experience
    by Dylan H. Roby & Gerald F. Kominski & Nadereh Pourat
  • 2008 Health Beliefs and Culture: Essential Considerations for Outcome Measurement
    by Kamaldeep Bhui & Sokratis Dinos
  • 2008 Antimicrobial Stewardship Programs: Role in Optimizing Infectious Disease Outcomes
    by Christine J. Kubin
  • 2008 Information Technology to Support Self-Management in Chronic Care: A Systematic Review
    by Michael R. Solomon
  • 2008 Use of Collaboration to Improve Outcomes in Chronic Disease: An Overview
    by Monica Gilbert & Carole Staley & Sharryn Lydall-Smith & David J. Castle
  • 2008 Is the Rate of Generic Drug Prescribing a Fair Measure for Pay for Performance?
    by Stephen Buetow & Linda Bryant
  • 2008 Acknowledgment
    by Adis International Limited
  • 2008 Evaluation Methods in Disease Management Studies: 2004-07
    by Thomas Wilson & Martin MacDowell & Patricia Salber & Gary Montrose & Carolyn Hamm
  • 2008 Symptom Perspectives: Patient-Professional Differences and Communication
    by Cathy Michaels & Suzanne C. Lareau
  • 2008 Patients with Chronic Obstructive Pulmonary Disease: Between Reality and Expectations - A Patient
    by Wlodzimierz Vlady Rozenbaum
  • 2008 Patients with Alpha-1 Antitrypsin Deficiency: Disease Management Considerations
    by Rick Carter & Brian L. Tiep
  • 2008 Successful Smoking Cessation
    by Gary L. Huber & Vijay K. Mahajan
  • 2008 Clinical Decision Processes and Patient Engagement in Self-Management
    by Jean Bourbeau
  • 2008 Disease Management of Chronic Obstructive Pulmonary Disease from a Disease Management Organization Perspective: Providing Technology and Time to Address Gaps in Care
    by Christobel E. Selecky
  • 2008 Integrated Chronic Obstructive Pulmonary Disease Management in Primary Care
    by Niels H. Chavannes
  • 2008 Disease Management for Chronic Obstructive Pulmonary Disease: A Clinical Strategy
    by Brian L. Tiep & Mary C. Barnett
  • 2008 Asthma as a Model for Chronic Disease Management Programs: The Interplay between Pulmonary Function and Quality of Life
    by Aris C. Garro & Robert B. Klein
  • 2008 Optimizing Disease Management of Chronic Obstructive Pulmonary Disease
    by Philip Corsello & David Tinkelman
  • 2008 Approaches to Chronic Disease and Chronic Care: From Oxymoron to Modern Zeitgeist
    by Anna M. Tacon
  • 2008 The Emerging Chronic Obstructive Pulmonary Disease Epidemic: Clinical Impact, Economic Burden, and Opportunities for Disease Management
    by Rick Carter & Brian L. Tiep & Rebecca E. Tiep
  • 2008 Chronic Obstructive Pulmonary Disease: The Challenge and the Solution
    by Thomas L. Petty
  • 2008 Delivering Diabetes Self-Management Education (DSME) in Primary Care: The Pittsburgh Regional Initiative For Diabetes Education (PRIDE)
    by Linda M. Siminerio & Kristine Ruppert & Sharlene Emerson & Francis X. Solano & Gretchen A. Piatt
  • 2008 Disease Management Programs Targeting Obesity in Children: Setting the Scene for Wellness in the Future
    by Adrienne R. Hughes & John J. Reilly
  • 2008 Community Pharmacy, Disease State Management, and Adherence to Medication: A Review
    by Carol Lyn Armour & Lorraine Smith & Ines Krass
  • 2008 Clinical Pharmacy Services in the Home
    by Linda D. MacKeigan & Lisa M. Nissen
  • 2008 Launch of a National Mandatory Chronic Disease Prevention Program in Japan
    by Atsushi Kobayashi
  • 2008 Measuring Quality in Pay-for-Performance Programs: From `One-Size-Fits-All' Measures to Individual Patient Risk-Reduction Scores
    by Jennifer A. Meddings & Laurence F. McMahon
  • 2008 Pharmacy Continuity of Care: What do Community Pharmacists Need from an Acute Care Hospital to Improve Continuity of Pharmaceutical Care?
    by Cherokee Layson-Wolf & Jill A. Morgan
  • 2008 An Italian Chart for Cardiovascular Risk Estimate Including High-Density Lipoprotein-Cholesterol
    by Alessandro Menotti & Mariapaola Lanti
  • 2008 Clinical and Economic Effects of a Therapeutic Substitution Policy for Proton Pump Inhibitors in Aboriginal Patients in Northern Communities in Canada's Northwest Territories
    by Kathryn Gaebel & Neda Toeg & Mitchell Levine
  • 2008 Why it Pays for Hospitals to Initiate a Heart Failure Disease Management Program
    by Mauricio Velez & Bethany Westerfeldt & Peter S. Rahko
  • 2008 Creating the Virtual Team: Application to Diabetes Mellitus Disease Management
    by Roger Mazze
  • 2008 Pharmacist-Led Interventions for the Management of Cardiovascular Disease: Opportunities and Obstacles
    by Karen J. McConnell & Anne M. Denham & Kari L. Olson
  • 2008 Considerations in Culturally Directed Asthma Disease Management Programs
    by Michelle M. Cloutier
  • 2008 Employee Disease Management in US and Global Workplaces: Integrating Strategies and Expanding their Scope
    by Robin C. Rager & Joseph A. Leutzinger & Jeff A. Hochberg & Wolf Kirsten & David H. Chenoweth
  • 2008 The Potential and Pitfalls of Medicine Management: What Have We Learned So Far?
    by Alison Blenkinsopp & Christine M. Bond
  • 2008 Lessons from Early Experience with Pay for Performance
    by Tim Doran
  • 2008 Disease Management Update
    by Adis International Limited
  • 2008 Intensified Diabetes Care Monitoring and Physician Education: Impact on Outcomes and Costs of Care
    by Ann Donnelly & Prasad Kommareddi & Michael James & Jerry Van Horn & Christopher Zacker & Dan Belletti
  • 2008 Cost Analysis of a Maternity Disease Management Program
    by Gary Stanziano & Niki Istwan
  • 2008 Interdisciplinary Coordination for Breast Healthcare: A Rational Approach to Detection, Diagnosis, and Treatment
    by Benjamin O. Anderson & Cary S. Kaufman & Krystyna D. Kiel & Robert W. Carlson
  • 2008 Disease Management Update
    by Adis International Limited
  • 2008 Nursing Workload Associated with Hospital Patient Care
    by Nicole Mittmann & Soo Jin Seung & Luca F. Pisterzi & Pierre K. Isogai & Donna Michaels
  • 2008 General Pain and Frequency of Medical Visits in Family Medicine: A Retrospective Analysis of Medical Records
    by James E. Rohrer & Stephen P. Merry & Steven C. Adamson & Darryl E. Barnes
  • 2008 Challenges and Applications of the Transtheoretical Model in Patients with Diabetes Mellitus
    by Ana Andres & Juana Gomez & Carmina Saldana
  • 2008 Poor Adherence to Medication in Adults with Rheumatoid Arthritis: Reasons and Solutions
    by Rachel A. Elliott
  • 2008 Challenges Facing Nurse-Led Disease Management for Heart Failure
    by Paul L. Hebert & Jane E. Sisk
  • 2008 Cost-Effectiveness Analysis of Entecavir versus Lamivudine in the First-Line Treatment of Australian Patients with Chronic Hepatitis B
    by Elizabeth Arnold & Yong Yuan & Uchenna Iloeje & Greg Cook
  • 2008 Does Extending Health Insurance Coverage to the Uninsured Improve Population Health Outcomes?
    by James A. Thornton & Jennifer L. Rice
  • 2008 Cost-Effectiveness Analysis of Vaccination against Rotavirus with RIX4414 in France
    by Baudouin Standaert & Nathalie Parez & Bertrand Tehard & Xavier Colin & Bruno Detournay
  • 2008 A Pharmacoeconomic Analysis of Compliance Gains on Antipsychotic Medications
    by Joep Damen & Per-Olof Thuresson & Bart Heeg & Mickael Lothgren
  • 2008 Community-Based Interventions to Promote Increased Physical Activity: A Primer
    by Melissa Bopp & Elizabeth Fallon
  • 2008 The Impact of Direct-to-Consumer Advertised Drugs on Drug Sales in the US and New Zealand
    by Edward Norey & Tessa M. Simone & Shaker A. Mousa
  • 2008 The Impact of Banning Smoking in Workplaces: What are the Early Effects?
    by Shane Allwright
  • 2008 Cost Analysis of Amlodipine versus Enalapril in Patients with Coronary Artery Disease and Normal Blood Pressure: Findings from the CAMELOT Economic Substudy
    by Joseph Menzin & Luke Boulanger & Simon Tang & Kamlesh Thakker & Steven E. Nissen
  • 2008 The Association of Adherence to Antiretroviral Therapy with Healthcare Utilization and Costs for Medical Care
    by Edward M. Gardner & Moises E. Maravi & Cornelis Rietmeijer & Arthur J. Davidson & William J. Burman
  • 2008 Households' Willingness to Pay for a Motorcycle Helmet in Hanoi, Vietnam
    by Khanh H. Pham & Quynh X. Le Thi & Dennis J. Petrie & Jon Adams & Christopher M. Doran
  • 2008 Cost Effectiveness of Ultrasound and Bone Densitometry for Osteoporosis Screening in Post-Menopausal Women
    by Dirk Mueller & Afschin Gandjour
  • 2008 Direct Medical Costs for Type 2 Diabetes Mellitus Complications in the US Commercial Payer Setting: A Resource for Economic Research
    by Elise M. Pelletier & Paula J. Smith & Kristina S. Boye & Derek A. Misurski & Sandra L. Tunis & Michael E. Minshall
  • 2008 Cost Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention in a Belgian Context
    by Mattias Neyt & Nancy Thiry & Dirk Ramaekers & Hans Van Brabandt
  • 2008 The Lifetime Cost of Hepatocellular Carcinoma: A Claims Data Analysis from a Medical Centre in Taiwan
    by Hui-Chu Lang & Jaw-Ching Wu & Sang-Hue Yen & Chung-Fu Lan & Shi-Liang Wu
  • 2008 Cost-Effectiveness Analysis of Switching Antipsychotic Medication to Long-Acting Injectable Risperidone in Patients with Schizophrenia: A 12- and 24-Month Follow-Up from the e-STAR Database in Spain
    by Jose M. Olivares & Alfonso Rodriguez-Martinez & Jose A. Buron & David Alonso-Escolano & Alexander Rodriguez-Morales
  • 2008 Wealth Status and Risky Sexual Behaviour in Ghana and Kenya
    by Kofi Awusabo-Asare & Samuel K. Annim
  • 2008 Differences in Generic Drug Prices between the US and Canada
    by Malcolm Gooi & Chaim M. Bell
  • 2008 Cost Effectiveness of Screen-and-Treat Strategies for Low Bone Mineral Density: How Do We Screen, Who Do We Screen and Who Do We Treat?
    by John T. Schousboe
  • 2008 School Management: Norwegian Legacies Bowing to New Public Management
    by Arild Tjeldvoll
  • 2008 Means of Knowledge Acquisition of Entrepreneurs and Their Success
    by Barbara Hvalic Erzetic
  • 2008 Las facultades de la modernización: contexto de aparición de los programas de contaduría pública en Colombia
    by EDISON FREDY LEÓN PAIME
  • 2008 Determinantes de los resultados de las evaluaciones de profesores: el caso de la Universidad de los Andes
    by Gaviria Alejandro & Alejandro Hoyos
  • 2007 Teacher Licensure Exams: How Do They Compare?
    by Duncan Chaplin & Steven Glazerman & Gail Baxter & Elizabeth Seif
  • 2007 Medicaid Populations with Chronic and Disabling Conditions: A Compilation of Data on Their Characteristics, Health Conditions, Service Use, and Medicaid Payments
    by Carol V. Irvin & Christopher Johnson
  • 2007 Frequently Asked Questions by Parents About the Universal Preschool Study
    by Mathematica Policy Research
  • 2007 The Effects of PACE on Medicare and Medicaid Expenditures
    by Leslie Foster & Robert Schmitz & Peter Kemper & Amy Zambrowski & Mei-Ling Mason & Matthew Jacobus & Jill Gurvey & Jeffrey Holt
  • 2007 Elementary-Grade Math Programs in the Pittsburgh Public Schools: A Comparison of Everyday Mathematics and Harcourt Math
    by Catherine Nelson & Julia Kaufman & Kevin Booker & Brian Gill
  • 2007 Packing Your Bags with the Evaluation Toolkit
    by Christopher Trenholm
  • 2007 Case Study of Missouri: Exploring Medicaid and SCHIP Enrollment Trends and Their Links to Policy and Practice
    by Benjamin Cook & Whitney Schott & Chris Trenholm
  • 2007 Feasibility of a Star Teacher Demonstration
    by Jeffrey Max & Allison McKie & Steven Glazerman
  • 2007 Case Study of Oregon: Exploring Medicaid and SCHIP Enrollment Trends and Their Links to Policy and Practice
    by Brigette Courtot & Ian Hill & Chris Trenholm
  • 2007 Covering Kids & Families Coalitions Propel Policy and Procedural Changes
    by Sheila Hoag & Judith Wooldridge
  • 2007 Federal Program Expenditures for Working-Age People with Disabilities
    by Nanette J. Goodman & David C. Stapleton
  • 2007 Evaluation of the Home Health Independence Demonstration: Barriers to a Successful Experiment Were Multifaceted, and Difficult Policy Issues Remain
    by Valerie Cheh & Nancy Duda & Barbara Lepidus Carlson & Karen CyBulski & Amy Zambrowski & Andrew McGuirk
  • 2007 Implementation of the National Reporting System in Migrant/Seasonal Head Start Programs: Year Two Update
    by Renée Nogales & Diane Paulsell & Louisa Tarullo
  • 2007 A National Survey of State Licensing, Regulating, and Monitoring of Residential Facilities for Children with Mental Illness
    by Judith L. Teich & Henry T. Ireys
  • 2007 Technical Report of the NAEP Mathematics Assessment in Puerto Rico: Focus on Statistical Issues
    by G.P. Baxter & S. Ahmed & E. Sikali & T. Waits & M. Sloan & S. Salvucci
  • 2007 Evaluation of the Teacher Advancement Program (TAP) in the Chicago Public Schools: Study Design Report
    by Steven Glazerman & Allison McKie & Nancy Carey & Dominic Harris
  • 2007 FACES 2006: Study Design
    by Jerry West & Louisa Tarullo & Nikki Aikens & Susan Sprachman & Christine Ross & Barbara Lepidus Carlson
  • 2007 Research Design for the Money Follows the Person Evaluation
    by Carol Irvin & Randall Brown & Sam Simon
  • 2007 Using EQROs to Improve the Quality of Preventive and Developmental Services
    by Henry T. Ireys & Tara Krissik & Anne Markus & Sara Rosenbaum
  • 2007 Dynamics in Medicaid and SCHIP Eligibility Among Children in SCHIP's Early Years: Implications for Reauthorization
    by Anna S. Sommers & Lisa Dubay & Linda J. Blumberg & Fredric E. Blavin & John L. Czajka
  • 2007 Results from the "I Am Moving, I Am Learning" Stage 1 Survey
    by Daniel Finkelstein & Robert Whitaker & Elaine Hill & Mary Kay Fox & Linda Mendenko & Kimberly Boller
  • 2007 Issues in Calculating Average Effect Sizes in Meta-Analyses
    by Rebecca Maynard & Nianbo Dong & Irma Perez-Johnson
  • 2007 National Assessment of Title I Final Report: Volume II: Closing the Reading Gap: Findings from a Randomized Trial of Four Reading Interventions for Striving Readers. Appendices
    by Joseph Torgesen & Allen Schirm & Laura Castner & Sonya Vartivarian & Wendy Mansfield & David Myers & Fran Stancavage & Donna Durno & Rosanne Javorsky & Cinthia Haan
  • 2007 National Assessment of Title I Final Report: Volume II: Closing the Reading Gap: Findings from a Randomized Trial of Four Reading Interventions for Striving Readers
    by Joseph Torgesen & Allen Schirm & Laura Castner & Sonya Vartivarian & Wendy Mansfield & David Myers & Fran Stancavage & Donna Durno & Rosanne Javorsky & Cinthia Haan
  • 2007 Federal Medical and Disability Program Costs Associated with Diabetes, 2005. Summary of Methods and Key Findings
    by Marsha Gold & Craig Thornton & Allison Hedley & Cheryl Fahlman & Suzanne Felt-Lisk & Bob Weathers & Thomas Croghan
  • 2007 How Do Medicaid Buy-In Participants Who Collect Social Security Disability Insurance Benefits Use SSA Work Incentive Programs?
    by Kristin Andrews & Bob Weathers & Su Liu
  • 2007 Living Arrangements and School Dropout Among Teen Mothers Following Welfare Reform
    by Heather Koball
  • 2007 National Survey of Substance Abuse Treatment Services (N-SSATS): 2006. Data on Substance Abuse Treatment Facilities
    by Synectics for Management Decisions & Inc. & Mathematica Policy Research
  • 2007 Leading the Way? Maine's Initial Experience in Expanding Coverage Through Dirigo Health Reforms
    by Debra J. Lipson & James M. Verdier & Lynn Quincy
  • 2007 Assessment of State Capacity to Identify and Track Disparities in the Leading Health Indicators
    by Allison Hedley Dodd & Melissa Neuman & Marsha Gold
  • 2007 When Elementary Schools Stay Open Late: Results from The National Evaluation of the 21st Century Community Learning Centers Program
    by Susanne James-Burdumy & Mark Dynarski & John Deke
  • 2007 Posttransition Experiences of Former Child SSI Recipients
    by Pamela J. Loprest & David C. Wittenburg
  • 2007 Using Vouchers to Deliver Social Services: Considerations Based on the Child Care and Development Fund (CCDF) and Temporary Assistance for Needy Families (TANF) Program Experiences
    by Gretchen Kirby & Andrew Burwick
  • 2007 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for November, 2007
    by Stephanie Peterson & Marsha Gold
  • 2007 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for October, 2007
    by Stephanie Peterson & Marsha Gold
  • 2007 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for September, 2007
    by Stephanie Peterson & Marsha Gold
  • 2007 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for August, 2007
    by Stephanie Peterson & Marsha Gold
  • 2007 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for June, 2007
    by Stephanie Peterson & Marsha Gold
  • 2007 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for May, 2007
    by Stephanie Peterson & Marsha Gold
  • 2007 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for April, 2007
    by Stephanie Peterson & Marsha Gold
  • 2007 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for March, 2007
    by Stephanie Peterson & Marsha Gold
  • 2007 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for February, 2007
    by Stephanie Peterson & Marsha Gold
  • 2007 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for January, 2007
    by Stephanie Peterson & Marsha Gold
  • 2007 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for December, 2006
    by Stephanie Peterson & Marsha Gold
  • 2007 When Work First Is Not Enough: Using Innovative Assessment Techniques and Intensive Case Management to Address the Needs of Long-Term TANF Recipients in Ramsey County, Minnesota
    by LaDonna Pavetti & Jackie Kauff & Michelle K. Derr
  • 2007 Measuring Children's Progress from Preschool Through Third Grade
    by Sally Atkins-Burnett
  • 2007 Material Hardship, Poverty, and Disability Among Working-Age Adults
    by Peiyun She & Gina A. Livermore
  • 2007 Improving Processes and Increasing Efficiency: The Case for States Participating in a Process Improvement Collaborative
    by Sheila Hoag & Judith Wooldridge
  • 2007 Elementary Math Programs in the Pittsburgh Public Schools: A Comparison of Everyday Math and Harcourt Math
    by Brian Gill & Catherine Nelson & Julia Kaufman & Kevin Booker
  • 2007 Leading The Way? Maine's Initial Experience in Expanding Coverage Through Dirigo Health Reforms
    by Debra Lipson & James Verdier & Lynn Quincy & Robert Hurley & Elizabeth Seif & Shanna Shulman & Matt Sloan
  • 2007 Medicare Advantage Special Needs Plans Reauthorization: What Should Congress Consider?
    by James M. Verdier
  • 2007 Measuring Trends in Mental Health Care Disparities, 2000-2004
    by Benjamin L. Cook & Thomas McGuire & Jeanne Miranda
  • 2007 Governing the Family Through Education: A Genealogy on the Home/School Relation
    by Kirsten Kainz & Nikki L. Aikens
  • 2007 Authorship and Publication Practices: Evaluation of the Effect of Responsible Conduct of Research Instruction to Postdoctoral Trainees
    by Carolyn L. Funk & Kirsten A. Barrett & Francis L. Macrina
  • 2007 Three Independent Evaluations of Healthy Kids Programs Find Dramatic Gains in Well-Being of Children and Families
    by Christopher Trenholm & Embry Howell & Ian Hill & Dana Hughes
  • 2007 Health Plans' Use of Physician Resource Use and Quality Measures
    by Timothy Lake & Margaret Colby & Stephanie Peterson
  • 2007 Evaluation of Maine Dirigo Health Reform: Selection of Measures and Data to Assess Progress
    by Debra J. Lipson
  • 2007 Oral Health Promotion, Prevention, and Treatment Strategies for Head Start Families: Early Findings from the Oral Health Initiative Evaluation. Volume II: Site Profiles
    by Patricia Del Grosso & Amy Brown & Heather Zaveri & Sandra Silva & Beth Zimmerman & Anne Hopewell & Diane Paulsell
  • 2007 Oral Health Promotion, Prevention, and Treatment Strategies for Head Start Families: Early Findings from the Oral Health Initiative Evaluation. Volume I: Final Interim Report
    by Patricia Del Grosso & Amy Brown & Heather Zaveri & Sandra Silva & Beth Zimmerman & Anne Hopewell & Diane Paulsell
  • 2007 Receiving Advice About Child Mental Health From a Primary Care Provider: African American and Hispanic Parent Attitudes
    by Jonathan D. Brown & Lawrence S. Wissow & Ciara Zachary & Benjamin L. Cook
  • 2007 Impact of Drug Coverage on Medical Expenditures Among the Elderly
    by Boyd H. Gilman & Barbara Gage & Susan Haber & Sonja Hoover & Jyoti Aggarwal
  • 2007 Convergence and Dissonance: Evolution In Private-Sector Approaches to Disease Management and Care Coordination
    by Glen P. Mays & Melanie Au & Gary Claxton
  • 2007 Evaluation of the Medicaid Value Program: Health Supports for Consumers with Chronic Conditions
    by Dominick Esposito & Erin Fries Taylor & Kristin Andrews & Marsha Gold
  • 2007 Evaluation of the Medicaid Value Program: Health Supports for Consumers with Chronic Conditions
    by Dominick Esposito & Erin Fries Taylor & Kristin Andrews & Marsha Gold
  • 2007 Evaluation of the Ticket to Work Program. Assessment of Post-Rollout Implementation and Early Impacts
    by Craig Thornton & Gina Livermore & Thomas Fraker & David Stapleton & Bonnie O'Day & David Wittenburg & Robert Weathers & Nanette Goodman & Tim Silva & Emily Sama Martin & Jesse Gregory & Debra Wright & Arif Mamun
  • 2007 Evaluation of the Ticket to Work Program. Assessment of Post-Rollout Implementation and Early Impacts
    by Craig Thornton & Gina Livermore & Thomas Fraker & David Stapleton & Bonnie O'Day & David Wittenburg & Robert Weathers & Nanette Goodman & Tim Silva & Emily Sama Martin & Jesse Gregory & Debra Wright & Arif Mamun
  • 2007 Physician and Patient Characteristics Associated with Discussion of Psychosocial Health During Pediatric Primary Care Visits
    by Jonathan D. Brown & Lawrence S. Wissow & Anne W. Riley
  • 2007 Medicaid Managed Long-Term Care: Challenges and Opportunities for State Policymakers and Low-Income Individuals
    by James M. Verdier
  • 2007 Medicare Advantage Special Needs Plans: Overview of Issues by Type of Plan
    by James M. Verdier
  • 2007 Medicare Advantage in Rural Areas: Experience Under the MMA
    by Marsha Gold
  • 2007 Medicaid Eligibility After Release from State Institutions
    by Henry T. Ireys & Carrie Slatton-Hodges & Bob Mann
  • 2007 Sampling with Uncertain Frame Counts: Challenges in Sampling Head Start Children for the FACES Study
    by Barbara Lepidus Carlson
  • 2007 Options for Expanding Coverage in Missouri: State Offer of a Small Group Product
    by Deborah Chollet & Su Liu
  • 2007 Evaluation of the National Survey of Recent College Graduates (NSRCG) Postsecondary Institution Sample
    by Donsig Jang & Xiaojing Lin
  • 2007 Evaluation of the NSRCG School Sample
    by Donsig Jang & Xiaojing Lin
  • 2007 Quantitative and Comparative Analysis of Reform Options for Extending Health Care Coverage in New Mexico
    by Deborah Chollet & Su Liu & Beth Gillia & Paul Biderman & Lee Reynis & William Wiese
  • 2007 Using Work-Oriented Sanctions to Increase TANF Program Participation
    by Jacqueline Kauff & Michelle K. Derr & LaDonna Pavetti & Emily Sama Martin
  • 2007 Administration of Mental Health Services by Medicaid Agencies
    by James Verdier & Allison Barrett & Sarah Davis
  • 2007 Mental Health Services in Special Needs Plans: Integrated Care for Persons with Mental Disorders
    by James M. Verdier
  • 2007 Intergenerational Neighborhood-Type Mobility: Examining Differences Between Blacks and Whites
    by Thomas P. Vartanian & Page Walker Buck & Philip Gleason
  • 2007 The Evolving SNP Marketplace and the Role of States
    by James M. Verdier
  • 2007 SCHIP at 10: A Synthesis of the Evidence on Substitution of SCHIP for Other Coverage
    by So Limpa-Amara & Angela Merrill & Margo Rosenbach
  • 2007 Increasing Children's Coverage and Access: A Decade of SCHIP Lessons
    by Margo Rosenbach
  • 2007 SCHIP at 10: A Synthesis of the Evidence on Access to Care in SCHIP
    by Shanna Shulman & Margo Rosenbach
  • 2007 What Is the Demonstration to Maintain Independence and Employment (DMIE) and Who Is Participating?
    by Gilbert W. Gimm & Bob Weathers
  • 2007 Cash and Counseling: Improving the Lives of Medicaid Beneficiaries Who Need Personal Care or Home- and Community-Based Services
    by Randall Brown & Barbara Lepidus Carlson & Stacy Dale & Leslie Foster & Barbara Phillips & Jennifer Schore
  • 2007 Impacts of the Heritage Keepers® Life Skills Education Component
    by Melissa A. Clark & Christopher Trenholm & Barbara Devaney & Justin Wheeler & Lisa Quay
  • 2007 Lessons from Local Access Initiatives: Contributions and Challenges
    by Karen Minyard & Deborah Chollet & Laurie Felland & Lindsey Lonergan & Chris Parker & Tina Anderson-Smith & Claudia Lacson & Jaclyn Wong
  • 2007 Rhetoric vs. Reality: What We Know and What We Need to Know About Vouchers and Charter Schools
    by Brian Gill & P. Mike Timpane & Karen Ross & Dominic Brewer & Kevin Booker
  • 2007 Providing Work Opportunities and Support for TANF Recipients with Disabilities
    by Michelle K. Derr
  • 2007 Case Study of Michigan: Exploring Medicaid and SCHIP Enrollment Trends and Their Links to Policy and Practice
    by Eileen Ellis & Jenna Walls & Donna Marks & Chris Trenholm
  • 2007 Upward Bound Math-Science: Program Description and Interim Impact Estimates
    by Robert Olsen & Neil Seftor & Tim Silva & David Myers & David DesRoches & Julie Young
  • 2007 Title I School Choice, Supplemental Educational Services, and Student Achievement
    by Ron Zimmer & Brian Gill & Paula Razquin & Kevin Booker & J.R. Lockwood III
  • 2007 Forging Successful Partnerships Between Health Plans and States
    by James M. Verdier
  • 2007 Strategies for Supporting Quality in Kith and Kin Child Care: Findings from the Early Head Start Enhanced Home Visiting Pilot Evaluation
    by Diane Paulsell & Debra Mekos & Patricia Del Grosso & Cassandra Rowand & Patti Banghart
  • 2007 Early Childhood Longitudinal Study, Birth Cohort (ECLS-B) 9-Month Twin Triad Restricted-Use Data File
    by Nikki Aikens & Nana Kwakye & Amy Rathbun & Jennifer Park & Jodi Jacobson Chernoff
  • 2007 Observations of Mother-Twin Interactions at 9 Months: User's Manual for the Early Childhood Longitudinal Study, Birth Cohort (ECLS-B) 9-Month Twin Triad Restricted-Use Data File
    by Nikki Aikens & Nana Kwakye & Amy Rathbun & Jennifer Park & Jodi Jacobson Chernoff
  • 2007 How Do Buy-In Participants Compare with Other Medicaid Enrollees with Disabilities?
    by Jody Schimmel & Carol V. Irvin & Su Liu
  • 2007 What Have We Learned About Homeschooling?
    by Eric J. Isenberg
  • 2007 What Prevents State Covering Kids & Families' Grantees from Achieving the Program's Goals? A Synthesis of Findings on Barriers, 2003-2006
    by Sheila Hoag & Nora Paxton
  • 2007 Can Care Coordination (CC) Help Control Medicare Costs?
    by Randy Brown & Debbie Peikes & Arnold Chen & Jennifer Schore
  • 2007 Selection Bias in College Admissions Test Scores
    by Melissa Clark & Jesse Rothstein & Diane Whitmore Schanzenbach
  • 2007 Evolution of State Outreach Efforts Under SCHIP
    by Susan R. Williams & Margo L. Rosenbach
  • 2007 Prescription Drug Use and Expenditures Among Dually Eligible Beneficiaries
    by Ann D. Bagchi & Dominick Esposito & James M. Verdier
  • 2007 The Medicaid Analytic eXtract (MAX) Chartbook
    by Audra T. Wenzlow & Dan Finkelstein & Ben Le Cook & Kathy Shepperson & Christine Yip & David Baugh
  • 2007 Study of Federal Spending on Diabetes: An Opportunity for Change
    by Marsha Gold & Ronette Briefel & Allison Hedley & Meredith Lee & Cheryl Fahlman & Katherine Gruene Segersten & Melissa Neuman
  • 2007 Ingredients of a Successful Summer Learning Program: A Case Study of the Building Educated Leaders for Life (BELL) Accelerated Learning Summer Program
    by Jeffrey Capizzano & Kendra Bischoff & Nicola Woodroffe & Duncan Chaplin
  • 2007 Stable Coverage Benefits Healthy Kids Children
    by Christopher Trenholm
  • 2007 Medicare Advantage in 2007: What Congress Intended?
    by Marsha Gold
  • 2007 A Study of Federal Spending on Diabetes: An Opportunity for Federal Leadership in Diabetes
    by Marsha Gold & Ronette Briefel
  • 2007 Study of Federal Spending on Diabetes: An Opportunity for Change
    by Marsha Gold & Ronette Briefel & Allison Hedley & Meredith Lee & Cheryl Fahlman & Katherine Gruene Segersten & Melissa Neuman
  • 2007 The Effects of Marriage on Health: A Synthesis of Recent Research Evidence
    by Robert G. Wood & Brian Goesling & Sarah Avellar
  • 2007 The Effects of Marriage on Health: A Synthesis of Recent Research Evidence
    by Robert G. Wood & Brian Goesling & Sarah Avellar
  • 2007 Study of Federal Spending on Diabetes: Summaries of Federal Government Agencies and Their Relevant Activities
    by Marsha Gold & Ronette Briefel & Meredith Lee & Katherine Gruene Segersten & Melissa Neuman & Tara Krissik
  • 2007 Study of Federal Spending on Diabetes: An Opportunity for Change
    by Marsha Gold & Ronette Briefel & Allison Hedley & Meredith Lee & Cheryl Fahlman & Katherine Gruene Segersten & Melissa Neuman
  • 2007 Do Participants Increase Their Earnings After Enrolling in the Medicaid Buy-In Program?
    by Su Liu & Bob Weathers
  • 2007 New Medicaid Drug Use and Cost Data Highlight Issues for States After Medicare Part D
    by James Verdier & Ann Bagchi & Dominick Esposito
  • 2007 Adherence to Medications for the Treatment of Congestive Heart Failure and Its Association with Health Care Expenditures
    by Ann Bagchi & Dominick Esposito & Myoung Kim & James Verdier & Deo Bencio
  • 2007 Do Referral Patterns Differ When Physicians Own the Hospital? Evidence from Texas
    by Su Liu & Cheryl Fahlman & Deborah Chollet
  • 2007 Identification of Usual Source of Care Providers for Frail Medicare Beneficiaries: Development and Use of a Claims-Based Approach
    by Sam Simon
  • 2007 Considerations in Performance Measurement and Value-Based Purchasing for Providers Treating Vulnerable Patients
    by Hoangmai H. Pham & Erin Fries Taylor & Timothy Lake & Melanie Au & Stephanie Peterson & Angela Merrill
  • 2007 Practice Workflows, Reporting Time, and Implementation Experiences Associated with PVRP
    by Angela Merrill
  • 2007 Operational Testing of PVRP Measures
    by Timothy Lake
  • 2007 Options for Validating Claims-Based Ambulatory Care Quality Data for Value-Based Purchasing
    by Myles Maxfield
  • 2007 Medicare Value-Based Purchasing: Physician Voluntary Reporting Program (PVRP)
    by Myles Maxfield
  • 2007 Medicare Advantage: What Congress Intended?
    by Marsha Gold
  • 2007 Building Strong Families: Testing Marriage and Relationship Skills Education for Unmarried Couples
    by Alan M. Hershey
  • 2007 National Evaluation of Early Reading First
    by Russell Jackson & Ann McCoy & Carol Pistorino & Anna Wilkinson & John Burghardt & Melissa Clark & Christine Ross & Peter Schochet & Paul Swank & Stefanie R. Schmidt
  • 2007 Administration of Mental Health Services Under Medicaid
    by James Verdier & Allison Barrett & Sarah Davis
  • 2007 Identification of Youth Psychosocial Problems During Pediatric Primary Care Visits
    by Jonathan D. Brown & Anne W. Riley & Lawrence S. Wissow
  • 2007 Quality Care for Special Kids: Profiles of Children with Chronic Conditions and Disabilities
    by Henry T. Ireys & Shanna Shulman & Stephanie Peterson
  • 2007 Personal Health Records: What Do Underserved Consumers Want?
    by Lorenzo Moreno & Stephanie Peterson & Ann Bagchi & Raquel af Ursin
  • 2007 Hospital Response to Public Reporting of Quality Indicators
    by Mary Laschober & Myles Maxfield & Suzanne Felt-Lisk & David J. Miranda
  • 2007 Testing Consumers' Comprehension of Quality Measures Using Alternative Reporting Formats
    by Margaret Gerteis & Jessie S. Gerteis & David Newman & Christopher Koepke
  • 2007 Why Women Have Higher Attainments in Post-Secondary Education Than Men
    by Glen Cain & Duncan Chaplin
  • 2007 Medicare Advantage in 2006-2007: What Congress Intended?
    by Marsha Gold
  • 2007 The Interaction of Policy and Enrollment in the Medicaid Buy-In Program, 2005
    by Henry T. Ireys & Sarah R. Davis & Kristin L. Andrews
  • 2007 Public Reporting of Quality Information on Medicaid Health Plans
    by Suzanne Felt-Lisk & Allison Barrett & Rebecca Nyman
  • 2007 Considerations in Designing Personal Health Records for Underserved Populations
    by Ann Bagchi & Lorenzo Moreno & Raquel af Ursin
  • 2007 Impacts of Four Title V, Section 510 Abstinence Education Programs
    by Christopher Trenholm & Barbara Devaney & Ken Fortson & Lisa Quay & Justin Wheeler & Melissa Clark
  • 2007 Using Vouchers to Deliver Social Services: Learning from the Goals, Uses, and Key Elements of Existing Federal Voucher Programs
    by Andrew Burwick & Gretchen Kirby
  • 2007 Effectiveness of Reading and Mathematics Software Products: Findings from the First Student Cohort
    by Mark Dynarski & Roberto Agodini & Sheila Heaviside & Timothy Novak & Nancy Carey & Larissa Campuzano & Barbara Means & Robert Murphy & William Penuel & Hal Javitz & Deborah Emery & Willow Sussex
  • 2007 Quality Care for Children with ADHD: The Role of Primary Care Physicians
    by Stephanie Peterson & Shanna Shulman & Henry Ireys
  • 2007 Santa Clara County Children's Health Initiative Improves Children's Health
    by Embry Howell (Urban Institute) & Christopher Trenholm
  • 2007 Physicians' Experiences Using Commercial E-Prescribing Systems
    by Joy M. Grossman & Anneliese Gerland & Marie C. Reed & Cheryl Fahlman
  • 2007 The Nation's Report Card: Mathematics 2003 and 2005 Performance in Puerto Rico—Highlights
    by Gail P. Baxter & Martha M. Bleeker & Tiffany L. Waits & Sameena Salvucci
  • 2007 National Evaluation of the State Children's Health Insurance Program: A Decade of Expanding Coverage and Improving Access
    by Margo Rosenbach & Carol Irvin & Angela Merrill & Shanna Shulman & John Czajka & Christopher Trenholm & Susan Williams & So Sasigant Limpa-Amara & Anna Katz
  • 2007 Moving Research into Practice: Lessons from the US Agency for Healthcare Research and Quality's IDSRN Program
    by Marsha Gold & Erin Fries Taylor
  • 2007 The Evaluation of the Medicare Coordinated Care Demonstration: Findings for the First Two Years
    by Randall Brown & Deborah Peikes & Arnold Chen & Judy Ng & Jennifer Schore & Clara Soh
  • 2007 Private Plans in Medicare: A 2007 Update
    by Marsha Gold
  • 2007 Who Are the Top Earners in the Medicaid Buy-In Program?
    by Gilbert W. Gimm & Henry T. Ireys & Caitlin Johnson
  • 2007 WISEWOMAN Best Practices Toolkit: Lessons Learned from Selected Projects
    by Melanie Besculides & Heather Zaveri & Charlotte Hanson
  • 2007 What Covering Kids & Families Tells Us About SCHIP
    by Judith Wooldridge
  • 2007 Impact on Family and Work
    by Shanna Shulman & Henry Ireys & Stephanie Peterson
  • 2007 Deficit Reduction Act Citizenship Requirements Through the Eyes of Covering Kids & Families Grantees
    by Sheila Hoag
  • 2007 Making Health Care a Reality for Low-Income Children and Families
    by Judith Wooldridge
  • 2007 Coordinating Care for Children with Special Health Care Needs
    by Stephanie Peterson & Shanna Shulman & Henry Ireys
  • 2007 How Caregivers and Workers Fared in Cash and Counseling
    by Leslie Foster & Stacy B. Dale & Randall Brown
  • 2007 How Does Cash and Counseling Affect Costs?
    by Stacy B. Dale & Randall S. Brown
  • 2007 Effects of Cash and Counseling on Personal Care and Well-Being
    by Barbara Lepidus Carlson & Leslie Foster & Stacy B. Dale & Randall Brown
  • 2007 Consumer Enrollment and Experiences in the Cash and Counseling Program
    by Jennifer Schore & Leslie Foster & Barbara Phillips
  • 2007 The Research Design and Methodological Issues for the Cash and Counseling Evaluation
    by Randall S. Brown & Stacy B. Dale
  • 2007 Impact of Influenza Immunization on Medical Expenditures Among Medicare Elderly, 1999-2003
    by Boyd H. Gilman & Arthur J. Bonito & Celia Eicheldinger
  • 2007 Commentary: Should I Blame Mom or Dad? Identifying the Relative Contribution of Each Parent's Body Size to That of Their Offspring
    by Robert C. Whitaker
  • 2007 Improving Health Care Quality Reporting: Lessons from the California HealthCare Foundation
    by Beth Stevens & Tim Lake & Erin Fries Taylor
  • 2007 TANF at 10: Welfare Reform in New Jersey, New York, and Pennsylvania
    by Robert G. Wood & Justin Wheeler
  • 2007 Publications: German Economic Research Institutes on Track
    by Ketzler, Rolf & Zimmermann, Klaus F.
  • 2007 Teacher Shortages, Teacher Contracts and their Impact on Education in Africa
    by Bourdon, Jean & Frölich, Markus & Michaelowa, Katharina
  • 2007 Introduction to When Washington Shut Down Wall Street: The Great Financial Crisis of 1914 and the Origins of America's Monetary Supremacy
    by William L. Silber
  • 2007 The Authors' Reply
    by Dominic P. Tilden & Segundo Mariz & Gillies O'Bryan-Tear & Julia Bottomley & Alexander Diamantopoulos
  • 2007 A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK
    by Philip Home & Adrian Bagust & Matthew Taylor & Philip Ambery & Samara Mendes da Costa
  • 2007 Reliability of Medicaid Claims Versus Medical Record Data: In a Cost Analysis of Palivizumab
    by Julie Jacobson Vann & John Feaganes & Steven Wegner
  • 2007 Preferences of Community Pharmacists for Extended Roles in Primary Care: A Survey and Discrete Choice Experiment
    by Anthony Scott & Christine Bond & Jackie Inch & Aileen Grant
  • 2007 Long-Term Clopidogrel Therapy in Patients Receiving Percutaneous Coronary Intervention
    by Bart M.S. Heeg & Ron J.G. Peters & Marc Botteman & Ben A. van Hout
  • 2007 Epidemiology and Economic Impact of Meticillin-Resistant Staphylococcus aureus: Review and Analysis of the Literature
    by Andrew F. Shorr
  • 2007 Modelling Disease Progression in Alzheimer's Disease: A Review of Modelling Methods used for Cost-Effectiveness Analysis
    by Colin Green
  • 2007 The Increasingly Complex Fourth Hurdle for Pharmaceuticals
    by Joshua Cohen & Elly Stolk & Maartje Niezen
  • 2007 Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children: Theoretical and Methodological Considerations
    by Lisa A. Prosser & James K. Hammitt & Ron Keren
  • 2007 A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease
    by Maureen P.M.H. Rutten-van Molken & Floortje E. van Nooten & Marion Lindemann & Manfred Caeser & Peter M.A. Calverley
  • 2007 A Stated Preference Binary Choice Experiment to Explore NICE Decision Making
    by Paul Tappenden & John Brazier & Julie Ratcliffe & James Chilcott
  • 2007 Direct Costs in Patients Hospitalised with Community-Acquired Pneumonia After Non-Response to Outpatient Treatment with Macrolide Antibacterials in the US
    by Joseph A. Paladino & Martin H. Adelman & Jerome J. Schentag & Paul B. Iannini
  • 2007 Healthcare Utilisation and Costs Associated with Adding Montelukast to Current Therapy in Patients with Mild to Moderate Asthma and Co-Morbid Allergic Rhinitis: PRAACTICAL Study
    by Roberto Dal Negro & Peter Piskorz & Roberto Vives & Magda Guilera & Vasilisa Sazonov Kocevar & Xavier Badia
  • 2007 The Contrast and Convergence of Bayesian and Frequentist Statistical Approaches in Pharmacoeconomic Analysis
    by Grant H. Skrepnek
  • 2007 Impact of Pharmaceutical Prior Authorisation Policies: A Systematic Review of the Literature
    by Jaume Puig-Junoy & Ivan Moreno-Torres
  • 2007 When Drugs Don't Work: Economic Assessment of Enhancing Compliance with Interventions Supported by Electronic Monitoring Devices
    by Dyfrig Hughes
  • 2007 Cost-Utility Analysis in China: Differences and Difficulties Compared with Developed Countries
    by Liu Bao Peng & Chong Qing Tan & Xiao Min Wan & Wei Cui
  • 2007 Direct and Indirect Costs Attributable to Alcohol Consumption in Germany
    by Alexander Konnopka & Hans-Helmut Konig
  • 2007 The Use of Disease-Specific Outcome Measures in Cost-Utility Analysis: The Development of Dutch Societal Preference Weights for the FACT-L Scale
    by Leida M. Lamers & Carin A. Uyl-de Groot & Ivonne Buijt
  • 2007 A Cost-Effectiveness Analysis of First-Line Controller Therapies for Persistent Asthma
    by Ya-Chen Tina Shih & Josephine Mauskopf & Rohit Borker
  • 2007 Retrospective Economic and Outcomes Analyses Using Non-US Databases: A Review
    by Lizheng Shi & Eric Q Wu & Meredith Hodges & Andrew Yu & Howard Birnbaum
  • 2007 Cost Considerations in the Treatment of Colorectal Cancer
    by Frank G.A. Jansman & Maarten J. Postma & Jacobus R.B.J. Brouwers
  • 2007 Perspectives on Dynamic Optimisation and Control Theory in Treating Hyperlipidaemia
    by John A. Vernon
  • 2007 Being Led Down the Wrong Garden PATH: the Importance of Knowledge and Facts for the Crossroads
    by Ron Goeree & Daria O'Reilly & Jean-Eric Tarride & Jim Bowen & Gord Blackhouse & Kaitryn Campbell & Rob Hopkins & Morgan Lim & Lisa Patterson
  • 2007 Building Bridges Between Academic Research and Policy Formulation: When Costing Less Means Costing More
    by Amiram Gafni & Stephen Birch
  • 2007 Costs and Benefits of Direct-to-Consumer Advertising: The Case of Depression
    by Adam E. Block
  • 2007 Cost Effectiveness of Oseltamivir Treatment for Patients with Influenza-Like Illness Who Are at Increased Risk for Serious Complications of Influenza: Illustration for The Netherlands
    by Maarten J. Postma & Annoesjka Novak & Huib W.K.F.H. Scheijbeler & Marlene Gyldmark & Marianne L.L. van Genugten & Jan C. Wilschut
  • 2007 Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs: A Retrospective Analysis among Managed Care Patients with Chronic Myelogenous Leukaemia
    by Theodore Darkow & Henry J. Henk & Simu K. Thomas & Weiwei Feng & Jean-Francois Baladi & George A. Goldberg & Alan Hatfield & Jorge Cortes
  • 2007 A Systematic Review of Economic Evaluation Literature in Thailand: Are the Data Good Enough to be Used by Policy-Makers?
    by Yot Teerawattananon & Steve Russell & Miranda Mugford
  • 2007 Estimation, Power and Sample Size Calculations for Stochastic Cost and Effectiveness Analysis
    by S.D. Walter & Amiram Gafni & Stephen Birch
  • 2007 Reform of Prescription Drug Reimbursement and Pricing in the German Social Health Insurance Market: A Comparison of Three Scenarios
    by Stefan Gress & Dea Niebuhr & Uwe May & Jurgen Wasem
  • 2007 Cost Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast Cancer: A Lifetime Model
    by J. Alasdair Millar & Michael J. Millward
  • 2007 Economic Evaluation of Treatment Administration Strategies of Ganciclovir for Cytomegalovirus Retinitis in HIV/AIDS Patients in Thailand: A Simulation Study
    by Kanlaya Teerawattananon & Saniorn Iewsakul & Chawewan Yenjitr & Somsanguan Ausayakhun & Watanee Yenjitr & Miranda Mugford & Yot Teerawattananon
  • 2007 Costs of a Community Pharmacist-Led Medicines Management Service for Patients with Coronary Heart Disease in England: Healthcare System and Patient Perspectives
    by Anthony Scott & Michela Tinelli & Christine Bond
  • 2007 The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): Responsiveness to Change and English Language Validation
    by Peter Wahlqvist & Gordon H. Guyatt & David Armstrong & Alessio Degl'Innocenti & Diane Heels-Ansdell & Samer El-Dika & Ingela Wiklund & Carlo A. Fallone & Lisa Tanser & Sander Veldhuyzen van Zanten & Peggy Austin & Alan N. Barkun & Naoki Chiba & Holger J. Schunemann
  • 2007 Health Utilities Using the EQ-5D in Studies of Cancer
    by A. Simon Pickard & Caitlyn T. Wilke & Hsiang-Wen Lin & Andrew Lloyd
  • 2007 Replace Pharmaceutical Patents Now
    by Earl L. Grinols & James W. Henderson
  • 2007 Book Review
    by Adis International Limited
  • 2007 Therapeutic Use of Granulocyte Colony-Stimulating Factors for Established Febrile Neutropenia: Effect on Costs from a Hospital Perspective
    by Leon E. Cosler & Adi Eldar-Lissai & Eva Culakova & Nicole M. Kuderer & David Dale & Jeffrey Crawford & Gary H. Lyman
  • 2007 Cost Effectiveness of Once-Daily Oral Chelation Therapy with Deferasirox versus Infusional Deferoxamine in Transfusion-Dependent Thalassaemia Patients: US Healthcare System Perspective
    by Thomas E. Delea & Oleg Sofrygin & Simu K. Thomas & Jean-Francois Baladi & Pradyumna D. Phatak & Thomas D. Coates
  • 2007 Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer
    by Steven B. Zeliadt & David F. Penson
  • 2007 The Economic Implications of Glaucoma: A Literature Review
    by Jordana K. Schmier & Michael T. Halpern & Mechelle L. Jones
  • 2007 Measuring Patient-Reported Outcomes in Solid Organ Transplant Recipients: An Overview of Instruments Developed to Date
    by Irina Cleemput & Fabienne Dobbels
  • 2007 Letter From the Commissioner's Office at the US FDA
    by John A. Vernon
  • 2007 Modelling Cost Effectiveness of Insulin Glargine for the Treatment of Type 1 and 2 Diabetes in Canada
    by Daniel T. Grima & Melissa F. Thompson & Luc Sauriol
  • 2007 Cost Effectiveness of an Adherence-Improving Programme in Hypertensive Patients
    by Danielle E.M. Brunenberg & Gwenn E.C. Wetzels & Patricia J. Nelemans & Carmen D. Dirksen & Johan L. Severens & Henri E.J.H. Stoffers & Jan S.A.G. Schouten & Martin H. Prins & Peter W. de Leeuw & Manuela A. Joore
  • 2007 Recombinant Erythropoietin for Chemotherapy-Related Anaemia: Economic Value and Health-Related Quality-of-Life Assessment Using Direct Utility Elicitation and Discrete Choice Experiment Methods
    by Diego F. Ossa & Andrew Briggs & Emma McIntosh & Warren Cowell & Tim Littlewood & Mark Sculpher
  • 2007 Do Drugs Reduce Utilisation of Other Healthcare Resources?
    by Pierre-Yves Cremieux & Pierre Ouellette & Patrick Petit
  • 2007 Enzyme Replacement Therapy in Orphan and Ultra-Orphan Diseases: The Limitations of Standard Economic Metrics as Exemplified by Fabry-Anderson Disease
    by David F. Moore & Markus Ries & Evelyn L. Forget & Raphael Schiffmann
  • 2007 Economic Evaluations of Cholesterol-Lowering Drugs: A Critical and Systematic Review
    by Pearl D. Gumbs & Monique W.M. Verschuren & Aukje K. Mantel-Teeuwisse & Ardine G. de Wit & Anthonius de Boer & Olaf H. Klungel
  • 2007 Economic Evaluation and Decision Making: Reimbursing Trastuzumab in Early-Stage Breast Cancer
    by Steven Simoens
  • 2007 Measuring Preferences for Cost-Utility Analysis: How Choice of Method May Influence Decision-Making
    by Christine M. McDonough & Anna N.A. Tosteson
  • 2007 Is Medication Review by Pharmacists of Any Use?
    by Arnold G. Zermansky & Nick Freemantle
  • 2007 Letter From the Commissioner's Office at the US FDA
    by John A. Vernon
  • 2007 Home-Based Medication Review in Older People: Is it Cost Effective?
    by Margaret Pacini & Richard D. Smith & Edward C.F. Wilson & Richard Holland
  • 2007 Acute/Subacute Herpes Zoster: Healthcare Resource Utilisation and Costs in a Group of US Health Plans
    by Ralph P. Insinga & Robbin F. Itzler & James M. Pellissier
  • 2007 Conjoint Analysis of French and German Parents' Willingness to Pay for Meningococcal Vaccine
    by David Bishai & Roger Brice & Isabelle Girod & Aneta Saleh & Jenifer Ehreth
  • 2007 Disease Burden of Overactive Bladder: Quality-of-Life Data Assessed Using ICI-Recommended Instruments
    by Ramandeep Basra & Con Kelleher
  • 2007 A `League Table' of Contingent Valuation Results for Pharmaceutical Interventions: A Hard Pill to Swallow?
    by Tracey H. Sach & Richard D. Smith & David K. Whynes
  • 2007 Time Preferences for Health in Northern Tanzania: An Empirical Analysis of Alternative Discounting Models
    by Bjarne Robberstad & John Cairns
  • 2007 Reducing the Societal Burden of Depression: A Review of Economic Costs, Quality of Care and Effects of Treatment
    by Julie M. Donohue & Harold Alan Pincus
  • 2007 Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children: A UK Analysis
    by Mark J.C. Nuijten & Wolfgang Wittenberg & Maximilian Lebmeier
  • 2007 A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK
    by Dominic P. Tilden & Segundo Mariz & Gillies O'Bryan-Tear & Julia Bottomley & Alexander Diamantopoulos
  • 2007 Rates and Probabilities in Economic Modelling: Transformation, Translation and Appropriate Application
    by Rachael L. Fleurence & Christopher S. Hollenbeak
  • 2007 Cost Effectiveness of a Pharmacy-Based Coaching Programme to Improve Adherence to Antidepressants
    by Judith E. Bosmans & Oscar H. Brook & Hein P.J. van Hout & Martine C. de Bruijne & Hugo Nieuwenhuyse & Lex M. Bouter & Wim A.B. Stalman & Maurits W. van Tulder
  • 2007 Letter From the Commissioner's Office at the US FDA
    by John A. Vernon
  • 2007 NICE Cost-Effectiveness Appraisal of Cholinesterase Inhibitors: Was the Right Question Posed? Were the Best Tools Used?
    by Denis Getsios & Kristen Migliaccio-Walle & Jaime J. Caro
  • 2007 When NICE Says No!
    by Alan Haycox
  • 2007 Acknowledgement
    by Adis International Limited
  • 2007 Oral Antiplatelet Therapy in Secondary Prevention of Cardiovascular Events: An Assessment from the Payer's Perspective
    by Bart Heeg & Joep Damen & Ben Van Hout
  • 2007 Economic Evidence at the Local Level: Options for Making it More Useful
    by Kees van Gool & Gisselle Gallego & Marion Haas & Rosalie Viney & Jane Hall & Robyn Ward
  • 2007 Atorvastatin: A Pharmacoeconomic Review of its Use in the Primary and Secondary Prevention of Cardiovascular Events
    by Greg L. Plosker & Katherine A. Lyseng-Williamson
  • 2007 Recombinant Factor VIIa (Eptacog Alfa): A Pharmacoeconomic Review of its Use in Haemophilia in Patients with Inhibitors to Clotting Factors VIII or IX
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2007 The Economic Impact of Introducing Serotonin-Noradrenaline Reuptake Inhibitors into the Brazilian National Drug Formulary: Cost-Effectiveness and Budget-Impact Analyses
    by Marcio Machado & Michael Iskedjian & Ines A. Ruiz & Thomas R. Einarson
  • 2007 Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis B
    by David L. Veenstra & Sean D. Sullivan & Lauren Clarke & Uche H. Iloeje & Eskinder Tafesse & Adrian Di Bisceglie & Kris V. Kowdley & Robert G. Gish
  • 2007 Strategies for the Management of Suspected Heparin-Induced Thrombocytopenia: A Cost-Effectiveness Analysis
    by Amanda R. Patrick & Wolfgang C. Winkelmayer & Jerry Avorn & Michael A. Fischer
  • 2007 Economic Evaluations of Calcineurin Inhibitors in Renal Transplantation: A Literature Review
    by Alec H. Miners & Guiqing Yao & James Raftery & Rod S. Taylor
  • 2007 The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis: A Structured Review of the Literature
    by Rachael L. Fleurence & Cynthia P. Iglesias & Jeanene M. Johnson
  • 2007 It's Time to Choose the Study Design!: Net Benefit Analysis of Alternative Study Designs to Acquire Information for Evaluation of Health Technologies
    by Oren Shavit & Moshe Leshno & Assaf Goldberger & Amir Shmueli & Amnon Hoffman
  • 2007 Warfarin Pharmacogenetics: Economic Considerations
    by Dyfrig A. Hughes & Munir Pirmohamed
  • 2007 Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin: Economic Comparison in Adult and Adolescent Type 1 Diabetes Mellitus in Australia
    by Neale Cohen & Michael E. Minshall & Lyn Sharon-Nash & Katerina Zakrzewska & William J. Valentine & Andrew J. Palmer
  • 2007 Cost Effectiveness of Pegaptanib for the Treatment of Age-Related Macular Degeneration in the UK
    by Sorrel E. Wolowacz & Neil Roskell & Steven Kelly & Fiona M. Maciver & Chris S. Brand
  • 2007 Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients
    by Ya-Chen Tina Shih & Nebiyou B. Bekele & Ying Xu
  • 2007 A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD
    by Laura Bojke & Edward Hornby & Mark Sculpher
  • 2007 Valuing Children's Health: A Comparison of Cost-Utility Analyses for Adult and Paediatric Health Interventions in the US
    by Joseph A. Ladapo & Peter J. Neumann & Ron Keren & Lisa A. Prosser
  • 2007 Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions: Why Uncertainty About the Outcome, Estimate and Willingness to Pay Matters
    by Jeffrey S. Hoch & Carolyn S. Dewa
  • 2007 Ninth Annual Disease Management Leadership Forum and First Disease Management Association of America-National Association of Manufacturers Integrated Care Summit: Las Vegas, Nevada, 16-19 September 2007
    by Ginny-Louise MacKay
  • 2007 Cost-Effectiveness Analysis of a Pharmacy Asthma Care Program in Australia
    by Adam Gordois & Carol Armour & Martha Brillant & Sinthia Bosnic-Anticevich & Deborah Burton & Lynne Emmerton & Ines Krass & Bandana Saini & Lorraine Smith & Kay Stewart
  • 2007 Nurse Practitioner-Based Diabetes Care Management: Impact of Telehealth or Telephone Intervention on Glycemic Control
    by Karen Chang & Rita Davis & Judy Birt & Pete Castelluccio & Peter Woodbridge & David Marrero
  • 2007 Patient and Physician Factors Contributing to Poor Outcomes in Patients with Asthma and COPD
    by Adrian Gillissen & Hubertus Wirtz & Uwe Juergens
  • 2007 Health Support of People with Disabilities in South Australia: Innovations in Policy and Practice
    by David Caudrey & Marguerite Dissinger
  • 2007 Disease Management of Chronic Heart Failure in the Elderly: Issues and Options
    by Ken McDonald
  • 2007 Acknowledgment
    by Adis International Limited
  • 2007 Disease Management Update
    by Adis International Limited
  • 2007 Consensus Development and Application of ICD-9-CM Codes for Defining Chronic Illnesses and their Complications
    by Ariel Linden & Thomas J. Biuso & Gopal Allada & Alan F. Barker & Joaquin Cigarroa & Sai Praveen Haranath & Diana Rinkevich & Karl Stajduhar
  • 2007 Obesity and Medical Visits in Family Medicine: A Retrospective Analysis of Medical Records
    by James E. Rohrer & Steven C. Adamson & Joseph W. Furst
  • 2007 Health Coaching as an Intervention in Health Management Programs
    by Susan W. Butterworth & Ariel Linden & Wende McClay
  • 2007 Selection of Proton Pump Inhibitors for Formulary Inclusion: Making Decisions Based on Appropriate Criteria
    by Stephen W. Nissen & Keith M. Olsen
  • 2007 Health Plan Employer Data and Information Set (HEDIS(R)) Criteria to Determine the Quality of Asthma Care in Children: What Are the Limitations?
    by Harold J. Farber & Michael Schatz
  • 2007 Perspectives on Premenstrual Syndrome/Premenstrual Dysphoric Disorder: Outcomes From a Meeting of the Latin America Experts Group
    by Luis Bahamondes & Santiago Cordova-Eguez & Jose Enrique Pons & Lee Shulman
  • 2007 Disease Management Update
    by Adis International Limited
  • 2007 The Role of Medication Adherence as a Determinant of Blood Pressure Control in a Managed Care Population
    by Nilay D. Shah & MaryAnn E. Steiner & Lee C. Vermeulen & Lawrence A. Fleming & Patrick R. Cory
  • 2007 Consumer-Directed Health Plans and the Chronically Ill
    by Stephen T. Parente & Jon B. Christianson & Roger Feldman
  • 2007 Measuring the Quality of Healthcare: The Connection between Structure, Process, and Outcomes of Care, Using the Example of Myocardial Infarction Treatment in Germany
    by Ansgar Wubker
  • 2007 Evaluation of an Online Relapse Prevention Program for Bipolar Disorder: An Overview of the Aims and Methodology of a Randomized Controlled Trial
    by Caryl Barnes & Robin Harvey & Philip Mitchell & Michael Smith & Kay Wilhelm
  • 2007 Physician-Patient e-Visit Programs: Implementation and Appropriateness
    by Pamela Whitten & Lorraine Buis & Brad Love
  • 2007 Disease Management Programs for Glaucoma: Has the Vision Become a Reality?
    by Lawrence D. Goldberg
  • 2007 Disease Management Update
    by Adis International Limited
  • 2007 Psychoeducational Approaches to Medication Adherence in Patients with Bipolar Disorder
    by Martha Sajatovic & Peijun Chen & Philipp Dines & Edwin R. Shirley
  • 2007 Treating Allergic Asthma with Omalizumab
    by Paul P. Belliveau & Monina R. Lahoz
  • 2007 Design, Measurement, and Evaluation of an Education Strategy in the Hospital Setting to Combat Antimicrobial Resistance: Theoretical Considerations and a Practical Example
    by Celine Pulcini & Sally Crofts & Diane Campbell & Peter Davey
  • 2007 Implementation of an HPV-Vaccination Program: Key Factors for Success
    by Shalini L. Kulasingam
  • 2007 Disease Management and the Medical Home Model: Competing or Complementary?
    by Vincent Kuraitis
  • 2007 Abandoning the UK NHS?
    by Tony Clive Hockley
  • 2007 The Role of Spirometry in Evaluating Therapeutic Responses in Advanced COPD
    by Pierantonio Laveneziana & Denis E. O'Donnell
  • 2007 The Rise of Specialty Pharmacy Costs: Issues for Providers, Payers, and Patients
    by Steve B. Miller & Tracy A. Hoffman & Jonah C. Houts & Jane L. Miller & Britton L. Pim & Andrew Behm
  • 2007 Exploring Disease Management Programs for Diabetes Mellitus: Proposal of a Novel Hybrid Model
    by Kerri L. Cavanaugh & Richard O. White & Russell L. Rothman
  • 2007 Physician Prescribing and Medicare Part D: Closing the Gaps
    by William H. Shrank
  • 2007 Disease Management Update
    by Adis International Limited
  • 2007 Patient-Motivated Prevention of Lifestyle-Related Disease in Japan: A Randomized, Controlled Clinical Trial
    by Akira Babazono & Chihoko Kame & Reiko Ishihara & Eiji Yamamoto & Alan L. Hillman
  • 2007 Techniques for Measuring Medication Adherence in Hypertensive Patients in Outpatient Settings: Advantages and Limitations
    by Jay Hawkshead & Marie A. Krousel-Wood
  • 2007 Initiatives to Promote Effective Self-Care Skills in Children and Adolescents with Diabetes Mellitus
    by Barbara J. Anderson & Britta Svoren & Lori Laffel
  • 2007 Estimating the Effect of Regression to the Mean in Health Management Programs
    by Ariel Linden
  • 2007 Disease Management Update
    by Adis International Limited
  • 2007 Spotlight on the Pharmacoeconomics of Candesartan Cilexetil in Chronic Heart Failure and Hypertension
    by Greg L. Plosker & Susan J. Keam
  • 2007 The Impact of Nebulized Levalbuterol on Health Care Payments for Elderly Asthma and Chronic Obstructive Pulmonary Disease Patients in Medicaid Plans
    by Ronald J. Ozminkowski & Shaohung Wang & Stacey R. Long
  • 2007 Estimating the Impact of a Congestive Heart Failure Disease Management Program on Prescription Drug Use: A State Medicaid Program
    by Anthony C. Moscoso & Matthew J. Strand & Gregory D. Berg & Gary K. Grunwald
  • 2007 Hypertension Home Telemonitoring: Current Evidence and Recommendations for Future Studies
    by Mirou Jaana & Guy Pare & Claude Sicotte
  • 2007 Use of the Pre-Post Method to Measure Cost Savings in Disease Management: Issues and Implications
    by Ariel Linden
  • 2007 Initiatives and Barriers to Adopting Health Information Technology: A US Perspective
    by Henry A. DePhillips
  • 2007 Estimating procedure for the macronutrients latent prices in food security models
    by Milena N. Agostinelli M.
  • 2007 A Closer Look at Serial Growth Rate Correlation
    by Alex Coad
  • 2007 The sales effect of word of mouth: a model for creative goods and estimates for novels
    by Jonathan Beck
  • 2006 Accounting for Inequality: A Proposed Revision of the Human Development Index
    by Elizabeth Stanton
  • 2006 Mental Health Services in Medicaid, 1999
    by James M. Verdier & Ann Cherlow & Deo Bencio & Mei-Ling Mason & Jeffrey A. Buck & Judith L. Teich
  • 2006 Building Strong Families: The Evaluation Design
    by Sheena McConnell & Robert Wood & Barbara Devaney & Sarah Avellar & M. Robin Dion & Heather H. Zaveri
  • 2006 A Framework to Improve the Quality of Treatment for Depression in Primary Care
    by Thomas W. Croghan & Michael Schoenbaum & Cathy D. Sherbourne & Paul Koegel
  • 2006 Evaluation of a Learning Collaborative's Process and Effectiveness to Reduce Health Care Disparities Among Minority Populations
    by Marsha Gold & Erin Fries Taylor & Katherine Gruene Segersten & Patrick Doreian & Jennifer Coughlan & Debra Lipson
  • 2006 How Integrated Care Programs Use Community-Based, Primary Care Physicians
    by Valerie Cheh
  • 2006 Data Comparability in a Mixed Mode Telephone and Face to Face Survey of Persons with Disabilities
    by Matt Sloan & Debra Wright & Kirsten Barrett
  • 2006 National Survey of Substance Abuse Treatment Services (N-SSATS): 2005. Data on Substance Abuse Treatment Facilities
    by Synectics for Management Decisions & Inc. & Mathematica Policy Research
  • 2006 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for November, 2006
    by Stephanie Peterson & Marsha Gold
  • 2006 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for October, 2006
    by Stephanie Peterson & Marsha Gold
  • 2006 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for September, 2006
    by Stephanie Peterson & Marsha Gold
  • 2006 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for August, 2006
    by Stephanie Peterson & Marsha Gold
  • 2006 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for July, 2006
    by Stephanie Peterson & Marsha Gold
  • 2006 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for June, 2006
    by Stephanie Peterson & Marsha Gold
  • 2006 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for April, 2006. Addendum
    by Stephanie Peterson & Marsha Gold
  • 2006 Tracking Medicare Health and Prescription Drug Plans: Monthly Report for April, 2006
    by Stephanie Peterson & Marsha Gold
  • 2006 Uses of Data on Child Outcomes and Program Processes in Early Childhood Accountability Systems: Assumptions, Challenges, and Consequences
    by John M. Love
  • 2006 Continued Progress in Performance Measurement Reporting by SCHIP
    by Margo Rosenbach & Anna Katz & Sibyl Day
  • 2006 Evaluation of AHRQ's Partnerships for Quality Program
    by Debra Lipson & Marsha Gold & Melanie Au & Katherine Gruene Segersten
  • 2006 Evaluation of AHRQ's Partnerships for Quality Program
    by Marsha Gold & Debra Lipson & Melanie Au & Katherine Gruene Segersten
  • 2006 Evaluation of the Local Initiative Rewarding Results Collaborative Demonstrations
    by Suzanne Felt-Lisk & Gilbert Gimm & Stephanie Peterson
  • 2006 Seeding Entrepreneurship Across Campus: Early Implementation Experiences of the Kauffman Campuses Initiative
    by Lara Hulsey & Linda Rosenberg & Benita Kim
  • 2006 Hunt for the Right Counterfactual: Estimating Disparities in Minority Health Care
    by Benjamin Cook
  • 2006 Are the Partnerships Affecting Policy in Their States and Communities?
    by Bridget Lavin & Valerie Cheh & Beth Stevens
  • 2006 Challenges and Opportunities in Caring for Medicare-Medicaid Dual Eligibles: The Role of Special Needs Plans
    by James M. Verdier
  • 2006 Findings from the Survey of Early Head Start Programs: Communities, Programs, and Families
    by Cheri A. Vogel & Nikki Aikens & rew Burwick & Laura Hawkinson & Angela Richardson & Linda Mendenko & Rachel Chazan-Cohen
  • 2006 Trends in Lung Surgery: United States 1988 to 2002
    by Stavros G. Memtsoudis & Melanie C. Besculides & Lambros Zellos & Namrata Patil & Selwyn O. Rogers
  • 2006 Detecting Enrollment Outbreaks in Three States: The Link Between Program Enrollment and Outreach
    by Carol Irvin & Christopher Trenholm & Margo Rosenbach
  • 2006 An Overview of the Longest-Running Statewide Marriage Initiative in the U.S
    by M. Robin Dion
  • 2006 Treating Emotional and Behavioral Disorders in Children and Adolescents
    by Shanna Shulman & Henry Ireys & Stephanie Peterson
  • 2006 SCHIP at 10: A Synthesis of the Evidence on Retention
    by Shanna Shulman & Margo Rosenbach & Sylvia Kuo
  • 2006 SCHIP and Medicaid: Working Together to Keep Low-Income Children Insured
    by Angela Merrill & Margo Rosenbach
  • 2006 Analysis of Niche Hospitals in Texas and the Financial Impact on General Hospitals
    by Deborah Chollet & Su Liu & Gilbert Gimm & Cheryl Fahlman & Laurie Felland & Anneliese Gerland & Michelle Banker & Allison Liebhaber
  • 2006 Strategies for Supporting Quality in Kith and Kin Child Care: Findings from the Early Head Start Enhanced Home Visiting Pilot Evaluation
    by Diane Paulsell & Debra Mekos & Patricia Del Grosso & Cassandra Rowand & Patti Banghart
  • 2006 2006 Medicare Advantage Benefits and Premiums
    by Marsha Gold & Maria Cupples Hudson & Sarah Davis
  • 2006 Gender Gaps in College and High School Graduation by Race, Combining Public and Private Schools
    by Duncan Chaplin & Daniel Klasik
  • 2006 Case Study of Virginia: Exploring Medicaid and SCHIP Enrollment Trends and Their Links to Policy and Practice
    by Embry Howell & Christopher Trenholm & Kathy Gifford & Bridget Lavin
  • 2006 Case Study of New Jersey: Exploring Medicaid and SCHIP Enrollment Trends and Their Links to Policy and Practice
    by Christopher Trenholm & Bridget Lavin & Judith Wooldridge
  • 2006 Case Study of California: Exploring Medicaid and SCHIP Enrollment Trends and Their Links to Policy and Practice
    by Jennifer Sullivan & Ian Hill & Christopher Trenholm
  • 2006 Case Study of Arkansas: Exploring Medicaid and SCHIP Enrollment Trends and Their Links to Policy and Practice
    by Jenna Walls & Bridget Lavin & Kathy Gifford & Christopher Trenholm
  • 2006 Poor Preventive Care Achievement and Program Retention Among Low Birth Weight Infant Medicaid Enrollees
    by Shanna Shulman
  • 2006 Pay for Performance: Are Hospitals Ready and Willing?
    by Suzanne Felt-Lisk & Mary Laschober
  • 2006 24 Million and Counting: Reflections on 40 Years of Head Start Research in Support of Children and Families
    by John M. Love
  • 2006 How Does the Medicaid Buy-In Program Relate to Other Federal Efforts to Improve Access to Health Coverage for Adults with Disabilities?
    by Sarah R. Davis & Henry T. Ireys
  • 2006 First Year Impacts of the Heritage Keepers® Life Skills Education Component
    by Melissa A. Clark & Barbara Devaney
  • 2006 Perspectives on Networking, Cultural Values, and Skills Among African American Men with Spinal Cord Injury: A Reconsideration of Social Capital Theory
    by M. Njeri Jackson & Michelle A. Meade & Phyllis Ellenbogen & Kirsten Barrett
  • 2006 Work Intensity and Variations in Health and Personal Characteristics of Individuals with Spinal Cord Injury (SCI)
    by Michelle A. Meade & Kirsten Barrett & Phyllis S. Ellenbogen & M. Njeri Jackson
  • 2006 Head Start: What Do We Know About Its Effectiveness? What Do We Need to Know?
    by John M. Love & Louisa Banks Tarullo & Helen Raikes & Rachel Chazan-Cohen
  • 2006 Evaluating Early Childhood Assessments: A Differential Analysis
    by Samuel J. Meisels & Sally Atkins-Burnett
  • 2006 TANF and SSI: Is It Time for a Systems Test?
    by David Butler & David Wittenburg
  • 2006 Couples Getting it Right: An Inside Look at Healthy Marriage/Relationship Skills Programs
    by M. Robin Dion
  • 2006 Early Lessons from the Building Strong Families Project
    by Sarah Avellar & M. Robin Dion & Heather H. Zaveri & Alan M. Hershey
  • 2006 Building Strong Families: Evaluating an Intervention to Nurture the Bond Between Unwed Parents
    by Sheena McConnell
  • 2006 The Impacts of a Home Visitation and Life Skills Education Program for Hard-to-Employ TANF Recipients: Findings from the Rural Welfare-to-Work Evaluation
    by Alicia Meckstroth & rew Burwick & Quinn Moore
  • 2006 Dual Eligible Populations and Special Needs Plans: Current and Future Strategies
    by James M. Verdier
  • 2006 A Profile of Young Children in the Los Angeles Healthy Kids Program: Who Are They and What Are Their Experiences on the Program?
    by Embry Howell & Lisa Dubay & Genevieve Kenney & Louise Palmer & Ian Hill & Moira Inkelas & Martha Kovac
  • 2006 Parental Interactions with Latino Infants: Variation by Country of Origin and English Proficiency
    by Natasha J. Cabrera & Jerry West & Jacqueline D. Shannon & Jeanne Brooks-Gunn
  • 2006 24 Million and Counting: Reflections on 40 Years of Head Start Research in Support of Children and Families. Presentation
    by John M. Love
  • 2006 24 Million and Counting: Reflections on 40 Years of Head Start Research in Support of Children and Families. Paper
    by John M. Love
  • 2006 Medicare Advantage Rate Setting and Risk Adjustment: A Primer for States Considering Contracting with Medicare Advantage Special Needs Plans to Cover Medicaid Benefits
    by James M. Verdier
  • 2006 Prescription Drug Costs for Children with Special Health Care Needs
    by Henry Ireys & Shanna Shulman & Stephanie Peterson
  • 2006 Children with Special Health Care Needs in Commercial Plans
    by Shanna Shulman & Henry Ireys & Stephanie Peterson
  • 2006 The First Ten Years of TANF in Three States: The Experiences of New Jersey, New York, and Pennsylvania
    by Robert G. Wood & Justin Wheeler
  • 2006 An Examination of the First Ten Years Under TANF in Three States: The Experiences of New Jersey, New York, and Pennsylvania
    by Robert G. Wood & Justin Wheeler
  • 2006 Expanding Beyond Academics: Who Benefits and How?
    by John Deke & Joshua Haimson
  • 2006 Analysis of the Characteristics of Medicare Advantage Plan Participation
    by Marsha Gold & Stephanie Peterson
  • 2006 Implementing the Institute of Medicine Definition of Disparities: An Application to Mental Health Care
    by Thomas G. McGuire & Margarita Alegria & Benjamin L. Cook & Kenneth B. Wells & Alan M. Zaslavsky
  • 2006 Reliability of a Structured Assessment for Nonclinicians to Detect Delirium Among New Admissions to Postacute Care
    by Samuel E. Simon & Margaret A. Bergman & Richard N. Jones & Katherine M. Murphy & E. John Orav & Edward R. Marcantonio
  • 2006 The Impact of Quality-Reporting Programs on Hospital Operations
    by Hoangmai H. Pham & Jennifer Coughlan & Ann S. O'Malley
  • 2006 En Búsqueda De Soluciones: Mejorando El Servicio Médico Para Las Personas Con Dominio Limitado Del Inglés En Connecticut
    by Ann Bagchi & Beth Stevens
  • 2006 Valuing Student Competencies: Which Ones Predict Postsecondary Educational Attainment and Earnings, and for Whom?
    by John Deke & Joshua Haimson
  • 2006 Estimates for the Cost of Interpretation Services for Connecticut Medicaid Recipients
    by Ann Bagchi & Beth Stevens
  • 2006 Estimating the Proportion of Health-Related Websites Disclosing Information That Can Be Used to Assess Their Quality
    by Margaret Gerteis & Anna Katz & Davene Wright & Frank Potter & Margo Rosenbach
  • 2006 Estimating the Proportion of Health-Related Websites Disclosing Information That Can Be Used to Assess Their Quality
    by Margaret Gerteis & Anna Katz & Davene Wright & Frank Potter & Margo Rosenbach
  • 2006 Food Insecurity and the Risks of Depression and Anxiety in Mothers and Behavior Problems in Their Preschool-Aged Children
    by Robert C. Whitaker & Shannon M. Phillips & Sean M. Orzol
  • 2006 Improving the Connectedness of Long-Term Care Providers: Cross Site Report
    by Beth Stevens & Bridget Lavin & Valerie Cheh
  • 2006 School Principals' Perspectives on the Passport to Teaching
    by Steven Glazerman & Christina Tuttle & Gail Baxter
  • 2006 Impacts of a Summer Learning Program: A Random Assignment Study of Building Educated Leaders for Life (BELL)
    by Duncan Chaplin & Jeffrey Capizzano
  • 2006 Public Financing of Home and Community Services for Children and Youth with Serious Emotional Disturbances: Selected State Strategies
    by Henry T. Ireys & Sheila Pires & Meredith Lee
  • 2006 Implementing Healthy Marriage Programs for Unmarried Couples with Children: Early Lessons from the Building Strong Families Project
    by M. Robin Dion & Sarah A. Avellar & Heather H. Zaveri & Alan M. Hershey
  • 2006 Disease Management: Promising, But Not Yet Proven
    by Debbie Peikes
  • 2006 Seeking Solutions: Enhancing Health Care Delivery for People in Connecticut with Limited English Proficiency
    by Ann Bagchi & Beth Stevens
  • 2006 State Regulation of Residential Facilities for Children with Mental Illness
    by Henry Ireys & Lori Achman & Ama Takyi
  • 2006 State Regulation of Residential Facilities for Adults with Mental Illness
    by Henry Ireys & Lori Achman & Ama Takyi
  • 2006 Mother-Child Bookreading in Low-Income Families: Correlates and Outcomes During the First Three Years of Life
    by Helen Raikes & Gayle Luze & Jeanne Brooks-Gunn & H. Abigail Raikes & Barbara Alexander Pan & Catherine S. Tamis-LeMonda & Jill Constantine & Louisa Banks Tarullo & Eileen T. Rodriguez
  • 2006 National Estimates of Mental Health Insurance Benefits
    by Myles Maxfield & Lori Achman & Jeffrey A. Buck & Judith L. Teich
  • 2006 State-By-State Mental Health Services and Expenditures in Medicaid, 1999
    by James Verdier & Ann Cherlow & Allison Barrett & Jeffrey Buck & Judith Teich
  • 2006 Medicaid RX Drug Use and Expenditures Among Medicaid and Medicare Dual Eligibles in 2001: Implications for Medicare Part D
    by James Verdier & Dominick Esposito & Ann Bagchi & Deo Bencio & Licia Gaber & Myoung Kim
  • 2006 Participation in the Medicaid Buy-In Program: A Statistical Profile from Integrated Data
    by Su Liu & Henry T. Ireys
  • 2006 How Much Are Medicaid Buy-In Participants Earning?
    by William E. Black & Su Liu & Henry T. Ireys
  • 2006 Medicare Advantage Special Needs Plans Site Visits
    by James Verdier & Melanie Au
  • 2006 Establishing and Managing a Successful Special Needs Program
    by James M. Verdier
  • 2006 Obesity Among U.S. Urban Preschool Children: Relationships to Race, Ethnicity, and Socioeconomic Status
    by Robert C. Whitaker & Sean Orzol
  • 2006 New Hospital Information Technology: Is It Helping to Improve Quality?
    by Suzanne Felt-Lisk
  • 2006 Medicare Advantage: Early Views and Trend Spotting: What We Know from Analyzing Public Data Files
    by Marsha Gold
  • 2006 The Early Reading and Mathematics Achievement of Children Who Repeated Kindergarten or Who Began School a Year Late
    by Lizabeth M. Malone & Jerry West & Kristin Denton Flanagan & Jen Park
  • 2006 Premiums and Cost-Sharing Features in Medicare's New Prescription Drug Program, 2006
    by Marsha Gold
  • 2006 The Struggle to Provide Community-Based Care to Low-Income People with Serious Mental Illnesses
    by Peter Cunningham & Kelly McKenzie & Erin Fries Taylor
  • 2006 An Evaluation of American Board Teacher Certification: Progress and Plans
    by Steven Glazerman & Christina Tuttle
  • 2006 Maternal Feeding Style During Infancy and Children's Adiposity at 5 Years of Age
    by Hillary L. Burdette & Robert C. Whitaker & Waynitra C. Hall & Stephen R. Daniels
  • 2006 Maternal Mental Health, Substance Use, and Domestic Violence in the Year After Delivery and Subsequent Behavior Problems in Children at Age 3 Years
    by Robert C. Whitaker & Sean M. Orzol & Robert S. Kahn
  • 2006 The Early Head Start Father Studies: Design, Data Collection, and Summary of Father Presence in the Lives of Infants and Toddlers
    by Kimberly Boller & Robert Bradley & Natasha Cabrera & Helen H. Raikes & Barbara Pan & Jeffrey Shears & Lori Roggman
  • 2006 Reaching Out to Kith and Kin Caregivers in Early Head Start
    by Diane Paulsell & Debra Mekos & Patricia Del Grosso & Patti Banghart & Renée Nogales
  • 2006 The National Evaluation of Reading Comprehension Interventions
    by Susanne James-Burdumy & David Myers & John Deke & Wendy Mansfield & Russell Gersten & Joseph Dimino & Jan Dole & Lauren Liang & Sharon Vaughn & Meaghan Edmonds
  • 2006 Measuring Physical Environments of Parks and Playgrounds: EAPRS Instrument Development and Inter-Rater Reliability
    by Brian E. Saelens & Lawrence D. Frank & Christopher Auffrey & Robert C. Whitaker & Hillary L. Burdette & Natalie Colabianchi
  • 2006 Second Report to Congress on the Evaluation of the Medicare Coordinated Care Demonstration
    by Randall Brown & Deborah Peikes & Arnold Chen & Judy Ng & Jennifer Schore & Clara Soh
  • 2006 A Study of the Effect of Talent Search on Secondary and Postsecondary Outcomes in Florida, Indiana, and Texas
    by Jill Constantine & Neil Seftor & Emily Sama Martin & Tim Silva & David Myers
  • 2006 Multiple Interfaces of Big Pharma and the Change of Global Health Governance in the Face of HIV/AIDS
    by Jan Peter Wogart
  • 2006 Italian Schools and New Linguistic Minorities: Nationality Vs. Plurilingualism. Which Ways and Methodologies for Mapping these Contexts?
    by Carla Bagna
  • 2006 On Backwardness And Fair Access To Higher Education In India: Some Results From Nss 55th Round Surveys 1999-2000
    by K. SUNDARAM
  • 2006 Review of Price Regulation of Airports Services
    by Productivity Commission
  • 2006 Australia's Health Workforce
    by Productivity Commission
  • 2006 The Authors' Reply
    by Adrian A. Bagust & Marc Evans & Sophie Beale & Philip Home & Andrew Perry & Murray Stewart & Arran Shearer & Alan Martin & Lisa Hulme & Andreas Liebl & Oliver Schoeffski & Anita Goertz & Javier Ampudia-Blasco & Belen Martinez-Lage & Isabel Perez Escolano & Gonzalo Paris
  • 2006 Modelling Lifetime Metabolic Progression and Cost Effectiveness of Treatment Strategies for Type 2 Diabetes
    by Andrew J. Palmer & Craig J. Currie
  • 2006 Missing Data Imputation in Quality-of-Life Assessment: Imputation for WHOQOL-BREF
    by Ting Hsiang Lin
  • 2006 Public Funding of Bosentan for the Treatment of Pulmonary Artery Hypertension in Australia: Cost Effectiveness and Risk Sharing
    by John H. Wlodarczyk & Leslie G. Cleland & Anne M. Keogh & Keith D. McNeil & Kate Perl & Robert G. Weintraub & Trevor J. Williams
  • 2006 Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996-2003
    by Yue-Chune Lee & Ming-Chin Yang & Yu-Tung Huang & Chien-Hsiang Liu & Sun-Bing Chen
  • 2006 Cost-of-Illness Studies: A Review of Current Methods
    by Ebere Akobundu & Jing Ju & Lisa Blatt & C. Daniel Mullins
  • 2006 Using Discrete Choice Experiments within a Cost-Benefit Analysis Framework: Some Considerations
    by Emma McIntosh
  • 2006 The Value of Thinly Spread QALYs
    by Duncan Mortimer
  • 2006 Accuracy versus Transparency in Pharmacoeconomic Modelling: Finding the Right Balance
    by David M. Eddy
  • 2006 US FDA Guidance: Apropos of PROs
    by Paul Kind
  • 2006 National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget
    by Slobodan M. Jankovic & Nebojsa Milivojevic
  • 2006 Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada
    by Michele Kohli & Cheryl Attard & Annette Lam & Daniel Huse & John Cook & Chantal Bourgault & Evo Alemao & Donald Yin & Michael Marentette
  • 2006 Costs of Inflammatory Bowel Disease in Germany
    by Renee Stark & Hans-Helmut Konig & Reiner Leidl
  • 2006 A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction
    by Mark Lamotte & Lieven Annemans & Pawel Kawalec & York Zoellner
  • 2006 Pharmacoeconomic Analyses of Azathioprine, Methotrexate and Prospective Pharmacogenetic Testing for the Management of Inflammatory Bowel Disease
    by Virginia L. Priest & Evan J. Begg & Sharon J. Gardiner & Christopher M.A. Frampton & Richard B. Gearry & Murray L. Barclay & David W.J. Clark & Paul Hansen
  • 2006 A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials
    by Darren J. Clayson & Diane J. Wild & Paul Quarterman & Isabelle Duprat-Lomon & Maria Kubin & Stephen Joel Coons
  • 2006 Prostaglandin Analogues for the Treatment of Glaucoma and Ocular Hypertension: A Systematic Review of Economic Evidence
    by Michelle Orme & Annabel Boler
  • 2006 Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma
    by Pamela C. Heaton
  • 2006 Clopidogrel: A Pharmacoeconomic Review of its Use in Patients with Non-ST Elevation Acute Coronary Syndromes
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2006 Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma
    by Gunnar Johansson & Emma B. Andreasson & Per E. Larsson & Claus F. Vogelmeier
  • 2006 Tapering Off Benzodiazepines in Long-Term Users: An Economic Evaluation
    by Richard C. Oude Voshaar & Paul F.M. Krabbe & Wim J.M.J. Gorgels & Eddy M.M. Adang & Anton J.L.M. van Balkom & Eloy H. van de Lisdonk & Frans G. Zitman
  • 2006 Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) Questionnaire in Patients with Diabetes in a Multi-Ethnic Asian Country
    by Hwee-Lin Wee & Chee-Eng Tan & Su-Yen Goh & Shu-Chuen Li
  • 2006 Hepatitis C: Cost of Illness and Considerations for the Economic Evaluation of Antiviral Therapies
    by John B. Wong
  • 2006 Cost of Lung Cancer: A Methodological Review
    by Laurent Molinier & Christophe Combescure & Cristos Chouaid & Jean-Pierre Daures & Bruno Housset & Didier Fabre & Alain Grand & Alain Vergnenegre
  • 2006 Developing Health-Related Quality-of-Life Instruments for Use in Asia: The Issues
    by Yin Bun Cheung & Julian Thumboo
  • 2006 Economic Models of Antiretroviral Therapy: Searching for the Optimal Strategy
    by Fred J. Hellinger
  • 2006 NICE Says No to Inhaled Insulin: What Lessons Should We Learn?
    by Nick Freemantle
  • 2006 The Authors' Reply
    by Colin Green & Joanna Picot & Emma Loveman & Andrea Takeda & Jo Kirby & Andrew Clegg
  • 2006 Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease
    by Nick Bosanquet & Andrew Yeates
  • 2006 Is the Childhood Asthma Questionnaire a Good Measure of Health-Related Quality of Life of Asthmatic Children in Asia?: Validation Among Paediatric Patients with Asthma in Singapore
    by Lee-Yee Chong & Oh-Moh Chay & Li Shu-Chuen
  • 2006 Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients: A Pharmacoeconomic Analysis
    by George Dranitsaris & Mark Vincent & Mark Crowther
  • 2006 Cost Effectiveness of Enoxaparin as Prophylaxis against Venous Thromboembolic Complications in Acutely Ill Medical Inpatients: Modelling Study from the Hospital Perspective in Germany
    by Peter K. Schadlich & Michael Kentsch & Manfred Weber & Wolfgang Kammerer & Josef Georg Brecht & Vijay Nadipelli & Eduard Huppertz
  • 2006 The Effects of Type 1 Diabetes and its Long-Term Complications on Physical and Mental Health Status
    by Jarmo Hahl & Helena Hamalainen & Tuula Simell & Olli Simell
  • 2006 The Impact of Losartan on the Lifetime Incidence of End-Stage Renal Disease and Costs in Patients with Type 2 Diabetes and Nephropathy
    by George W. Carides & Shahnaz Shahinfar & Erik J. Dasbach & William F. Keane & William C. Gerth & Charles M. Alexander & William H. Herman & Barry M. Brenner & the RENAAL Investigators
  • 2006 Healthcare Rationing in Spain: Framework, Descriptive Analysis and Consequences
    by Rosa Rodriguez-Monguio & Fernando Antonanzas Villar
  • 2006 Pharmacoeconomics of Angiotensin II Antagonists in Type 2 Diabetic Patients with Nephropathy: Implications for Decision Making
    by Cornelis Boersma & Jarir Atthobari & Ron T. Gansevoort & Lolkje T.W. de Jong-Van den Berg & Paul E. de Jong & Dick de Zeeuw & Lieven J.P. Annemans & Maarten J. Postma
  • 2006 The Authors' Reply
    by Lawrence D. Goldberg & John G. Walt
  • 2006 Cost Considerations in the Medical Management of Glaucoma in the US: Estimated Yearly Costs and Cost Effectiveness of Bimatoprost Compared with Other Medications
    by Javier Soto
  • 2006 Letrozole: A Pharmacoeconomic Review of its Use in Postmenopausal Women with Breast Cancer
    by Christopher Dunn & Susan J. Keam
  • 2006 Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced Anaemia: Evidence from a 16-Week Randomised Trial
    by Shelby D. Reed & Jasmina I. Radeva & Davey B. Daniel & Samir H. Mody & Jamie B. Forlenza & R. Scott McKenzie & Kevin A. Schulman
  • 2006 Comprehensive Decision-Analytic Model and Bayesian Value-of-Information Analysis: Pentoxifylline in the Treatment of Chronic Venous Leg Ulcers
    by Cynthia P. Iglesias & Karl Claxton
  • 2006 Encouraging Smokers to Quit: The Cost Effectiveness of Reimbursing the Costs of Smoking Cessation Treatment
    by Janneke Kaper & Edwin J. Wagena & Constant P. van Schayck & Johan L. Severens
  • 2006 Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: Based on Data from the Medical Research Council LU19 Trial
    by Laura Bojke & Mark Sculpher & Richard Stephens & Wendi Qian & Nick Thatcher & David Girling
  • 2006 Cost Effectiveness of Preventive Interventions in Type 2 Diabetes Mellitus: A Systematic Literature Review
    by Sylvia M.C. Vijgen & Mirjam Hoogendoorn & Caroline A. Baan & G. Ardine de Wit & Wien Limburg & Talitha L. Feenstra
  • 2006 Accounting for Tastes: A German Perspective on the Inclusion of Patient Preferences in Healthcare
    by Florian Vogt & David L.B. Schwappach & John F.P. Bridges
  • 2006 The Authors' Reply
    by Richard J. Milne & Kathy H. Heaton-Brown & Paul Hansen & David Thomas & Vernon Harvey & Alison Cubitt
  • 2006 Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women
    by Stephanie Land
  • 2006 Productivity Costs in Health-State Valuations: Does Explicit Instruction Matter?
    by Marieke Krol & Werner Brouwer & Pedram Sendi
  • 2006 A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy
    by Aslam H. Anis & Huiying Sun & Sonia Singh & John Woolcott & Bohdan Nosyk & Marc Brisson
  • 2006 Post-Exposure Influenza Prophylaxis with Oseltamivir: Cost Effectiveness and Cost Utility in Families in the UK
    by Beate Sander & Frederick G. Hayden & Marlene Gyldmark & Louis P. Garrison
  • 2006 Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment: A Review and Consolidation of Quality Assessment
    by Zoe Philips & Laura Bojke & Mark Sculpher & Karl Claxton & Su Golder
  • 2006 Optimal Assignment of Treatments to Health States Using a Markov Decision Model: An Introduction to Basic Concepts
    by Mohan V. Bala & Josephine A. Mauskopf
  • 2006 Economic and Developmental Considerations for Pharmacogenomic Technology
    by John A. Vernon & Scott J. Johnson & W. Keener Hughen & Antonio Trujillo
  • 2006 The Burden of Age-Related Macular Degeneration
    by Jordana K. Schmier & Mechelle L. Jones & Michael T. Halpern
  • 2006 Bernard S. Bloom, PhD
    by Henry A. Glick
  • 2006 Rationing of Drugs for Rare Diseases
    by Dyfrig Hughes
  • 2006 Bimatoprost: A Pharmacoeconomic Review of its Use in Open-Angle Glaucoma and Ocular Hypertension
    by Greg L. Plosker & Susan J. Keam
  • 2006 The Authors' Reply
    by Paul Kind & Sue Macran
  • 2006 Eliciting Social Preference Weights for Functional Assessment of Cancer Therapy-Lung Health States
    by A. Simon Pickard & Deborah Dobrez & David Cella
  • 2006 Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women
    by Richard J. Milne & Kathy H. Heaton-Brown & Paul Hansen & David Thomas & Vernon Harvey & Alison Cubitt
  • 2006 Functional Impairment, Healthcare Costs and the Prevalence of Institutionalisation in Patients with Alzheimer's Disease and Other Dementias
    by Jerrold Hill & Howard Fillit & Simu K. Thomas & Sobin Chang
  • 2006 Cost Considerations in the Medical Management of Glaucoma in the US: Estimated Yearly Costs and Cost Effectiveness of Bimatoprost Compared with Other Medications
    by Lawrence D. Goldberg & John Walt
  • 2006 Cost Effectiveness of Extended Adjuvant Letrozole in Postmenopausal Women after Adjuvant Tamoxifen Therapy: The UK Perspective
    by Jonathan Karnon & Thomas Delea & Stephen R.D. Johnston & Robert Smith & Jane Brandman & Jennifer Sung & Paul E. Goss
  • 2006 Trends in Outpatient Prescription Drug Use and Related Costs in the US: 1998-2003
    by Diane K. Wysowski & Laura A. Governale & Joslyn Swann
  • 2006 Aromatase Inhibitors in Breast Cancer: A Review of Cost Considerations and Cost Effectiveness
    by Jonathan Karnon
  • 2006 Less is More: Medicines that Require Less Frequent Administration Improve Adherence, but Are They Better?
    by Dyfrig Hughes
  • 2006 How Much is the Cost of Visual Impairment: the Author's Reply
    by Antoine Lafuma
  • 2006 How Much is the Cost of Visual Impairment: Caveat Emptor
    by Catherine Meads & Chris Hyde
  • 2006 Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries: France, Italy, Germany and the UK
    by Antoine Lafuma & Antoine Brezin & Stefania Lopatriello & Klaus Hieke & Julia Hutchinson & Viviane Mimaud & Gilles Berdeaux
  • 2006 The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia
    by Rachael L. DiSantostefano & Andrea K. Biddle & John P. Lavelle
  • 2006 A Multi-Country Economic Evaluation of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease
    by Mark Lamotte & Lieven Annemans & Thomas Evers & Maria Kubin
  • 2006 Combination Vaccine Against Invasive Meningococcal B and Pneumococcal Infections: Potential Epidemiological and Economic Impact in The Netherlands
    by Jasper M. Bos & Hans C. Rumke & Robert Welte & Lodewijk Spanjaard & Loek van Alphen & Maarten J. Postma
  • 2006 Differential Effects of Atypical versus Typical Antipsychotic Medication on Earnings of Schizophrenia Patients: Estimates from a Prospective Naturalistic Study
    by David Salkever & Eric Slade & Mustafa Karakus
  • 2006 Sociodemographic Differences in Quality of Life in Rheumatoid Arthritis
    by Erik J. Groessl & Theodore G. Ganiats & Andrew J. Sarkin
  • 2006 Better Analysis for Better Decisions: Has Pharmacoeconomics Come of Age?
    by Michael Drummond & Mark Sculpher
  • 2006 Economic Evaluation of Rivastigmine in Patients with Parkinson's Disease Dementia
    by Andrew R. Willan & Ron Goeree & Eleanor M. Pullenayegum & Christopher McBurney & Gordon Blackhouse
  • 2006 Cost Effectiveness of Bemiparin Sodium versus Unfractionated Heparin and Oral Anticoagulants in the Acute and Long-Term Treatment of Deep Vein Thrombosis
    by Antonio Gomez-Outes & Eduardo Rocha & Javier Martinez-Gonzalez & Vijay V. Kakkar
  • 2006 Evaluation of the Cost Effectiveness of Sirolimus versus Tacrolimus for Immunosuppression Following Renal Transplantation in the UK
    by Phil McEwan & Simon Dixon & Keshwar Baboolal & Pete Conway & Craig J. Currie
  • 2006 Interstitial Cystitis: Cost, Treatment and Co-morbidities in an Employed Population
    by Eric Q. Wu & Howard Birnbaum & Milena Mareva & Andrew Parece & Zihong Huang & David Mallett & Haya Taitel
  • 2006 Incorporating Carer Effects into Economic Evaluation
    by Simon Dixon & Mel Walker & Sam Salek
  • 2006 Too Important to Ignore: Informal Caregivers and Other Significant Others
    by Werner B.F. Brouwer
  • 2006 Costs of Irritable Bowel Syndrome in the UK and US
    by Stefanie Maxion-Bergemann & Frank Thielecke & Florian Abel & Rito Bergemann
  • 2006 Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis
    by A.E. Ades & Mark Sculpher & Alex Sutton & Keith Abrams & Nicola Cooper & Nicky Welton & Guobing Lu
  • 2006 The Authors' Reply
    by J.M. Bos & M.J. Postma & L. Annemans
  • 2006 Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies
    by Stuart Birks
  • 2006 Candesartan Cilexetil: A Pharmacoeconomic Review of its Use in Chronic Heart Failure and Hypertension
    by Greg L. Plosker & Susan J. Keam
  • 2006 Association of Co-Morbidities with Prescribing Patterns and Cost Savings: Olanzapine versus Risperidone for Schizophrenia
    by Wei Yu & Xinhua S. Ren & Austin F. Lee & Lawrence Herz & Yu-Hui Huang & Lewis E. Kazis
  • 2006 Cost Effectiveness of Tumour Necrosis Factor-alpha Inhibitors as First-Line Agents in Rheumatoid Arthritis
    by James R. Spalding & Joel Hay
  • 2006 Generic Health-Related Quality-of-Life Assessment in Children and Adolescents: Methodological Considerations
    by Ulrike Ravens-Sieberer & Michael Erhart & Nora Wille & Ralf Wetzel & Jennifer Nickel & Monika Bullinger
  • 2006 Assessing Generalisability in Model-Based Economic Evaluation Studies: A Structured Review in Osteoporosis
    by Hege Urdahl & Andrea Manca & Mark J. Sculpher
  • 2006 Letter From the Commissioner's Office at the US FDA
    by John A. Vernon
  • 2006 Do Pharmacogenomic Tests Provide Value to Policy Makers?
    by Ya-Chen Tina Shih & Lajos Pusztai
  • 2006 Acknowledgement
    by Adis International Limited
  • 2006 Economic Evaluation in the US: What is the Missing Link?
    by Peter J. Neumann & Sean D. Sullivan
  • 2006 Economic Evaluations in the Canadian Common Drug Review
    by Andreas Laupacis
  • 2006 Building Bridges Between Academic Research and Policy Formulation: The PRUFE Framework - an Integral Part of Ontario's Evidence-Based HTPA Process
    by Ron Goeree & Leslie Levin
  • 2006 Economic Evaluation and Decision Making in the UK
    by Martin J. Buxton
  • 2006 Information Created to Evade Reality (ICER): Things We Should Not Look to for Answers
    by Stephen Birch & Amiram Gafni
  • 2006 `Lost in Translation': Accounting for Between-Country Differences in the Analysis of Multinational Cost-Effectiveness Data
    by Andrea Manca & Andrew R. Willan
  • 2006 Analysis Sans Frontieres: Can We Ever Make Economic Evaluations Generalisable Across Jurisdictions?
    by Mark J. Sculpher & Michael F. Drummond
  • 2006 Pharmacoeconomics and Pharmacoepidemiology: Curious Bedfellows or a Match Made in Heaven?
    by Andrew H. Briggs & Adrian R. Levy
  • 2006 Utility Measurement in Healthcare: The Things I Never Got To
    by George W. Torrance
  • 2006 Using Value of Information Analysis to Prioritise Health Research: Some Lessons from Recent UK Experience
    by Karl P. Claxton & Mark J. Sculpher
  • 2006 Recent Developments in Decision-Analytic Modelling for Economic Evaluation
    by Milton C. Weinstein
  • 2006 Better Analysis for Better Decisions: Facing Up to the Challenges
    by Michael F. Drummond & Mark J. Sculpher
  • 2006 Hospitalisation Costs of Cystic Fibrosis
    by Jonas Schreyogg & Helge Hollmeyer & Miriam Bluemel & Doris Staab & Reinhard Busse
  • 2006 Disability and Quality of Life in Post-Traumatic Stress Disorder: Impact of Drug Treatment
    by Soraya Seedat & Christine Lochner & Bavanisha Vythilingum & Dan J. Stein
  • 2006 Single-Inhaler Combination Therapy for Asthma: A Review of Cost Effectiveness
    by Manabu Akazawa & David A. Stempel
  • 2006 Therapeutic Options for the Prevention and Treatment of Postoperative Nausea and Vomiting: A Pharmacoeconomic Review
    by Jean Lachaine
  • 2006 Should We Abandon QALYs as a Resource Allocation Tool?
    by Sandeep Vijan
  • 2006 QALYs: Are They Helpful to Decision Makers?
    by Maurice McGregor & J. Jaime Caro
  • 2006 The Generalisability of Pharmacoeconomic Studies: Issues and Challenges Ahead
    by James M. Mason & Anne R. Mason
  • 2006 Anticoagulation for Stroke Prevention: High Effectiveness, More Cost Benefit?
    by Eduard Shantsila & Timothy Watson & Gregory Y.H. Lip
  • 2006 The Cost Effectiveness of Anticoagulation Management Services for Patients with Atrial Fibrillation and at High Risk of Stroke in the US
    by Patrick W. Sullivan & Thomas W. Arant & Samuel L. Ellis & Heather Ulrich
  • 2006 The Initial Validation of a Markov Model for the Economic Evaluation of (New) Treatments for Rheumatoid Arthritis
    by Paco M.J. Welsing & Johan L. Severens & Margriet Hartman & Anke M. van Gestel & Piet L.C.M. van Riel & Roland F.J.M. Laan
  • 2006 2006 Disease Management Leadership Forum Meeting Report: Denver, Colorado, 2-5 December 2006
    by Julie A. Meek
  • 2006 Economic Analysis of a Telemedicine Intervention to Improve Glycemic Control in Patients with Diabetes Mellitus: Illustration of a Novel Analytic Method
    by James M. Mason & Robert J. Young & John P. New & J. Martin Gibson & Andrew F. Long & Tina Gambling & Tim Friede
  • 2006 Psychiatric Drug Use Among Patients of a Community Mental Health Service: Patterns and Implications
    by Natasa Gisev & J. Simon Bell & Andrew J. McLachlan & Manoranjenni Chetty & Timothy F. Chen
  • 2006 Combination Therapy for Asthma: Perspectives of the Patient, Provider, and Payer
    by Harold J. Farber & James Glauber
  • 2006 Targeted Screening and Treatment of Chronic Kidney Disease: Lessons Learned from the Kidney Early Evaluation Program
    by Joseph A. Vassalotti & Leslie Gracz-Weinstein & Monica R. Gannon & Wendy Weinstock Brown
  • 2006 Using Nicotine Replacement Therapy to Assist in Reducing Cigarette Consumption before Quitting: Another Strategy for Smoking Cessation?
    by Hayden McRobbie & Robyn Whittaker & Christopher Bullen
  • 2006 Putting a Public Health Face on Clinical Practice: Potential for Using an Infectious Disease Management Model for Chronic Disease Prevention
    by Donald O. Fedder & Harsha Desai & Migle Maciunskaite
  • 2006 Acknowledgment
    by Adis International Limited
  • 2006 Disease Management Update
    by Adis International Limited
  • 2006 The Role of Peginterferon alpha-2a (40kD) Plus Ribavirin in the Management of Chronic Hepatitis C Mono-Infection
    by Dene Simpson & Monique P. Curran
  • 2006 The Impact of Open Access to Atypical Antipsychotics on Treatment Costs for Medi-Cal Patients with Bipolar Disorder
    by Sangeeta Narayan & Kimberly L. Sterling & Jeffrey S. McCombs
  • 2006 Internet-Based Smoking Cessation Initiatives: Availability, Varieties, and Likely Effects on Outcomes
    by Anna M. McDaniel & Renee M. Stratton
  • 2006 Preparing for and Responding to Bioterrorist Attacks: The Role of Disease Management Initiatives
    by R. Gregory Evans & Steven J. Lawrence
  • 2006 Disease Management and Its Implications for Outpatient Physician Practice: A Memo for Physicians
    by Jaan Sidorov
  • 2006 Disease Management Update
    by Adis International Limited
  • 2006 Impact of a Diabetes Disease Management Program by Race and Ethnicity
    by Verna L. Welch & Natalia Vukshich Oster & Julie A. Gazmararian & Kimberly Rask & Laura Schild & Charles Cutler & Claire Spettell & Michael Reardon
  • 2006 Disease Management of the Frail Elderly Population
    by Stuart Levine & Judy Y. Reyes & Randy Schwartz & Dave Schmidt & Tim Schwab & Moon Leung
  • 2006 Poor Adherence to Anti-inflammatory Medication in Asthma: Reasons, Challenges, and Strategies for Improved Disease Management
    by Rachel A. Elliott
  • 2006 Developing a Specialist Patient Program for Migraine
    by Ann Turner
  • 2006 Adherence to Antipsychotic Treatment in Schizophrenia: What Role Does Cognitive Behavioral Therapy Play in Improving Outcomes?
    by Gary Donohoe
  • 2006 Measuring the Economic Value of Disease Management Programs
    by Don Fetterolf
  • 2006 In Search of Financial Savings from Disease Management: Applying the Number-Needed-to-Decrease Analysis to a Diabetic Population
    by Ariel Linden & Thomas J. Biuso
  • 2006 Disease Management Update
    by Adis International Limited
  • 2006 Community Direct Access Service for Early Detection and Treatment of Clinical Deterioration: Effectiveness and Impact on the Workload Pattern of a Hospital-Based Heart Failure Unit
    by Carmel Conlon & Christina O'Loughlin & Mark Ledwidge & Kenneth McDonald
  • 2006 Analysis of Factors Affecting Patient Satisfaction: Focus on Asthma Patients
    by Bayram Sahin & Mehtap Tatar
  • 2006 Impact of Telehealth on Healthcare Utilization by Congestive Heart Failure Patients
    by Craig A. Lehmann & Nancy Mintz & Jean Marie Giacini
  • 2006 Evaluation of an Asthma Disease Management Program in a Medicaid Population
    by Alice Lind & Louise Kaplan & Gregory D. Berg
  • 2006 Telemedicine for Diabetes Care
    by Toree H. Malasanos
  • 2006 Removing Prescription Charges for Patients with Mental Health Disorders: Would it Improve Patient Outcomes in the UK?
    by Ellen I. Schafheutle
  • 2006 Physician Voluntary Reporting Program
    by David W. Plocher
  • 2006 The Economic Burden of End-Stage Renal Disease with Hyperphosphatemia: A Study of Florida Medicaid
    by Annesha White & Folakemi Odedina & Hong Xiao & Ellen Campbell & Richard Segal
  • 2006 Process Optimization by Means of a Computerized Process Simulation Model in Cardiac Surgery
    by Richard Feyrer & Udo Kunzmann & Michael Weyand & Robert Cesnjevar
  • 2006 Promoting the Implementation of Best-Practice Guidelines Using a Matrix Tool: Focus on Cancer Care
    by Karen Luxford & David Hill & Richard Bell
  • 2006 Type 2 Diabetes Mellitus Treatment Patterns and Healthcare Costs in the Elderly Population
    by Gary Erwin & Shrividya Iyer & Rukmini Rajagopalan & James Astuto & Patricia Wilson & Justin Schaneman & Nathan Kleinman
  • 2006 Prescription to Over-the-Counter Switch of Second-Generation Antihistamines (Loratadine): A Review of Its Impact on Healthcare Costs and Resource Utilization
    by Kavita V. Nair
  • 2006 Disease Management Update
    by Adis International Limited
  • 2006 Management of Schizophrenia: Defining the Role of Long-Acting Injectable Risperidone
    by Monique P. Curran & Gillian M. Keating
  • 2006 The Cost of Lung Cancer Management in France from the Payor's Perspective
    by Alain Vergnenegre & Laurent Molinier & Christophe Combescure & Jean-Pierre Daures & Bruno Housset & Christos Chouaid
  • 2006 Population-Based Disease Management in the German Statutory Health Insurance: Implementation and Preliminary Results
    by Stephanie A.K. Stock & Marcus Redaelli & Karl W. Lauterbach
  • 2006 Clinical and Behavioral Impact of Implementing Community-Based Diabetes Disease Management in Japan
    by Hiroyuki Sakamaki & Shunya Ikeda & Naoki Ikegami & Michiko Norimoto & Shigemitsu Moriwaki
  • 2006 An Evaluation of the Factors Associated with Statin Dose Management and Low-Density Lipoprotein-Cholesterol Goal Attainment
    by Caron Ory & Christina Fontes & Setareh A. Williams & Gerald M. Borok & Kenneth McDonough & Eunice Chang
  • 2006 Disease Management for Hypertension: A Pilot Cluster Randomized Trial of 67 Australian General Practices
    by Deborah A. Turnbull & Justin J. Beilby & Tahereh Ziaian & Farooq Qureshi & Mark Nelson & Anne L. Tonkin & John E. Marley
  • 2006 Worksite Disease Management Programs for Depression: Potential Employer Benefits
    by Diane E. Steffick & John C. Fortney & Jeffrey L. Smith & Jeffrey M. Pyne
  • 2006 Access to Prescription Drugs: The Case of Medicaid
    by Peter J. Cunningham
  • 2006 The Author's Reply
    by Joshua Cohen
  • 2006 Comparing Patient Access to Pharmaceuticals in the UK and US
    by Joel W. Hay
  • 2006 Comparison of Individual and Group Valuation of Health State Scenarios across Communities in West Africa
    by Anayo Fidelis Akunne & John F.P. Bridges & Mamadou Sanon & Rainer Sauerborn
  • 2006 Maximising Responses to Discrete Choice Experiments: A Randomised Trial
    by Joanna Coast & Terry N. Flynn & Chris Salisbury & Jordan Louviere & Tim J. Peters
  • 2006 Impact of Cross-Reference Pricing on Pharmaceutical Prices: Manufacturers' Pricing Strategies and Price Regulation
    by Tom Stargardt & Jonas Schreyogg
  • 2006 Analysis of Healthcare Financing, Supply and Utilisation Trends in the New EU Countries
    by Jane E. Ruseski
  • 2006 Handling Value Added Tax (VAT) in Economic Evaluations: Should Prices Include VAT?
    by Mickael Bech & Terkel Christiansen & Dorte Gyrd-Hansen
  • 2006 Quality and Cost in Healthcare: A Relationship Worth Examining
    by Craig Mitton & Francois Dionne & Stuart Peacock & Sam Sheps
  • 2006 Acknowledgement
    by Adis International Limited
  • 2006 Patients' Preferences for Healthcare System Reforms in Hungary: A Conjoint Analysis
    by Baktygul Akkazieva & Laszlo Gulacsi & Agnes Brandtmuller & Marta Pentek & John F.P. Bridges
  • 2006 Comparing Patient Access to Pharmaceuticals in the UK and US
    by Joshua Cohen & Catherine Cairns & Cherie Paquette & Laura Faden
  • 2006 Community-Based Youth Tobacco Control Interventions: Cost Effectiveness of the Full Court Press Project
    by Hana Ross & Lisa M. Powell & Joseph E. Bauer & David T. Levy & Richard M. Peck & Hye-Ryeon Lee
  • 2006 Modelling the Costs and Outcomes of Changing Rates of Screening for Alcohol Misuse by GPs in the Australian Context
    by Marian Shanahan & Anthony Shakeshaft & Richard P. Mattick
  • 2006 To Retain or Remove User Fees?: Reflections on the Current Debate in Low- and Middle-Income Countries
    by Chris D. James & Kara Hanson & Barbara McPake & Dina Balabanova & Davidson Gwatkin & Ian Hopwood & Christina Kirunga & Rudolph Knippenberg & Bruno Meessen & Saul S. Morris & Alexander Preker & Yves Souteyrand & Abdelmajid Tibouti & Pascal Villeneuve & Ke Xu
  • 2006 Estimating Technical Efficiency in the Hospital Sector with Panel Data: A Comparison of Parametric and Non-Parametric Techniques
    by Luigi Siciliani
  • 2006 Supplier-Induced Demand: Reconsidering the Theories and New Australian Evidence
    by Jeffrey R.J. Richardson & Stuart J. Peacock
  • 2006 How Cost-of-Illness Studies Can be Made More Useful for Illicit Drug Policy Analysis
    by Timothy J. Moore & Jonathan P. Caulkins
  • 2006 Centralising Drug Review to Improve Coverage Decisions: Economic Lessons From (and For) Canada
    by Steve Morgan & Meghan McMahon & Craig Mitton
  • 2006 Factors Associated with Physicians' Choice of Working Sector: A National Longitudinal Survey in Finland
    by Terhi Kankaanranta & Jari Vainiomaki & Ville Autio & Hannu Halila & Harri Hyppola & Mauri Isokoski & Santero Kujala & Esko Kumpusalo & Kari Mattila & Irma Virjo & Jukka Vanska & Pekka Rissanen
  • 2006 Australian General Practice: Where Have the GP Services Gone?
    by Ian McRae
  • 2006 A Macroeconomic Approach to Evaluating Policies to Contain Antimicrobial Resistance: A Case Study of Methicillin-Resistant Staphylococcus aureus (MRSA)
    by Richard D. Smith & Milton Yago & Michael Millar & Joanna Coast
  • 2006 Recycling Blood: Sharing the Benefits of Cell Salvage
    by Bernard Crotty
  • 2006 Using Economic Analyses for Local Priority Setting: The Population Cost-Impact Approach
    by Richard F. Heller & Islay Gemmell & Edward C.F. Wilson & Richard Fordham & Richard D. Smith
  • 2006 The Relationship between Ex Ante Mortality Risk and End-of-Life Medical Costs
    by David H. Howard & Steven D. Culler & Benjamin G. Druss & Kenneth E. Thorpe
  • 2006 Genetic Health Technology and Economic Evaluation: A Critical Review
    by James Jarrett & Miranda Mugford
  • 2006 Methodological Aspects in the Assessment of Treatment Effects in Observational Health Outcomes Studies
    by Josep Maria Haro & Stathis Kontodimas & Miguel Angel Negrin & Mark Ratcliffe & David Suarez & Frank Windmeijer
  • 2006 Health Reform, Equity and Primary Healthcare: Taking Off the Make-Up
    by Stephen Thomas & Okore Okorafor & Sandi Mbatsha
  • 2006 Inter-variable Uncertainty In Decision Analytic Modeling: The Concept Of Second-order Sensitivity/Incertidumbre Entre Variables En Modelos De Decisión Analítica: El Concepto De Sensibilidad De Segundo Orden
    by MARK J.C. NUIJTEN MD, MBA1 & MAIWENN AL PHD1, & FRANS RUTTEN PHD1
  • 2006 “I’ll be Back” – Austrian Recalls
    by René Böheim
  • 2005 Políticas sociales para el crecimiento con equidad en Chile, 1990-2002
    by Arellano M., José Pablo
  • 2005 Review of National Competition Policy Reforms
    by Productivity Commission
  • 2005 A Behavioral Model of Cyclical Dieting
    by Steven M. Suranovic & Robert S. Goldfarb
  • 2005 Modeling Alternative Motives for Dieting
    by Robert S. Goldfarb & Thomas C. Leonard & Steven M. Suranovic
  • 2005 Child Malnutrition, Social Development and Health Services in the Andean Region
    by LARREA CARLOS & MONTALVO PEDRO & RICAURTE ANA
  • 2005 Global Health Governance: Conflicts on Global Social Rights
    by Wolfgang Hein & Lars Kohlmorgen
  • 2005 Cost Analysis of a Home Visiting Program to Cost Analysis of a Home Visiting Program to Cost Analysis of a Home Visiting Program to Prevent Child Abuse and Neglect
    by Catherine Boulatoff & Vonda Jump
  • 2005 Should Research Universities be Led by Top Researchers? Part 1: Are they?
    by Amanda H Goodall
  • 2005 Who Are Schooled in Urban Pakistan?
    by Rana Ejaz Ali Khan & Karamat Ali
  • 2005 Bargaining Over Sons' and Daughters' Schooling-Probit Analysis of Household Behavior
    by Rana Ejaz Ali Khan & Karamat Ali
  • 2005 Screening For Cancer And Market Structure:A Multilevel Analysis For Mammogram And Pap-Smear Utilization In The U.S
    by Yavuz Yasar
  • 2005 Reforming the Taxation of Human Capital: A Modest Proposal for Promoting Economic Growth
    by Paul A. David
  • 2005 Unemployment and Welfare Participation in a Structural VAR: Rethinking the 1990s in the United States (Revised)
    by Corrado Andini
  • 2005 Do study grants help refugees find jobs? A case study of the effects of the voluntary sector grants on the education, training and employment of refugees in the United Kingdom
    by Peter Ilmolelian
  • 2005 Self-Selection and Student Achievement
    by Honggao Cao
  • 2005 The Enrollment Effects of Merit-Based Financial Aid: Evidence from Georgia's HOPE Scholarship
    by Christopher M. Cornwell & David B. Mustard & Deepa Sridhar
  • 2005 Student Responses to Merit Retention Rules
    by Christopher M. Cornwell & Kyung Hee Lee & David B. Mustard
  • 2005 Public education and growth: cost-effectiveness of educational policies in developing countries
    by Rossana Patrón
  • 2005 Endogenous skill formation in developing countries
    by Rossana Patrón
  • 2005 Review of National Competition Policy Reforms
    by Productivity Commission
  • 2005 Impacts of Advances in Medical Technology in Australia
    by Productivity Commission
  • 2005 Book Review
    by Adis International Limited
  • 2005 Linezolid: A Pharmacoeconomic Review of its Use in Serious Gram-Positive Infections
    by Greg L. Plosker & David P. Figgitt
  • 2005 Cost Effectiveness of Dalteparin for Preventing Venous Thromboembolism in Abdominal Surgery
    by Adrienne Heerey & Sanjeev Suri
  • 2005 Cost-Benefit Analysis of Vaccination against Tick-Borne Encephalitis among French Troops
    by Guillaume Desjeux & Laurent Galoisy-Guibal & Cyrille Colin
  • 2005 A Systematic Review of Patient-Reported Outcome Instruments Measuring Sleep Dysfunction in Adults
    by Emily Beth Devine & Zafar Hakim & Jesse Green
  • 2005 Economic Implications of Biological Therapies for Crohn's Disease: Review of Infliximab
    by Keith Bodger
  • 2005 The Role of Economic Evaluation in Vaccine Decision Making: Focus on Meningococcal Group C Conjugate Vaccine
    by Robert Welte & Caroline L. Trotter & W. John Edmunds & Maarten J. Postma & Philippe Beutels
  • 2005 The Authors' Reply
    by Anthony O'Hagan & Christopher McCabe & Ron Akehurst & Alan Brennan & Andrew Briggs & Karl Claxton & Elisabeth Fenwick & Dennis Fryback & Mark Sculpher & David Spiegelhalter & Andrew Willan
  • 2005 Incorporation of Uncertainty in Health Economic Modelling Studies
    by Mark Nuijten
  • 2005 An Economic Evaluation of Rizatriptan in the Treatment of Migraine
    by Melissa Thompson & Marek Gawel & Brigitte Desjardins & Nicole Ferko & Daniel Grima
  • 2005 Cost of Illness and its Predictors for Parkinson's Disease in Germany
    by Annika E. Spottke & Martin Reuter & Olaf Machat & Bernhard Bornschein & Sonja von Campenhausen & Karin Berger & Rudolf Koehne-Volland & Jurgen Rieke & Alexander Simonow & Dirk Brandstaedter & Uwe Siebert & Wolfgang H. Oertel & Gudrun Ulm & Richard Dodel
  • 2005 Economic Evaluation of Temozolomide in the Treatment of Recurrent Glioblastoma Multiforme
    by Janne A. Martikainen & Akseli Kivioja & Taru Hallinen & Pia Vihinen
  • 2005 Societal Discounting of Health Effects in Cost-Effectiveness Analyses: The Influence of Life Expectancy
    by Suzanne Polinder & Willem Jan Meerding & Job van Exel & Werner Brouwer
  • 2005 Parent-Proxy EQ-5D Ratings of Children with Attention-Deficit Hyperactivity Disorder in the US and the UK
    by Louis S. Matza & Kristina Secnik & Sally Mannix & F. Randy Sallee
  • 2005 Granulocyte Colony-Stimulating Factor for Chemotherapy-Induced Neutropenia in Patients with Small Cell Lung Cancer: The 40% Rule Revisited
    by Elizabeth A. Calhoun & Glen T. Schumock & June M. McKoy & Simon Pickard & Karen A. Fitzner & Elizabeth A. Heckinger & Eowyn F. Powell & Kathyrn R. McCaffrey & Charles L. Bennett
  • 2005 Pharmaceutical Policy regarding Generic Drugs in Belgium
    by Steven Simoens & Kristien De Bruyn & Marc Bogaert & Gert Laekeman
  • 2005 Real-World Trials to Answer Real-World Questions
    by Nick Freemantle & Lawrence Blonde & Bjorn Bolinder & Robert A. Gerber & F.D. Richard Hobbs & Luc Martinez & Stuart Ross
  • 2005 The Authors' Reply
    by Andrew Moore & Ceri Phillips & Elke Hunsche & James Pellissier & Simone Crespi
  • 2005 Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
    by Eduardo Carracedo-Martinez
  • 2005 Costs and Medical Care Consequences Associated with the Diagnosis of Peripheral Arterial Disease
    by Kristen Migliaccio-Walle & J. Jaime Caro & Khajak J. Ishak & Judith A. O'Brien
  • 2005 Economic Assessment of Adjustable Maintenance Treatment with Budesonide/Formoterol in a Single Inhaler versus Fixed Treatment in Asthma
    by Bernd Bruggenjurgen & Dagmar Selim & Peter Kardos & Kai Richter & Claus Vogelmeier & Stephanie Roll & Wolfgang Meyer-Sabellek & Roland Buhl & Stefan N Willich
  • 2005 Introducing Economic Evaluation as a Policy Tool in Korea: Will Decision Makers get Quality Information?: A Critical Review of Published Korean Economic Evaluations
    by Kun-Sei Lee & Werner B.F. Brouwer & Sang-Il Lee & Hye-Won Koo
  • 2005 The State of Patient-Reported Outcomes in Atrial Fibrillation: A Review of Current Measures
    by Karin Coyne & Mary Kay Margolis & Susan Grandy & Peter Zimetbaum
  • 2005 Evaluating Health-Related Quality-of-Life Studies in Paediatric Populations: Some Conceptual, Methodological and Developmental Considerations and Recent Applications
    by Mirella De Civita & Dean Regier & Abul H. Alamgir & Aslam H. Anis & Mark J. FitzGerald & Carlo A. Marra
  • 2005 Price Differentiation and Transparency in the Global Pharmaceutical Marketplace
    by David B. Ridley
  • 2005 Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies
    by J.M. Bos & Maarten J. Postma & Lieven Annemans
  • 2005 Development of an Economic Model to Assess the Cost Effectiveness of Treatment Interventions for Chronic Obstructive Pulmonary Disease
    by Michael Spencer & Andrew H. Briggs & Ronald F. Grossman & Laureen Rance
  • 2005 The Cost Effectiveness of Infliximab for Severe Treatment-Resistant Rheumatoid Arthritis in the UK
    by Marco Barbieri & John B. Wong & Michael Drummond
  • 2005 Pharmacoeconomic Evaluation of Antidepressants: A Critical Appraisal of Methods
    by Sheikh Usman Iqbal & Mark Prashker
  • 2005 Bipolar Disorder and Health-Related Quality of Life: Review of Burden of Disease and Clinical Trials
    by Dennis A. Revicki & Louis S. Matza & Emuella Flood & Andrew Lloyd
  • 2005 Remission from Depression: A Review of Venlafaxine Clinical and Economic Evidence
    by Donald Han & Edward C.Y. Wang
  • 2005 The Economics of Topical Immunomodulators for the Treatment of Atopic Dermatitis
    by William Abramovits & Mark Boguniewicz & Amy S. Paller & Diane L. Whitaker-Worth & Mary M. Prendergast & Michael Tokar & Kuo B. Tong
  • 2005 Health Utilities in Alzheimer's Disease and Implications for Cost-Effectiveness Analysis
    by Peter J. Neumann
  • 2005 Incorporation of Uncertainty in Health Economic Modelling Studies
    by Anthony O'Hagan & Christopher McCabe & Ron Akehurst & Alan Brennan & Andrew Briggs & Karl Claxton & Elisabeth Fenwick & Dennis Fryback & Mark Sculpher & David Spiegelhalter & Andrew Willan
  • 2005 On Pharmacogenomics and Cost-Effectiveness Analysis at the Individual Level
    by Mohan V. Bala & Gary A. Zarkin
  • 2005 Cost Effectiveness of Imatinib Compared with Interferon-alpha or Hydroxycarbamide for First-Line Treatment of Chronic Myeloid Leukaemia
    by Kim Dalziel & Ali Round & Ruth Garside & Ken Stein
  • 2005 Reductions in Anaemia and Fatigue are Associated with Improvements in Productivity in Cancer Patients Receiving Chemotherapy
    by Ernst Berndt & Joel Kallich & Anne McDermott & Xiao Xu & Howard Lee & John Glaspy
  • 2005 Economic Evaluation of Levetiracetam as an Add-On Therapy in Patients with Refractory Epilepsy
    by Lucie Blais & Odile Sheehy & Jean-Marc Saint-Hilaire & Gilles-Pierre Bernier & Philippe Godfroid & Jacques LeLorier
  • 2005 Economic Considerations in the Prescribing of Third-Generation Antidepressants
    by Stuart Montgomery & John J. Doyle & Lee Stern & Christopher R. McBurney
  • 2005 The Health-Related Quality of Life and Economic Burden of Constipation
    by Cheryl Dennison & Manishi Prasad & Andrew Lloyd & Samir K. Bhattacharyya & Ravinder Dhawan & Karin Coyne
  • 2005 Valuing Patient and Caregiver Time: A Review of the Literature
    by Jennifer E. Tranmer & Denise N. Guerriere & Wendy J. Ungar & Peter C. Coyte
  • 2005 Does Pharmacogenomics Provide an Ethical Challenge to the Utilisation of Cost-Effectiveness Analysis by Public Health Systems?
    by Adam La Caze
  • 2005 Effects of Antidepressants on Quality of Life in Women with Premenstrual Dysphoric Disorder
    by Ellen W. Freeman
  • 2005 Willingness to Pay for a QALY: Theoretical and Methodological Issues
    by Dorte Gyrd-Hansen
  • 2005 Quality Control in the Regulation of Pharmaceuticals
    by Alan Maynard
  • 2005 Modelling Cost Effectiveness and Cost Utility of Sequential DMARD Therapy Including Leflunomide for Rheumatoid Arthritis in Germany: II. The Contribution of Leflunomide to Efficiency
    by Peter K. Schadlich & Henning Zeidler & Angela Zink & Erika Gromnica-Ihle & Matthias Schneider & Christoph Straub & Josef G. Brecht & Eduard Huppertz
  • 2005 Modelling Cost Effectiveness and Cost Utility of Sequential DMARD Therapy Including Leflunomide in Rheumatoid Arthritis in Germany: I. Selected DMARDs and Patient-Related Costs
    by Peter K. Schadlich & Henning Zeidler & Angela Zink & Erika Gromnica-Ihle & Matthias Schneider & Christoph Straub & Josef G. Brecht & Eduard Huppertz
  • 2005 Cost Effectiveness of Budesonide/Formoterol in a Single Inhaler for COPD Compared with Each Monocomponent Used Alone
    by Claes-Goran Lofdahl & Asa Ericsson & Klas Svensson & Emma Andreasson
  • 2005 Health-Related QOL in Acute Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary Disease: A Review of the Literature
    by Helen Doll & Marc Miravitlles
  • 2005 Review of the Cost Effectiveness of Immunisation Strategies for the Control of Epidemic Meningococcal Meningitis
    by Mark A. Miller & Cathryn K. Shahab
  • 2005 Pharmacoeconomic Analyses Using Discrete Event Simulation
    by J. Jaime Caro
  • 2005 Future Challenges for the Economic Evaluation of Healthcare: Patient Preferences, Risk Attitudes and Beyond
    by John F.P. Bridges
  • 2005 Meningococcal Vaccination: Cui Bono?
    by Thomas D. Szucs
  • 2005 Cost-Effectiveness Model Of Long-Acting Risperidone in Schizophrenia in the US
    by Natalie C. Edwards & Marcia F.T. Rupnow & Chris L. Pashos & Marc F. Botteman & Ronald J. Diamond
  • 2005 The Case of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Rheumatoid Arthritis: A Budget Impact Analysis
    by Jan Sorensen & Lis S. Andersen
  • 2005 A Pharmacoeconomic Evaluation of Statins in the Treatment of Hypercholesterolaemia in the Primary Care Setting in Spain
    by Pedro J. Tarraga-Lopez & Angel Celada-Rodriguez & Miguel Cerdan-Oliver & Juan Solera-Albero & Jose M Ocana-Lopez & Mateo A. Lopez-Cara & Jaime De Miguel-Clave
  • 2005 Oral Serotonin Receptor Agonists: A Review of Their Cost Effectiveness in Migraine
    by Jennifer H. Lofland & David B. Nash
  • 2005 International Variation in Resource Utilisation and Treatment Costs for Rheumatoid Arthritis: A Systematic Literature Review
    by Hubertus Rosery & Rito Bergemann & Stefanie Maxion-Bergemann
  • 2005 The Economic Impact of Neuropsychiatric Symptoms in Alzheimer's Disease: Can Drugs Ease the Burden?
    by Daniel L. Murman & Christopher C. Colenda
  • 2005 Penny and Pound Wise: Pharmacoeconomics from a Governmental Perspective
    by Mike F. van Oostenbruggen & Ronald B. Jansen & Katja Mur & Huib Kooijman
  • 2005 The Relationship between Productivity and Health-Related QOL: An Exploration
    by Werner B.F. Brouwer & Willem-Jan Meerding & Leida M. Lamers & Johan L. Severens
  • 2005 EMEA: For Patients or For Industry?
    by Silvio Garattini
  • 2005 Memantine: A Pharmacoeconomic Review of its Use in Moderate-to-Severe Alzheimer's Disease
    by Greg L. Plosker & Katherine A. Lyseng-Williamson
  • 2005 The Impact of Anaemia and its Treatment on Employee Disability and Medical Costs
    by Ernst Berndt & William Crown & Joel Kallich & Stacey Long & Xue Song & Gary H. Lyman
  • 2005 Cost-Minimisation Analysis of Sivelestat for Acute Lung Injury Associated with Systemic Inflammatory Response Syndrome
    by Naoki Aikawa & Seitaro Fujishima & Makoto Kobayashi & Shozo Matsuoka & Taira Abiru
  • 2005 Evaluation of the Cost Effectiveness of Escitalopram versus Venlafaxine XR in Major Depressive Disorder
    by Jose-Luis Fernandez & Stuart Montgomery & Clement Francois
  • 2005 Providing Systematic Guidance in Pharmacoeconomic Guidelines for Analysing Costs
    by Philip Jacobs & Arto Ohinmaa & Bruce Brady
  • 2005 Cost Effectiveness of Treating Low HDL-Cholesterol in the Primary Prevention of Coronary Heart Disease
    by Joel W. Hay & Kimberly L. Sterling
  • 2005 The Case for Stratified Cost-Effectiveness Analysis by Baseline Health-Related QOL: Theory and Sensitivity Analysis
    by Joseph Schaafsma
  • 2005 The Diffusion of Health Economics Knowledge in Europe: The EURONHEED (European Network of Health Economics Evaluation Database) Project
    by Gerard de Pouvourville & Philippe Ulmann & John Nixon & Stephanie Boulenger & Julie Glanville & Michael Drummond
  • 2005 The Friction-Cost Method: Replacement for Nothing and Leisure for Free?
    by Werner B.F. Brouwer & Marc A. Koopmanschap
  • 2005 Friction-Cost Method as an Alternative to the Human-Capital Approach in Calculating Indirect Costs
    by Howard Birnbaum
  • 2005 Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder
    by Kristina Secnik & Andrine Swensen & Maureen J. Lage
  • 2005 A Randomised Trial of the Cost Effectiveness of Buprenorphine as an Alternative to Methadone Maintenance Treatment for Heroin Dependence in a Primary Care Setting
    by Anthony H. Harris & Elena Gospodarevskaya & Alison J. Ritter
  • 2005 Q-TWiST Analysis of Cyclophosphamide, Epirubicin, Fluorouracil versus Cyclophosphamide, Methotrexate, Fluorouracil Treatment for Premenopausal Women with Node-Positive Breast Cancer
    by Davide Radice & Alberto Redaelli
  • 2005 Household-Based Costs and Benefits of Vaccinating Healthy Children in Daycare Against Influenza Virus: Results from a Pilot Study
    by Maria Pisu & Martin I. Meltzer & Eugene S. Hurwitz & Michael Haber
  • 2005 Measuring Productivity Changes in Economic Evaluation: Setting the Research Agenda
    by Marc Koopmanschap & Alex Burdorf & Karin Jacob & Willem Jan Meerding & Werner Brouwer & Hans Severens
  • 2005 A Review of the Costs of Managing Childhood Epilepsy
    by Ettore Beghi & Barbara Frigeni & Massimiliano Beghi & Paola De Compadri & Livio Garattini
  • 2005 Pharmacoeconomic Impact of Non-Compliance with Statins
    by Andrew M. Peterson & William F. McGhan
  • 2005 Role of Pharmacoeconomic Analysis in R&D Decision Making: When, Where, How?
    by Paul Miller
  • 2005 Rizatriptan: A Pharmacoeconomic Review of its Use in the Acute Treatment of Migraine
    by Paul L. McCormack & Rachel H. Foster
  • 2005 Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease
    by Colin Green & Joanna Picot & Emma Loveman & Andrea Takeda & Jo Kirby & Andrew Clegg
  • 2005 Pramipexole and Levodopa in Early Parkinson's Disease: Dynamic Changes in Cost Effectiveness
    by Katia Noyes & Andrew W. Dick & Robert G. Holloway & The Parkinson Study Group
  • 2005 A Willingness-To-Pay Assessment of Parents' Preference for Shorter Duration Treatment of Acute Otitis Media in Children
    by Delphine Gueylard Chenevier & Jacques LeLorier
  • 2005 Estimating Mean Total Costs in the Presence of Censoring: A Comparative Assessment of Methods
    by Tracey A. Young
  • 2005 Willingness to Pay for Inhaled Insulin: A Contingent Valuation Approach
    by Hamid Sadri & Linda D. MacKeigan & Lawrence A. Leiter & Thomas R. Einarson
  • 2005 Cost-Effectiveness Acceptability Curves and a Reluctance to Lose
    by Johan L. Severens & Danielle E.M. Brunenberg & Elisabeth A.L. Fenwick & Bernie O'Brien & Manuela A. Joore
  • 2005 No Room for Kinkiness in a Public Healthcare System
    by Jack Dowie
  • 2005 The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development - The Authors' Reply
    by Joseph A. DiMasi & Cherie Paquette
  • 2005 Comment on _The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development_
    by Aidan Hollis
  • 2005 Acknowledgement
    by Adis International Limited
  • 2005 The Importance of Drug Adverse Effects Compared with Seizure Control for People with Epilepsy: A Discrete Choice Experiment
    by Andrew Lloyd & Emma McIntosh & Martin Price
  • 2005 Economic Evaluation of Three Two-Drug Chemotherapy Regimens in Advanced Non-Small-Cell Lung Cancer
    by Niels Neymark & Pilar Lianes & Egbert F. Smit & Jan P. van Meerbeeck
  • 2005 Eliciting Social Preference Weights for Functional Assessment of Cancer Therapy-Lung Health States
    by Paul Kind & Susan Macran
  • 2005 Acute Pyelonephritis Among Adults: Cost of Illness and Considerations for the Economic Evaluation of Therapy
    by Patricia Brown & Moran Ki & Betsy Foxman
  • 2005 Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the US: Analytic Framework and Review of the Literature
    by Ralph P. Insinga & Erik J. Dasbach & Elamin H. Elbasha
  • 2005 Antiviral Agents for Influenza: A Comparison of Cost-Effectiveness Data
    by Larry D. Lynd & Ron Goeree & Bernie J. O'Brien
  • 2005 Economic Evaluations of Healthcare Programmes and Decision Making: The Influence of Economic Evaluations on Different Healthcare Decision-Making Levels
    by Marieke E. van Velden & Johan L. Severens & Annoesjka Novak
  • 2005 Reporting Pharmacoeconomic Evaluations
    by C.I. Carswell & J.A. Paladino
  • 2005 Pharmacological Management of Overactive Bladder: A Systematic and Critical Review of Published Economic Evaluations
    by Denis Getsios & Wissam El-Hadi & Ingrid Caro & J. Jaime Caro
  • 2005 Measuring Health-Related Quality of Life in Older Patient Populations: A Review of Current Approaches
    by Anne Hickey & Maja Barker & Hannah McGee & Ciaran O'Boyle
  • 2005 Transparency in Economic Evaluations
    by Suzanne Hill
  • 2005 Eplerenone: A Pharmacoeconomic Review of its Use in Patients with Post-Myocardial Infarction Heart Failure
    by Katherine F. Croom & Greg L. Plosker
  • 2005 Financial Impact of Two Different Ways of Evaluating Early Virological Response to Peginterferon-alpha-2b Plus Ribavirin Therapy in Treatment-Naive Patients with Chronic Hepatitis C Virus Genotype 1
    by Maria Buti & Miguel A. Casado & Leslie Fosbrook & Rafael Esteban
  • 2005 Economic Analysis of On-Demand Maintenance Therapy with Proton Pump Inhibitors in Patients with Non-Erosive Reflux Disease
    by Dyfrig A. Hughes & Keith Bodger & Peter Bytzer & Dirk de Herdt & Dominique Dubois
  • 2005 Using Policy Simulation to Predict Drug Plan Expenditure when Planning Reimbursement Changes
    by Colin R. Dormuth & Sean Burnett & Sebastian Schneeweiss
  • 2005 The Cost Effectiveness of Orlistat in a 1-Year Weight-Management Programme for Treating Overweight and Obese Patients in Sweden: A Treatment Responder Approach
    by Peter Hertzman
  • 2005 Cost Effectiveness of a Clinical Decision Support System Based on the Recommendations of the European Society of Cardiology and Other Societies for the Management of Hypercholesterolemia: Report of a Cluster-Randomized Trial
    by Albert Cobos & Jordi Vilaseca & Cesar Asenjo & Juan Pedro-Botet & Emilia Sanchez & Alicia Val & Eva Torremade & Cristina Espinosa & Salvador Bergonon
  • 2005 Consumer Knowledge of the Impact of a Change in Prescription Drug Benefit Design
    by Roger Feldman & Jean Abraham & Linda Davis & Caroline Carlin
  • 2005 Utilization and Medical Care Expenditures in Patients with Chronic Obstructive Pulmonary Disease: A Managed Care Claims Data Analysis
    by Kristina S. Yu-Isenberg & Ann Vanderplas & Eunice Y. Chang & Hemal Shah
  • 2005 Education and Phone Follow-Up in Postmenopausal Women at Risk for Osteoporosis: Effects on Calcium Intake, Exercise Frequency, and Medication Use
    by John T. Schousboe & Rowan C. DeBold & Linda S. Kuno & Thomas W. Weiss & Ya-Ting Chen & Thomas A. Abbott
  • 2005 Efficiency of Interventions in HIV Infection, 1994-2004
    by Guy Harling & Robin Wood & Eduard J. Beck
  • 2005 How Should Functionally Equivalent Drugs be Reimbursed?: A Retrospective Analysis of Reimbursement for Epoetin-alpha and Darbepoetin-alpha in 2001-3 and the Cost Implications for CMS
    by Panos G. Kanavos & Omer R. Saka
  • 2005 Acknowledgment
    by Adis International Limited
  • 2005 US FDA Drug Classification System
    by Alan J. Johnson & Edward Fleegler & Gregory D. Berg
  • 2005 Management of Hormone-Responsive Postmenopausal Breast Cancer: Defining the Role of Anastrozole
    by Lynda R. Wiseman & Lesley J. Scott
  • 2005 Clinical and Utilization Outcomes for a Heart Failure Care Support Program: A Matched-Cohort Study
    by Alan Johnson & Gregory Berg & Edward Fleegler & Jeanne Lehn
  • 2005 Predicted Effects of a New Combination Vaccine on Childhood Immunization Coverage Rates and Vaccination Activities
    by Allen S. Meyerhoff & David P. Greenberg & R. Jake Jacobs
  • 2005 Evaluation and Treatment of Depression in Managed Care (Part II): Quality Improvement Programs
    by Christy L. Beaudin & Teresa L. Kramer
  • 2005 Evaluation and Treatment of Depression (Part I): Benefits for Patients, Providers, and Payors
    by Teresa L. Kramer & Christy L. Beaudin & Carol R. Thrush
  • 2005 Using the Internet in Asthma Management: Current Concepts and Challenges
    by Ashok M. Patel
  • 2005 Cost of Acute Myocardial Infarction in Hong Kong
    by Vivian W.Y. Lee & Wai Kwong Chan & Nelson L.C. Lam & Kenneth K.C. Lee
  • 2005 Impact of Bipolar Disorder on Employers: Rationale for Workplace Interventions
    by Leslie B. Montejano & Ron Z. Goetzel & Ronald J. Ozminkowski
  • 2005 The Performance Gap between Clinical Trials and Patient Treatment for Dyslipidemia: A Comprehensive Review
    by Joseph J. Saseen & Setareh A. Williams & Robert J. Valuck & John C. O'Donnell & Kenneth McDonough
  • 2005 The Challenge of Suicide Prevention: An Overview of National Strategies
    by Martin Anderson & Rachel Jenkins
  • 2005 Impact of Coaching Patients on Coronary Risk Factors: Lessons from The COACH Program
    by Margarite J. Vale & Michael V. Jelinek & James D. Best
  • 2005 Use of Short-Acting Insulin Secretagogues for Type 2 Diabetes Mellitus: Considerations for National Health Systems
    by Maribel Salas & Jamie Banks
  • 2005 Impact of Practice Changes on an Antiretroviral Budget in an HIV Care Program
    by Hartmut B Krentz & M. John Gill
  • 2005 Work Loss, Healthcare Utilization, and Costs among US Employees with Chronic Pain
    by Laura T. Pizzi & Chureen T. Carter & Jamie B. Howell & Susan M. Vallow & Albert G. Crawford & Evan D. Frank
  • 2005 Psychoeducational Programs for Patients with Epilepsy
    by Theodor W. May & Margarete Pfafflin
  • 2005 Economic, Patient Preference, and Health-Related Quality of Life Considerations for Intranasal Corticosteroids in Allergic Rhinitis: Implications for Managed Care
    by Gireesh V. Gupchup & Matthew E. Borrego & Richard Santos & Bijal M. Shah
  • 2005 Evaluating Disease Management Program Effectiveness: An Introduction to the Bootstrap Technique
    by Ariel Linden & John L. Adams & Nancy Roberts
  • 2005 Impact of Insurance Coverage on the Use and Effects of Smoking Cessation Medications
    by Leif I. Solberg
  • 2005 Consultation-Liaison Psychiatry: Advantages for Healthcare Systems
    by James A. Bourgeois & Donald M. Hilty & Mark E. Servis & Robert E. Hales
  • 2005 Prescription to Over-the-Counter Switching of Drugs: Methodological Issues and Implications for Non-Sedating Antihistamines
    by John A. Rizzo & Ronald J. Ozminkowski & Ron Z. Goetzel
  • 2005 Effectiveness of Interventions to Increase Adherence to Statin Therapy
    by Jacqueline Muller-Nordhorn & Stefan N. Willich
  • 2005 Management of Metastatic Colorectal Cancer: Defining the Role of Capecitabine
    by Lynda R. Wiseman & Katherine A. Lyseng-Williamson
  • 2005 Examining the Association Between Preventive Screenings and Subsequent Health Services Utilization by Patients with Type 2 Diabetes Mellitus
    by Fevzi Akinci & Joseph S. Coyne & Joni Minear & Kenn Daratha & Dan Simonson
  • 2005 Identifying Future High-Healthcare Users: Exploring the Value of Diagnostic and Prior Utilization Information
    by Amy K. Rosen & Fei Wang & Maria E. Montez & Carter C. Rakovski & Dan R. Berlowitz & Jaime C. Lucove
  • 2005 Using Propensity Scores to Construct Comparable Control Groups for Disease Management Program Evaluation
    by Ariel Linden & John L. Adams & Nancy Roberts
  • 2005 Walking for the Management of Obesity
    by Mikael Fogelholm
  • 2005 Impact of a Clinical Decision Support System on the Management of Patients with Hypercholesterolemia in the Primary Healthcare Setting
    by Alex Bassa & Miguel del Val & Albert Cobos & Eva Torremade & Salvador Bergonon & Carlos Crespo & Max Brosa & Silvia Munio & Cristina Espinosa
  • 2005 Early Intervention in Psychosis: Rationale and Evidence for Effectiveness
    by Bethan Reading & Max Birchwood
  • 2005 Telemanagement in Chronic Heart Failure: A Review
    by Ruth M. Kleinpell & Boaz Avitall
  • 2005 Clinical Outcomes Associated with Pharmacist Involvement in Patients with Dyslipidemia: A Review
    by L. Brian Cross & Andrea S. Franks
  • 2005 Non-Pharmacological Treatments for Chronic Pain: A Disease Management Context
    by Dennis C. Turk & Bill McCarberg
  • 2005 Drug-Eluting Stents in the Management of Coronary Artery Disease: Implications for Payors and Hospitals
    by James B. Hermiller
  • 2005 The Incremental Cost Effectiveness of Withdrawing Pulmonary Artery Catheters from Routine Use in Critical Care
    by Katherine Stevens & Christopher McCabe & Carys Jones & Joanne Ashcroft & Sheila Harvey & Kathy Rowan
  • 2005 Determining Priority for Liver Transplantation: A Comparison of Cost per QALY and Discrete Choice Experiment-Generated Public Preferences
    by Julie Ratcliffe & Martin Buxton & Tracey Young & Louise Longworth
  • 2005 The Cost Effectiveness of Universal versus Selective Newborn Screening for Sickle Cell Disease in the US and the UK: A Critique
    by Scott D. Grosse & Richard S. Olney & Mary Ann Baily
  • 2005 The Australian Health Policy Changes of 1999 and 2000: An Evaluation
    by Sandra Hopkins & Peter Zweifel
  • 2005 What Value Health?: A Review of Health State Values Used in Early Technology Assessments for NICE
    by Ken Stein & Alison Fry & Ali Round & Ruairidh Milne & John Brazier
  • 2005 How to Present the Business Case for Healthcare Quality to Employers
    by Sean Nicholson & Mark V. Pauly & Daniel Polsky & Catherine M. Baase & Gary M. Billotti & Ronald J. Ozminkowski & Marc L. Berger & Claire E. Sharda
  • 2005 Should Patients Have a Greater Role in Valuing Health States?
    by John Brazier & Ron Akehurst & Alan Brennan & Paul Dolan & Karl Claxton & Chris McCabe & Mark Sculpher & Aki Tsuchyia
  • 2005 Acknowledgement
    by Stuart Birks & Gary Buurman
  • 2005 Book Review
    by Adis International Limited
  • 2005 Drug Costs Developments after Patent Expiry of Enalapril, Fluoxetine and Ranitidine: A Study Conducted for the Netherlands
    by Cornelis Boersma & Rogier M. Klok & Jasper M. Bos & Mark Naunton & Paul B. van den Berg & Lolkje T.W. de Jong-van den Berg & Maarten J. Postma
  • 2005 Barriers to the Equitable Funding of Primary Healthcare in South Africa
    by Stephen Thomas & Okore A. Okorafor & Sandi Mbatsha
  • 2005 Methodological Challenges Posed by Economic Evaluations of Early Childhood Intervention Programmes
    by Stavros Petrou & Ron Gray
  • 2005 Can We Use Contingent Valuation to Assess the Demand for Childhood Immunisation in Developing Countries?: A Systematic Review of the Literature
    by Raymond Y.T. Yeung & Richard D. Smith
  • 2005 Prisoner Healthcare Co-Payment Policy: A Cost-Cutting Measure that Might Threaten Inmates' Health
    by Niyi Awofeso
  • 2005 Can Privatising Selected Services Benefit the Public Healthcare System?: The Greek Case
    by Dimitris Niakas & Mamas Theodorou & Lycurgus Liaropoulos
  • 2005 The Chinese Pharmaceutical Market at the Crossroads: Pro-Competition Solutions to Improve Access, Quality and Affordability
    by Y. Richard Wang
  • 2005 The Infrastructure of Obesity and the Obesity Epidemic: Implications for Public Policy
    by Kenneth R. Stanton & Zoltan J. Acs
  • 2005 The Impact of Deficit Reduction on the Nursing Labour Market in Canada: Unintended Consequences of Fiscal Reform
    by Marko Vujicic & Robert G. Evans
  • 2005 What is Required to Evaluate the Impact of Pharmaceutical Reference Pricing?
    by Jaume Puig-Junoy
  • 2005 Using Contingent Choice Methods to Assess Consumer Preferences About Health Plan Design
    by M. Susan Marquis & Melinda Beeuwkes Buntin & Kanika Kapur & Jill M. Yegian
  • 2005 Handling Missing Data in Patient-Level Cost-Effectiveness Analysis alongside Randomised Clinical Trials
    by Andrea Manca & Stephen Palmer
  • 2005 Comparing the Preferences of Health Professionals and Members of the Public for Setting Healthcare Priorities: Experiences from Australia
    by Virginia Wiseman
  • 2005 Procedural Justice in Public Healthcare Resource Allocation
    by Aki Tsuchiya & Luis Silva Miguel & Richard Edlin & Allan Wailoo & Paul Dolan
  • 2005 Prescribing Incentive Schemes: A Useful Approach?
    by Anne R. Mason & Michael F. Drummond & Jane A. Hunter & Adrian K. Towse & Jonathan Cooke
  • 2005 Medicare Coverage and Reimbursement of Outpatient Prescription Drugs in the US: History, Recent Changes and Outlook for the Future
    by Sharon Forrest & Mireille M Goetghebeur & Joel Hay
  • 2005 A Wolf Dressed in Sheep's Clothing: Perhaps Quality Measures are Just Unmeasured Severity
    by John F.P. Bridges & Avi Dor & Michael Grossman
  • 2005 Untangling the Debate Surrounding Strategies for Achieving Sustainable High Coverage of Insecticide-Treated Nets
    by Warren Stevens
  • 2005 Decentralisation Strategies and Provider Incentives in Healthcare: Evidence from the English National Health Service
    by Russell Mannion & Maria Goddard & Michael Kuhn & Angela Bate
  • 2005 Using Value of Information Analysis to Inform Publicly Funded Research Priorities
    by Laura Ginnelly & Karl Claxton & Mark J. Sculpher & Sue Golder
  • 2005 Affordability of Medicines and Patients' Cost-Reducing Behaviour: Empirical Evidence Based on SUR Estimates from Italy and the UK
    by Vincenzo Atella & Ellen Schafheutle & Peter Noyce & Karen Hassell
  • 2005 Key Performance Indicators for the Implementation of Social Health Insurance
    by Guy Carrin & Chris James
  • 2005 Impact of Demographic Changes on Healthcare Expenditures and Funding in the EU
    by Afschin Gandjour & Juliette Greb & Eckart Bomsdorf & Karl Wilhelm Lauterbach
  • 2004 Estimating the causal effect of income on health: Evidence from post-reunification Germany
    by Michael A. Shields & Paul Frijters & John Haisken-DeNew
  • 2004 Deutsche Finanzpolitik zwischen Konsolidierung und Wachstum
    by Arne Heise
  • 2004 Canadian And Us Health Care Systems Performance And Governance: Elements Of Convergence
    by Steven Globerman & Luther H. Hodges & Aidan Vining
  • 2004 Social Security in Theory and Practice: An Essay
    by Dariusz Stanko
  • 2004 A Study About Poverty, Health, Education And Human Deprivation In India
    by sivakumarmarimuthu & sarvalingam
  • 2004 Poverty, Inequality, and Redistribution Under Lexicographic Social Welfare
    by Roehlano M. Briones
  • 2004 Modifying behaviour on STI including HIV and oncogenic HPV: a draft protocol for a registry open to the registered subject, generating the concept of a 'STI passport'
    by Thomas Colignatus
  • 2004 Asymmetric Information and the Demand for Health Care - the Case of Double Moral Hazard
    by Udo Schneider
  • 2004 Peer and selection effects on youth smoking in California
    by Brian Krauth
  • 2004 Sorting and inequality in Canadian schools
    by Jane Friesen & Brian Krauth
  • 2004 Schooling, cognitive ability, and health
    by M. Christopher Auld & Nirmal Sidhu
  • 2004 Schooling, cognitive ability, and health
    by M. Christopher Auld & Nirmal Sidhu
  • 2004 Socio-economic status, sexual behavior, and differential AIDS mortality Evidence from Cˆote d’Ivoire
    by Michael Grimm & Denis Cogneau
  • 2004 The medium and long term effects of an expansion of education on poverty in Côte d Ivoire A dynamic microsimulation study
    by Michael Grimm
  • 2004 HIV/AIDS and its impact on convergence in life expectancy, infant and child survival rates
    by Eric Neumayer
  • 2004 Can Patient Self-Management Help Explain the SES Health Gradient?
    by Dana P. Goldman & James P. Smith
  • 2004 Socioeconomic Status and Racial and Ethnic Differences in Functional Status Associated with Chronic Diseases
    by Raynard S. Kington & James P. Smith
  • 2004 Race, Socioeconomic Status, and Health in Late Life
    by James P. Smith & Raynard Kington
  • 2004 Measuring Health and Economic Status of Older Adults in Developing Countries
    by James P. Smith
  • 2004 The Relationship of Self-rated Vision and Hearing to Functional Status and Well-being Among Seniors 70 Years and Older
    by Paul Lee & James P. Smith & Raynard Kington
  • 2004 The Associations Between Self-Rated Vision and Hearing and Functional Status in Middle Age
    by Paul Lee & James P. Smith & Raynard S. Kington
  • 2004 Modelo para valorar la atribución de Sustentabilidad
    by Luis Vildosola
  • 2004 A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous Thromboembolism: Use in Patients Undergoing Major Orthopaedic Surgery
    by Sean D. Sullivan & Bruce L. Davidson & Susan R. Kahn & James E. Muntz & Gerry Oster & Gary Raskob
  • 2004 The Burden of Migraine in Spain: Beyond Direct Costs
    by Xavier Badia & Sol Magaz & Laura Gutierrez & Jordi Galvan
  • 2004 A Cost-Effectiveness Analysis of Docetaxel in the Second-Line Treatment of Non-Small Cell Lung Cancer
    by Jeremy Holmes & David Dunlop & Lindsay Hemmett & Peter Sharplin & Uday Bose
  • 2004 Cost Effectiveness and Cost Utility of Adjuvant Interferon alpha in Cutaneous Melanoma: A Review
    by Ralph Crott
  • 2004 Global Registries for Measuring Pharmacoeconomic and Quality-of-Life Outcomes: Focus on Design and Data Collection, Analysis and Interpretation
    by Lisa Kennedy & Ann-Marie Craig
  • 2004 Outcome Measures for Pharmacoeconomics Education
    by Vittorio Maio & Jennifer H. Lofland
  • 2004 Psychometric and Utility-Based Measures of Health Status of Asthmatic Patients with Different Disease Control Level
    by Agota Szende & Klas Svensson & Elisabeth Stahl & Agnes Meszaros & Gyula Y. Berta
  • 2004 An Economic Evaluation of Fluvastatin used for the Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention in the UK
    by Paul A. Scuffham & Stephen Chaplin
  • 2004 Growth Hormone Therapy and Quality of Life in Adults and Children
    by Deborah J. Radcliffe & Joseph S. Pliskin & J.B. Silvers & Leona Cuttler
  • 2004 Pharmacogenomics and the Evolution of Healthcare: Is it Time for Cost-Effectiveness Analysis at the Individual Level?
    by Mohan V. Bala & Gary A. Zarkin
  • 2004 The Role of Cost-Effectiveness Analysis in the Era of Pharmacogenomics
    by Christopher R. Flowers & David Veenstra
  • 2004 Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C. The Authors' Reply
    by Sean D. Sullivan & Kavita Patel & Jesse Green
  • 2004 Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive
    by Miguel Arguedas
  • 2004 Drotrecogin Alfa (Activated): A Pharmacoeconomic Review of its Use in Severe Sepsis
    by James E. Frampton & Rachel H. Foster
  • 2004 Management and Costs of Treating Lung Cancer Patients in a University Hospital
    by Konstantin J. Dedes & Thomas D. Szucs & Stephan Bodis & Markus Joerger & Adam Lowy & Erich W. Russi & Hans C. Steinert & Walter Weder & Rolf A. Stahel
  • 2004 Economic Evaluations of Treatments for Systemic Fungal Infections: A Systematic Review of the Literature
    by Simon Dixon & Emma McKeen & Margaret Tabberer & Suzy Paisley
  • 2004 Adherence to Guidelines for Community-Acquired Pneumonia: Does it Decrease Cost of Care?
    by Patricia D. Brown
  • 2004 Repaglinide: A Pharmacoeconomic Review of its Use in Type 2 Diabetes Mellitus
    by Greg L. Plosker & David P. Figgitt
  • 2004 Measuring Treatment Preferences and Willingness to Pay for Docetaxel in Advanced Ovarian Cancer
    by George Dranitsaris & Julia Elia-Pacitti & Wayne Cottrell
  • 2004 Economic Implications of Treatment-Resistant Depression Among Employees
    by Paul Greenberg & Patricia K. Corey-Lisle & Howard Birnbaum & Maryna Marynchenko & Ami Claxton
  • 2004 The Economic Burden of Allergic Rhinitis: A Critical Evaluation of the Literature
    by Shelby D. Reed & Todd A. Lee & Douglas C. McCrory
  • 2004 Bernard J. O'Brien, BA, MSc, PhD
    by Deborah A. Freund
  • 2004 Cost Effectiveness of Combination Therapy with Pioglitazone for Type 2 Diabetes Mellitus from a German Statutory Healthcare Perspective
    by Kurt Neeser & Georg Lubben & Uwe Siebert & Wendelin Schramm
  • 2004 Cost Effectiveness of Representatives of Three Classes of Antidepressants Used in Major Depression in the UK
    by Alan Lenox-Smith & Pete Conway & Chris Knight
  • 2004 Pharmacoeconomic Analysis of Amphotericin B Lipid Complex versus Liposomal Amphotericin B in the Treatment of Fungal Infections
    by Joseph L. Kuti & Srividya Kotapati & Peter Williams & Blair Capitano & Charles H. Nightingale & David P. Nicolau
  • 2004 How Often Do Sensitivity Analyses for Economic Parameters Change Cost-Utility Analysis Conclusions?
    by Bruce R. Schackman & Heather Taffet Gold & Patricia W. Stone & Peter J. Neumann
  • 2004 Longitudinal versus Cross-Sectional Methodology for Estimating the Economic Burden of Breast Cancer: A Pilot Study
    by C. Daniel Mullins & Junling Wang & Jesse L. Cooke & Lisa Blatt & Claudia R. Baquet
  • 2004 Economic Impact of Respiratory Syncytial Virus-Related Illness in the US: An Analysis of National Databases
    by L. Clark Paramore & Vincent Ciuryla & Gabrielle Ciesla & Larry Liu
  • 2004 The NICE Reference Case Requirement: More Pain for What, if Any, Gain?
    by Amiram Gafni & Stephen Birch
  • 2004 The NICE Reference Case Requirement: Implications for Drug Manufacturers and Health Systems
    by Paul C. Langley
  • 2004 Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C
    by Sean D. Sullivan & Antonio Craxi & Alfredo Alberti & Giovanni Giuliani & Claudio De Carli & Neil Wintfeld & Kavita K. Patel & Jesse Green
  • 2004 Development and Validation of an Acceptability and Satisfaction Questionnaire for a Contraceptive Vaginal Ring, NuvaRing(R)
    by Annoesjka Novak & Christine de la Loge & Linda Abetz
  • 2004 A
    by Manishi Prasad & Peter Wahlqvist & Rich Shikiar & Ya-Chen Tina Shih
  • 2004 Aggressive Non-Hodgkin
    by Stephen M. Beard & Lucy Wall & Louise Gaffney & Fiona Sampson
  • 2004 Psychometric Validation of the National Eye Institute Visual Function Questionnaire - 25 (NEI VFQ-25) French Version: In a Population of Patients Treated for Ocular Hypertension and Glaucoma
    by Jean-Phillipe Nordmann & Muriel Viala & Kate Sullivan & Benoit Arnould & Gilles Berdeaux
  • 2004 Cost Effectiveness of Interventions for Lateral Epicondylitis: Results from a Randomised Controlled Trial in Primary Care
    by Ingeborg B.C. Korthals-de Bos & Nynke Smidt & Maurits W. van Tulder & Maureen P.M.H. Rutten-van Molken & Herman J. Ader & Danielle A.W.M. van der Windt & Willem J.J. Assendelft & Lex M. Bouter
  • 2004 A Review of Health-Related Workplace Productivity Loss Instruments
    by Jennifer H. Lofland & Laura Pizzi & Kevin D. Frick
  • 2004 Cost-of-Illness Studies in Diabetes Mellitus
    by Lorraine Ettaro & Thomas J. Songer & Ping Zhang & Michael M. Engelgau
  • 2004 Education in Pharmacoeconomics: An International Multidisciplinary View
    by Karen L. Rascati & Michael F. Drummond & Lieven Annemans & Peter G. Davey
  • 2004 Cost of Stress Urinary Incontinence: A Claims Data Analysis
    by Howard G. Birnbaum & Stephanie A. Leong & Emily F. Oster & Kraig Kinchen & Peter Sun
  • 2004 Health Economic Evaluation of Non-Melanoma Skin Cancer and Actinic Keratosis
    by Mitchell K. Higashi & David L. Veenstra & Paul C. Langley
  • 2004 The Generation Gap: Differences Between Children and Adults Pertinent to Economic Evaluations of Health Interventions
    by Ron Keren & Susmita Pati & Chris Feudtner
  • 2004 Economic Evaluation of Varicella Vaccination Programmes: A Review of the Literature. The Authors' Reply
    by Nancy Thiry & Philippe Beutels & Pierre Van Damme & Eddy Van Doorslaer
  • 2004 Economic Evaluation of Varicella Vaccination Programmes: A Review of the Literature
    by Thomas Hammerschmidt & Kurt Banz & Stefan Wagenpfeil & Albrecht Neiss & Peter Wutzler
  • 2004 Infliximab: A Pharmacoeconomic Review of its Use in Rheumatoid Arthritis
    by Katherine A. Lyseng-Williamson & Rachel H. Foster
  • 2004 Cost-Effective Strategies in the Prevention of Diabetic Nephropathy
    by Jonathan D. Rippin & Anthony H. Barnett & Stephen C. Bain
  • 2004 Allocation of Resources Between Smoking Cessation Methods and Lovastatin Treatment of Hypercholesterolaemia: Based on Cost Effectiveness and the Social Welfare Function
    by Pedro Plans-Rubio
  • 2004 A Multicentre Study of Patient Survival, Disability, Quality of Life and Cost of Care: Among Patients with AIDS in Northern Italy
    by Andrea Tramarin & Stefano Campostrini & Maarten J. Postma & Guido Calleri & Keith Tolley & Nicoletta Parise & Fausto de Lalla
  • 2004 Why Did Drug Spending Increase During the 1990s?: A Decomposition Based on Swedish Data
    by Ulf-G. Gerdtham & Douglas Lundin
  • 2004 Assessing the Value of Antipsychotics for Treating Schizophrenia: The Importance of Evaluating and Interpreting the Clinical Significance of Individual Service Costs
    by Sandra L. Tunis & Haya Ascher-Svanum & Michael Stensland & Bruce J. Kinon
  • 2004 The Economic Implications of Non-Adherence after Renal Transplantation
    by Irina Cleemput & Katrien Kesteloot & Yves Vanrenterghem & Sabina De Geest
  • 2004 The Effect of Cost Construction Based on Either DRG or ICD-9 Codes or Risk Group Stratification on the Resulting Cost-Effectiveness Ratios
    by Elinor C.G. Chumney & Andrea K. Biddle & Kit N. Simpson & Morris Weinberger & Kathryn M. Magruder & William N. Zelman
  • 2004 Discrete Choice Experiment to Derive Willingness To Pay for Methyl Aminolevulinate Photodynamic Therapy Versus Simple Excision Surgery in Basal Cell Carcinoma
    by Adele Weston & Patrick FitzGerald
  • 2004 Economic Costs to Business of the HIV/AIDS Epidemic
    by Gordon G. Liu & Jeff J. Guo & Scott R. Smith
  • 2004 Valuing Prevention Through Economic Evaluation: Some Considerations Regarding the Choice of Discount Model for Health Effects with Focus on Infectious Diseases
    by Jasper M. Bos & Philippe Beutels & Lieven Annemans & Maarten J. Postma
  • 2004 Acknowledgement
    by Adis International Limited
  • 2004 Cost Effectiveness of Raloxifene in the Treatment of Osteoporosis in Sweden: An Economic Evaluation Based on the MORE Study
    by Fredrik Borgstrom & Olof Johnell & John A. Kanis & Anders Oden & David Sykes & Bengt Jonsson
  • 2004 Relative Cost Effectiveness of Depo-Provera(R), Implanon(R), and Mirena(R) in Reversible Long-Term Hormonal Contraception in the UK
    by Susan J. Varney & Julian F. Guest
  • 2004 Validation of the Work and Health Interview
    by Walter F. Stewart & Judith A. Ricci & Carol Leotta & Elsbeth Chee
  • 2004 Measurement of Health-Related QOL in Diabetes Mellitus
    by Ken Watkins & Cathleen M. Connell
  • 2004 Reconciliation of Economic Concerns and Health Policy: Illustration of an Equity Adjustment Procedure Using Proportional Shortfall
    by Elly A. Stolk & Gijs van Donselaar & Werner B.F. Brouwer & Jan J.V. Busschbach
  • 2004 Etanercept: A Pharmacoeconomic Review of its Use in Rheumatoid Arthritis
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2004 Use and Cost of Antiretrovirals in France 1995-2000: An Analysis Based on the Medical Dossier on Human Immunodeficiency (release 2) Database
    by Yves A. Flori & Marc le Vaillant
  • 2004 Cost-Effectiveness Analysis of Extended-Release Formulations of Oxybutynin and Tolterodine for the Management of Urge Incontinence
    by Dyfrig A. Hughes & Dominique Dubois
  • 2004 Clinical and Economic Impact of Epoetins in Cancer Care
    by Monia Marchetti & Giovanni Barosi
  • 2004 Economic Impact of Migraine and Other Episodic Headaches in France: Data from the GRIM2000 Study
    by Andre Pradalier & Jean-Paul Auray & Abdelkader El Hasnaoui & Kazem Alzahouri & Jean-Francois Dartigues & Gerard Duru & Patrick Henry & Michel Lanteri-Minet & Christian Lucas & Guy Chazot & Anne-Francois Gaudin
  • 2004 Does Seropositivity for Helicobacter pylori Antibodies Increase Outpatient Costs for Gastric and Duodenal Ulcer or Inflammation?
    by Akira Babazono & Motonobu Miyazaki & Hiroshi Une & Eiji Yamamoto & Toshihide Tsuda & Yoshio Mino & Alan L. Hillman
  • 2004 Cost Effectiveness of Ramipril in Patients at High Risk for Cardiovascular Events: Economic Evaluation of the HOPE (Heart Outcomes Prevention Evaluation) Study for Germany from the Statutory Health Insurance Perspective
    by Peter K. Schadlich & Josef G. Brecht & Badrudin Rangoonwala & Eduard Huppertz
  • 2004 Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus
    by Frederick B. Dong & Stephen W. Sorensen & Diane L. Manninen & Theodore J. Thompson & Venkat Narayan & Carlyn E. Orians & Edward W. Gregg & Richard C. Eastman & Erik J. Dasbach & William H. Herman & Jeffrey M. Newman & Andrew S. Narva & David J. Ballard & Michael M. Engelgau
  • 2004 Comparisons of Hypertension-Related Costs from Multinational Clinical Studies
    by C. Daniel Mullins & Mirko Sikirica & Viran Seneviratne & Jeonghoon Ahn & Kasem S. Akhras
  • 2004 The Costs and Benefits of Community Thrombolysis for Acute Myocardial Infarction: A Decision-Analytic Model
    by Luke Vale & Harvey Steffens & Cam Donaldson
  • 2004 Cost-Benefit Analysis of First-Generation Antihistamines in the Treatment of Allergic Rhinitis
    by Patrick W. Sullivan & Sheryl L. Follin & Michael B. Nichol
  • 2004 Pharmacoeconomic Burden of Undertreating Hypertension
    by Luca Degli Esposti & Giorgia Valpiani
  • 2004 Pharmacoeconomic Implications of New Therapies in Sepsis
    by Kelly A. Wood & Derek C. Angus
  • 2004 Pharmacoeconomic Analysis of Bemiparin and Enoxaparin as Prophylaxis for Venous Thromboembolism in Total Knee Replacement Surgery
    by Jesus Honorato & Antonio Gomez-Outes & Antonio Navarro-Quilis & Javier Martinez-Gonzalez & Eduardo Rocha & Andre Planes
  • 2004 Cost Effectiveness of Ibutilide With Prophylactic Magnesium in the Treatment of Atrial Fibrillation
    by Craig I. Coleman & James S. Kalus & C. Michael White & Anne P. Spencer & James P. Tsikouris & Jenny O. Chung & Kenneth W. Kenyon & Martin Ziska & Jeffrey Kluger & Prabashni Reddy
  • 2004 A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between Countries
    by Robert Welte & Talitha Feenstra & Hans Jager & Reiner Leidl
  • 2004 Varicella Vaccination in Italy: An Economic Evaluation of Different Scenarios
    by Laurent Coudeville & Alain Brunot & Carlo Giaquinto & Carlo Lucioni & Benoit Dervaux
  • 2004 Acute Rhinosinusitis: A Pharmacoeconomic Review of Antibacterial Use
    by Jean-Blaise Wasserfallen & Francoise Livio & Giorgio Zanetti
  • 2004 Transferability of Economic Evaluation Results
    by Fernando Antonanzas
  • 2004 Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma
    by Richard D. OConnor & Harold Nelson & Rohit Borker & Amanda Emmett & Priti Jhingran & Kathleen Rickard & Paul Dorinsky
  • 2004 Economic Aspects of Severe Sepsis: A Review of Intensive Care Unit Costs, Cost of Illness and Cost Effectiveness of Therapy
    by Hilmar Burchardi & Heinz Schneider
  • 2004 Assessing the Use of Retrospective Databases in Conducting Economic Evaluations of Drugs: The Case of Asthma
    by Fredrik Berggren
  • 2004 Incorporation of Statistical Uncertainty in Health Economic Modelling Studies Using Second-Order Monte Carlo Simulations
    by Mark J.C. Nuijten
  • 2004 Resource Use and Cost of Care for Patients Hospitalised with Community Acquired Pneumonia: Impact of Adherence to Infectious Diseases Society of America Guidelines
    by Joanne J. Orrick & Richard Segal & Thomas E. Johns & Wayne Russell & Feng Wang & Donald D. Yin
  • 2004 Healthcare Costs with Tiotropium Plus Usual Care versus Usual Care Alone Following 1 Year of Treatment in Patients with Chronic Obstructive Pulmonary Disorder (COPD)
    by Mitchell Friedman & Shailendra S. Menjoge & Susan F. Anton & Steven Kesten
  • 2004 Economic Aspects of Pneumococcal Pneumonia: A Review of the Literature
    by Diana De Graeve & Philippe Beutels
  • 2004 Effect of Second-Generation Antipsychotics on Employment and Productivity in Individuals with Schizophrenia: An Economic Perspective
    by Mauro Percudani & Corrado Barbui & Michele Tansella
  • 2004 The Measurement of Contingent Valuation for Health Economics
    by Ahmed M. Bayoumi
  • 2004 On Cost Effectiveness and Sample Size in Clinical Trials. The Author's Reply
    by Martin E. Backhouse
  • 2004 On Cost Effectiveness and Sample Size in Clinical Trials
    by Augustinus A.M. Hart & Marcel G.W. Dijkgraaf
  • 2004 Warfarin in the Secondary Prevention of Thromboembolism in Atrial Fibrillation: Impact of Bioavailability on Costs and Outcomes
    by Nicole Mittmann & Paul I. Oh & Scott E. Walker & William R. Bartle
  • 2004 Economic Assessment of the Secondary Prevention of Ischaemic Stroke with Dipyridamole plus Aspirin (Aggrenox(R)/Asasantin(R)) in France
    by Jean-Pierre Marissal & Bernard Selke
  • 2004 Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
    by Andrew Moore & Ceri Phillips & Elke Hunsche & James Pellissier & Simone Crespi
  • 2004 From Randomised Clinical Trials to Clinical Practice: A Pragmatic Cost-Effectiveness Analysis of Paclitaxel in First-Line Therapy for Advanced Ovarian Cancer
    by Samuel Limat & Marie-Christine Woronoff-Lemsi & Celine Menat & Anne Madroszyk-Flandin & Yacine Merrouche
  • 2004 An Economic Model of 2-Hour Post-Dose Ciclosporin Monitoring in Renal Transplantation
    by Paul A. Keown & Bryce Kiberd & Robert Balshaw & Shideh Khorasheh & Carlo Marra & Philip Belitsky & Zoltan Kalo
  • 2004 Effectiveness, Quality of Life, and Cost of Caring for Children in France with Recurrent Acute Rhinopharyngitis Managed by Homeopathic or Non-Homeopathic General Practitioners: A Pragmatic, Prospective Observational Study
    by Melanie Trichard & Gilles Chaufferin & Christian Dubreuil & Nicolas Nicoloyannis & Gerard Duru
  • 2004 The Burden of Osteoporosis and the Case for Disease Management
    by William D. Fraser
  • 2004 Long-Term Drug Treatment of GERD: Economic Issues for Formulary Decision Makers
    by James Chan & Theodore R. Levin
  • 2004 Development of a Regionalized, Comprehensive Care Network for Pediatric Sickle Cell Disease to Improve Access to Care in a Rural State
    by Lee M. Hilliard & Mary H. Maddox & Shenghui Tang & Thomas H. Howard
  • 2004 Socioeconomic Implications of Long-Term Warfarin Use
    by Joseph Menzin & Talia Foster & Rebecca Audette
  • 2004 Improving Treatment Regimen Adherence in Coronary Heart Disease by Targeting Patient Types
    by Robin S. Turpin & Jeffrey B. Simmons & Janice F. Lew & Charles M. Alexander & Marie A. Dupee & Patricia Kavanagh & Ellen R. Cameron
  • 2004 Thiazolidinediones for Diabetes Mellitus: Considerations for Reimbursements by Third-Party Payors
    by Andrew J. Palmer & William J. Valentine & Joshua A. Ray
  • 2004 Barrett
    by Deepak V. Gopal & Mark Reichelderfer & Eric A. Gaumnitz & Josephine Harter & Blair A. Jobe
  • 2004 Acknowledgments
    by Adis International Limited
  • 2004 Management of Benign Prostatic Hyperplasia: Defining the Role of Tamsulosin
    by Katherine F. Croom & Antona J. Wagstaff
  • 2004 Caring for Hypertension on Initiation: Costs and Effectiveness (CHOICE): A Naturalistic Design and Rationale for the Study of Patterns of Care in Hypertension
    by Jaime J. Caro & Norman Hollenberg & Joseph D Jackson & Krista A Payne & Gil LItalien
  • 2004 Overview of Disease Management Approaches: Implications for Corporate-Sponsored Programs
    by Shirley A. Musich & Alyssa B. Schultz & Wayne N. Burton & Dee W. Edington
  • 2004 National Performance Measures for Diabetes Mellitus Care: Implications for Health Care Providers
    by Fevzi Akinci & Joseph Coyne & Bernard Healey & Joni Minear
  • 2004 Pulmonary Rehabilitation Programs: Improving Outcomes in Elderly Patients with COPD
    by Jorg D. Leuppi & Roland M. Bingisser
  • 2004 Impact of a Migraine Disease Management Program: Humanistic Outcomes
    by Henry X. Hu & Glen D. Solomon & Kathleen Conboy & Lisa Deml & Leona E. Markson
  • 2004 Economic Benefits of Including Environmental Issues as a Component of Comprehensive Asthma Care: A Managed Care Perspective
    by Doug Brugge & James Hyde & Bonnie H. Weinbach & Jonathan I. Levy & Suzanne Steinbach
  • 2004 Reducing the Incidence of Type 2 Diabetes Mellitus: A Healthcare Plan and Program Implementation Perspective
    by Nicolaas P. Pronk & Jackie Boucher & Robert W. Jeffery & Nancy E. Sherwood & Raymond Boyle
  • 2004 Opportunities for Pharmacists to Aid in the Management of Acid-Peptic Disorders
    by C. Wayne Weart & Harry Leider
  • 2004 Specialist and Generalist Care for Type 1 Diabetes Mellitus: Differential Impact on Processes and Outcomes
    by Janice C. Zgibor & Trevor J. Orchard
  • 2004 Short-Term Aggressive Disease Management Programs for Heart Failure: Effect on Drug Utilization, Clinical Outcomes, and Costs
    by Kwame O. Akosah & Stephanie Carothers
  • 2004 Performance Measurement of Disease Management Programs: Examination of Recent Guidelines
    by Barry M. Zajac
  • 2004 Spotlight on Eptifibatide in Percutaneous Coronary Intervention and Acute Coronary Syndromes
    by Greg L. Plosker & Tim Ibbotson
  • 2004 A Surveillance System for the Real-Time Reporting of Influenza Activity
    by Helmut Uphoff & Irena Groniewicz & Marc Soriano & Isabel Burckhardt-Batista
  • 2004 Dosing Patterns of Anti-TNF Therapy in Patients with Rheumatoid Arthritis in a Managed Care Setting
    by Karen Stockl & Manal Jarrar & Neeta Tandon
  • 2004 The Costs of Non-Adherence to Oral Antihyperglycemic Medication in Individuals with Diabetes Mellitus and Concomitant Diabetes Mellitus and Cardiovascular Disease in a Managed Care Environment
    by T. Jeffrey White & Ann Vanderplas & Eunice Chang & Christopher M. Dezii & Geoffrey D. Abrams
  • 2004 Atypical Antipsychotics as First-Line Treatments for Schizophrenia: Advantages for Stakeholders in the UK Healthcare System
    by Ann M. Mortimer
  • 2004 Optimizing Drug Prescribing in Managed Care Populations: Improving Clinical and Economic Outcomes
    by Rachel Czubak & Jasmine Tucker & Barbara J. Zarowitz
  • 2004 The Department of Health (England) Action Plan for Improving Services for People with Epilepsy: Will It Improve Quality of Care?
    by Frank M.C. Besag
  • 2004 Improvements in Asthma Pharmacotherapy and Self-Management: An Example of a Population-Based Disease Management Program
    by Richard A. Feifer & Robert R. Verbrugge & Mona Khalid & Rebecca Levin & Gwendolyn B. OKeefe & Ronald E. Aubert
  • 2004 Impact of Three-Tier Pharmacy Benefit Structures on Consumer Attitudes, Pharmacy, Medical Utilization and Costs: A Critical Review
    by Kavita V. Nair & Robert J. Valuck
  • 2004 Impact of Guidelines on Healthcare from the Patient and Payor Perspective: Example of the American Pain Society Guidelines
    by Bill McCarberg
  • 2004 Management of Overactive Bladder: Defining the Role of Extended-Release Tolterodine
    by Susan J. Keam & Caroline M. Perry
  • 2004 Management of Genital Herpes: Defining the Role of Valaciclovir
    by Antona J. Wagstaff & Susan J. Keam & David P. Figgitt
  • 2004 Employer-Based Disease Management Programs in Cancer: Experience to Date
    by Frederick C. Lee
  • 2004 Management of Mild to Moderate Alzheimer Disease: Defining the Role of Rivastigmine
    by Greg L. Plosker & Gillian M. Keating
  • 2004 Management of Parkinson Disease: Defining the Role of Ropinirole
    by David Murdoch & Susan M. Cheer & Antona J. Wagstaff
  • 2004 Prevention and Treatment of Osteoporosis in Postmenopausal Women: Defining the Role of Alendronate
    by Susan J. Keam & Greg L. Plosker
  • 2004 Adalimumab for Rheumatoid Arthritis: Considerations for Reimbursement by Third-Party Payors
    by Leo van de Putte & Michael B. Nichol
  • 2004 Nurses
    by Erik Magnus Saether
  • 2004 Burning a Hole in the Budget: Tobacco Spending and its Crowd-Out of Other Goods
    by Susan H. Busch & Mireia Jofre-Bonet & Tracy A. Falba & Jody L. Sindelar
  • 2004 Income-Related Inequality in the Use of Dental Services in Finland
    by Lien Nguyen & Unto Hakkinen
  • 2004 Tackling Regional Health Inequalities in France by Resource Allocation: A Case for Complementary Instrumental and Process-Based Approaches?
    by Martine M. Bellanger & Alain Jourdain
  • 2004 Consumer Mobility in Social Health Insurance Markets: A Five-Country Comparison
    by Trea Laske-Aldershof & Erik Schut & Konstantin Beck & Stefan Gress & Amir Shmueli & Carine Van de Voorde
  • 2004 Senior Citizens and the Burden of Prescription Drug Outlays: What Lessons for the Medicare Prescription Drug Benefit?
    by Panos Kanavos & Marin Gemmill
  • 2004 How Much Might Universal Health Insurance Reduce Socioeconomic Disparities in Health?: A Comparison of the US and Canada
    by Sandra L. Decker & Dahlia K. Remler
  • 2004 Is Patient Choice an Effective Mechanism to Reduce Waiting Times?
    by Diane Dawson & Rowena Jacobs & Steve Martin & Peter Smith
  • 2004 Do Patients Always Prefer Quicker Treatment?: A Discrete Choice Analysis of Patients
    by Peter Burge & Nancy Devlin & John Appleby & Charlene Rohr & Jonathan Grant
  • 2004 Guest Editorial
    by Adam Oliver
  • 2004 Aggregating Public Preferences for Healthcare: Putting Theory into Practice
    by Virginia Wiseman
  • 2004 Examining Within-Country Variation of Maternity Costs in the Context of a Multicountry, Multicentre Randomised Controlled Trial
    by Guy Hutton & Julia Fox-Rushby & Miranda Mugford & Jadsada Thinkhamrop & Bandit Thinkhamrop & Ana Maria Galvez & Manuel Alvarez
  • 2004 Medicare Payment Policy and the Controversy over Hospital Cost Shifting
    by Rick Mayes & Jason S. Lee
  • 2004 Listening to the Decision Makers: Sustainability of PBMA in Alberta
    by Craig Mitton & San Patten & Cam Donaldson
  • 2004 Productivity Research and Healthcare Delivery Innovation
    by Karen Eggleston & Jerome Grossman & David Cutler
  • 2004 Observations on Health Financing Reform in the Republic of Georgia, 1996-2002
    by Kees Schaapveld & Grant Rhodes
  • 2004 Calculating Society
    by Jeff Richardson & Richard D. Smith
  • 2004 Healthcare Expenditure and Ageing: A Comment
    by J. Francois Outreville
  • 2004 EQ-5D versus SF-6D in an Older, Chronically Ill Patient Group
    by Karen Gerard & Tricia Nicholson & Mark Mullee & Raj Mehta & Paul Roderick
  • 2004 The Use of Probabilistic Decision Models in Technology Assessment: The Case of Total Hip Replacement
    by Andrew Briggs & Mark Sculpher & Jill Dawson & Ray Fitzpatrick & David Murray & Henrik Malchau
  • 2004 Improving Road Safety and Residential Quality of Life: Evaluating the Automated Wayside Horn System
    by Roy E. Lucke & Richard A. Raub & Thomas E. Thunder
  • 2004 The Economics of Prevention in a Post-Managed-Care Environment
    by Cyril F. Chang & Teresa M. Waters & David M. Mirvis
  • 2004 Should We Maximise QALYs?: A Debate with Respect to Peak-End Evaluation
    by Adam Oliver
  • 2004 Do Interventions to Increase Income Improve the Health of the Poor in Developed Economies and Are Such Policies Cost Effective?
    by Anne Ludbrook & Kathy Porter
  • 2004 Modelling the Ability of Risk Adjusters to Reduce Adverse Selection in Managed Care
    by Randall S. Stafford & Donglin Li & Roger B. Davis & Lisa I. Iezzoni
  • 2004 Comparing Utility Scores Before and After Hearing-Aid Provision: Results According to the EQ-5D, HUI3 and SF-6D
    by Garry R. Barton & John Bankart & Adrian C. Davis & Quentin A. Summerfield
  • 2004 Driver Perception Response Time During the Signal Change Interval
    by Pin-Kai Goh & Yiik-Diew Wong
  • 2004 A Tribute to the Life and Work of Bernie O
    by John F.P. Bridges
  • 2004 The Value of Life and Accident Costing: A Willingness-to-Pay Study Amongst Motorcyclists in Malaysia
    by Mohd Y. Mohd Fauzi & Mohd N. Nor Ghani & Radin S. Radin Umar & Hashim Ahmad Hariza
  • 2004 Healthcare Payment Incentives: A Comparative Analysis of Reforms in Taiwan, South Korea and China
    by Karen Eggleston & Chee-Ruey Hsieh
  • 2004 The Impact of Physician Payment Methods on Raising the Efficiency of the Healthcare System: An International Comparison
    by Steven Simoens & Antonio Giuffrida
  • 2004 The Reliability of Willingness to Pay for Changes in Health Status
    by Richard D. Smith
  • 2004 Road Safety and Accident Prevention
    by Richard Tay
  • 2004 An Alternative Approach to Resource Allocation: Weighted Capacity to Benefit Plus MESH Infrastructure
    by Gavin Mooney & Shane Houston
  • 2004 Self-Reported Effectiveness of Double-Fine Zones as a Speed Control Measure
    by Barnie Jones & Kevin Haas & Alan Kirk & Andrew Griffith
  • 2004 Editorial Foreword
    by Adis International Limited
  • 2003 On the value of life
    by Thomas Cool
  • 2003 State Policies to promote marriage
    by Plamen Nikolov & Karen Gardiner & Mike Fishman
  • 2003 Economic Costs of Diabetes in the U.S. in 2002
    by Tim Dall & Plamen Nikolov & Paul Hogan
  • 2003 Managed competition in health care
    by Productivity Commission
  • 2003 Rescuing Patients from the Rule of Efficiency: A Need to Debate the
    by Sophia Kessabi & Richard de Abreu Lourenco & Michael Wonder
  • 2003 Direct Treatment Costs for Patients with Lung Cancer from First Recurrence to Death in France
    by Anne-Chantal Braud & Christine Levy-Piedbois & Pascal Piedbois & Youri Piedbois & Alain Livartovski & Beatrice Le Vu & Jean Tredaniel & Francois Reboul & Yvelise Brewer & Said Talbi & Francois Blanchon & Britta Paschen & Isabelle Durand-Zaleski
  • 2003 Economic Evaluation of Norethisterone Acetate/Ethinylestradiol (FemHRT(R)) for Women with Menopausal Symptoms
    by Douglas Coyle & Ann Cranney & Peter Tugwell
  • 2003 The Comparative Medical Costs of Atherothrombotic Disease in European Countries
    by Emile Levy & Sylvie Gabriel & Jerome Dinet
  • 2003 Assessing the Economic Impact of Adverse Drug Effects
    by Rosa Rodriguez-Monguio & Maria Jose Otero & Joan Rovira
  • 2003 Costs of Bipolar Disorder
    by Leah S. Kleinman & Ana Lowin & Emuella Flood & Gian Gandhi & Eric Edgell & Dennis A. Revicki
  • 2003 Cost Effectiveness of Pneumococcal Vaccination for Infants and Children with the Conjugate Vaccine PnC-7 in Germany
    by Christa Claes & Johann-Matthias Graf von der Schulenburg
  • 2003 The Cost Effectiveness of ACE Inhibitors as First-Line Antihypertensive Therapy
    by Alain J. Nordmann & Murray Krahn & Alexander G. Logan & Gary Naglie & Allan S. Detsky
  • 2003 Labour Force Participation Among Individuals with Hepatitis C in the US
    by Philip Jacobs & Ying Chu Ng & Tania Stafinski & Roger Dodd & Bryce Larke & Winnie Wong
  • 2003 The Economics of Screening and Treatment in Type 2 Diabetes Mellitus
    by Maria Raikou & Alistair McGuire
  • 2003 Quality of Life and Economic Considerations in the Management of Prostate Cancer
    by Marco Turini & Alberto Redaelli & Paola Gramegna & Davide Radice
  • 2003 A Stochastic Economic Evaluation of Letrozole versus Tamoxifen as a First-Line Hormonal Therapy: For Advanced Breast Cancer in Postmenopausal Patients
    by Jon Karnon & Trefor Jones
  • 2003 Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus
    by Andreas Maetzel & Jorg Ruof & Melva Covington & Anne Wolf
  • 2003 Using Gross National Product to Calculate Acceptable Immunisation Costs: Deploying Cost-Effectiveness Calculations in Reverse
    by Vineet Tyagi & Saroj K. Singh & Ashu Sawhney & Vikas Taneja & Jacob M. Puliyel
  • 2003 Measuring the Outcomes and Pharmacoeconomic Consequences of Venous Thromboembolism Prophylaxis in Major Orthopaedic Surgery
    by Sean D. Sullivan & Susan R. Kahn & Bruce L. Davidson & Lars Borris & Patrick Bossuyt & Gary Raskob
  • 2003 Cytomegalovirus Infection in Solid Organ Transplantation: Economic Implications
    by Ananya Das
  • 2003 Pharmaceutical Care Programmes for the Elderly: Economic Issues
    by Grainne E. Crealey & Ian K. Sturgess & James C. McElnay & Carmel M. Hughes
  • 2003 Factors Affecting UK Primary-Care Costs of Managing Patients with Asthma over 5 Years
    by Roben Das Gupta & Julian F. Guest
  • 2003 Cost Effectiveness of Nasal Budesonide versus Surgical Treatment for Nasal Polyps
    by Fredrik Berggren & Leif Johansson
  • 2003 Peginterferon alpha-2a (40kD) [Pegasys(R)] Improves HR-QOL Outcomes Compared with Unmodified Interferon alpha-2a [Roferon(R)-A]: In Patients with Chronic Hepatitis C
    by Jens Rasenack & Stefan Zeuzem & S. Victor Feinman & E. Jenny Heathcote & Michael Manns & Eric M. Yoshida & Mark G. Swain & Edward Gane & Moises Diago & Dennis A. Revicki & Amy Lin & Neil Wintfeld & Jesse Green
  • 2003 Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer's Disease
    by Anders Wimo & Bengt Winblad & Albrecht Stoffler & Yvonne Wirth & Hansjorg Mobius
  • 2003 The Cost Effectiveness of Two New Antiepileptic Therapies in the Absence of Direct Comparative Data: A First Approximation
    by Ben A. van Hout & Dennis D. Gagnon & Pauline Mcnulty & Anthony O'Hagan
  • 2003 Cost Effectiveness of Alendronate (Fosamax(R)) for the Treatment of Osteoporosis and Prevention of Fractures
    by Olof Johnell & Bengt Jonsson & Linus Jonsson & Dennis Black
  • 2003 A Simulation Model for Estimating Direct Costs of Type 1 Diabetes Prevention
    by Jarmo Hahl & Tuula Simell & Antti Kupila & Paivi Keskinen & Mikael Knip & Jorma Ilonen & Olli Simell
  • 2003 Ontario's Formulary Committee: How Recommendations Are Made
    by Anne M. PausJenssen & Peter A. Singer & Allan S. Detsky
  • 2003 A Study of Influenza and Influenza-Related Complications among Children in a Large US Health Insurance Plan Database
    by Jeanne Loughlin & Nick Poulios & Pavel Napalkov & Yann Wegmuller & Arnold S. Monto
  • 2003 Unit Costs of Inpatient Hospital Days
    by Jan B. Oostenbrink & Tineke Buijs-Van der Woude & Michel van Agthoven & Marc A. Koopmanschap & Frans F.H. Rutten
  • 2003 Cost Comparisons of Pharmacological Strategies in Open-Heart Surgery
    by Prabashni Reddy & Jessica Song
  • 2003 Health-Related Quality-of-Life Assessments in Patients with Advanced Cancer of the Prostate
    by Jan Adolfsson
  • 2003 Specialist Nurse Management Programmes: Economic Benefits in the Management of Heart Failure
    by Simon Stewart & John D. Horowitz
  • 2003 Bedside Rapid Flu Test and Zanamivir Prescription in Healthy Working Adults: A Cost-Benefit Analysis
    by Michael Schwarzinger & Bruno Housset & Fabrice Carrat
  • 2003 Cost-Minimisation Study of Dorzolamide versus Brinzolamide in the Treatment of Ocular Hypertension and Primary Open-Angle Glaucoma: In Four European Countries
    by Jeanfrancois Rouland & Claude Lepen & Carlos Gouveiapinto & Patrizia Berto & Gilles Berdeaux
  • 2003 A Meta-Analysis of Quality-of-Life Estimates for Stroke
    by Tammy O. Tengs & Ting H. Lin
  • 2003 The Burden of Age-Related Macular Degeneration: Results of a Cohort Study in Two French Referral Centres
    by Julia Bonastre & Claude Le Pen & Gisele Soubrane & Gabriel Quentel
  • 2003 Treatment of Atopic Dermatitis and Impact on Quality of Life: A Review with Emphasis on Topical Non-Corticosteroids
    by Roman Schiffner & Julia Schiffner-Rohe & Michael Landthaler & Wilhelm Stolz
  • 2003 NICE Methodological Guidelines and Decision Making in the National Health Service in England and Wales
    by Amiram Gafni & Stephen Birch
  • 2003 European Healthcare Policies for Controlling Drug Expenditure
    by Silvia M. Ess & Sebastian Schneeweiss & Thomas D. Szucs
  • 2003 Discounting in Cost-Utility Analysis of Healthcare Interventions: Reassessing Current Practice
    by Brian J. Cohen
  • 2003 Cost Effectiveness and Cost Utility of Acetylcysteine versus Dimethyl Sulfoxide for Reflex Sympathetic Dystrophy
    by Hiske E.M. van Dieten & Roberto S.G.M. Perez & Maurits W. van Tulder & Jaap J. de Lange & Wouter W.A. Zuurmond & Herman J. Ader & Hindrik Vondeling & Maarten Boers
  • 2003 Economic Implications of the Use of Basiliximab in Addition to Triple Immunosuppressive Therapy in Renal Allograft Recipients: A UK Perspective
    by Stephen J. Walters & Malcolm Whitfield & Ronald L. Akehurst & James B. Chilcott
  • 2003 Cost Analysis of Ropinirole versus Levodopa in the Treatment of Parkinson's Disease
    by Michael Iskedjian & Thomas R. Einarson
  • 2003 Cost of Illness of Atopic Dermatitis in Children: A Societal Perspective
    by Andrew S. Kemp
  • 2003 Comparative Cost Effectiveness of Angiotensin II Receptor Blockers in a US Managed Care Setting: Olmesartan Medoxomil Compared with Losartan, Valsartan, and Irbesartan
    by W. Robert Simons
  • 2003 Potential Costs and Effects of the National Service Framework for Coronary Heart Disease in the UK
    by Venanzio Vella
  • 2003 Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies
    by Niklas Zethraeus & Magnus Johannesson & Bengt Jonsson & Mickael Lothgren & Magnus Tambour
  • 2003 Economic Evaluations of Varicella Vaccination Programmes: A Review of the Literature
    by Nancy Thiry & Philippe Beutels & Pierre Van Damme & Eddy Van Doorslaer
  • 2003 Generic Clozapine: A Cost-Saving Alternative to Brand Name Clozapine?
    by Gordon Tse & Deborah Thompson & Ric M. Procyshyn
  • 2003 An Evaluation of the Cost Effectiveness of Drotrecogin Alfa (Activated) Relative to the Number of Organ System Failures
    by Madeline Betancourt & Peggy S. McKinnon & R. Michael Massanari & Salmaan Kanji & David Bach & John W. Devlin
  • 2003 The Health Economics of Bladder Cancer: A Comprehensive Review of the Published Literature
    by Marc F. Botteman & Chris L. Pashos & Alberto Redaelli & Benjamin Laskin & Robert Hauser
  • 2003 Economic Evaluations of Granulocyte Colony-Stimulating Factor: In the Prevention and Treatment of Chemotherapy-Induced Neutropenia
    by Marc Esser & Helmut Brunner
  • 2003 Development and Validation of the Diabetic Foot Ulcer Scale-Short Form (DFS-SF)
    by Carla M. Bann & Sheri E. Fehnel & Dennis D. Gagnon
  • 2003 The Cost Effectiveness of Tacrolimus versus Microemulsified Cyclosporin: A 10-Year Model of Renal Transplantation Outcomes
    by Michelle E. Orme & Wieslaw A. Jurewicz & Nagappan Kumar & Tracy L. McKechnie
  • 2003 Economic Implications of Attention-Deficit Hyperactivity Disorder for Healthcare Systems
    by Cynthia L. Leibson & Kirsten Hall Long
  • 2003 Screening, Prevention and Socioeconomic Costs Associated with the Treatment of Colorectal Cancer
    by Alberto Redaelli & Carole W. Cranor & Gary J. Okano & Pat Ray Reese
  • 2003 Pharmaceutical Expenditure and Therapeutic Value of New Medicines in Spain
    by Josep Darba
  • 2003 Escitalopram: A Pharmacoeconomic Review of its Use in Depression
    by Katherine F. Croom & Greg L. Plosker
  • 2003 The Cost Effectiveness of Apligraf(R) Treatment of Diabetic Foot Ulcers
    by W. Ken Redekop & Joseph McDonnell & Paul Verboom & Kornelia Lovas & Zoltan Kalo
  • 2003 Cost-Utility Analysis of Survival with Epoetin-Alfa versus Placebo in Stage IV Breast Cancer
    by Silas C. Martin & Dennis D. Gagnon & Lucy Zhang & Carsten Bokemeyer & Marinus Van Marwijk Kooy & Ben van Hout
  • 2003 Costs and Cost Effectiveness of Low Molecular Weight Heparins and Platelet Glycoprotein IIb/IIIa Inhibitors: In the Management of Acute Coronary Syndromes
    by Nick Bosanquet & Bengt Jonsson & Keith A.A. Fox
  • 2003 Reductions in Individual Work Productivity Associated with Type 2 Diabetes Mellitus
    by Jill E. Lavigne & Charles E. Phelps & Alvin Mushlin & Wayne M. Lednar
  • 2003 Indirect Costs in Ambulatory Patients with HIV/AIDS in Spain: A Pilot Study
    by Juan Oliva & Cesar Roa & Juan del Llano
  • 2003 Methods to Analyse Cost Data of Patients Who Withdraw in a Clinical Trial Setting
    by Jan B. Oostenbrink & Maiwenn J. Al & Maureen P.M.H. Rutten-van Molken
  • 2003 Heartburn in Patients with Gastro-Oesophageal Reflux Disease in Germany and Sweden: A Study on Patients
    by Roger Jones & Silke Horbach & Peter Sander & Tina Ryden-Bergsten
  • 2003 Frequency of Hospitalisations and Inpatient Care Costs of Manic Episodes: In Patients with Bipolar I Disorder in France
    by Marie de Zelicourt & Roland Dardennes & Helene Verdoux & Gian Gandhi & Babak Khoshnood & Eric Chomette & Marie-Laure Papatheodorou & Eric T. Edgell & Christian Even & Francis Fagnani
  • 2003 Evaluating Minimal Clinically Important Differences for the Acne-Specific Quality of Life Questionnaire
    by Lori D. McLeod & Sheri E. Fehnel & Jane Brandman & Tara Symonds
  • 2003 Cost-Effectiveness League Tables: Valuable Guidance for Decision Makers?
    by Josephine Mauskopf & Frans Rutten & Warren Schonfeld
  • 2003 Prevention of Recurrent Rhinopharyngitis in At-Risk Children in France: A Cost-Effectiveness Model for a Nonspecific Immunostimulating Bacterial Extract (OM-85 BV)
    by Jean-Jacques Pessey & Francoise Megas & Benoit Arnould & Florence Baron-Papillon
  • 2003 A Cost Comparison of Oral Tegafur Plus Uracil/Folinic Acid and Parenteral Fluorouracil for Colorectal Cancer in Canada
    by Jean A. Maroun & Carl Asche & Francoise Romeyer & Jayanti Mukherjee & Christine Cripps & Amit Oza & Jamie R. Skillings & Jacques Letarte
  • 2003 Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer
    by Linus Jonsson
  • 2003 Cystic Fibrosis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies
    by Christian Krauth & Noushin Jalilvand & Tobias Welte & Reinhard Busse
  • 2003 Inhaled Salmeterol/Fluticasone Propionate Combination: A Pharmacoeconomic Review of its Use in the Management of Asthma
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2003 The Incorporation of Potential Confounding Variables in Markov Models
    by Mark J.C. Nuijten & Frans Rutten
  • 2003 Quality of Life in Patients with Rheumatoid Arthritis: Which Drugs Might Make a Difference?
    by Barbara Blumenauer & Ann Cranney & Jennifer Clinch & Peter Tugwell
  • 2003 Practical Aspects of Designing and Conducting Pharmacoeconomic Studies in Japan
    by Jim Doherty & Keiko Sato
  • 2003 Eptifibatide: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Intervention and Acute Coronary Syndromes
    by Greg L. Plosker & Tim Ibbotson
  • 2003 Validation of Expert Opinion in Identifying Comorbidities Associated with Atopic Dermatitis/Eczema
    by Charles N. Ellis & Lynn A. Drake & Mary M. Prendergast & William Abramovits & Mark Boguniewicz & C. Ralph Daniel & Mark Lebwohl & Seth R. Stevens & Diane L. Whitaker-Worth & Kuo B. Tong
  • 2003 Defining Monetary Values for Quality of Life Improvements: An Exploratory Study
    by Jean Lachaine & Claudine Laurier & Andre-Pierre Contandriopoulos
  • 2003 Recurrent Genital Herpes Treatments and Their Impact on Quality of Life
    by Mathijs H. Brentjens & Kimberly A. Yeung-Yue & Patricia C. Lee & Stephen K. Tyring
  • 2003 Integer/Linear Mathematical Programming Models: A Tool for Allocating Healthcare Resources
    by Stephanie R. Earnshaw & Susan L. Dennett
  • 2003 Economic Model of First-Line Drug Strategies to Achieve Recommended Glycaemic Control in Newly Diagnosed Type 2 Diabetes Mellitus
    by Joe W. Ramsdell & Seth N. Braunstein & Jennifer M. Stephens & Christopher F. Bell & Marc F. Botteman & Scott T. Devine
  • 2003 Can Sequential Administration Minimise the Cost of High Dose Chemotherapy?: An Economic Assessment in Inflammatory Breast Cancer
    by Patricia Marino & Anne-Gaelle Le Corroller & Thao Palangie & Maud Janvier & Michel Fabbro & Laurent Molinier & Thierry Delozier & Alain Livartowski & Jean-Paul Moatti & Patrice Viens
  • 2003 Cost Evaluation of Basiliximab Treatment for Renal Transplant Patients in Japan
    by Tomonori Hasegawa & Hidehiko Imai & Sunao Miki
  • 2003 The Impact of Treatment for Gastro-Oesophageal Reflux Disease on Health-Related Quality of Life: A Literature Review
    by Manishi Prasad & Anne M. Rentz & Dennis A. Revicki
  • 2003 A Role for Two-Stage Pharmacoeconomic Appraisal?: Is There a Role for Interim Approval of a Drug for Reimbursement Based on Modelling Studies with Subsequent Full Approval Using Phase III Data?
    by Suzanne Hill & Nick Freemantle
  • 2003 Lower Respiratory Tract Infections: Impact on the Workplace
    by Howard G. Birnbaum & Melissa Morley & Stephanie Leong & Paul Greenberg & Gene L. Colice
  • 2003 Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in Patients with Acute Coronary Syndrome in Poland: Modelling Study from the Hospital Perspective
    by Ewa Orlewska & Andrzej Budaj & Dariusz Tereszkowski-Kaminski
  • 2003 Consumer Preference for Dinoprostone Vaginal Gel Using Stated Preference Discrete Choice Modelling
    by Susan J. Taylor & Carol L. Armour
  • 2003 Cost Effectiveness of Adding Folinic Acid to Fluorouracil Plus Levamisole as Adjuvant Chemotherapy in Patients with Colon Cancer in Germany
    by Brigitta U.M. Monz & Hans-Helmut Konig & Reiner Leidl & Ludger Staib & Karl-Heinrich Link
  • 2003 Determinants of Drug Costs in Hospitalised Patients with Haemophilia: Impact of Recombinant Activated Factor VII
    by Jean Philippe Galanaud & Nathalie Pelletier-Fleury & Helene Logerot-Lebrun & Thierry Lambert
  • 2003 Olanzapine versus Risperidone in the Treatment of Schizophrenia: A Comparison of Costs among Texas Medicaid Recipients
    by Karen L. Rascati & Michael T. Johnsrud & M. Lynn Crismon & Maureen J. Lage & Beth L. Barber
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 Validation of the Pneumonia Severity Index Among Patients Treated at Home or in the Hospital
    by Brian S. Armour & Stephen R. Pitts & M. Melinda Pitts & Jennifer Wike & Linda Alley & Jeff Etchason
  • 2003 School-Based Prevention Programs for Eating Disorders: Achievements and Opportunities
    by Riccardo Dalle Grave
  • 2003 Comprehensive Case Management Models For Pulmonary Tuberculosis
    by Patrick Chaulk & Vahe A. Kazandjian
  • 2003 What is the Return on Investment Associated with Diabetes Disease Management?: A Report from One Managed Care Organization in Pennsylvania, USA
    by Jaan Sidorov & Peter Paulick & Lila Sobel
  • 2003 A Review of Telemedicine and Asthma
    by Claire Wainwright & Richard Wootton
  • 2003 The MELD System for Liver Allocation: Implications for Patients and Payors
    by Richard B. Freeman
  • 2003 Certification for Disease-Specific Care Programs
    by Charles A. Mowll
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 New Biochemical Tools for Diagnosing Acute Coronary Syndromes: Impact on Patient Outcomes and Resource Utilization in Hospitals
    by W. Frank Peacock & Fred Wilson
  • 2003 Acute Care for Elders Units: Practical Considerations for Optimizing Health Outcomes
    by Robert M. Palmer & Steven R. Counsell & Seth C. Landefeld
  • 2003 Supporting Herbal Resource Needs for Health Plan Members: Complementary and Alternative Medicine by Telephone
    by Jodi A. Chaffin & Jolene J. Thoennes & Jackie L. Boucher & Nicolaas P. Pronk
  • 2003 Improving the Health Status of US Working Adults with Type 2 Diabetes Mellitus: A Review
    by Fevzi Akinci & Bernard J. Healey & Joseph S. Coyne
  • 2003 Chronic Disease Management: A Definition And Systematic Approach To Component Interventions
    by Susan L. Norris & Russell E. Glasgow & Michael M. Engelgau & Patrick J. OConnor & David McCulloch
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 Utilization and Financial Outcomes of an Asthma Disease Management Program Delivered to Medicaid Members: Results of a Three-Group Comparison Study
    by Alan E. Johnson & Ming Yin & Gregory Berg
  • 2003 Cost Effectiveness of Diabetes Mellitus Management Programs: A Health Plan Perspective
    by Todd Gilmer & Patrick J. OConnor
  • 2003 The Role of Evidence-Based Medicine in Disease Management
    by Paul H. Keckley
  • 2003 Diabetes Self-Management Education Research: An International Review of Intervention Methods, Theories, Community Partnerships and Outcomes
    by Leonard Jack, Jr
  • 2003 How Can Social Workers Improve Outcomes and Costs in Disease Management?
    by Nancy Claiborne & Henry Vandenburgh
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 Identifying Future High-Cost Cases Through Predictive Modeling
    by Yang Zhao & Arlene S. Ash & John Haughton & Benjamin McMillan
  • 2003 Disease Management of Migraine and the Importance of Stratified Care
    by Richard B. Lipton & Marcelo E. Bigal & Wsalter F. Stewart
  • 2003 Screening for Depression in Patients with Chronic Illness: Why and How?
    by Jeffrey M. Davis & Christine M. Gershtein
  • 2003 Disease Management Programs in the Geriatric Setting: Practical Considerations
    by Kenneth J. Steinman & Michael A. Steinman & Theodore I. Steinman
  • 2003 Medicaid Disease Management Programs: Findings from Three Leading US State Programs
    by Jeann L. Gillespie & Louis F. Rossiter
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 A Comparative Cost Analysis of Participating versus Non-Participating Somatizing Patients Referred to a Behavioral Medicine Group in a Health Maintenance Organization
    by Steven E. Locke & Patricia Ford & Thomas McLaughlin
  • 2003 Educating the Public About Stroke: Role in Improving Outcomes
    by Richard N. Bradley
  • 2003 Disease-Specific Self-Management Programs in Patients with Advanced Chronic Obstructive Pulmonary Disease: A Comprehensive and Critical Evaluation
    by Jean Bourbeau
  • 2003 Health Screening and Health Promotion Programs for the Elderly
    by Adam Drewnowski & Elaine Monsen & Diana Birkett & Susan Gunther & Susan Vendeland & Jeff Su & Gillian Marshall
  • 2003 Telemedicine from the Payor Perspective: Considerations for Reimbursement Decisions
    by Pamela Whitten & Emily Kuwahara
  • 2003 Can Genomics Deliver on the Promise of Improved Outcomes and Reduced Costs?: Background and Recommendations for Health Insurers
    by Marc S. Williams
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 Estimating Influenza-Related Hospital Admissions in Children and Adults: A Time Series Analysis
    by Paul A. Scuffham
  • 2003 Active Management of Patients with Chronic Renal Insufficiency: The Effect on Hospital Days During the Initial Hemodialysis Period
    by Ilan Zawadzki & Moshe Fridman & Wing Chan & Seonyoung Ryu
  • 2003 Importance of Cultural Sensitivity in Therapeutic Transactions: Considerations for Healthcare Providers
    by Oyedeji Ayonrinde
  • 2003 The Effectiveness of Asthma Nurse Intervention: The Need for Change
    by Christine Wrench & Alyn H. Morice
  • 2003 Structured Outpatient Education and Treatment Programs for Patients with Diabetes Mellitus and/or Hypertension: The German Experience
    by Monika Gruesser & Karola Hoffstadt & Viktor Joergens
  • 2003 Teledermatology Can Produce High-Quality Care at Low Cost
    by Keng Chen & Stephen Shumack & Richard Wootton
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 Spotlight on Insulin Lispro in Diabetes Mellitus This Spotlight is derived from abstract and summary text of an Adis Pharmacoeconomic Drug Evaluation originally published in full in PharmacoEconomics 2002; 20 (14): 989-1025
    by Christopher J. Dunn & Greg L. Plosker
  • 2003 Results of a Men's Urological Health Screening Program at Lockheed Martin Aeronautical Systems
    by Pamella Thomas & Ron Z. Goetzel & Ronald J. Ozminkowski & Vahan S. Kassabian & David C. Schutt
  • 2003 Antidepressant Treatment Patterns and Success Rates in a Managed Care Organization
    by Edward P. Armstrong
  • 2003 Electronic Management Systems in Diabetes Mellitus: Impact on Patient Outcomes
    by Riccardo Bellazzi
  • 2003 Designing and Evaluating Health Promotion Programs: Simple Rules for a Complex Issue
    by Nicolaas P. Pronk
  • 2003 Physician Financial Incentives in Managed Care: Resource Use, Quality and Cost Implications
    by Brian S. Armour & Mmelinda Pitts
  • 2003 An Overview of Community Pharmacist Interventions: Assessing Cost-Effectiveness and Patients' Willingness To Pay
    by Shu Chuen Li
  • 2003 Interdisciplinary Team-Based Disease Management of Heart Failure
    by Thomas G. Di Salvo & Lynne Warner Stevenson
  • 2003 Assessment Methods for Patient-Reported Outcomes
    by Michael R. Hufford & Saul Shiffman
  • 2003 Ethical Considerations in Disease Management: A Managed Care Perspective
    by Robert A. Baldor
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 Spotlight on Galantamine in Alzheimer's Disease This Spotlight is derived from abstract and summary text of an Adis Drug Evaluation originally published in full in PharmacoEconomics 2002; 20 (13): 919-942
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2003 Assessing Beneficiary Health Outcomes and Disease Management Initiatives in Medicare
    by Samuel C. Haffer & Sonya E. Bowen & Erin Dowd Shannon & Brenda M. Fowler
  • 2003 Economic Impact of Patient Adherence with Antidepressant Therapy Within a Managed Care Organization
    by T. Jeffrey White & Ann Vanderplas & Caron Ory & Christopher M. Dezii & Eunice Chang
  • 2003 Determinants of Quality of In-Hospital Care for Patients with Acute Coronary Syndromes
    by Ian A. Scott
  • 2003 Reducing Racial and Ethnic Disparities in Disease Management to Improve Health Outcomes
    by Dennis P. Andrulis
  • 2003 Predictive Modeling in Health Plans
    by Randy C. Axelrod & David Vogel
  • 2003 Long-Term Care Insurance in Japan: Its Frameworks, Issues and Roles
    by Kiyomi Asahara & Yumiko Momose & Sachiyo Murashima
  • 2003 Acknowledgment
    by Adis International Limited
  • 2003 Management of Rheumatoid Arthritis: Defining the Role of Leflunomide
    by Christopher I. Carswell & Caroline M. Perry & Tim Ibbotson
  • 2003 Clinical and Utilization Outcomes for a Pediatric and Adolescent Telephonic Asthma Care Support Program: A Propensity Score-Matched Cohort Study
    by Gregory D. Berg & Alan Johnson & Edward Fleegler
  • 2003 Impact of Antimicrobial Control Programs on Patient Outcomes: Pharmacy Perspective
    by David T. Bearden & George P. Allen
  • 2003 Health Outcomes Assessment in Cancer: Current Measurement Strategies and Recommendations for Improvement
    by William F. Lawrence & Carolyn M. Clancy
  • 2003 The Approaches to Schizophrenia Communication (ASC) Tool: Including the Patient Perspective in Treatment
    by Albana M. Dassori & Alexander L. Miller & Peter J. Weiden
  • 2003 Specialist Nurse-Led Intervention in Outpatients with Congestive Heart Failure: Impact on Clinical and Economic Outcomes
    by Nicholas D. Palmer & Barbara Appleton & Erwin A. Rodrigues
  • 2003 Management of Postmenopausal Osteoporosis: Defining the Role of Raloxifene
    by Keri Wellington & Greg L. Plosker
  • 2003 Antibacterials for Viral Respiratory Infections: Results of a Physician-Based Intervention in a Predominantly Preferred Provider Organization Setting
    by John Berthiaume & Helen O. Chernicoff & Jaok J. Kim & Richard S. Chung & Roberta C. Pang & Antonio P. Legorreta
  • 2003 Global Efforts for Reducing the Burden of Smoking
    by Frank J. Chaloupka & Prabhat Jha & Marlo A. Corrao & Vera Luiza da Costa e Silva & Hana Ross & Christina C. Ciecierski & Derek Yach
  • 2003 Provider Training and Education in Disease Management: Current and Innovative Technology
    by Myra L. Muramoto & Jean Campbell & Zenen Salazar
  • 2003 Long-Term Effects of Second-Generation Cholinesterase Inhibitors on Clinical Outcomes and Costs of Alzheimer
    by J. Jaime Caro & Denis Getsios
  • 2003 A Schema for Effective Osteoporosis Management: Outcomes of the Geisinger Health System Osteoporosis Program
    by Eric D. Newman
  • 2002 Health policy roundtable
    by Productivity Commission Melbourne Institute of Applied Economic & Social Research
  • 2002 Levels and Differentials in Maternal Mortality in Rural India:New Evidence from Sisterhood Data
    by Mari Bhat, P.N.
  • 2002 Demographic transition, family size and child schooling
    by Mari Bhat, P.N.
  • 2002 Evaluating Welfare Reform in the United States
    by Rebecca M. Blank
  • 2002 Assessment of Health Economics in Alzheimer's Disease (AHEAD): Treatment with Galantamine in Sweden
    by Frances B. Garfield & Denis Getsios & J. Jaime Caro & Anders Wimo & Bengt Winblad
  • 2002 Cost Effectiveness of Treatment of Parkinson's Disease with Entacapone in the United States
    by Cynthia S. Palmer & Mark J.C. Nuijten & Jordana K. Schmier & Prasun Subedi & Edward H. Snyder
  • 2002 Direct Medical Cost of Managing Deep Vein Thrombosis According to the Occurrence of Complications
    by Judith A. O'Brien & Jaime J. Caro
  • 2002 Cost Effectiveness of Tinzaparin Sodium Versus Unfractionated Heparin in the Treatment of Proximal Deep Vein Thrombosis
    by J. Jaime Caro & Denis Getsios & Ingrid Caro & Judith A. O'Brien
  • 2002 Reference-Based Pricing Schemes: Effect on Pharmaceutical Expenditure, Resource Utilisation and Health Outcomes
    by Lisa L. Ioannides-Demos & Joseph E. Ibrahim & John J. McNeil
  • 2002 On-Demand and Intermittent Therapy for Gastro-Oesophageal Reflux Disease: Economic Considerations
    by John M. Inadomi
  • 2002 Economic Benefits of Amlodipine Treatment in Patients with Coronary Artery Disease
    by Roman Casciano & John J. Doyle & John Chen & Steve Arikian & Julian Casciano & Heather Kugel & Raul Arocho
  • 2002 Stroke Rehabilitation Services to Accelerate Hospital Discharge and Provide Home-Based Care: An Overview and Cost Analysis
    by Craig Anderson & Cliona Ni Mhurchu & Paul M. Brown & Kristie Carter
  • 2002 Ready-to-Use Injection Preparations versus Conventional Reconstituted Admixtures: Economic Evaluation in a Real-Life Setting
    by Phillipe van der Linden & Jacques Douchamps & Claude Schmitt & Dominique Forget
  • 2002 Cost-Effective Approaches to the Treatment of Community-Acquired Pneumonia in the Era of Resistance
    by Joseph L. Kuti & Blair Capitano & David P. Nicolau
  • 2002 Methods for Claims-Based Pharmacoeconomic Studies in Psychosis
    by Frank Gianfrancesco & Ruey-Hua Wang & Ramy Mahmoud & Richard White
  • 2002 Cost Effectiveness of Paclitaxel/Cisplatin Compared with Cyclophosphamide/Cisplatin in the Treatment of Advanced Ovarian Cancer in Belgium
    by Niels Neymark & Thierry Gorlia & Ines Adriaenssen & Benoit Baron & Martine Piccart
  • 2002 A Model to Estimate the Cost Benefit of an Occupational Vaccination Programme for Influenza with Influvac(R) in the UK Use of the tradename is for product identification purposes only and does not imply endorsement
    by Roben Das Gupta & Julian F. Guest
  • 2002 Limitations of the Methods Used for Calculating Quality-Adjusted Life-Year Values
    by Gerard Duru & Jean Paul Auray & Ariel Beresniak & Michel Lamure & Abby Paine & Nicolas Nicoloyannis
  • 2002 Health-Related Quality of Life and Cost Impact of Irritable Bowel Syndrome in a UK Primary Care Setting
    by Ron L. Akehurst & John E. Brazier & Nigel Mathers & Caroline O'Keefe & Eva Kaltenthaler & Anne Morgan & Maria Platts & Stephen J. Walters
  • 2002 Standardisation of Costs: The Dutch Manual for Costing in Economic Evaluations
    by Jan B. Oostenbrink & Marc A. Koopmanschap & Frans F.H. Rutten
  • 2002 Homocyst(e)ine and Coronary Heart Disease: Pharmacoeconomic Support for Interventions to Lower Hyperhomocyst(e)inaemia
    by Brahmajee K. Nallamothu & A. Mark Fendrick & Gilbert S. Omenn
  • 2002 Use of Healthcare Services by Patients Treated with Risperidone Versus Conventional Antipsychotic Agents
    by Frank Gianfrancesco & Michael B. Durkin & Ramy Mahmoud & Ruey-Hua Wang
  • 2002 Reporting Heterogeneity in the Measurement of Health and Health-Related Quality of Life
    by Amir Shmueli
  • 2002 Estimating the Effect of Changes in Body Mass Index on Health State Preferences
    by Zafar Hakim & Anne Wolf & Louis P. Garrison
  • 2002 A Fair Innings for NICE?
    by Nick Freemantle & Karen Bloor & Joanne Eastaugh
  • 2002 Cost Effectiveness of Treatments for Amyotrophic Lateral Sclerosis: A Review of the Literature
    by Gary Ginsberg & Serena Lowe
  • 2002 Sickle Cell Anaemia: Epidemiology and Cost of Illness
    by Paul J. Nietert & Marc D. Silverstein & Miguel R. Abboud
  • 2002 The Cost of Gastro-Oesophageal Reflux Disease, Dyspepsia and Peptic Ulcer Disease in Sweden
    by Lars Agreus & Lars Borgquist
  • 2002 The Practice of Splitting Tablets: Cost and Therapeutic Aspects
    by John Bachynsky & Cheryl Wiens & Krystal Melnychuk
  • 2002 Economic Evaluation of Gemcitabine Alone and in Combination with Cisplatin in the Treatment of Nonsmall Cell Lung Cancer
    by M. Lees & M. Aristides & N. Maniadakis & J. McKendrick & N. Botwood & D. Stephenson
  • 2002 Cost Effectiveness of Oral Terbinafine (Lamisil(R)) Compared with Oral Fluconazole (Diflucan(R)) in the Treatment of Patients with Toenail Onychomycosis
    by Heini Salo & Markku Pekurinen
  • 2002 Economic Considerations Related to Providing Adequate Pain Relief for Women in Labour: Comparison of Epidural and Intravenous Analgesia
    by Cecil Huang & Alex Macario
  • 2002 Quality-of-Life Assessment in Osteoporosis: Health-Status and Preference-Based Measures
    by Anna N.A. Tosteson & Cristina S. Hammond
  • 2002 Cost Effectiveness of Esomeprazole Compared with Omeprazole in the Acute Treatment of Patients with Reflux Oesophagitis in the UK
    by Peter Wahlqvist & Ola Junghard & Andy Higgins & Jonathan Green
  • 2002 Cost Effectiveness of Proton Pump Inhibitors in Gastro-Oesophageal Reflux Disease Without Oesophagitis: Comparison of On-Demand Esomeprazole with Conventional Omeprazole Strategies
    by Peter Wahlqvist & Ola Junghard & Andy Higgins & Jonathan Green
  • 2002 Assessment of the Relationship Between Measures of Disease Severity, Quality of Life, and Willingness to Pay in Asthma
    by Alan J. Zillich & Karen Blumenschein & Magnus Johannesson & Patricia Freeman
  • 2002 Putting Your Money Where Your Mouth Is: Willingness to Pay for Dental Gel
    by Debora Matthews & Angela Rocchi & Amiram Gafni
  • 2002 Enoxaparin: A Pharmacoeconomic Review of its Use in the Prevention and Treatment of Venous Thromboembolism and in Acute Coronary Syndromes
    by David Bergqvist
  • 2002 A Monte Carlo Simulation for Modelling Outcomes of AIDS Treatment Regimens
    by Anke Richter & Brett Hauber & Kit Simpson & Josephine A. Mauskopf & Dongping Yin
  • 2002 Economic Value of Thrombolysis with Adjunctive Abciximab in Patients with Subacute Peripheral Arterial Occlusion
    by Stephan H. Duda & Gunnar Tepe & Mohan Bala & Oliver Luz & Gerhard Ziemer & Kenneth Ouriel & Benjamin Pusich & Jakub Wiskirchen & Claus D. Claussen & Kurt Banz
  • 2002 Economic Evaluation of Triflusal and Aspirin in the Treatment of Acute Myocardial Infarction
    by Josep Darba & Inaki Izquierdo & Caridad Pontes & Carlos Navas & Joan Rovira
  • 2002 Development of an Economic Model to Assess the Cost Effectiveness of Asthma Management Strategies
    by Martin J. Price & Andrew H. Briggs
  • 2002 Intermittent Claudication: Pharmacoeconomic and Quality-of-Life Aspects of Treatment
    by Gregorio Brevetti & Roberta Annecchini & Roxanna Bucur
  • 2002 Acute Exacerbations of Chronic Bronchitis: A Pharmacoeconomic Review of Antibacterial Use
    by Stephen Morris & Pippa Anderson & Debra E. Irwin
  • 2002 Optimising Drug Utilisation in Long Term Care
    by Kate L. Lapane & Carmel M. Hughes
  • 2002 Cost-Effectiveness Analysis of Stratified Versus Stepped Care Strategies for Acute Treatment of Migraine: The Disability in Strategies for Care (DISC) Study
    by Mark Sculpher & David Millson & David Meddis & Lynne Poole
  • 2002 Design, Analysis and Presentation of Multinational Economic Studies: The Need for Guidance
    by Francis Pang
  • 2002 Tamoxifen Plus Chemotherapy versus Tamoxifen Alone as Adjuvant Therapies for Node-Positive Postmenopausal Women with Early Breast Cancer: A Stochastic Economic Evaluation
    by Jonathan Karnon & Jackie Brown
  • 2002 Health-Related Quality of Life in a UK-Based Population of Men with Erectile Dysfunction
    by Julian F. Guest & Roben Das Gupta
  • 2002 Cost-Effectiveness Analysis of Exemestane Compared with Megestrol in Advanced Breast Cancer: A Model for Europe and Australia
    by Peter Lindgren & Bengt Jonsson & Alberto Redaelli & Davide Radice
  • 2002 Pharmacy Benefit Management: Enhancing the Applicability of Pharmacoeconomics for Optimal Decision Making
    by C. Daniel Mullins & Junling Wang
  • 2002 Economic Comparison of Leflunomide and Methotrexate in Patients with Rheumatoid Arthritis: An Evaluation Based on a 1-Year Randomised Controlled Trial
    by Andreas Maetzel & Vibeke Strand & Peter Tugwell & George Wells & Claire Bombardier
  • 2002 Economic Impact of Low Dose Polyethylene Glycol 3350 Plus Electrolytes Compared with Lactulose in the Management of Idiopathic Constipation in the UK
    by Angela H. Christie & Pearl Culbert & Julian F. Guest
  • 2002 Antihypertensive Treatment with and without Benazepril in Patients with Chronic Renal Insufficiency: A US Economic Evaluation
    by Thomas J. Hogan & William J. Elliott & Arnold H. Seto & George L. Bakris
  • 2002 Onychomycosis: Health-Related Quality of Life Considerations
    by James W. Shaw & Vijay N. Joish & Stephen Joel Coons
  • 2002 Economic Evaluation of Vaccination Programmes: A Consensus Statement Focusing on Viral Hepatitis
    by Philippe Beutels & W. John Edmunds & Fernando Antonanzas & G. Ardine de Wit & David Evans & Rachel Feilden & A. Mark Fendrick & Gary M. Ginsberg & Henry A. Glick & Eric Mast & Marc Pechevis & Eddy K.A. Van Doorslaer & Ben A. van Hout
  • 2002 Health State Preference Assessment in Diabetic Peripheral Neuropathy
    by Sean D. Sullivan & Doris P. Lew & E. Beth Devine & Zafar Hakim & Gayle E. Reiber & David L. Veenstra
  • 2002 Use of Randomised Controlled Trials for Producing Cost-Effectiveness Evidence: Potential Impact of Design Choices on Sample Size and Study Duration
    by Martin E. Backhouse
  • 2002 Quality of Life in Patients with Epilepsy and Impact of Treatments
    by Patrizia Berto
  • 2002 Developing the Revised NICE Appraisal Technical Guidance to Manufacturers and Sponsors: Opportunity or Threat?
    by Rod S. Taylor & John Hutton & Anthony J. Culyer
  • 2002 Insulin Lispro: A Pharmacoeconomic Review of its Use in Diabetes Mellitus
    by Christopher J. Dunn & Greg L. Plosker
  • 2002 Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in the Secondary Prevention of Acute Coronary Syndrome
    by Max Brosa & Carlos Rubio-Terres & Ibrahim Farr & Vijay Nadipelli & Jenaro Froufe
  • 2002 Pharmacoeconomic Considerations in Assessing and Selecting Congestive Heart Failure Therapies
    by Emile Levy & Pierre Levy
  • 2002 Theoretical Arguments for the Discounting of Health Consequences: Where Do We Go from Here?
    by Angelina Lazaro
  • 2002 Galantamine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2002 Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma
    by Ketan Sheth & Rohit Borker & Amanda Emmett & Kathleen Rickard & Paul Dorinsky
  • 2002 The Annual Societal Cost of Alcohol Misuse in Scotland
    by Susan J. Varney & Julian F. Guest
  • 2002 The Cost to the United Kingdom National Health Service of Managing Erectile Dysfunction: The Impact of Sildenafil and Prescribing Restrictions
    by Edward C.F. Wilson & Emma S. McKeen & Paul A. Scuffham & Martin C.J. Brown & Kevan Wylie & Geoff Hackett
  • 2002 The Economic Costs of Early Stage Prostate Cancer
    by Christopher S. Saigal & Mark S. Litwin
  • 2002 Combining a Budgetary-Impact Analysis and a Cost-Effectiveness Analysis Using Decision-Analytic Modelling Techniques
    by Mark J.C. Nuijten & Frans Rutten
  • 2002 Costs and Effectiveness of Using Coumarins Before, During and After Coronary Angioplasty
    by Jurrien M. ten Berg & Johannas C. Kelder & Thys H.W. Plokker & Ben A. van Hout
  • 2002 UK Department of Health Guidance on Prescribing for Impotence Following the Introduction of Sildenafil: Potential to Contain Costs in the Average Health Authority District
    by Martin Ashton-Key & Michael Sadler & Byron Walmsley & Simon Holmes & Sarah Randall & Michael H. Cummings
  • 2002 Cost-Effectiveness Comparison of Tizanidine and Baclofen in the Management of Spasticity
    by David N. Rushton & Adam C. Lloyd & Pippa M. Anderson
  • 2002 Long Term Cost-of-Illness in Stroke: An International Review
    by Krista A. Payne & Krista F. Huybrechts & Jjaime Caro & Traci J. Craig Green & Wendy S. Klittich
  • 2002 Vision-Specific Instruments for the Assessment of Health-Related Quality of Life and Visual Functioning: A Literature Review
    by Mary Kay Margolis & Karin Coyne & Tessa Kennedy-Martin & Timothy Baker & Oliver Schein & Dennis A. Revicki
  • 2002 Cost Effectiveness of Asthma Management Strategies
    by Mike Thomas & John Haughney & David Price
  • 2002 The Impact of Health Economics on Healthcare Delivery: A Health Economist's Perspective: A Primary Care Response
    by David Kernick
  • 2002 Conjoint Analysis of a New Chemotherapy: Willingness to Pay and Preference for the Features of Raltitrexed versus Standard Therapy in Advanced Colorectal Cancer
    by Mike Aristides & Jack Chen & Mark Schulz & Eve Williamson & Stephen Clarke & Kaye Grant
  • 2002 Cost-Utility Analysis of Primary Prophylaxis versus Treatment On-Demand for Individuals with Severe Haemophilia
    by Alexander H. Miners & Caroline A. Sabin & Keith H. Tolley & Christine A. Lee
  • 2002 Burden of Illness in Irritable Bowel Syndrome Comparing Rome I and Rome II Criteria
    by Xavier Badia & Fermin Mearin & Agustin Balboa & Eva Baro & Ellen Caldwell & Mercedes Cucala & Manuel Diaz-Rubio & Arturo Fueyo & Julio Ponce & Mentse Roset & Nicholas J. Talley
  • 2002 Valuation of Symptomatic Hepatitis A in Adults: Estimates Based on Time Trade-Off and Willingness-To-Pay Measurement
    by R Jake Jacobs & Ronald J. Moleski & Allen S. Meyerhoff
  • 2002 Cost Effectiveness of Implantable Cardioverter Defibrillator Therapy versus Drug Therapy for Patients at High Risk of Sudden Cardiac Death
    by Marian A. Spath & Bernie J. O'Brien
  • 2002 Prospective Study Designs in Outcomes Research: The Case of Migraine
    by Elizabeth A. Rothermich & Meryl I. Brod & Warren H. Schonfeld & Clayton R. Rowland & Baltazar Gomez-Mancilla
  • 2002 Mycophenolate Mofetil: A Pharmacoeconomic Review of its Use in Solid Organ Transplantation
    by Melissa Young & Greg L. Plosker
  • 2002 Economic Analysis of Filgrastim Use for Patients with Acute Myeloid Leukaemia in the UK: A Comparison of Collection Methods of Resource Use Data
    by Bo Standaert & Janet Goldstone & Z. John Lu & Moshe Haim Erder & John Liu Yin
  • 2002 The Cost Effectiveness of Chlorofluorocarbon-Free Beclomethasone Dipropionate in the Treatment of Chronic Asthma: A Cost Model Based on a 1-Year Pragmatic, Randomised Clinical Study
    by David Price & John Haughney & Martin Duerden & Charles Nicholls & Charlotte Moseley
  • 2002 Cost of Illness of Crohn's Disease
    by Keith Bodger
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Cost-Benefit Analysis of Vaccination Against Influenza of Employees from an Academic Medical Centre
    by Wilma Parlevliet & Corianne de Borgie & Gerard Frijstein & Henk-Jan Guchelaar
  • 2002 An Independent Practice Association-Supported Disease Management Program: Impact on Patients with Coronary Artery Disease
    by Miriam Cannon-Wagner & Diane S. Soule & David R. Walker & Richard P. Vance
  • 2002 The Influence of Socioeconomic and Psychological Factors on Patient Adherence to Self-Management Strategies: Lessons Learned in Asthma
    by John Kolbe
  • 2002 Disease Management and the Application of Privacy Guidelines
    by Marybeth Regan
  • 2002 Pulmonary Rehabilitation Programs: Outcomes in Patients with Chronic Obstructive Pulmonary Disease
    by Nicolino Ambrosino
  • 2002 National Service Framework for Older People: Will Access to Health Services for Elderly Patients Improve?
    by Sumeet Chadha & John Young
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Prevalence and Management of Anemia Among Patients with Chronic Kidney Disease in a Health Maintenance Organization
    by Annamaria T. Kausz & Earl P. Steinberg & Allen R. Nissenson & Brian J.G. Pereira
  • 2002 Methods Aimed at Improving Asthma Care and Outcomes Management: A Case Study
    by Felicia C. Allen-Ramey & Gregory B. Diette & Robert C. McDonald & Elizabeth A. Skinner & Donald M. Steinwachs & Albert W. Wu
  • 2002 Migraine Prophylaxis in Managed Care Organizations: Unclear Role in Disease Management Programs
    by Jennifer H. Lofland & Purna K. Lakhia
  • 2002 Supporting Patient Care by Using Innovative Information Technology: A Case Study from Clinical Psychiatry
    by Elske Ammenwerth & Frauke Ehlers & Ulrike Kutscha & Ansgar Kutscha & Ronald Eichstadter & Franz Resch
  • 2002 Building the Outcomes-Based Formulary
    by Brian T. Sweet & Marcus D. Wilson & William J. Waugh & Andrea D. Hess & Joshua J. Spooner
  • 2002 Managed Drug Use in Assisted Living and Home Care Settings: Who Benefits?
    by Stephen M. Setter & David Alexander Sclar & Brian J. Gates
  • 2002 Disease Management Programs: The Second Generation
    by Paul S. Shelton
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Management of Erectile Dysfunction: Defining the Role of Sildenafil
    by Katherine A. Lyseng-Williamson & Antona J. Wagstaff
  • 2002 The Role of Different Types of Health Insurance on Access and Utilization of Antihypertensive Drugs: An Empirical Study in a US Hypertensive Population
    by Christine Huttin
  • 2002 Community Mental Health Services for Individuals with Intellectual Disabilities: Issues and Approaches to Optimizing Outcomes
    by Angela Hassiotis
  • 2002 Preventing Relapse of Psychotic Illness: Role of Self-Monitoring of Prodromal Symptoms
    by Lisa Hewitt & Max Birchwood
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Management of Type 2 Diabetes Mellitus: Defining the Role of Nateglinide
    by Christopher I. Carswell & Christine R. Culy & Caroline M. Perry
  • 2002 A Formulary Analysis of Angiotensin II Antagonists in a UK Teaching Hospital
    by Andrew P. Moore & Nigel M. Wheeldon & Mike Jennings
  • 2002 Models of Palliative Care Service Delivery: What is Most Cost Effective?
    by Nick Bosanquet
  • 2002 Lymphedema After Surgery for Cancer: The Role of Patient Support Groups in Patient Therapy
    by Stanley G. Rockson
  • 2002 Health Promotion for Individuals with Disabilities: The Need for a Transitional Model in Service Delivery
    by James H. Rimmer
  • 2002 Antibacterials and Acute Exacerbation of Chronic Bronchitis: Issues for Formulary Decision Makers
    by Alan Chock & Vera Gong & Christopher J. Destache
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Management of Relapsing-Remitting Multiple Sclerosis: Defining the Role of Subcutaneous Recombinant Interferon-beta-1a (Rebif(R)) Use of a tradename is for product identification purposes only, and does not imply endorsement
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2002 New Trends in Patient Monitoring
    by Senen Barro & Jesus Presedo & Paulo Felix & Daniel Castro & Jose Antonio Vila
  • 2002 Integration of Case and Disease Management: Why and How?
    by Margaret A. Radzwill
  • 2002 Telemedicine, Outcomes and Policy Decisions
    by Arto Ohinmaa & David Hailey
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Spotlight on Paclitaxel in Ovarian Cancer The full text of this article was published in PharmacoEconomics 2001; 19 (12): 1227-1259
    by Melissa Young & Greg L. Plosker
  • 2002 Excess Healthcare Costs Associated with Excess Health Risks in Diseased and Non-Diseased Health Risk Appraisal Participants
    by Shirley Musich & Timothy McDonald & David Hirschland & Dee W. Edington
  • 2002 Standardized Telephonic Case Management in a Hispanic Heart Failure Population: An Effective Intervention
    by Barbara Riegel & Beverly Carlson & Dale Glaser & Zoe Kopp & Tomas E. Romero
  • 2002 The Potential Impact of Measuring Healthcare Quality on Pharmaceutical-Related Costs and Outcomes
    by William L. Roper & R. Tamara Hodlewsky & Hugh Tilson & Kathleen N. Lohr & William H. Campbell
  • 2002 The Emerging Role of the Consumer in Pharmaceutical Pricing Decisions
    by Elinor C. Chumney & Kit N. Simpson
  • 2002 Pharmacy Benefit Managers' Role in Facilitating Medicare Beneficiary Access to Pharmaceutical Care
    by Joshua Cohen & Jennifer Chee
  • 2002 Risks and Benefits of the Use of Capitation Formulae in Primary Care
    by Azeem Majeed
  • 2002 Pharmaceutical Company Websites as Sources of Information for Consumers: How Appropriate and Informative Are They?
    by Kathleen M. Griffiths & Helen Christensen & Kimberley Evans
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Piperacillin/Tazobactam in Moderate to Severe Bacterial Infections The full text of this article was published in PharmacoEconomics 2001; 19 (11): 1135-1175
    by Melissa Young & Greg L. Plosker
  • 2002 Use of the Internet by Patients with Chronic Illness
    by Richard W. Millard & Patricia A. Fintak
  • 2002 Employer Role in Integrative Workplace Health Management: A New Model in Progress
    by Cordia Chu & Sophie Dwyer
  • 2002 Development of a Migraine Disease Management Initiative in a Managed Care Plan
    by Glen D. Solomon & Henry X. Hu & Rick Simmons & Kathleen Conboy & Rob Jeddeloh & Marie Eastburn
  • 2002 The Fifth Vital Sign: Cornerstone of a New Pain Management Strategy
    by Hildegarde J. Berdine
  • 2002 Utilizing an Intranet in Disease Management
    by Marybeth Regan
  • 2002 Role of Family Physicians in Implementing Asthma Self-Management Programs
    by Bart P.A. Thoonen & Chris van Weel
  • 2002 Outcomes Associated with a Disease Management Program for End-Stage Renal Disease
    by Allen R. Nissenson
  • 2002 Clinical and Economic Implications of Non-Adherence to HAART in HIV Infection
    by Alissa Scalera & Ahmed M. Bayoumi & Paul Oh & Nancy Risebrough & Neil Shear & Alice Lin-in Tseng
  • 2002 Integrating Healthcare Standards and Performance Measurement
    by Richard G. Koss & Linda S. Hanold & Jerod M. Loeb
  • 2002 Effective Utilization of Pharmacoeconomics for Decision Makers
    by Judith D. Bentkover & Ron Corey
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Spotlight on Paclitaxel in Non-Small Cell Lung Cancer The full text of this article was published in PharmacoEconomics 2001; 19 (11): 1111-1134
    by Greg L. Plosker & Miriam Hurst
  • 2002 The Development of a Tool to Assess Quality of Cost Estimates
    by Philip Jacobs & Greg Finlayson & Ben Faienza & Murray Brown & Betty Newson & Nadine MacLean
  • 2002 Role of Parent Training in the Effective Management of Attention-Deficit/Hyperactivity Disorder
    by Thomas J. Power & Heather F. Russell & Stephen L. Soffer & Jessica Blom-Hoffman & Suzanne M. Grim
  • 2002 Practical Considerations for the Design and Evaluation of Disease Education and Management Programs in the Workplace
    by Seth Serxner & David Anderson
  • 2002 Worksite Health Promotion: A Critical Investment
    by Bruce Sherman
  • 2002 An HMO-Sponsored Primary Care-Based Disease Management and Case Management Initiative: Economic and Selected Clinical Outcomes
    by Jaan Sidorov & Franz Joseph Fisher & Sabrina Girolami & Otto Wolke
  • 2002 Disease Management Update: From the World Literature
    by Adis International Limited
  • 2002 Management of Acute Bacterial Exacerbations of Chronic Bronchitis: Defining the Role of Moxifloxacin
    by Harinder S. Malhotra & Caroline M. Perry & Douglas Ormrod
  • 2002 Management of Alzheimer's Disease: Defining the Role of Donepezil
    by Tim Ibbotson & Karen L. Goa
  • 2002 Management of Rheumatoid Arthritis: Defining the Role of Etanercept
    by Gillian M. Keating & Blair Jarvis
  • 2002 Improved Diabetes Control Through a Provider-Based Disease Management Program
    by Rose Maljanian & Neil Grey & Ilene Staff & Marisol Cruz-Marino-Aponte
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Spotlight on Mycophenolate Mofetil in Solid Organ Transplantation This Spotlight is derived from abstract and summary text of an Adis Pharmacoeconomic Drug Evaluation originally published in full in PharmacoEconomics 2002; 20 (10): 675-713
    by Melissa Young & Greg L. Plosker
  • 2002 Strategies for Pharmacists in the Implementation of Diabetes Mellitus Management Programs: New Roles in Primary and Collaborative Care
    by Gloria J. Nichols-English & Melanie Provost & Dayin Koompalum & Hua Chen & Masood Athar
  • 2002 Rural Psychiatry: Special Issues and Models of Service Delivery
    by Fiona Judd & Caitlin Fraser & Margaret Grigg & Joseph Scopelliti & Gene Hodgins & Adrian Donoghue & John Humphreys
  • 2002 On the Evaluation of Drug Benefits Policy Changes with Longitudinal Claims Data: Concepts of Income-Based Deductibles and Issues Related to Causal Inference
    by Sebastian Schneeweiss & Malcolm Maclure & Colin Dormuth
  • 2002 Point of Care Testing: Potential for Tracking Disease Management Outcomes
    by Christopher P. Price
  • 2002 Clinical Guidelines in Disease Management
    by Albert I. Wertheimer & Nicole M. Chaney
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 An Empirical Model for the Development of Disease Management Programs in General Practice: A Case Study Using Hypertension
    by Deborah A. Turnbull & Helen Mensforth & Justin J. Beilby & John E. Marley & Farooq Qureshi & Anne L. Tonkin
  • 2002 Patients Diagnosed with Irritable Bowel Syndrome: Medical Record Validation of a Claims-Based Identification Algorithm
    by Antonio P. Legorreta & Jean-Francois Ricci & Mike Markowitz & Priti Jhingran
  • 2002 The Relationship of Diabetes Mellitus Performance Indicators with Self-Reported Health and Patient Satisfaction
    by David P. Nau & Ritesh N. Kumar
  • 2002 Guidelines and Care Management Issues for People with Alzheimer's Disease and Other Dementias
    by Katie Maslow & John Selstad & Susan J. Denman
  • 2002 The Effects of the Internet on Pharmaceutical Consumers and Providers
    by Francois M.H.M. Dupuits
  • 2002 Telemedicine Screening for Diabetic Retinopathy: Improving Patient Access to Care
    by Kanagasingam Yogesan & Ian J. Constable & Ian Chan
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Management of Parkinson's Disease: Defining the Role of Entacapone
    by Tim Ibbotson & Karen L. Goa
  • 2002 Improving Patient Outcomes with Tools for Asthma Self-Monitoring: A Review of the Literature
    by Timothy R. Myers
  • 2002 A Complex System Perspective on Medication Compliance: Information for Healthcare Providers
    by Simon Rietveld & Jos M. Koomen
  • 2002 Evaluating Disease Management Programs
    by David R. Walker & Byron K. McKinney & Miriam Cannon-Wagner & Richard P. Vance
  • 2002 The Developing Role of Pharmacists in Patient Access to Emergency Contraception
    by Judith A. Soon & Marc Levine & Mary H.H. Ensom & Jacqueline S. Gardner & Hilary M. Edmondson & David W. Fielding
  • 2001 International pharmaceutical price differences
    by Productivity Commission
  • 2001 Private hospitals in Australia
    by Productivity Commission
  • 2001 Long-term aged care: expenditure trends and projections
    by Alan Madge
  • 2001 Earning and education among ethnic groups in rural India
    by Unni, Jeemol
  • 2001 Health status and curative health care in rural India
    by Duraiswamy, P.
  • 2001 A Multinational Study to Measure the Value that Patients with Cancer Place on Improved Emesis Control Following Cisplatin Chemotherapy
    by George Dranitsaris & Pauline Leung & Renoto Ciotti & Ana Ortega & Maria Spinthouri & Lycurgus Liaropoulos & Roberto Labianca & Antonello Quadri
  • 2001 The Cost of Palliative Care for Hepatocellular Carcinoma in Hong Kong
    by Anthony T.C. Chan & Philip Jacobs & Winnie Yeo & Maria Lai & Clarke B. Hazlett & Tony S.K. Mok & Thomas W.T. Leung & Wan Y. Lau & Philip J. Johnson
  • 2001 The Economics of HIV Vaccines: Projecting the Impact of HIV Vaccination of Infants in Sub-Saharan Africa
    by Jasper M. Bos & Maarten J. Postma
  • 2001 Cost-Utility Analysis of Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke: A Canadian Healthcare Perspective
    by Shannon E. Sinclair & Luciana Frighetto & Peter S. Loewen & Rubina Sunderji & Philip Teal & Susan C. Fagan & Carlo A. Marra
  • 2001 Different Approaches To Valuing the Lost Productivity of Patients with Migraine
    by Jennifer H. Lofland & Julie C. Locklear & Kevin D. Frick
  • 2001 Cost Effectiveness of Bisoprolol in the Treatment of Chronic Congestive Heart Failure in Sweden: Analysis Using Data from the Cardiac Insufficiency Bisoprolol Study II Trial
    by Mattias Ekman & Niklas Zethraeus & Bengt Jonsson
  • 2001 Impact of Allergic Rhinitis Treatment on Quality of Life
    by Anju Tripathi & Roy Patterson
  • 2001 Cost-Effectiveness Analysis of Dopamine Agonists in the Treatment of Parkinson's Disease in Japan
    by Takuro Shimbo & Kenji Hira & Manabu Takemura & Tsuguya Fukui
  • 2001 Cost-Efficacy Analysis of Fluticasone Propionate versus Zafirlukast in Patients with Persistent Asthma
    by Rogelio Menendez & Richard H. Stanford & Lisa Edwards & Christopher Kalberg & Kathleen Rickard
  • 2001 Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer
    by Sabrina Trippoli & Monica Vaiani & Carlo Lucioni & Andrea Messori
  • 2001 Incremental Cost Analysis of Ambulatory Clinic and Home-Based Intravenous Therapy for Patients with Multiple Myeloma
    by Peter C. Coyte & Mark J. Dobrow & Larry Broadfield
  • 2001 Cost Effectiveness in Canada of a Multidrug Prepackaged Regimen (Hp-PAC(R)) Use of tradenames is for product identification only and does not imply endorsement. for Helicobacter pylori Eradication
    by Karen Agro & Gordon Blackhouse & Ron Goeree & Andrew R. Willan & Jia-Qing Huang & Richard H. Hunt & Bernie J. O'Brien
  • 2001 The Cost Effectiveness of Stratified Care in the Management of Migraine
    by Paul Williams & Andrew J. Dowson & Alan M. Rapoport & James Sawyer
  • 2001 A Review of the Direct Costs of Rheumatoid Arthritis: Managed Care versus Fee-for-Service Settings
    by Deborah P. Lubeck
  • 2001 The Impact of Health Economics on Healthcare Delivery: The Health Economists' Perspective
    by Ruth McDonald & Alan Haycox & Tom Walley
  • 2001 Pharmacoeconomic Fellowships: The Need for Outcome Measures
    by Vittorio Maio & Tammy K. Girts & Jennifer H. Lofland & David B. Nash
  • 2001 Iatrogenic Cost Factors Incorporating Mild and Moderate Adverse Events in the Economic Comparison of Aceclofenac and Other NSAIDs
    by Francesc Peris & Eduard Martinez & Xavier Badia & Max Brosa
  • 2001 Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries
    by Ola Ghatnekar & Ulf Persson & Michael Willis & Knut Odegaard
  • 2001 Emerging Role of Pharmacoeconomics in the Research and Development Decision-Making Process
    by Joseph A. Dimasi & Erol Caglarcan & Maria Wood-Armany
  • 2001 Economic and Health-Related Quality of Life Considerations of New Therapies in Parkinson's Disease
    by Linda M. Rubenstein & Andrea DeLeo & Elizabeth A. Chrischilles
  • 2001 A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs
    by Sherine E. Gabriel & Douglas Coyle & Larry W. Moreland
  • 2001 Highly Active Antiretroviral Therapy: Pharmacoeconomic Issues in the Management of HIV Infection
    by Pedram Sendi & Andrew J. Palmer & Amiram Gafni & Manuel Battegay
  • 2001 Torasemide: A Pharmacoeconomic Review of its Use in Chronic Heart Failure
    by Melissa Young & Greg L. Plosker
  • 2001 International Validation of the CLAU-S Quality-of-Life Questionnaire for Use in Patients with Intermittent Claudication
    by Patrick Marquis & Sylvie Comte & Philippe Lehert
  • 2001 An Epidemiological Approach to Assess the Economic Burden of NSAID-Induced Gastrointestinal Events in The Netherlands
    by Ronald M.C. Herings & Olaf H. Klungel
  • 2001 Quality of Life in Irritable Bowel Syndrome
    by Richard Lea & Peter J. Whorwell
  • 2001 An Economic Overview of Chronic Obstructive Pulmonary Disease
    by Hirsch S. Ruchlin & Erik J. Dasbach
  • 2001 Developing Guidance for Budget Impact Analysis
    by Paul Trueman & Michael Drummond & John Hutton
  • 2001 The Cost Effectiveness of Tapered versus Abrupt Discontinuation of Oral Cyclosporin Microemulsion for the Treatment of Psoriasis
    by Leona Hakkaart-van Roijen & Paul Verboom & W. Ken Redekop & Karien R. Touw & Frans F.H. Rutten
  • 2001 Cost Effectiveness of Desirudin Compared with a Low Molecular Weight Heparin in the Prevention of Deep Vein Thrombosis after Total Hip Replacement Surgery
    by Lars-Ake Levin & David Bergqvist
  • 2001 Gastrointestinal-Related Healthcare Resource Usage Associated with a Fixed Combination of Diclofenac and Misoprostol versus Other NSAIDs
    by Elham Rahme & Lawrence Joseph & Sheldon X. Kong & Douglas J. Watson & James M. Pellissier & Jacques LeLorier
  • 2001 Cost Effectiveness of Nasal Calcitonin in Postmenopausal Women: Use of Cochrane Collaboration Methods for Meta-Analysis Within Economic Evaluation
    by Douglas Coyle & Ann Cranney & Karen M. Lee & Vivian Welch & Peter Tugwell
  • 2001 Economic Evaluation of a New Acellular Vaccine for Pertussis in Canada
    by Michael Iskedjian & Thomas R. Einarson & Bernie J. O'Brien & J. Gaston De Serres & Ron Gold & Ian M. Gemmill & Natalie Milkovich & Andrew Rosner
  • 2001 Economic Evaluation of Systemic Treatments for Cytomegalovirus Retinitis in Patients with AIDS
    by Todd A. Lee & Sean D. Sullivan & David L. Veenstra & Scott D. Ramsey & Patrick J.K. Steger & Raffaele Malinverni & Andreas M. Pleil & Todd Williamson
  • 2001 Cost Effectiveness of Selective Decontamination of the Digestive Tract in Liver Transplant Patients
    by Petra J. van Enckevort & Jan H. Zwaveling & Jan T. Bottema & John K. Maring & Ids J. Klompmaker & Maarten J.H. Slooff & Elisabeth M. Ten Vergert
  • 2001 The Cost of Inadequate Prescriptions for Hypolipidaemic Drugs
    by Luisa Cabello Ballesteros & M. Isabel Fernandez San Martin & Teresa Sanz Cuesta & Esperanza Escortell Mayor & Carmen Lopez Bilbao
  • 2001 Cost Effectiveness of Ramipril in Patients with Non-Diabetic Nephropathy and Hypertension: Economic Evaluation of Ramipril Efficacy In Nephropathy (REIN) Study for Germany from the Perspective of Statutory Health Insurance
    by Peter K. Schadlich & Josef Georg Brecht & Massimo Brunetti & Eva Pagano & Badrudin Rangoonwala & Eduard Huppertz
  • 2001 The Lifetime Cost of Bipolar Disorder in the US: An Estimate for New Cases in 1998
    by Charles E. Begley & John F. Annegers & Alan C. Swann & Christopher Lewis & Sharon Coan & William B. Schnapp & Lynda Bryant-Comstock
  • 2001 Cost Considerations in the Use of Anaesthetic Drugs
    by Ian Smith
  • 2001 Hip Fracture Prevention: Cost-Effective Strategies
    by Peter Vestergaard & Lars Rejnmark & Leif Mosekilde
  • 2001 Lifestyle Drugs: Determining Their Value and Who Should Pay
    by Devora Mitrany
  • 2001 Efavirenz: A Pharmacoeconomic Review of its Use in HIV Infection
    by Greg L. Plosker & Caroline M. Perry & Karen L. Goa
  • 2001 Cost-Effectiveness Analysis of n-3 Polyunsaturated Fatty Acids (PUFA) after Myocardial Infarction: Results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial
    by Maria Grazia Franzosi & Massimo Brunetti & Roberto Marchioli & Rosa Maria Marfisi & Gianni Tognoni & Franco Valagussa
  • 2001 Cost Effectiveness of Continuous Terbinafine Compared with Intermittent Itraconazole in the Treatment of Dermatophyte Toenail Onychomycosis: An Analysis Based on Results from the L.I.ON. Study
    by Ronald Jansen & W. Ken Redekop & Frans F.H. Rutten
  • 2001 Cost-Benefit Analysis of a Haemophilus Influenzae Type B Meningitis Prevention Programme in The Philippines
    by M. Rhona M.T. Limcangco & Carol L. Armour & Eugene G. Salole & Susan J. Taylor
  • 2001 The Cost of Treatment of Alzheimer's Disease in The Netherlands: A Regression-Based Simulation Model
    by Joseph McDonnell & W. Ken Redekop & Nicole van der Roer & Elles Goes & Annemieke Ruitenberg & Jan J.V. Busschbach & Monique M.B. Breteler & Frans F.H. Rutten
  • 2001 Augmenting Reference Pricing of Pharmaceuticals in New Zealand with Strategic Cross-Product Agreements
    by Alan Woodfield
  • 2001 Symptom and Health-Related Quality-of-Life Measures for Use in Selected Gastrointestinal Disease Studies: A Review and Synthesis of the Literature
    by Anne M. Rentz & Carmelina Battista & Elyse Trudeau & Robert Jones & Patricia Robinson & Sheldon Sloan & Sonika Mathur & Lori Frank & Dennis A. Revicki
  • 2001 Pharmacoeconomics of Hypertension Management: The Place of Combination Therapy
    by Ettore Ambrosioni
  • 2001 On Individual Preferences and Aggregation in Economic Evaluation in Healthcare
    by Bengt Liljas & Bjorn Lindgren
  • 2001 Rivastigmine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease
    by Harriet M. Lamb & Karen L. Goa
  • 2001 Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients
    by Adrian D. Griffin & Andrew S. Perry & Douglas M. Fleming
  • 2001 Cost-Benefit Analysis of Active Vaccination Campaigns Against Hepatitis A Among Daycare Centre Personnel in Israel
    by Gabriel Chodick & Yehuda Lerman & Tamar Peled & Hava Aloni & Shai Ashkenazi
  • 2001 Cost of Treatment for Onychomycosis: Data from a 9-Month Observational Study
    by David M. Stier & Curt Henke & Jeff Schein & Joe Doyle & Warren H. Schonfeld & Jeanette Broering
  • 2001 Cost Effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries
    by Carlos Gouveia Pinto & Antoine Lafuma & Francis Fagnani & Mark J.C. Nuijten & Gilles Berdeaux
  • 2001 Economic Burden of Chronic Obstructive Pulmonary Disease: Impact of New Treatment Options
    by Mitchell Friedman & Daniel E. Hilleman
  • 2001 Workplace Productivity: A Review of the Impact of Migraine and its Treatment
    by Paul Stang & Roger Cady & Alice Batenhorst & Lynn Hoffman
  • 2001 Influenza: Cost of Illness and Considerations in the Economic Evaluation of New and Emerging Therapies
    by Peter Cram & Susan G. Blitz & Arnold Monto & A. Mark Fendrick
  • 2001 Cost-Effectiveness Analysis of Pneumococcal Vaccination for Elderly Individuals in The Netherlands
    by Maarten J. Postma & Marielouise A. Heijnen & Johannes C. Jager
  • 2001 Usefulness of US Cost-of-Illness Studies in Healthcare Decision Making
    by Bernard S. Bloom & Douglas J. Bruno & Daniel Y. Maman & Ravi Jayadevappa
  • 2001 The Multinational Impact of Migraine Symptoms on Healthcare Utilisation and Work Loss
    by William C. Gerth & George W. Carides & Erik J. Dasbach & W. Hester Visser & Nancy C. Santanello
  • 2001 Health-Related Quality of Life (HR-QOL) and Regulatory Issues: An Assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) Recommendations on the Use of HR-QOL Measures in Drug Approval
    by Giovanni Apolone & Gianfranco De Carli & Massimo Brunetti & Silvio Garattini
  • 2001 A Review of Health-Related Quality-of-Life Measures in Stroke
    by Beatrice A. Golomb & Barbara G. Vickrey & Ron D. Hays
  • 2001 Changing Therapeutic Regimens in Benign Prostatic Hyperplasia: Clinical and Economic Considerations
    by Herman J. Stoevelaar & Joseph McDonnell
  • 2001 Quality-of-Life Assessment in Comparative Therapeutic Trials and Causal Structure Considerations in Peripheral Occlusive Arterial Disease
    by Philippe Lehert
  • 2001 Direct-to-Consumer Promotion of Prescription Drugs: Economic Implications for Patients, Payers and Providers
    by Steven D. Findlay
  • 2001 Economic Analysis of Initial HIV Treatment: Efavirenz- versus Indinavir-Containing Triple Therapy
    by J. Jaime Caro & Judith A. O'Brien & Kristen Migliaccio-Walle & Gabriel Raggio
  • 2001 Cost Efficacy of Tazobactam/Piperacillin versus Imipenem/Cilastatin in the Treatment of Intra-Abdominal Infection
    by Eva Susanne Dietrich & Bjorn Schubert & Winfried Ebner & Franz Daschner
  • 2001 A General Model of the Effects of Sleep Medications on the Risk and Cost of Motor Vehicle Accidents and its Application to France
    by Joseph Menzin & Kathleen M. Lang & Pierre Levy & Emile Levy
  • 2001 Dermatan Sulfate versus Unfractionated Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Surgery for Cancer: A Cost-Effectiveness Analysis
    by Ermanno Attanasio & Pierluigi Russo & Gabriella Carunchio & Luciano Caprino
  • 2001 Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non-ST-Segment Elevation Acute Coronary Syndromes: Estimating the Economic Implications
    by William B. Hillegass & Anne R. Newman & Dominic L. Raco
  • 2001 Enteroviral Meningitis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies
    by T.V. Parasuraman & Kathleen Frenia & Jose Romero
  • 2001 The Cost of HIV Treatment and Care: A Global Review
    by Eduard J. Beck & Alec H. Miners & Keith Tolley
  • 2001 Paclitaxel: A Pharmacoeconomic Review of its Use in the Treatment of Ovarian Cancer
    by Melissa Young & Greg L. Plosker
  • 2001 Direct Costs of Schizophrenia in Italian Community Psychiatric Services
    by Livio Garattini & Carlotta Rossi & Fabrizio Tediosi & Cesare Cornaggia & Giampiero Covelli & Corrado Barbui & Fabio Parazzini
  • 2001 Economic Evaluation of Collagenase-Containing Ointment and Hydrocolloid Dressing in the Treatment of Pressure Ulcers
    by Elvira Muller & Martin W.F. van Leen & Rito Bergemann
  • 2001 Incremental Cost Effectiveness of Prophylaxis for Cytomegalovirus Disease in Patients with AIDS
    by John H. Kempen & Kevin D. Frick & Douglas A. Jabs
  • 2001 Accounting for Noncompliance in Pharmacoeconomic Evaluations
    by Dyfrig A. Hughes & Adrian Bagust & Alan Haycox & Tom Walley
  • 2001 Piperacillin/Tazobactam: A Pharmacoeconomic Review of its Use in Moderate to Severe Bacterial Infections
    by Melissa Young & Greg L. Plosker
  • 2001 Paclitaxel: A Pharmacoeconomic Review of its Use in Non-Small Cell Lung Cancer
    by Greg L. Plosker & Miriam Hurst
  • 2001 Cost-Effectiveness Analysis and the Consistency of Decision Making: Evidence from Pharmaceutical Reimbursement in Australia (1991 to 1996)
    by Bethan George & Anthony Harris & Andrew Mitchell
  • 2001 Cost Effectiveness of Treatment Options in Advanced Breast Cancer in the UK
    by Ruth E. Brown & John Hutton & Anita Burrell
  • 2001 Quality-of-Life Assessment in Patients with Benign Prostatic Hyperplasia: Effects of Various Interventions
    by Jose-Emilio Batista-Miranda & Marta De la Cruz Diez & Pedro Arano Bertran & Humberto Villavicencio
  • 2001 Economic Evaluations During Early (Phase II) Drug Development: A Role for Clinical Trial Simulations?
    by Dyfrig A. Hughes & Tom Walley
  • 2001 Which Antifungal Agent for Onychomycosis?: A Pharmacoeconomic Analysis
    by Vijay N. Joish & Edward P. Armstrong
  • 2001 Formulary Restriction of Selective Serotonin Reuptake Inhibitors for Depression: Potential Pitfalls
    by Paula L. Hensley & H. George Nurnberg
  • 2001 A Cost-Cost Study Comparing Etanercept with Infliximab in Rheumatoid Arthritis
    by Mark J.C. Nuijten & Peter Engelfriet & Klaas Duijn & George Bruijn & David Wierz & Marc Koopmanschap
  • 2001 Incremental Cost-Effectiveness Analysis Comparing Rofecoxib with Nonselective NSAIDs in Osteoarthritis: Ontario Ministry of Health Perspective
    by John K. Marshall & James M. Pellissier & Cheryl L. Attard & Sheldon X. Kong & Michael A. Marentette
  • 2001 Health-Related Quality of Life and Healthcare Utilisation in Patients with Parkinson's Disease: Impact of Motor Fluctuations and Dyskinesias
    by Richard C. Dodel & Karin Berger & Wolfgang H. Oertel
  • 2001 Barrett's Oesophagus: A Review of Costs of the Illness
    by Miguel R. Arguedas & Mohamad A. Eloubeidi
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Combining Utility Measurements: Exploring Different Approaches
    by Denise E. Bonds & Kenneth A. Freedberg
  • 2001 Management of Pharmaceutical Resources for the Primary Prevention of Coronary Heart Disease in Catalonia (Spain) Based on Efficiency and Equity
    by Pedro Plans-Rubio
  • 2001 Measuring and Managing Health Outcomes and Quality of Care in End-Stage Renal Disease
    by Kraig S. Kinchen & Neil R. Powe
  • 2001 Improving Quality of Life for Patients with Angina Pectoris: A Team Approach to Disease Management
    by Margaret E. Cupples & Martin Dempster
  • 2001 Improving the Use of Data Sources in Disease Management Programs
    by Jacob Abarca & Edward P. Armstrong
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Healthcare Reform and Disease Management in Italy: Promoting the Effectiveness and Appropriateness of Health Service Use
    by Roberto Grilli & Andrea Donatini & Francesco Taroni
  • 2001 Disease Management Programs for Hepatitis C: A Team Approach to Setting Goals
    by Raymond S. Koff
  • 2001 Effective Employer-Vendor Partnerships: Encouraging Positive Disruptive Innovations in Healthcare
    by Julie A. Meek & Vince Kuraitis
  • 2001 Patient-Centered Healthcare: The Role of the Internet
    by Dixie B. Baker
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Management of Advanced Breast Cancer: Defining the Role of Anastrozole
    by Gillian M. Keating & Karen L. Goa
  • 2001 Hepatitis C Screening and Treatment versus Liver Transplantation: A Financial Option Appraisal and Commissioning Model for Purchasers
    by Nevil Batra
  • 2001 Implementation of Guidelines for Diagnosing and Treating Hypertension
    by Finlay A. McAlister & Raj Padwal
  • 2001 Disability Prevention: New Paradigm for the Management of Occupational Back Pain
    by Patrick Loisel & Marie-Jose Durand & Diane Berthelette & Nicole Vezina & Raymond Baril & Denis Gagnon & Christian Lariviere & Claude Tremblay
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Shared Care Versus Secondary Outpatient Care in The Netherlands
    by Raymond C.W. Hutubessy & Hindrik Vondeling & Jeroen J.J. de Sonnaville & Louisa P. Colly & Jan L..J. Smit & Robert J. Heine
  • 2001 Improved Bone Health Behavior Using Community Pharmacists as Educators: The Geisinger Health System Community Pharmacist Osteoporosis Education Program
    by Eric D. Newman & Philip Hanus
  • 2001 Early Recognition and Intervention: The Key to Success in the Treatment of Schizophrenia?
    by Jan Olav Johannessen
  • 2001 Neonatal Care Management: An Integrated Approach
    by Michael N. Musci & John J. Esslinger & Michael Kornhauser
  • 2001 Sickle Cell Disease Screening Programs: Integration Into Managed Care
    by Sally C. Davies & Lola Oni
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Management of Colorectal Cancer: Defining the Role of Raltitrexed
    by Anna J. Matheson & Stuart Noble
  • 2001 Analysis of Antidepressant Use Through Hierarchical Disease Analysis: Using a Managed Care Administrative Database
    by Edward P. Armstrong
  • 2001 The National Lung Health Education Program and Managed Care: The Importance of Early Identification and Intervention in Chronic Obstructive Pulmonary Disease
    by Thomas L. Petty
  • 2001 The Internet as a Resource for Consumer Healthcare
    by Deborah Lewis & Kimberly Behana
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Management of Chronic Hepatitis B: Defining the Role of Lamivudine
    by Blair Jarvis & Caroline M. Perry
  • 2001 Risperidone, Haloperidol and Clozapine in the South Carolina Medicaid Program: A Comparative Analysis of Utilisation and Expenditure
    by Kenneth M. Shermock & M. Kay Sadik & Chris M. Kozma & Anne-Marie Sesti & C.E. Reeder
  • 2001 The Role of the Patient in Maximizing Efficacy of Drug Therapy in Migraine
    by William Pryse-Phillips
  • 2001 Maximizing Treatment Outcome in Depression: Strategies to Overcome Social Stigma and Noncompliance
    by Glen L. Stimmel
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Analysis of Asthma-Related Costs and Patterns of Resource Utilization in a Managed-Care Population
    by Edward P. Armstrong & Kem Krueger & Paul C. Langley
  • 2001 Assertive Community Treatment for People with Severe Mental Illness: Critical Ingredients and Impact on Patients
    by Gary R. Bond & Robert E. Drake & Kim T. Mueser & Eric Latimer
  • 2001 Utilizing and Integrating the Internet in Disease Management
    by Marybeth Regan
  • 2001 Managing Patients with Diabetes Mellitus and Mental Health Problems: Administrative and Clinical Challenges
    by Barbara H. Warren & Cynthia K. Crews & Martina M. Schulte
  • 2001 Role of the Workplace in Migraine Disease Management
    by Leon J. Warshaw & Wayne N. Burton & William J. Schneider
  • 2001 Behavioral Aspects of Arthritis and Rheumatic Disease Self-Management
    by Julie J. Keysor & Shannon S. Currey & Leigh F. Callahan
  • 2001 Training Issues in the Use of Inhalers
    by Martin Duerden & David Price
  • 2001 Pharmaceutical Restrictions: Possible Effect on Patient/Physician Buy-In of Disease Management Programs
    by C. Daniel Mullins & Simu K. Thomas & David S. Roffman
  • 2001 Community-Acquired Pneumonia and its Management: The Role of Levofloxacin
    by Caroline M. Perry & Karen L. Goa
  • 2001 Trends in the Rate of Self-Report and Diagnosis of Erectile Dysfunction in the United States 1990-1998: Was the Introduction of Sildenafil an Influencing Factor?
    by Tracy L. Skaer & David A. Sclar & Linda M. Robison & Richard S. Galin
  • 2001 Cost Effectiveness of Antibacterial Restriction Strategies in a Tertiary Care University Teaching Hospital
    by Caterina Tsiata & Vassilis Tsekouras & Antonis Karokis & John Starakis & Harry P. Bassaris & Mihalis Maragoudakis & Athanasios T. Skoutelis
  • 2001 Health Utility Attributes for Chronic Conditions
    by Nicole Mittmann & Derek Chan & Kostas Trakas & Nancy Risebrough
  • 2001 Data Warehousing Solutions and Internet Initiatives in the Disease Management Era: Important Issues to Consider
    by Alejandro Jaramillo
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Management of Diabetes Mellitus: Defining the Role of Insulin Lispro Mix75/25 (Humalog(R) Mix75/25(TM))
    by Christine R. Culy & Blair Jarvis
  • 2001 Increased National Cholesterol Education Program (NCEP) Goal Attainment: Outcome Assessment of Department of Defense Conversion to Cerivastatin and Simvastatin
    by Dennis Beaudoin & Emery Spaar & Susan Pitman Lowenthal & Karen C. Chung
  • 2001 Primary Care Clinic-Based Chronic Disease Care: Features of Successful Programs
    by Patrick J. O'Connor & JoAnn M. Sperl-Hillen & Nicolaas P. Pronk & Terry Murray
  • 2001 Optimizing the Delivery of Effective Diabetes Care: An English Perspective
    by Abdu Mohiddin & Martin Gulliford
  • 2001 Health Plans and Disease Management: Threats and Opportunities
    by Karen Ignagni
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Cost and Cost Effectiveness of Venous and Pressure Ulcer Protocols of Care
    by Morris D. Kerstein & Eric Gemmen & Lia van Rijswijk & Courtney H. Lyder & Tania Phillips & George Xakellis & Katharine Golden & Catherine Harrington
  • 2001 Unique Co-Operative Worksite-Based Osteoporosis Project: Employer, Healthcare Plan and Pharmaceutical Company Combine Efforts to Screen and Manage Women at Risk
    by Larry K. Cantley & Cheryl Summers & David E. Rice
  • 2001 Treatment Expectations in Hypertension: Implications for Patients Enrolled in Disease Management Programs
    by Debbie Cohen & Raymond Townsend & Mark Miani & David Bernard
  • 2001 A Fully Integrated Clinical Information System to Support Management of End-Stage Renal Disease: Design and Implementation
    by William D. Mattern & Sue Scott
  • 2001 The Role of Mental Health Patient Organizations in Disease Management: Focus on the US National Depressive and Manic-Depressive Association
    by Lydia Lewis
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Chronic Obstructive Pulmonary Disease in a Managed-Care Setting
    by Steven Kesten
  • 2001 Technology-Based Disease Management: A Low-Cost, High-Value Solution for the Management of Chronic Disease
    by Wally H. Gomaa & Thomas Morrow & Pieter Muntendam
  • 2001 Comparing Smoking Cessation Interventions for Work-Site Disease Management
    by Todd Greenwood
  • 2001 Implementing Change: It's as Hard as it Looks
    by Caren Heller & Ahsan Arozullah
  • 2001 Work Productivity in Psychiatry: Trends in Interventions and Outcomes
    by Pamela L. Moriearty & Eugene Oulvey & Karen Lee
  • 2001 Specialty Pharmacies: Filling a Unique Position in the Disease Management Industry
    by Thomas Morrow
  • 2001 Broad Disease Management Interventions: Reducing Health Care Costs for Plan Members with Congestive Heart Failure
    by Joel C. Hoffman
  • 2000 Exploring the Social and Economic Costs of Abuse in Later lIfe
    by Charmaine Spencer
  • 2000 Household expenditure on elementary education : Implications for cost recovery mechanisms
    by Shariff, Abusaleh & Burgohain, Tarujyoti & Ghosh, P.K.
  • 2000 Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine
    by A. Brett Hauber & Josephine A. Mauskopf & Edward H. Snyder
  • 2000 Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine
    by Karen W. Linkins & John R. Lloyd & Gregory O. Hjelmstad & Holly J. Strausbaugh
  • 2000 Inhaled Salmeterol/Fluticasone Propionate Combination: A Pharmacoeconomic Review of its Use in the Management of Asthma
    by Anthony Markham & Julie C. Adkins
  • 2000 Association between Abciximab and Length of Stay in Intensive Care for Patients Undergoing Percutaneous Coronary Intervention: A 2-Stage Econometric Model in a Naturalistic Setting
    by Maureen J. Lage & Beth L. Barber & Mohan Bala & Patrick L. McCollam & Daniel E. Ball
  • 2000 Olanzapine versus Risperidone: A Prospective Comparison of Clinical and Economic Outcomes in Schizophrenia
    by Eric T. Edgell & Scott W. Andersen & Bryan M. Johnstone & Brian Dulisse & Dennis Revicki & Alan Breier
  • 2000 Effectiveness of Eletriptan in Reducing Time Loss Caused by Migraine Attacks
    by Nicholas E.J. Wells & Timothy J. Steiner
  • 2000 Stratified Administration of Serotonin 5-HT3 Receptor Antagonists (Setrons) for Chemotherapy-Induced Emesis: Economic Implications
    by Lisa A. Sanchez & Mark Holdsworth & Sylvia B. Bartel
  • 2000 The Single Market for Pharmaceuticals in the European Union in Light of European Court of Justice Rulings
    by Panos Kanavos
  • 2000 Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon(R)
    by Ceri J. Phillips
  • 2000 Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon(R)
    by Pekka Rissanen
  • 2000 Inhaled Fluticasone Propionate: A Pharmacoeconomic Review of its Use in the Management of Asthma
    by Harriet M. Lamb & Christine R. Culy & Diana Faulds
  • 2000 Economic Impact of Tibolone Compared with Continuous-Combined Hormone Replacement Therapy: In the Management of Postmenopausal Women with Climacteric Symptoms in the UK
    by Jonathan M. Plumb & Julian F. Guest
  • 2000 Cost-Effectiveness Analysis of Topical Calcipotriol versus Short- Contact Dithranol: In the Treatment of Mild to Moderate Plaque Psoriasis
    by Darren M. Ashcroft & Alain Li Wan Po & Hywel C. Williams & Christopher E.M. Griffiths
  • 2000 Economic Impact of Increased Clinical Intervention Rates in Community Pharmacy: A Randomised Trial of the Effect of Education and a Professional Allowance
    by Shalom I. Benrimoj & Jane H. Langford & Geoffrey Berry & David Collins & Roberta Lauchlan & Kay Stewart & Michael Aristides & Matthew Dobson
  • 2000 Cost Analysis of an Adult Outpatient Parenteral Antibiotic Therapy (OPAT) Programme: A Canadian Teaching Hospital and Ministry of Health Perspective
    by Amy O. Wai & Luciana Frighetto & Carlo A. Marra & Emily Chan & Peter J. Jewesson
  • 2000 Health-Related Quality-of-Life Measurement in Hypertension: A Review of Randomised Controlled Drug Trials
    by Isabelle Cote & Jean-Pierre Gregoire & Jocelyne Moisan
  • 2000 HIV-1 Drug Resistance Genotyping: A Review of Clinical and Economic Issues
    by Carine Chaix-Couturier & Christopher Holtzer & Kathryn A. Phillips & Isabelle Durand-Zaleski & John Stansell
  • 2000 The Concept of Clinically Meaningful Difference in Health-Related Quality of Life Research: How Meaningful is it?
    by Ron D. Hays & J. Michael Woolley
  • 2000 Cocaine Medications, Cocaine Consumption and Societal Costs
    by William S. Cartwright
  • 2000 The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS
    by Aslam H. Anis & Daphne Guh & Robert S. Hogg & Xiao-Hua Wang & Benita Yip & Kevin J.P. Craib & Michael V. O'Shaughnessy & Martin T. Schechter & Julio S.G. Montaner
  • 2000 Cost Effectiveness of Acute Imipramine Therapy versus Two Imipramine Maintenance Treatment Regimens for Panic Disorder
    by Matig R. Mavissakalian & Jordana K. Schmier & Jennifer A. Flynn & Dennis A. Revicki
  • 2000 Cost Effectiveness of Cephalosporin Monotherapy and Aminoglycoside/ Ureidopenicillin Combination Therapy: For the Treatment of Febrile Episodes in Neutropenic Patients
    by Joseph A. Paladino & Debra A. Fong & Alan Forrest & Reuben Ramphal
  • 2000 Cost Effectiveness of Human Immunodeficiency Virus Postexposure Prophylaxis for Healthcare Workers
    by Dewey C. Scheid & Robert M. Hamm & Kevin W. Stevens
  • 2000 Socioeconomic Issues Affecting the Treatment of Obesity in the New Millennium
    by Louis F. Martin & Alex Robinson & Barbara J. Moore
  • 2000 Cost Effectiveness of Therapies for Atrial Fibrillation: A Review
    by Mark P. Teng & Edward Catherwood & Daniel P. Melby
  • 2000 The Impact of Health Economics on Healthcare Delivery: A Primary Care Perspective
    by David P. Kernick
  • 2000 Glipizide: A Review of the Pharmacoeconomic Implications of the Extended-Release Formulation in Type 2 Diabetes Mellitus
    by Rachel H. Foster & Greg L. Plosker
  • 2000 The Economic Value of a New Insulin Preparation, Humalog(R) Mix 25(TM): Measured by a Willingness-To-Pay Approach
    by George Dranitsaris & Christopher J. Longo & Loren D. Grossman
  • 2000 Cost Effectiveness of Abciximab During Routine Medical Practice
    by Shelby Ogilvie Reed & C. Daniel Mullins & Laurence S. Magder
  • 2000 Cost Implications for the Use of Inhaled Anti-Inflammatory Medications in the Treatment of Asthma
    by Ronald J. Ozminkowski & Shaohung Wang & William D. Marder & John Azzolini & David Schutt
  • 2000 Cost-Effectiveness Model of Cytomegalovirus Management Strategies in Renal Transplantation: Comparing Valaciclovir Prophylaxis with Current Practice
    by Josephine A. Mauskopf & Anke Richter & Lieven Annemans & Grant Maclaine
  • 2000 Costs of Deep Foot Infections in Patients with Diabetes Mellitus
    by Gunnel Ragnarson Tennvall & Jan Apelqvist & Magnus Eneroth
  • 2000 The Epidemic of Alzheimer's Disease: How Can We Manage the Costs?
    by Neil Johnson & Tim Davis & Nick Bosanquet
  • 2000 The Need for an Iterative Process for Assessing Economic Outcomes Associated with SSRIs
    by Tracy L. Skaer & David A. Sclar & Linda M. Robison & Richard S. Galin
  • 2000 Antiviral Therapies for Herpes Zoster Infections: Are They Economically Justifiable?
    by Kenneth J. Smith & Mark S. Roberts
  • 2000 Economic Assessment of the Secondary Prevention of Ischaemic Events with Lysine Acetylsalicylate
    by Jean-Pierre Marissal & Bernard Selke & Therese Lebrun
  • 2000 Economic Evaluations of Influenza Vaccination in Healthy Working-Age Adults: Employer and Society Perspective
    by Susan C. Wood & Van Hung Nguyen & Claudia Schmidt
  • 2000 Cost Effectiveness of Epoetin-alpha to Augment Preoperative Autologous Blood Donation in Elective Cardiac Surgery
    by Douglas Coyle & Karen M. Lee & Dean A. Fergusson & Andreas Laupacis
  • 2000 Differences in Attitudes, Knowledge and Use of Economic Evaluations in Decision-Making in The Netherlands: The Dutch Results from the EUROMET Project
    by Jeannette E.F. Zwart-van Rijkom & Hubertus G.M. Leufkens & Jan J.V. Busschbach & Andre W. Broekmans & Frans F.H. Rutten
  • 2000 Pharmacoeconomic Analysis of Antidepressants for Major Depressive Disorder in the United Kingdom
    by Hugh Freeman & Steve Arikian & Alan Lenox-Smith
  • 2000 Clinical Trials and the New Good Clinical Practice Guideline in Japan: An Economic Perspective
    by Shunsuke Ono & Yasuo Kodama
  • 2000 Patient Compliance with Drug Therapy in Schizophrenia: Economic and Clinical Issues
    by Eva Lindstrom & Kerstin Bingefors
  • 2000 Economic Issues in the Prevention of Vertical Transmission of HIV
    by A.E. Ades & Julie Ratcliffe & Diana M. Gibb & Mark J. Sculpher
  • 2000 Economic Evaluation of Enoxaparin Sodium versus Heparin in Unstable Angina: A French Sub-Study of the ESSENCE Trial
    by Bruno Detournay & Xavier Huet & Francois Fagnani & Gilles Montalescot
  • 2000 The Impact of Pituitary Adenoma on Morbidity: Increased Sick Leave and Disability Retirement in a Cross-Sectional Analysis of Swedish National Data
    by Bjorn Jonsson & Bo Nilsson
  • 2000 Health-Related Quality of Life in Asymptomatic Patients with HIV: Evaluation of the SF-36 Health Survey in Italian Patients
    by Fabio Arpinelli & Giovanni Visona & Raffaele Bruno & Gianfranco Decarli & Giovanni Apolone
  • 2000 Using Economic Evaluations to Make Formulary Coverage Decisions: So Much for Guidelines
    by Aslam H. Anis & Yves Gagnon
  • 2000 Long Term Treatment of Multiple Sclerosis with Interferon-beta May Be Cost Effective
    by Malcolm Kendrick & K. Ian Johnson
  • 2000 A Review of Alternative Approaches to Healthcare Resource Allocation
    by Stavros Petrou & Jane Wolstenholme
  • 2000 Social Phobia: Epidemiology and Cost of Illness
    by Joshua D. Lipsitz & Franklin R. Schneier
  • 2000 Introduction to the Pharmacoeconomics of Herbal Medicines
    by Peter A.G.M. De Smet & Gouke Bonsel & Ary Van der Kuy & Yechiel A. Hekster & Marja H. Pronk & Mark J.A. Brorens & Jacques H.M. Lockefeer & Mark J.C. Nuijten
  • 2000 Cost of Illness in Adult Patients with Hypopituitarism
    by Christer Ehrnborg & Leona Hakkaart-Van Roijen & Bjorn Jonsson & Frans F.H. Rutten & Bengt-Ake Bengtsson & Thord Rosen
  • 2000 Cost Effectiveness of Zanamivir for the Treatment of Influenza in a High Risk Population in Australia
    by Josephine A. Mauskopf & Sheryl C. Cates & Adrian D. Griffin & Deirdre M. Neighbors & Sarah C. Lamb & Carolyn Rutherford
  • 2000 Costs for Acute Myocardial Infarction in a Tertiary Care Centre and Nationwide in France
    by Olivier Montagne & Carine Chaix & Alain Harf & Alain Castaigne & Isabelle Durand-Zaleski
  • 2000 Cost-Effectiveness Analysis of Pneumococcal Vaccination of Adults and Elderly Persons in Belgium
    by Diana De Graeve & Geert Lombaert & Herman Goossens
  • 2000 Low-Flow Anaesthesia: Does it have Potential Pharmacoeconomic Consequences?
    by Stefan Suttner & Joachim Boldt
  • 2000 A Critical Review of Published Economic Modelling Studies in Depression
    by Michael T. Jones & Paul C. Cockrum
  • 2000 Expert Judgement in Pharmacoeconomic Studies: Guidance and Future Use
    by Christopher Evans & Bruce Crawford
  • 2000 Disease Management: A Global Cost-Containing Initiative?
    by Karen Bloor & Alan Maynard
  • 2000 Mirtazapine: A Pharmacoeconomic Review of its Use in Depression
    by Kristin J. Holm & Blair Jarvis & Rachel H. Foster
  • 2000 Testing the Validity of Cost-Effectiveness Models
    by Chris McCabe & Simon Dixon
  • 2000 Handling Uncertainty in Cost-Effectiveness Models
    by Andrew H. Briggs
  • 2000 Assessing Quality in Decision Analytic Cost-Effectiveness Models: A Suggested Framework and Example of Application
    by Mark Sculpher & Elisabeth Fenwick & Karl Claxton
  • 2000 Modelling in Health Economic Evaluation: What is its Place? What is its Value?
    by Alan Brennan & Ron Akehurst
  • 2000 Decision Analytic Modelling in the Economic Evaluation of Health Technologies: A Consensus Statement
    by Adis International Limited
  • 2000 Healthcare Costs of Patients with Heart Failure Treated with Torasemide or Furosemide
    by Kevin T. Stroupe & Melissa M. Forthofer & D. Craig Brater & Michael D. Murray
  • 2000 Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis B
    by Steven J. Crowley & David Tognarini & Paul V. Desmond & Michael Lees
  • 2000 Cost Effectiveness of Competing Strategies to Prevent or Treat GORD-Related Dysphagia
    by Amnon Sonnenberg
  • 2000 Cost Analysis of the Treatment of Schizophrenia in the UK: A Simulation Model Comparing Olanzapine, Risperidone and Haloperidol
    by Stephen Almond & Owen O'Donnell
  • 2000 Initial Treatment Choice in Depression: Impact on Medical Expenditures
    by Eric T. Edgell & Timothy R. Hylan & JoLaine R. Draugalis & Stephen Joel Coons
  • 2000 Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy: A Comparison of Raltitrexed and Fluorouracil plus Folinic Acid
    by Mark Sculpher & Michael K. Palmer & Anne Heyes
  • 2000 Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine
    by A. Brett Hauber & Ari Gnanasakthy & Edward H. Snyder & Mohan V. Bala & Anke Richter & Josephine A. Mauskopf
  • 2000 Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio
    by Anthony O'Hagan & John W. Stevens & Jacques Montmartin
  • 2000 Economic Burden of Irritable Bowel Syndrome: Proposed Strategies to Control Expenditures
    by Michael Camilleri & Donald E. Williams
  • 2000 Cost Effectiveness of Combination HIV Therapy: 3 Years Later
    by Richard D. Moore
  • 2000 The Importance of Achieving Additional Drug Benefits at a Reasonable Cost: A Review of the Fluoxetine Years
    by Nick Freemantle & James Mason
  • 2000 Household Income Losses Associated With Ischaemic Heart Disease For US Employees
    by Jeph Herrin & Charles B. Cangialose & Stephen J. Boccuzzi & William S. Weintraub & David J. Ballard
  • 2000 The Cost Effectiveness of Misoprostol Prophylaxis Alongside Long Term Nonsteroidal Anti-Inflammatory Drugs: Implications of the MUCOSA Trial
    by Peter J. Davey & Eric Meyer
  • 2000 Economics of the Antithymocyte Globulins Thymoglobulin(R) and Atgam(R) in the Treatment of Acute Renal Transplant Rejection
    by Mark A. Schnitzler & Robert S. Woodward & Jeffrey A. Lowell & Leah Amir & Timothy J. Schroeder & Gary G. Singer & Daniel C. Brennan
  • 2000 Assessing Health Utilities in Schizophrenia: A Feasibility Study
    by Lakshmi N. Voruganti & A. George Awad & L. Kola Oyewumi & Leonardo Cortese & Sandra Zirul & Ravinder Dhawan
  • 2000 Evaluating the Potential
    by Eric L. Eisenstein & Eric D. Peterson & James G. Jollis & Barbara E. Tardiff & Robert M. Califf & J. David Knight & Daniel B. Mark
  • 2000 Clinical and Economic Factors Important to Anaesthetic Choice for Day-Case Surgery
    by Edmond I. Eger & Paul F. White & Martin S. Bogetz
  • 2000 ACE Inhibitors after Myocardial Infarction: Clinical and Economic Considerations
    by Andrew P. Davie
  • 2000 Bridging Decision Analytic Modelling with a Cross-Sectional Study: Application to Parkinson's Disease
    by Mark J.C. Nuijten
  • 2000 Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon(R)
    by Ceri J. Phillips
  • 2000 Cost-of-Illness of Epilepsy in Italy: Data from a Multicentre Observational Study (Episcreen)
    by P. Berto & P. Tinuper & S. Viaggi
  • 2000 Impact of Zanamivir Treatment on Productivity, Health Status and Healthcare Resource Use in Patients with Influenza
    by Fred Y. Aoki & Douglas M. Fleming & Adrian D. Griffin & Loretto A. Lacey & Sally Edmundson
  • 2000 Pharmacoeconomics and Clinical Practice Guidelines: A Survey of Attitudes in Swedish Formulary Committees
    by Anders Anell & Patrick Svarvar
  • 2000 The Costs of Pharmacological Treatment for Major Depression: The Italian Prospective Multicentre Observational Incidence-Based Study
    by Rosanna Tarricone & Giovanni Fattore & Simone Gerzeli & Giulio Serra & Cristina Taddei & Mauro Percudani
  • 2000 Valuing Health-Related Quality of Life: A Review of Health State Valuation Techniques
    by Colin Green & John Brazier & Mark Deverill
  • 2000 Pharmacoeconomic Considerations in Treating Ovarian Cancer
    by Diane Bodurka-Bevers & Charlotte C. Sun & David M. Gershenson
  • 2000 New Generation Aromatase Inhibitors in Breast Cancer: Weighing Out Potential Costs and Benefits
    by Gerald M. Higa
  • 2000 Diagnosis Related Group Costs in a Regulated Environment: A Note About Their Economic Interpretation
    by Claude Le Pen & Gilles Berdeaux
  • 2000 Economic Cost of Male Erectile Dysfunction Using a Decision Analytic Model: For a Hypothetical Managed-Care Plan of 100 000 Members
    by Howard L. Tan
  • 2000 The Cost of Urinary Incontinence in Italian Women: A Cross-Sectional Study
    by Fabrizio Tediosi & Fabio Parazzini & Angela Bortolotti & Livio Garattini
  • 2000 Use and Cost of Hospital and Community Service Provision for Children with HIV Infection at an English HIV Referral Centre
    by Eduard J. Beck & Sundhiya Mandalia & Rebecca Griffith & Jeni Beecham & M. D. Sam Walters & Mary Boulton & David L. Miller
  • 2000 Economic Evaluation of Specific Immunotherapy Versus Symptomatic Treatment of Allergic Rhinitis in Germany
    by Peter K. Schadlich & Josef G. Brecht
  • 2000 A Comparative Review of Generic Quality-of-Life Instruments
    by Stephen Joel Coons & Sumati Rao & Dorothy L. Keininger & Ron D. Hays
  • 2000 Estimating the Long Term Cost Savings from the Treatment of Alzheimer's Disease: A Modelling Approach
    by Peter J. Neumann
  • 2000 Formulary Management of Low Molecular Weight Heparins
    by William E. Wade & Bradley C. Martin & Jeffrey A. Kotzan & William J. Spruill & Marie A. Chisoholm & Matthew Perri
  • 2000 Management of Acute Repetitive Seizures: Defining the Role of Rectal Diazepam Gel
    by Matthew N. Lowe & Katharine J. Palmer & Michelle I. Wilde
  • 2000 Management of Acute Otitis Media: Defining the Role of Cefuroxime Axetil
    by Harriet M. Lamb & Caroline M. Spencer
  • 2000 Self-Management of Epilepsy: A Review of the Concept and Its Outcomes
    by Janice M. Buelow & Joyce Johnson
  • 2000 The Role of Minimal- and No-Contact Behavioural Treatments in Migraine: A Review of Efficacy and Cost Effectiveness
    by Lisa Scharff & Joseph Etherage
  • 2000 Healthcare Reforms in Germany: Managed Care, An Opportunity?
    by Reinhard Rychlik & Karin Guntertgomann & Anne Kilburg & Jeffrey B. Frazier
  • 2000 Epoetin Alfa Drug Use Evaluation Using A Software System: Lessons Learned
    by Edward P. Armstrong & Ruth E. Cherrick
  • 2000 Economic Evaluations of Influenza Vaccination in the Elderly: Impact on Public Health Policy
    by Susan C. Wood & Van Hung Nguyen & Claudia Schmidt
  • 2000 Recombinant Human Erythropoietin as an Alternative to Blood Transfusion in Cancer-Related Anaemia
    by Andreas Engert
  • 2000 An Integrated Model for the Management of Co-Occurring Psychiatric and Substance Disorders in Managed-Care Systems
    by Kenneth Minkoff
  • 2000 Outcome Measures of Efficacy Associated with a Web-Enabled Asthma Self-Management Programme: Findings from a Quasi-Experiment
    by Martin Atherton
  • 2000 Targeting High Utilisers: Predictive Validity of a Screening Questionnaire
    by Julie A. Meek & Brenda L. Lyon & Frederick E. May & Wendy D. Lynch
  • 2000 Interventions for Families of Individuals with Schizophrenia: Maximising Outcomes for their Relatives
    by Phyllis Solomon
  • 2000 Breast Cancer Epidemiology, Prevention and Costs of Care: Implications for Disease Management Programmes
    by K. Robin Yabroff & Ruth Brown & Michael Halpern
  • 2000 The Role of Community Health Information Networks in Disease Management
    by Francois M.H.M. Dupuits
  • 2000 The Value of Disease Management: Approaching the Industrialisation of Modern Medicine
    by Marc L. Berger & Peter Nebenfuhr & Richard K. Murray
  • 2000 Economic Impact of an Asthma Education Programme on Medical Care Utilisation
    by Dong-Churl Suh & Soungkook Shin & Robert M. Voytovich & Allan Zimmerman
  • 2000 Smoking Cessation: The Contribution of Community Pharmacy
    by James C. McElnay & Terry A. Maguire & Ashlinn Drummond & Carmel M. Hughes
  • 2000 Dynamic Assessment in Disease Management
    by Ira S. Nash
  • 2000 Screening and Brief Intervention in the Management of Early Problem Drinkers: Integration into Healthcare Settings
    by Vania Modestolowe & Ava Boornazian
  • 2000 Disease Management as a Part of Total Health and Productivity Management
    by Ron Z. Goetzel & Ronald J. Ozminkowski
  • 2000 Management of Narcolepsy: Defining the Role of Modafinil
    by Alison M. Comer & Caroline M. Spencer
  • 2000 Recent Developments for Optimal End-Points in Rheumatoid Arthritis Clinical Studies
    by Esmeralda T.H. Molenaar & Maarten Boers & Peter M. Brooks & Lee Simon & Vibeke Strand & Peter Tugwell
  • 2000 Managing Influenza in Primary Care: A Practical Guide to Clinical Diagnosis
    by Rene Snacken
  • 2000 Lipid Clinics as Disease Management Programmes in the United States: Essential Elements and Practical Considerations
    by Ralph L. Laforge
  • 2000 Potential Role of Telecommunication Technologies in the Management of Chronic Health Conditions
    by Joseph Finkelstein & Robert H. Friedman
  • 2000 Medical Savings Account Plans: A Patient-Centred Approach to Medical Insurance
    by David T. Springer
  • 2000 Modification of Albumin Use Pattern After an Educational Intervention
    by Veronica De Miguel & Emilio Vargas & Antonio Portoles & Miguel Puerro & Ana Isabel Terleira & Alfonso Moreno
  • 2000 Cost Estimates for Chronic Diseases
    by Jean Woo & Clive Cockram
  • 2000 Psychosocial Components of Asthma Management in Children
    by Shari L. Wade
  • 2000 Impact of Disease and Health Management Strategies on Formulary Design and Management
    by Michael Toscani & Dong Churl Suh & Brent Benedict
  • 2000 The Economics of Hepatitis B Virus Vaccination: An Analysis of Cost-Effectiveness Results for Switzerland
    by Pascal Zurn & Guy Carrin & Jean-Pierre Danthine & Raoul Kammerlander & Mark Kane
  • 2000 Quality-of-Care Indicators for HIV/AIDS
    by Albert W. Wu & Allen Gifford & Steven Asch & Susan E. Cohn & Samuel A. Bozzette & Robin Yurk
  • 2000 Performance Measurement and Management of Healthcare Professionals: Some Topical Issues
    by Martin N. Marshall & Huw T.O. Davies
  • 2000 Electronic Point-of-Care Prescribing: Writing the `Script'
    by Gordon Schiff & David W. Bates
  • 2000 Management of Hypertension in Patients with Diabetes Mellitus: Defining the Role of Lisinopril
    by Blair Jarvis & Caroline M. Spencer
  • 2000 Formulary Management of Eradication Therapies for Helicobacter pylori: Drug Selection by Means of the SOJA Method
    by Robert Janknegt & Leopold G.J.B. Engels
  • 2000 Computer-Assisted Drug Therapy Problem Notification
    by Ronald A. Lyon & Yvette J. Crockell & Nancy P. England
  • 2000 Developments in Influenza Prevention and Treatment: A Managed Care Perspective
    by Arnold S. Monto & A. Mark Fendrick
  • 2000 Challenging Current Asthma Treatment Guidelines: Improved Control of Asthma Symptoms with Nebulised Budesonide in Patients with Severe Asthma Receiving Continuous Oral Steroids
    by Kevin C. Connolly & Michael D. Peake & David M.G. Halpin & Lynda Golightly & Marlyn L. Turbitt
  • 2000 The Management of Women at High Risk of Experiencing Hereditary Breast and Ovarian Cancer: The Lahey Guidelines
    by Kevin S. Hughes & Constance A. Roche & Timothy Whitney & Robert McLellan
  • 2000 Technology-Based Advances in the Management of Depression: Focus on the COPE(TM) Program
    by John H. Greist & Deborah J. Osgood-Hynes & Lee Baer & Isaac M. Marks
  • 2000 Assessing the Economic Impact of Telemedicine
    by David M. Hailey & Bernard L. Crowe
  • 2000 A Population-Based Approach to Asthma Disease Management
    by Pamela J. Algatt-Bergstrom & Leona E. Markson & Richard K. Murray & Marc L. Berger
  • 2000 Management of Major Depression in the Workplace: Impact on Employee Work Loss
    by Howard G. Birnbaum & Pierre Y. Cremieux & Paul E. Greenberg & Ronald C. Kessler
  • 2000 The Health Hero(R) Online Service: A New Internet-Based Communications Platform for Disease Management, Case Management and Performance Measurement
    by Michael A. O'Connell & Julie Cheitlin Cherry
  • 2000 Designing and Developing Effective Disease Management Programmes: Key Decisions for Programme Success
    by Ann Scheck McAlearney
  • 2000 Performance-Based Contracts and Provider Efficiency: The State of the Art
    by Mingshan Lu & Cam Donaldson
  • 2000 Patients' Views on Healthcare: A Driving Force for Improvement in Disease Management
    by Michel Wensing & Richard Grol
  • 2000 Management of Dyslipidaemias: The Role of Simvastatin
    by Karen M. Hvizdos & Karen L. Goa
  • 2000 The Role of Home Infusion Therapy in Haemophilia: A Disease Management Perspective
    by Erik Berntorp & Stefan Lethagen
  • 2000 Interactive Internet Web Sites: A Potentially Powerful Tool for Disease Management
    by David W. Bulger & Chris Reeves
  • 2000 The Patient's Responsibility for Optimum Healthcare
    by Douglas P. Olsen
  • 2000 The Patient Perspective as an Integral Part of Diabetes Disease Management
    by Kathleen M. Rayman & Geraldine C. Ellison
  • 2000 Monitoring Outcomes of Care in Older People in a UK Community Setting: The North East Fife Outcomes Project
    by Petra Kliempt & Danny Ruta
  • 2000 Health and Disease Management Within an Academic Health System
    by David B. Bernard & Kenneth D. Coburn & Mark A. Miani
  • 2000 Achieving Patient Buy-In and Long Term Compliance with Antihypertensive Treatment
    by Frances B. Garfield & J. Jaime Caro
  • 2000 Medicare Risk Plans and Disease Management Vendors: Present and Future Relationships
    by Sam Forman
  • 2000 Salud y productividad laboral en Colombia
    by Ribero Rocio
  • 1999 Acamprosate: Pharmacoeconomic Implications of Therapy
    by Rachel H. Foster & Karen J. McClellan
  • 1999 Abciximab: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Revascularisation
    by Christopher J. Dunn & Rachel H. Foster
  • 1999 Annual Cost of Erectile Dysfunction to UK Society
    by Jonathan M. Plumb & Julian F. Guest
  • 1999 Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis
    by Ron Goeree & Bernie O'Brien & Richard Hunt & Gordon Blackhouse & Andrew Willan & Jan Watson
  • 1999 Health Economics in the Canadian Pharmaceutical Industry
    by Lila Assiff & Michael R. Pollock & Patricia Manzi & Ben Faienza & Devidas Menon
  • 1999 The Effect of Generic Competition on Prescription to Over-the-Counter Switching
    by Christopher S. Hollenbeak
  • 1999 Managing Pharmaceutical Expenditure while Increasing Access: The Pharmaceutical Management Agency (PHARMAC) Experience
    by Richard Braae & Wayne McNee & David Moore
  • 1999 Diagnosis and Management of Osteomyelitis: Decision Analytic and Pharmacoeconomic Considerations
    by Manouche Tavakoli & Peter Davey & Benedict A. Clift & Huw T. O. Davies
  • 1999 Measuring Quality of Life in Paediatric Patients
    by Melinda A. Connolly & Jeffrey A. Johnson
  • 1999 The Doctor-Patient Relationship and Prescribing Patterns: A View from Primary Care
    by Doug T. Steinke & Thomas M. MacDonald & Peter G. Davey
  • 1999 Cost-Effectiveness Analysis of Antiplatelet Therapy in the Prevention of Recurrent Stroke in the UK: Aspirin, Dipyridamole and Aspirin-Dipyridamole
    by Mike Chambers & John Hutton & John Gladman
  • 1999 Economic Impact of Providing Workplace Influenza Vaccination: A Model and Case Study Application at a Brazilian Pharma-Chemical Company
    by Emmanuel Burckel & Talat Ashraf & Jose P. Galvao de Sousa Filho & Eduardo Forleo Neto & Hubert Guarino & Caio Yauti & Fernando de Barros Barreto & Louis Champion
  • 1999 Cost Effectiveness of Ciprofloxacin plus Metronidazole versus Imipenem-Cilastatin in the Treatment of Intra-Abdominal Infections
    by Daniel J. Walters & Joseph S. Solomkin & Joseph A. Paladino
  • 1999 Cost Effectiveness of Amphotericin B plus G-CSF Compared with Amphotericin B Monotherapy: Treatment of Presumed Deep-Seated Fungal Infection in Neutropenic Patients in the UK
    by Terry N. Flynn & Stephen M. Kelsey & Dena L. Hazel & Julian F. Guest
  • 1999 Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin for Acute Coronary Syndromes: A Canadian Hospital Perspective
    by Robert M. Balen & Carlo A. Marra & Peter J. Zed & Marc Cohen & Luciana Frighetto
  • 1999 Cost Effectiveness of Fluticasone Propionate and Flunisolide in the Treatment of Corticosteroid-Naive Patients with Moderate Asthma
    by Timm Volmer & Adrian Kielhorn & Hans H. Weber & Karl J. Wiessmann
  • 1999 Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year
    by George Torrance & Valery Walker & Ronald Grossman & Jayanti Mukherjee & David Vaughan & Jacques La Forge & Noel Lampron
  • 1999 Cost Effectiveness of Omeprazole and Ranitidine in Intermittent Treatment of Symptomatic Gastro-Oesophageal Reflux Disease
    by Nils-Olov Stalhammar & Jonas Carlsson & Robert Peacock & Stefan Mullerlissner & Marcandre Bigard & Gabriele B. Porro & Julio Ponce & James Hosie & Mairi Scott & Donald G. Weir & Claire Fulton & Keith Gillon & Karna D. Bardhan
  • 1999 Linking Health-Related Quality-of-Life Indicators to Large National Data Sets
    by John A. Rizzo & Jody L. Sindelar
  • 1999 Cost Effectiveness, Quality-Adjusted Life-Years and Supportive Care: Recombinant Human Erythropoietin as a Treatment of Cancer-Associated Anaemia
    by Pierre-Yves Cremieux & Stan N. Finkelstein & Ernst R. Berndt & Jeffrey Crawford & Mitchell B. Slavin
  • 1999 Real World Designs in Economic Evaluation: Bridging the Gap Between Clinical Research and Policy-Making
    by Rob Baltussen & Reiner Leidl & Andre Ament
  • 1999 Measuring the Effects of Medication Use on Health-Related Quality of Life in Patients with Rheumatoid Arthritis: A Review
    by Michael B. Nichol & Ann S. M. Harada
  • 1999 Pharmacoeconomics and Health Policy: Current Applications and Prospects for the Future
    by Paul E. Greenberg & Almudena Arcelus & Howard G. Birnbaum & Pierre-Yves Cremieux & Jacques LeLorier & Pierre Ouellette & Mitchell B. Slavin
  • 1999 A Review of Quality of Life in Alzheimer's Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects. The Authors Reply
    by Sam S. Salek & Melvyn D. Walker & Anthony J. Bayer
  • 1999 A Review of Quality of Life in Alzheimer's Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects
    by Stephen P. McKenna & Lynda C. Doward
  • 1999 Costs of Mini Mental State Examination-Related Cognitive Impairment
    by Linus Jonsson & Peter Lindgren & Anders Wimo & Bengt Jonsson & Bengt Winblad
  • 1999 Costs Associated with Symptomatic Systolic Heart Failure
    by Peter G. Davey & Peter B. Clarkson & Alex McMahon & Thomas M. MacDonald
  • 1999 Cost Effectiveness of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in the UK
    by Mark Nuijten & Liebeth Meester & Franz Waibel & Suzanne Wait
  • 1999 Economic Evaluation of the Treatment of Chronic Wounds: Hydroactive Wound Dressings in Combination with Enzymatic Ointment Versus Gauze Dressings in Patients with Pressure Ulcer and Venous Leg Ulcer in Germany
    by Rito Bergemann & Karl W. Lauterbach & Wolfgang Vanscheidt & Klaus-Dieter Neander & Reinhard Engst
  • 1999 Decision Analysis of Histamine H2-Receptor Antagonist Maintenance Therapy Versus Helicobacter pylori Eradication Therapy: A Randomised Controlled Trial in Patients with Continuing Pain After Duodenal Ulcer
    by Manouche Tavakoli & Andrzej T. Prach & Mo Malek & David Hopwood & Bernard W. Senior & Frank E. Murray
  • 1999 Clinical and Economic Considerations of Empirical Antibacterial Therapy of Febrile Neutropenia in Cancer
    by George Dranitsaris
  • 1999 Therapeutic Options in the Treatment of Multiple Myeloma: Pharmacoeconomic and Quality-of-Life Considerations
    by Finn Wisloff & Nina Gulbrandsen & Erik Nord
  • 1999 Herbal Remedies: Issues in Licensing and Economic Evaluation
    by Darren M. Ashcroft & Alain Li Wan Po
  • 1999 Decreased Medical Expenditures for Care of HIV-Seropositive Patients: The Impact of Highly Active Antiretroviral Therapy at a US Veterans Affairs Medical Center
    by Larry Mole & Kimberly Ockrim & Mark Holodniy
  • 1999 Cost Effectiveness of Helicobacter pylori Eradication Therapies in Patients with Duodenal Ulcer: An Analysis of Triple Therapy Versus Two Dual Therapy Alternatives
    by Gunnel R. Tennvall & Anna Norinder & Bo Ohlin
  • 1999 Patient-Level Estimates of the Cost of Complications in Diabetes in a Managed-Care Population
    by Scott D. Ramsey & Katherine Newton & David Blough & David K. McCulloch & Nirmala Sandhu & Edward H. Wagner
  • 1999 Pharmacotherapeutic Circles: Results of an 18-Month Peer-Review Prescribing-Improvement Programme for General Practitioners
    by Liselotte von Ferber & Jurgen Bausch & Ingrid Koster & Ingrid Schubert & Peter Ihle
  • 1999 A Review of Quality-of-Life Evaluations in Patients with Congestive Heart Failure
    by Colin Berry & John McMurray
  • 1999 Formulary Management of Proton Pump Inhibitors
    by Michael F. Byrne & Frank E. Murray
  • 1999 Formulary Submission Guidelines for Blue Cross and Blue Shield of Colorado and Nevada: Structure, Application and Manufacturer Responsibilities
    by Paul C. Langley
  • 1999 Choice of Cost-Effectiveness Measure in the Economic Evaluation of Cholesterol-Modifying Pharmacotherapy: An Illustrative Example Focusing on the Primary Prevention of Coronary Heart Disease in Canada
    by Stephen Morris & Ed Godber
  • 1999 Cost Comparison of Antibacterial Therapies for Serious Infections: A New Zealand 3-Hospital Study
    by W. Guy Scott & Helen M. Scott & Seton Henderson & Alison Inder & Joanne Sanders & Ruth Spearing & Colin McArthur & James Judson & Bartrum Baker & Peter Hicks & Philippa Cotterell
  • 1999 The Influence of Hospital-Based Prescribers on Prescribing in General Practice
    by John Feely & Robert Chan & John McManus & Brendan O'Shea
  • 1999 Estimating Long Term Cost Savings from Treatment of Alzheimer's Disease: A Modelling Approach
    by Paul Fenn & Alastair Gray
  • 1999 Cost Effectiveness of Riluzole in Amyotrophic Lateral Sclerosis
    by Andrea Messori & Sabrina Trippoli & Paola Becagli & Gaetano Zaccara
  • 1999 Review of Quality-of-Life Evaluations in Patients with Angina Pectoris
    by Afschin Gandjour & Karl W. Lauterbach
  • 1999 A Review of Quality-of-Life Evaluations in Prostate Cancer
    by Sunshine D. Sommers & Scott D. Ramsey
  • 1999 Challenges to the Economic Evaluation of New Biotechnological Interventions in Healthcare
    by James Mason
  • 1999 Donepezil: Pharmacoeconomic Implications of Therapy
    by Rachel H. Foster & Greg L. Plosker
  • 1999 The Pharmacoeconomics of Hormone Replacement Therapy
    by David J Torgerson & David M Reid
  • 1999 Diclofenac/Misoprostol: Pharmacoeconomic Implications of Therapy
    by Greg L. Plosker & Harriet M. Lamb
  • 1999 Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS
    by Anita Rachlis & Fiona Smaill & Valery Walker & Lorraine Hotchkies & Amy Jones
  • 1999 Cost of Illness and Disease Severity in a Cohort of French Patients with Parkinson's Disease
    by Claude Le Pen & Suzanne Wait & Frederic Moutard-Martin & Max Dujardin & Marc Ziegler
  • 1999 Economic Analysis of Carboplatin Versus Cisplatin in Lung and Ovarian Cancer
    by Zeba M. Khan & Karen L. Rascati & Jim M. Koeller
  • 1999 Measuring Sensitivity in Pharmacoeconomic Studies: Refining Point Sensitivity and Range Sensitivity by Incorporating Probability Distributions
    by Mark J.C. Nuijten
  • 1999 Benefit Valuation in Economic Evaluation of Cancer Therapies: A Systematic Review of the Published Literature
    by Jackie Brown & Mark Sculpher
  • 1999 Using Healthcare Claims Data for Outcomes Research and Pharmacoeconomic Analyses
    by Howard G. Birnbaum & Pierre Y. Cremieux & Paul E. Greenberg & Jacques LeLorier & JoAnn Ostrander & Laura Venditti
  • 1999 A Review of Quality of Life in Alzheimer's Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects
    by Sam S. Salek & Melvyn D. Walker & Anthony J. Bayer
  • 1999 A Review of Quality of Life in Alzheimer's Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects
    by Marianne Greer & Helma Monteban
  • 1999 Olanzapine: A Pharmacoeconomic Review of its Use in Schizophrenia
    by Rachel H. Foster & Karen L. Goa
  • 1999 Cost of Schizophrenia to UK Society: An Incidence-Based Cost-of-Illness Model for the First 5 Years Following Diagnosis
    by Julian F. Guest & Ron F. Cookson
  • 1999 Costs of Diabetes: A Methodological Analysis of the Literature
    by Eva Pagano & Massimo Brunetti & Fabrizio Tediosi & Livio Garattini
  • 1999 A Model to Compute the Medical Cost of Patients in Intensive Care
    by Carine Chaix & Isabelle Durand-Zaleski & Corinne Alberti & Christian Brun-Buisson
  • 1999 Hospital Selection for Unit Cost Estimates in Multicentre Economic Evaluations: Does the Choice of Hospitals Make a Difference?
    by Ron Goeree & Amiram Gafni & Mary Hannah & Terri Myhr & Gordon Blackhouse
  • 1999 Standard Cost Lists for Healthcare in Canada: Issues in Validity and Inter-Provincial Consolidation
    by Philip Jacobs & Noralou P. Roos
  • 1999 Angiotensin Converting Enzyme (ACE) Inhibitors and Heart Failure: The Consequences of Underprescribing
    by Fredrik Andersson & Charles Cline & Tina Ryden-Bergsten & Leif Erhardt
  • 1999 Outstanding Regulatory Aspects in the European Pharmaceutical Market
    by Panos Kanavos & Elias Mossialos
  • 1999 Direct Costs of Hip Fractures in Patients Over 60 Years of Age in Belgium
    by Jean-Yves Reginster & Pierre Gillet & Wafa Ben Sedrine & Geoffrey Brands & Olivier Ethgen & Cecile defroidmont & Christiane Gosset
  • 1999 Medical Resource Use and Cost of Venlafaxine or Tricyclic Antidepressant Therapy: Following Selective Serotonin Reuptake Inhibitor Therapy for Depression
    by Robert I. Griffiths & Erin M. Sullivan & Richard G. Frank & Michael J. Strauss & Robert J. Herbert & Jon Clouse & Howard H. Goldman
  • 1999 Reconciling Decision Models With the Real World: An Application to Anaemia of Renal Failure
    by Ya-Chen Tina Shih & Teresa L. Kauf
  • 1999 Clinical and Economic Outcomes of Olanzapine Compared With Haloperidol for Schizophrenia: Results From a Randomised Clinical Trial
    by Susan H. Hamilton & Dennis A. Revicki & Eric T. Edgell & Laura A. Genduso & Gary Tollefson
  • 1999 The Revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals
    by Judith L. Glennie & George W. Torrance & Jean Francois Baladi & Catherine Berka & Eleanor Hubbard & Devidas Menon & Nick Otten & Marc Riviere
  • 1999 Counting the Costs of Drug-Related Adverse Events
    by T. Jeffrey White & Annet Arakelian & Jay P. Rho
  • 1999 Prescribing at the Interface Between Primary and Secondary Care in the UK: Towards Joint Formularies?
    by Martin Duerden & Tom Walley
  • 1999 Pharmacoeconomic Evaluation in the Real World: Effectiveness Versus Efficacy Studies
    by Dennis A. Revicki & Lori Frank
  • 1999 Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Pharmacoeconomic Review
    by Allan J. Coukell & Stuart Noble & Diana Faulds
  • 1999 Cost Analysis of the Treatment of Severe Spinal Spasticity With a Continuous Intrathecal Baclofen Infusion System
    by M. Postma & Dettie Oenema & Symon Terpstra & Jelte Bouma & Hannah Kuipersupmeijer & Michiel J. Staal & Berry J. Middel
  • 1999 Applying Epidemiology-Based Outcomes Research to Clinical Decision-Making: A Hypothetical Model of Biotechnology Therapy in Gram-Negative Sepsis
    by Edward C.Y. Wang & Thaddeus H. Grasela & Cynthia A. Walawander
  • 1999 Treatment of Locally Advanced Pancreatic Carcinoma in Sweden: A Health Economic Comparison of Palliative Treatment With Best Supportive Care Versus Palliative Treatment With Gemcitabine in Combination With Best Supportive Care
    by Gunnel Ragnarsont Tennvall & Nils Wilking
  • 1999 Utility Scores for Chronic Conditions in a Community-Dwelling Population
    by Nicole Mittmann & Kostas Trakas & Nancy Risebrough & Barbara A. Liu
  • 1999 Recent Advances in the Methods of Cost-Benefit Analysis in Healthcare: Matching the Art to the Science
    by Emma McIntosh & Cam Donaldson & Mandy Ryan
  • 1999 Methodological Hurdles in Conducting Pharmacoeconomic Analyses
    by J. Douglasrizzo & Neil R. Powe
  • 1999 The Clinical and Economic Potential of Cyclosporin Drug Interactions
    by Jill E. Martin & A. Jamal Daoud & Timothy J. Schroeder & M. Royfirst
  • 1999 Costs of Peripheral Blood Progenitor Cell Transplantation Using Whole Blood Mobilised by Filgrastim as Compared With Autologous Bone Marrow Transplantation in Non-Hodgkin's Lymphoma
    by Carin A. Uyl-de Groot & Gert J. Ossenkoppele & Ivanne Buijt & Peter C. Huijgens
  • 1999 Pharmaceutical Price Regulation: A Study on the Impact of the Rate-of-Return Regulation in the UK
    by Joan-Ramon Borrell
  • 1999 Simvastatin After Orthotopic Heart Transplantation: Costs and Consequences
    by Karl J. Krobot & Klaus Wenke & Bruno Reichart
  • 1999 New Drugs for Osteoporosis: Comparison of the Costs and Required Returns With Those of Other Drugs Intended for Long-Term Use
    by Martin Edwards
  • 1999 Under-Utilisation of beta-Blockers After Acute Myocardial Infarction: Pharmacoeconomic Implications
    by W. David Bradford & Jersey Chen & Harlan M. Krumholz
  • 1999 Patient Self-Reports in Pharmacoeconomic Studies: Their Use and Impact on Study Validity
    by Christopher Evans & Bruce Crawford
  • 1999 The Economics of Multiple Sclerosis: Distribution of Costs and Relationship to Disease Severity
    by Amy Nicole Grudzinski & Zafar Hakim & Emily R. Cox & J. Lyle Bootman
  • 1999 Pharmacoeconomic Consequences of Variable Patient Compliance With Prescribed Drug Regimens
    by John Urquhart
  • 1999 Primary Care Purchasing: Are Integrated Primary Care Provider/Purchasers the Way Forward?
    by Stephen Peckham
  • 1999 Approaches to Missing Data Inference Results from CaPSURE: An Observational Study of Patients with Prostate Cancer
    by Deborah P. Lubeck & David J. Pasta & Scott C. Flanders & James M. Henning
  • 1999 Cost Effectiveness of Recombinant Human Insulin-Like Growth Factor I Therapy in Patients with ALS
    by Stacey J. Ackerman & Erin M. Sullivan & Kathleen M. Beusterien & Howard M. Natter & Deborah F. Gelinas & Donald L. Patrick
  • 1999 Pharmacoeconomic Considerations in Treating Patients With Acute Leukaemia
    by Viggo Jonsson & Mogen Mork Hansen & Per Ljungman & Stein Kaasa
  • 1999 Health-Related Quality-of-Life Measurement in Patients with Parkinson's Disease
    by Crispin Jenkinson & Ray Fitzpatrick & Viv Peto
  • 1999 Determining Clinically Important Differences in Health Status Measures: A General Approach with Illustration to the Health Utilities Index Mark II
    by Greg Samsa & David Edelman & Margaret L. Rothman & G. Rhys Williams & Joseph Lipscomb & David Matchar
  • 1999 The Effect of Managed Care on Prescription Drug Costs and Benefits
    by Alan Lyles & Francis B. Palumbo
  • 1999 Valuing Health-Related Quality of Life: Issues and Controversies
    by Paul Dolan
  • 1999 Economic Evaluation of Antibacterials in the Treatment of Acute Sinusitis
    by Claudine Laurier & Jean Lachaine & Murray Ducharme
  • 1999 Willingness to Pay as a Measure of Health Benefits
    by Mohan V. Bala & Josephine A. Mauskopf & Lisa L. Wood
  • 1999 Cost Analysis of 2 Empiric Antibacterial Regimens Containing Glycopeptides for the Treatment of Febrile Neutropenia in Patients with Acute Leukaemia
    by Giampaolo Bucaneve & Francesco Menichetti & Albano Del Favero
  • 1999 Cost-Benefit Analysis of Haemophilus influenzae Type b Vaccination in Children in Spain
    by F. Javier Jimenez & Pilar Guallar-Castillon & Carlos Rubio Terres & Eliseo Guallar
  • 1999 Pharmacoeconomics of Lipid-Lowering Agents for Primary and Secondary Prevention of Coronary Artery Disease
    by Joel W. Hay & Winnie M. Yu & Talat Ashraf
  • 1999 Evaluating Health-Related Quality-of-Life Outcomes in Patients with Congestive Heart Failure: A Review of Recent Randomised Controlled Trials
    by Nancy K. Leidy & Anne M. Rentz & Teresa M. Zyczynski
  • 1999 The Use of Meta-Analysis in Cost-Effectiveness Analysis: Issues and Recommendations
    by Sanjay Saint & David L. Veenstra & Sean D. Sullivan
  • 1999 Behavioural Medicine Group Intervention for High-Utilising Somatising Patients: Evaluation Across 7 Unrelated Healthcare Organisations
    by Steven E. Locke & Pauline P. Chan & Debra S. Morley & Caroline C. McLeod & Matthew A. Budd & Marcia Orlowski
  • 1999 Law and Disorder: Critical Legal Issues in Disease Management
    by James M. Jacobson & James M. Jorling & Neela A. Paykel
  • 1999 Implementing Disease Management Programmes within an Integrated Delivery System
    by Neal Friedman & Linda Skogmo & Pat Aruffo
  • 1999 Integrating Systems of Care: Responding to the Demand
    by Rufus Howe
  • 1999 Playing Disease Management Numbers Games
    by Robert E. Stone
  • 1999 Helping Cure Healthcare Systems: Changing Minds and Behaviour
    by James O. Prochaska & Janice M. Prochaska
  • 1999 Gaining Physician Buy-In for Disease Management Initiatives
    by Harry L. Leider
  • 1999 Episodes of Care: A Tool for Measuring the Impact of Healthcare Services on Cost and Quality
    by Edward Bassin
  • 1999 `Build versus Buy' in Disease Management: Separating Fact from Myth
    by Alfred Lewis
  • 1999 Point-of-Care Testing in Oral Anticoagulant Monitoring: Implications for Patient Management
    by Jennifer Sickels & Jennifer Elston Lafata & Jack E. Ansell
  • 1999 Disease Management by Prevention: The Prospects for Diabetic Retinopathy
    by Emily Y. Chew
  • 1999 Patient Compliance and its Impact on Treatment Outcomes
    by Laura T. Pizzi & Joseph E. Biskupiak
  • 1999 Enhancing Outcomes Research: The Experience of a Community Pharmacist Research Network
    by R. Leon Longe & A. Thomas Taylor & William E. Wade & William J. Spruill
  • 1999 Case Management: Transforming to Meet the Demands of an Evolving Healthcare System
    by Marianne E. Weiss
  • 1999 The Pros and Cons of Covering Lifestyle Drugs
    by Debi Reissman
  • 1999 Management of Community-Acquired Pneumonia: The Role of Clarithromycin
    by Julia A. Barman Balfour & Harriet M. Lamb
  • 1999 Guidelines for Glomerulonephritis: Their Importance in Diagnosis and Designing a Management Strategy
    by Edith Renoult & Luc Frimat & Michele Kessler
  • 1999 Cancer and Disease Management: Indications for Action
    by Marybeth Regan
  • 1999 What is the Role of Stroke Units in Overall Care?
    by Joanne V. Hickey & James C. Grotta
  • 1999 Community-Based Prevention and Chronic Disease Self-Management Programmes: Problems, Praises and Pitfalls
    by Mark Daniel & Lawrence W. Green
  • 1999 Treatment of Pneumonias in a Managed-Care Organisation: The Impact of a Treatment Guideline Promotion on Physician Prescribing Behaviour
    by Edward P. Armstrong & Paul C. Langley
  • 1999 Self-Management Services: Their Role in Disease Management
    by Jessie Gruman & Michael VonKorff
  • 1999 Wellness Programmes: Primary-Care Medicine
    by Sarita Verma & Evelyn Forsyth & Leslie Flynn
  • 1999 Selecting a Vendor for Disease Management Programmes
    by Harry L. Leider
  • 1999 Does Telemedicine Have a Role to Play in Disease Management?
    by John Craig & Maria Loane & Richard Wootton
  • 1999 Management of Patients with Cystic Fibrosis: Defining the Role of Inhaled Tobramycin
    by Harriet M. Lamb & Karen L. Goa
  • 1999 The Burden of Asthma Symptoms and the Positive Role of Patient Management
    by Edward C.Y. Wang & Kathryn A. Gaebel
  • 1999 Principles of Perioperative Antibacterial Prophylaxis: Management of Surgical Site Infections
    by John Bohnen
  • 1999 Carve-Outs: Their Place in Disease Management
    by Marybeth Regan
  • 1999 Guidelines for General Practitioners: Approaches for Managing the Information Influx for Effective Disease Management
    by David Pencheon
  • 1999 Epidemiology of Helicobacter pylori Infection: Disease Management Implications for Peptic Ulcer Disease
    by Hoda M. Malaty & David Y. Graham
  • 1999 Management Strategies for Ensuring Adequate Analgesia in Children
    by Melanie Lux & Chris L. Algren & John T. Algren
  • 1999 Disease State Management Programmes: Approaches and Applications
    by Mark G. Fuller
  • 1999 The Role of the Pharmacist in the Management of HIV/AIDS
    by Anthony J. Zappa
  • 1999 Optimising the Patient's Role: An Essential Component in Disease Management
    by Scott MacStravic
  • 1999 Hospital Length of Stay for Schizophrenia: Is Primary Payer an Influencing Factor?
    by David A. Sclar & Linda M. Robison & Tracy L. Skaer & Richard S. Galin
  • 1999 The Caregiver as Part of the Dementia Management Team
    by Steven M. Albert
  • 1999 Management of Acute Ischaemic Stroke: Recommended Practice Guidelines as a Component of Disease Management
    by Soren Paaske Johnsen & Steen Elkjaer Husted & Anne Thomassen
  • 1999 Patient Education in Asthma: Impact of Nurse Educators
    by Margot F. Underwood & Shirley G. Revitt & Stephen K. Field & Robert L. Cowie
  • 1999 An Inner-City Asthma Disease Management Initiative: Results of an Outcomes Evaluation
    by Rose Maljanian & Scott Wolf & John Goethe & Patricia Hernandez & Sheryl Horowitz
  • 1999 Direct-To-Consumer Advertising: Impact on Patient Expectations Regarding Disease Management
    by Joel Lexchin
  • 1999 Evaluation of Patients with Hypertension: Diagnosis, Screening and Risk Stratification
    by Michael Barenbrock & Martin Hausberg & Claus Spieker
  • 1999 Phased Competency: A New Model to Prepare Nurses for Enhanced Roles In Diabetes Disease Management
    by Linda L. Edwards
  • 1999 Practical Strategies to Increase Patient Education Effectiveness in a Disease State Management Programme
    by Marian Ryan Henry
  • 1999 Actual Costs Versus Diagnostic-Related Group Reimbursements for Unstable Angina: An Important Distinction for Effective Disease Management
    by Claudio Brunelli & Gian Paolo Bezante & Alberto Pasdera & Paolo Spallarossa & Maria Rosalia Merello & Pier Rossettin & Franco Zorzet & Salvatore Caponnetto
  • 1999 The Role of Behavioural Treatment in the Management of Insomnia
    by Chien-Ming Yang & Arthur J. Spielman
  • 1999 Outcomes, Outcomes Research and Disease Management: A View from the UK
    by Tom Walley
  • 1999 Use of Guidelines in the Management of Patients With Glaucoma
    by Paul Lee
  • 1999 Management of Advanced Non-Small Cell Lung Cancer: The Potential Role of Gemcitabine
    by Stuart Noble & Diana Faulds
  • 1999 Costs and Benefits of Prevention and Disease Management
    by Shirley A. Musich & Wayne N. Burton & Dee W. Edington
  • 1999 Design, Development and Implementation of a Multidisciplinary Diabetes Disease Management Programme
    by Robert E. Stone
  • 1999 Baseline Assessment of an Inner City Population Enrolled in an Asthma Disease Management Programme: Data for Continuous Programme Improvement
    by Rose Maljanian & John W. Goethe & Scott A. Wolf & Laura R. Triano & Patricia Hernandez
  • 1999 Message Tailoring: An Essential Component for Disease Management
    by David W. Bulger & Amy B. Smith
  • 1999 The Annual Cost of Chronic Obstructive Pulmonary Disease to the UK's National Health Service
    by Julian F. Guest
  • 1999 A Comparison of a Budesonide-Based and a Beclomethasone/Prednisolone-Based Management Strategy for the Treatment of Severe Asthma in General Practice
    by Govindaraj Mohan & Kevin A. MacLusky & Clifford C. Godley & Pamela L. Todd
  • 1999 Guidelines for the Diagnosis and Treatment of Meningococcal Meningitis
    by Bjorn-Erik Kristiansen & Trond Flaegstad
  • 1999 Diabetes Mellitus: Disease Management in a Multispecialty Group Practice
    by Jeremy M. Gleeson & Michael Foris & Marjorie Cypress & Donna J. Rodriguez & Neal Friedman & Martha Kent
  • 1999 Management of Febrile Episodes in Neutropenic Patients: Defining the Role of Meropenem
    by Harriet M. Lamb & Karen L. Goa
  • 1999 Management of Community-Acquired Pneumonia: Defining the Role of Azithromycin
    by Nishan S. Gunasekara & Julia A. Barman Balfour
  • 1999 Use of Surgical Procedures in the Treatment of Epilepsy: Interventions and Outcomes
    by John T. Langfitt & Kathryn Bronstein
  • 1999 The Burden of Obesity and Its Sequelae
    by Jacob C. Seidell
  • 1999 Measuring Outcomes in Alzheimer's Disease Research: Assessment of the Effectiveness of Interventions
    by Stacey Wood & Jeffrey L. Cummings
  • 1998 Common Errors and Controversies in Pharmacoeconomic Analyses
    by Stephen Palmer & Sarah Byford
  • 1998 Common Errors and Controversies in Pharmacoeconomic Analyses
    by Javier Soto
  • 1998 A Short Term Cost-Effectiveness Model for Oral Antidiabetic Medicines in Europe
    by Sheila Hood & Lieven Annemans & Maureen Rutten-van Molken
  • 1998 A Short Term Cost-Effectiveness Model for Oral Antidiabetic Medicines in Europe
    by Linda D. MacKeigan
  • 1998 Cyclosporin Microemulsion (Neoral(R)) Use of trade name is for product identification, and does not imply endorsement.: A Pharmacoeconomic Review of its Use Compared with Standard Cyclosporin in Renal and Hepatic Transplantation
    by Allan J. Coukell & Greg L. Plosker
  • 1998 Fosphenytoin: Pharmacoeconomic Implications of Therapy
    by Stephen M. Holliday & Paul Benfield & Greg L. Plosker
  • 1998 Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma
    by Maureen P.M.H. Rutten-van Molken & Eddy K.A. van Doorslaer & M. Denise Till
  • 1998 Cost-Effectiveness Analysis of Ramipril in Heart Failure after Myocardial Infarction: Economic Evaluation of the Acute Infarction Ramipril Efficacy (AIRE) Study for Germany from the Perspective of Statutory Health Insurance
    by Peter K. Schadlich & Eduard Huppertz & Josef Georg Brecht
  • 1998 The Use and Cost of HIV Service Provision in England in 1996
    by Eduard J. Beck & Keith Tolley & Amanda Power & Sundhiya Mandalia & Philippa Rutter & Junichi Izumi & Jeni Beecham & Alistair Gray & David Barlow & Philippa Easterbrook & Martin Fisher & John Innes & George Kinghorn & Bibhat Mandel & Anton Pozniak & Allan Tang & David Tomlinson & Ian Williams
  • 1998 Insomnia, Health-Related Quality of Life and Healthcare Resource Consumption: A Study of Managed-Care Organisation Enrollees
    by Hind T. Hatoum & Sheldon X. Kong & Christopher M. Kania & Josephine M. Wong & Wallace B. Mendelson
  • 1998 A Review of Quality of Life in Alzheimer's Disease: Part 2: Issues in Assessing Drug Effects
    by Sam S. Salek & Melvyn D. Walker & Antony J. Bayer
  • 1998 Thrombolysis, Stroke Units and Other Strategies for Reducing Acute Stroke Costs
    by Theodore H. Wein & Susan L. Hickenbottom & Andrei V. Alexandrov
  • 1998 Are Mental Health Services Losing Out in the US Under Managed Care?
    by Dale L. Johnson
  • 1998 Economic Evaluation of Nimesulide Versus Diclofenac in the Treatment of Osteoarthritis in Greece
    by Lycurgus Liaropoulos & Maria Spinthouri & Theodore Ignatiades & Georgia Ifandi & Fanis Katostaras & Emmanuel Diamantopoulos
  • 1998 Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis
    by Andrew J. Rosner & Daniel T. Grima & George W. Torrance & Cathy Bradley & Jonathan D. Adachi & Rolf J. Sebaldt & Donald J. Willison
  • 1998 Cost Effectiveness of Pramipexole in Parkinson's Disease in the US
    by Thomas J. Hoerger & Mohan V. Bala & Clayton Rowland & Marianne Greer & Elizabeth A. Chrischilles & Robert G. Holloway
  • 1998 Urge Incontinence: Quality of Life and Patients' Valuation of Symptom Reduction
    by Richard M. O'Conor & Magnus Johannesson & Steven L. Hass & Gisela Kobelt-Nguyen
  • 1998 A Review of Quality of Life in Alzheimer's Disease: Part 1: Issues in Assessing Disease Impact
    by Melvyn D. Walker & Sam S. Salek & Antony J. Bayer
  • 1998 A Review of the Economics of the Prevention and Control of Rabies: Part 2: Rabies in Dogs, Livestock and Wildlife
    by Martin I. Meltzer & Charles E. Rupprecht
  • 1998 Pharmaceutical Reference Prices: How do They Work in Practice?
    by Michael Dickson & Heinz Redwood
  • 1998 Willingness To Pay: What's in a Name?
    by Amiram Gafni
  • 1998 Docetaxel: A Pharmacoeconomic Review of its Use in the Treatment of Metastatic Breast Cancer
    by Harriet M. Lamb & Lynda R. Wiseman
  • 1998 Cost Effectiveness of Fluvoxamine in the Treatment of Recurrent Depression in France
    by Mark Nuijten & Lionel Hadjadjeba & Christopher Evans & John van den Berg
  • 1998 Threshold Analysis of Helicobacter pylori Therapy
    by Amnon Sonnenberg
  • 1998 A Method to Select an Instrument for Measurement of HR-QOL for Cross-Cultural Adaptation Applied to Dermatology
    by Adolfo Ga de Tiedra & Joan Mercadal & Xavier Badia & Jose Ma Mascaro & Rafael Lozano
  • 1998 The Burden of Illness of Hypopituitary Adults with Growth Hormone Deficiency
    by Leona Hakkaart-van Roijen & Albert Beckers & Achille Stevenaert & Frans F.H. Rutten
  • 1998 Economic Impact of Aminoglycoside Toxicity and its Prevention Through Therapeutic Drug Monitoring
    by Richard L. Slaughter & Diane M. Cappelletty
  • 1998 A Review of the Economics of the Prevention and Control of Rabies: Part 1: Global Impact and Rabies in Humans
    by Martin I. Meltzer & Charles E. Rupprecht
  • 1998 The Problem of Protocol Driven Costs in Pharmacoeconomic Analysis
    by Douglas Coyle & Karen M. Lee
  • 1998 Mega-Mergers in the Pharmaceutical Industry: In Whose Interests?
    by Alain Li Wan Po
  • 1998 Does Managed Care Fuel Pharmaceutical Industry Growth?
    by Michael D. Murray & Frank W. Deardorff
  • 1998 Methodological Quality of Economic Modelling Studies: A Case Study with Hepatitis B Vaccines
    by Michelle Wilde
  • 1998 Costs and Effects Associated with a Community Pharmacy-Based Smoking-Cessation Programme
    by Grainne E. Crealey & James C. McElnay & Terry A. Maguire & Ciaran O'Neill
  • 1998 Cost Effectiveness of Immunoprophylaxis in the Prevention of Recurrent Infectious Rhinitis in Adults
    by Gilles Berdeaux & Antoine Lafuma & Anne-Marie Perruchet & Francis Fagnani
  • 1998 The Economic Impact of Parkinson`s Disease: An Estimation Based on a 3-Month Prospective Analysis
    by Richard C. Dodel & Marikka Singer & Rudolf Kohne-Volland & Thomas Szucs & Bernard Rathay & Erich Scholz & Wolfgang H. Oertel
  • 1998 Cost Analysis of Palliative Care for Terminally Ill Cancer Patients in the UK After Switching from Weak to Strong Opioids
    by Julian F. Guest & Warren M. Hart & Ronald F. Cookson
  • 1998 Outcomes of Pharmacological and Surgical Treatment for Obesity
    by Jennifer Cerulli & Margaret Malone
  • 1998 Reporting Format for Economic Evaluation: Part II: Focus on Modelling Studies
    by C. Nuijten & Marja H. Pronk & Mark J. A. Brorens & Yechiel A. Hekster & Jacques H. M. Lockefeer & Peter A. G. M. de Smet & Gouke Bonsel & Ary van der Kuy
  • 1998 Methodological Quality of Economic Modelling Studies: A Case Study with Hepatitis B Vaccines
    by Tom Jefferson & Vittorio Demicheli
  • 1998 The Need for Pharmacoeconomic Evaluations in the NHS
    by John P. Griffin
  • 1998 Pravastatin: A Pharmacoeconomic Review of its use in Primary and Secondary Prevention of Coronary Heart Disease
    by Allan J. Coukell & Michelle I. Wilde
  • 1998 Cost Effectiveness of Screening for Subclinical Hypothyroidism in the Elderly: A Decision-Analytical Model
    by Massimo Bona & Ferruccio Santini & Giovanni Rivolta & Enzo Grossi & Roberto Grilli
  • 1998